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a n d  i n  a  H o s p i t a l  D i a b e t i c  C l i n i c .  
P r e v a l e n c e  o f  d i a b e t i c  c o m p l i c a t i o n s  o t h e r  
t h a n  r e t i n o p a t h y .
A s s o c i a t i o n  o f  d i f f e r e n t  c o m p l i c a t i o n s  o f  
d i a b e t e s .
R a n d o m  b l o o d  s u g a r  l e v e l s  i n  a  s a m p l e  o f  
d i  a b e t i c s .
R a n d o m  b l o o d  s u g a r  p a r a m e t e r s  a s  r e l a t e d  
t o  t h e  t r e a t m e n t  o f  d i a b e t e s .
R a n d o m  b l o o d  s u g a r  p a r a m e t e r s  a s  r e l a t e d  
t o  t h e  t r e a t i n g  b o d y .
P a r a m e t e r s  o f  g l y c o s y l a t e d  h a e m o g l o b i n  i n  
m a l e  a n d  f e m a l e  d i a b e t i c s .
P a r a m e t e r s  o f  g l y c o s y l a t e d  h a e m o g l o b i n  a s  
r e l a t e d  t o  t h e  t r e a t i n g  b o d y .
G l y c o s y l a t e d  h a e m o g l o b i n  a s  r e l a t e d  t o  t h e  
t r e a t m e n t  o f  d i a b e t i c s .
Ag e  p a r a m e t e r s  o f  p a t i e n t s  a t t e n d i n g  a  
G e n e r a l  H o s p i t a l  D i a b e t i c  C l i n i c .
Ag e  d i s t r i b u t i o n  o f  4 0 0  d i a b e t i c s  s c r e e n e d  
i n  a  G e n e r a l  H o s p i t a l .
Ag e  d i s t r i b u t i o n  by  s e x .
P a r a m e t e r s  o f  d u r a t i o n  o f  d i a b e t e s .  
D u r a t i o n  d i s t r i b u t i o n  by  s e x .
P a r a m e t e r s  o f  a g e  a t  d i a g n o s i s  o f  
d i  a b e  t e s .
Age  a t  d i a g n o s i s  by  s e x .
T r e a t m e n t  o f  d i a b e t e s  o f  4 0 0  p a t i e n t s  
a t t e n d i n g  a H o s p i t a l  D i a b e t i c  C l i n i c ,  a n d  
5 4  p a t i e n t s  a t t e n d i n g  G e n e r a l  P r a c t i c e .
1 1
T a b l e  4 6  : R e l a t i o n  o f  t r e a t m e n t  t o  t h e  d u r a t i o n  o f
d  i  a b e  t e s .
T a b l e  47  : P a r a m e t e r s  o f  a g e  a n d  t r e a t m e n t .
T a b l e  4 8  : T r e a t m e n t  i n  d i f f e r e n t  a g e  g r o u p s .
T a b l e  49  : S m o k i n g  h a b i t s  o f  4 0 0  d i a b e t i c s  s c r e e n e d
f o r  r e t i n o p a t h y .
T a b l e  5 0  : B l o o d  p r e s s u r e  m e a s u r e m e n t s .
T a b l e  51  : R e l a t i o n  o f  a g e  t o  h y p e r t e n s i o n .
T a b l e  5 2  : R e l a t i o n  b e t w e e n  d u r a t i o n  o f  d i a b e t e s  a n d
h y p e  r t e n s  i o n .
T a b l e  5 3  ; P r e v a l e n c e  o f  s o m e  o c u l a r  c o n d i t i o n s  i n
t h e  c l i n i c .
T a b l e  5 4  : Ag e  p a r a m e t e r s  i n  d i a b e t i c s  w i t h  a n d
w i t h o u t  l e n s  o p a c i t i e s .
T a b l e  5 5  : P r e v a l e n c e  o f  d i a b e t i c  r e t i n o p a t h y .
T a b l e  5 6  : P r e v a l e n c e  o f  d i f f e r e n t  t y p e s  o f  d i a b e t i c
r e t i n o p a t h y .
T a b l e  5 7  : R e l a t i v e  f r e q u e n c y  o f  d i f f e r e n t  t y p e s  o f
d i a b e t i c  r e t i n o p a t h y .
T a b l e  5 8  : R e l a t i v e  f r e q u e n c y  o f  s e r i o u s  t y p e s  o f
r e t i n o p a t h y .
T a b l e  59  : P r e v a l e n c e  r a t e s  o f  d i a b e t i c  r e t i n o p a t h y
i n  s o m e  c o u n t r i e s .
T a b l e  6 0  : I n c r e a s i n g  p r e v a l e n c e  o f  d i a b e t i c
r e t i n o p a t h y  w i t h  l o n g e r  d u r a t i o n  o f  
d i  a b e  t e s .
T a b l e  61  : D i a b e t i c  r e t i n o p a t h y  i n  m a l e  a n d  f e m a l e
d i a b e t i c s  w i t h  v a r y i n g  d u r a t i o n  o f  i l l n e s s
T a b l e  6 2  : P a r a m e t e r s  o f  d u r a t i o n  a n d  a g e  a t  o n s e t  o f
d i a b e t e s  i n  s u b j e c t s  w i t h  a n d  w i t h o u t  
r e t i n o p a t h y .
T a b l e  6 3  : R e l a t i o n  o f  d u r a t i o n  a n d  a g e  a t  d i a g n o s i s
t o  d i f f e r e n t  s e v e r i t y  o f  d i a b e t i c  r e t i n o ­
p a t h y  .
T a b l e  6 4  : D i s p o s a l  o f  p a t i e n t s .
T a b l e  6 5  : F r e q u e n c y  a n d  o u t c o m e  o f  r e f e r r a l s .
CHAPTER 8
T a b l e  6 6
T a b l e  6 7 
T a b l e  68
T a b l e  69
T a b l e  7 0
T a b l e  71
T a b l e  72
T a b l e  73
T a b l e  74
P r e v a l e n c e  r a t e s  o f  d i a b e t i  
i n  s o m e  c o u n t r i e s .
O c u l a r  a b n o r m a l i t i e s .  
P r e v a l e n c e  o f  d i a b e t i c  r e t i  
G e n e r a l  P r a c t i c e .  
A s s o c i a t i o n  o f  v a s c u l a r  d i s  
p a t i e n t s  w i t h  a n d  w i t h o u t  r  
M u l t i p l i c i t y  o f  s y s t e m i c  d i  
1 i c a  t  i o n s .
Age  a t  e x a m i n a t i o n  o f  p a t i e  
w i t h o u t  r e t i n o p a t h y .  
D u r a t i o n  o f  d i a b e t e s  i n  p a t  
w i t h o u t  r e t i n o p a t h y .
Age a t  d i a g n o s i s  i n  p a t i e n t  
w i t h o u t  r e t i n o p a t h y .
R a n d o m  b l o o d  s u g a r  a n d  g l y c  
h a e m o g l o b i n  i n  p a t i e n t s  w i t  
r e t i n o p a  t h y .
c  r e t i n o p a t h y
n op  a  t  hy i n
e a s e  i n  
e t  i n o p  a  t h y  . 
a b e t i c  c o m p -
n t s  w i t h  a n d
i e n t s  w i t h  a n d
s  w i t h  a nd
o s y l a t e d  
h a  nd w i t  h o u  t
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T a b l e  7 5
CHAPTER 9
T a b l e  7 6  
T a b l e  7 7
T a b l e  7 8
T a b l e  7 9
T a b l e  8 0  
T a b l e  81
T a b l e  82
T a b l e  83
T a b l e  8 4
T a b l e  8 5
T a b l e  8 6
T a b l e  8 7
T a b l e  8 8
T a b l e  8 9
T a b l e  90
T a b l e  91
T a b l e  92 
T a b l e  93
T a b l e  94
CHAPTER 11
T a b l e  9 5
T a b l e  9 6
T a b l e  97  
T a b l e  98
R a n d o m  b l o o d  s u g a r  a n d  g l y c o s y l a t e d  
h a e m o g l o b i n  i n  p a t i e n t s  w i t h  d i f f e r e n t  
t y p e s  o f  r e t i n o p a t h y .
b l i n d n e s s  i n  C a n a d a ,  
b l i n d n e s s  i n  E n g l a n d  a n d
' M a j o r  c a u s e s  o f  
M a j o r  c a u s e s  o f  
W a l e s .
I n c i d e n c e  o f  b l i n d  r e g i s t r a t i o n  i n  t h e  
W e s t  o f  S c o t l a n d .
C a u s e s  o f  v i s u a l  h a n d i c a p  i n  t h e  W e s t  o f  
T h e  y e a r  1 9 6 0 .
c a u s e s  o f  
b l i  n d n e s s
b l i  n d n e s s . 
i n  t h e  0 - 4
1 9 6 0 .  
y e a r s  o l d .
S c o t l a n d .
S e c o n d a  r y  
C a u s e s  o f  
1 9 6 0 .
C a u s e s  o f  b l i n d n e s s  i n  t h e  5 - 1 9  y e a r s  o l d .  
1 9 6 0 .
C a u s e s  o f  b l i n d n e s s  i n  t h e  2 0 - 4 4  y e a r s  o l d  
1 9 6 0 .
C a u s e s  o f  b l i n d n e s s  i n  t h e  4 5 - 6 4  y e a r s  o l d  
1 9 6 0 .
C a u s e s  
1 9 6 0 .
C a u  s e s  
1 9 6 0 .
Ag e  a t  o n s e t  o f  v i s u a l  h a n d i c a p  a n d  s e x  
o f  d i a b e t i c s  r e g i s t e r e d  i n  t h e  y e a r  1 9 6 0 .  
A g e  a t  o n s e t  o f  b l i n d n e s s  a n d  s e x  o f  t h e  
l e g a l l y  b l i n d  d i a b e t i c s ,  19 6 0 .
a g e  a t  o n s e t  o f  b l i n d n e s s  
r e g i s t e r e d  d u r i n g  t h e  y e a r
o f
o f
b l i  n d n e s s  
b l i  n d n e s s
i n  t h e  6 5 - 7 4  y e a r s  o l d  
i n  t h e  7 5 - 8 4  y e a r s  o l d
P a r a m e t e r s  o f  
p e  r s o n sa  mo ng 
1 9 8 0 .
Common c a u s e s  o f  l e g a l  b l i n d n e s s  i n  t h e  
W e s t  o f  S c o t l a n d .  1 9 8 0 .
F i r s t  f i v e  c o m m o n  c a u s e s  o f  l e g a l  
b l i n d n e s s  i n  m a l e  a n d  f e m a l e .  1 9 8 0 .
Ag e  p a r a m e t e r s  o f  b l i n d  d i a b e t i c s .  19 8 0 .  
Ag e  a t  o n s e t  o f  b l i n d n e s s  i n  p e r s o n s  
b l i n d e d  b y  d i f f e r e n t  c a u s e s .
C a u s e s  o f  b l i n d n e s s  a n d  v i s u a l  h a n d i c a p  i n  
s o m e  c o u n t r i e s .
N u m b e r s  o f  i n d i v i d u a l s  who  p a r t i c i p a t e d  i n  
t h e  s t u d y  o f  e f f e c t  o f  l i g h t  o n  v i s u a l  
f  u n c t  i o n s .
I n i t i a l  a n d  s u b s e q u e n t  v i s u a l  a c u i t i e s  o f  
n o r m a l  i n d i v i d u a l s  s u b j e c t e d  t o  s l i t - l a m p  
1 i g h t .
E f f e c t  o f  s l i t - l a m p  l i g h t  o n  v i s u a l  a c u i t y  
o f  d i a b e t i c s .
E f f e c t  o f  a r g o n  l a s e r  p h o t o c o a g u l a t i o n  o n  
t h e  v i s u a l  a c u i t y  o f  d i a b e t i c s  t r e a t e d  f o r  
p r o l i f e r a t i v e  r e t i n o p a t h y .
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T a b l e 9 9
T a b l e 1 0 0
T a b l e 1 0 1
T a b l e 1 0 2
T a b l e 1 0 3
T a b l e 1 0 4
T a b l e 1 0 5
M e a n  t o t a l  e r r o r  s c o r e s  o n  t h e  P . M .  1 0 0 - H u e  
t e s t  o f  g r o u p s  o f  s u b j e c t s  e x p o s e d  t o  l i g h t .  
S t a t i s t i c a l  s i g n i f i c a n c e  o f  c h a n g e s  i n  m e a n  
t o t a l  e r r o r  s c o r e s  a f t e r  l i g h t  e x p o s u r e .  
C h a n g e s  i n  c o n t r a s t  t h r e s h o l d s  o f  n o r m a l  
i n d i v i d u a l s  s u b j e c t e d  t o  s l i t - l a m p  l i g h t .  
C h a n g e s  o f  c o n t r a s t  t h r e s h o l d s  o f  d i a b e t i c s  
s u b j e c t e d  t o  s l i t - l a m p  l i g h t .
C h a n g e s  o f  c o n t r a s t  t h r e s h o l d s  o f  d i a b e t i c s  
t r e a t e d  w i t h  a r g o n  l a s e r .
S t a t i s t i c a l  s i g n i f i c a n c e  o f  c h a n g e s  i n  
c o n t r a s t  t h r e s h o l d s  o f  d i a b e t i c s  t r e a t e d  
w i t h  a r g o n  l a s e r .
E x p e r i m e n t a l  c o n d i t i o n s  i n  s o m e  s t u d i e s  
w h i c h  r e p o r t e d  r e t i n a l  d a m a g e  a f t e r  e x p o s u r e  
t o  l i g h t .
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D r a w i n g  o f  a  f u n d u s  b y  H i r s c h b e r g .  
R e l a t i o n  o f  d u r a t i o n  o f  d i a b e t e s  t o  
i n c r e a s i n g  i n c i d e n c e  o f  c o m p l i c a t i o n .
C o l o u r  f u n d u s  p h o t o g r a p h  s h o w i n g  t h e  
" s t r i n g  o f  s a u s a g e s "  a p p e a r a n c e  o f  v e i n s .  
C o l o u r  f u n d u s  p h o t o g r a p h ;  a d v a n c e d  
p r o l i f e r a t i v e  d i a b e t i c  r e t i n o p a t h y ,  a n d  
f o r m a t i o n  o f  f i b r o u s  t i s s u e .
C o l o u r  f u n d u s  p h o t o g r a p h ;  s i m p l e  b a c k ­
g r o u n d  r e t i n o p a t h y .
R e t i n a l  d i g e s t  p r e p a r a t i o n ;  f o r m a t i o n  o f  
m i c r o a n e u r y s m s .
H i s t o l o g i c a l  s e c t i o n ;  n o r m a l  r e t i n a l  
l a y e  r s .
C o l o u r  f u n d u s  p h o t o g r a p h ;  e x u d a t i v e  
d i a b e t i c  r e t i n o p a t h y .
C o l o u r  f u n d u s  p h o t o g r a p h ;  i s c h a e m i c  
d i a b e t i c  r e t i n o p a t h y .
C o m p o s i t e  f u n d u s  p h o t o g r a p h ;  p r o l i f e r a t i v e  
d i a b e t i c  r e t i n o p a t h y .
C o m p o s i t e  f u n d u s  p h o t o g r a p h ;  a d v a n c e d  
p r o l i f e r a t i v e  d i a b e t i c  r e t i n o p a t h y .
F u n d u s  f l u o r e s c e i n  a n g i o g r a m ;  a r e a s  o f  
c a p i l l a r y  n o n p e r f u s i o n  a n d  l e a k a g e  
t h r o u g h  b l o o d  v e s s e l  w a l l .
I r i s  p h o t o g r a p h ;  r u b e o s i s  i r i d i s .  
F l u o r e s c e i n  i r i d o g r a m ;  l e a k a g e  o f  d y e  i n  
r u b e o s i s  o f  t h e  i r i s .
C o l o u r  f u n d u s  p h o t o g r a p h ;  c o m b i n e d  
h y p e r t e n s i v e  a n d  d i a b e t i c  r e t i n o p a t h y .
F a r n s w o r t h - M u n s e l 1 1 0 0 - H u e  t e s t  t r a c e  o f  a 
n o r m a l  u n t r a i n e d  o b s e r v e r .
F a r n s w o r t h - M u n s e l 1 1 0 0 - H u e  t e s t  t r a c e  o f  a  
p a t i e n t  w i t h  b a c k g r o u n d  d i a b e t i c  
r e t i n o p a t h y ;  d i f f u s e  d y s c h r o m a t o p s i a .  
F a r n s w o r t h - M u n s e l 1 1 0 0 - H u e  t e s t  t r a c e  o f  a 
p a t i e n t  w i t h  d i a b e t i c  m a c u l o p a t h y .  
R e p r e s e n t a t i o n  o f  s q u a r e  r o o t s  o f  m e a n  
t o t a l  e r r o r  s c o r e s  ( o n  F . M .  1 0 0 - H u e  t e s t )  
f r o m  n o r m a l  a n d  d i a b e t i c  s u b j e c t s .
T a b l e ;  t - t e s t  c o m p a r i s o n  o f  m e a n  c o n t r a s t  
t h r e s h o l d s  o f  d i f f e r e n t  g r o u p s  o f  
i n d i v i d u a l s  t e s t e d  o n  t h e  A r d e n  g r a t i n g  
b o o k  .
T a b l e ;  F - t e s t  c o m p a r i s o n  o f  m e a n  c o n t r a s t  
t h r e s h o l d s  o f  d i f f e r e n t  g r o u p s  o f  
i n d i v i d u a l s  t e s t e d  o n  t h e  A r d e n  g r a t i n g  
b o o k  .
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F i g u r e  36  
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G r a p h i c a l  r e p r e s e n t a t i o n  o f  c o n t r a s t  
t h r e s h o l d s  o f  n o r m a l  i n d i v i d u a l s  i n  t w o  
s  t u d i e s .
G r a p h i c a l  r e p r e s e n t a t i o n  o f  c o n t r a s t  
t h r e s h o l d s  o f  n o r m a l  a n d  d i a b e t i c  
i  n d i v i d u a l s .
G r a p h i c a l  r e p r e s e n t a t i o n  o f  c o n t r a s t  
t h r e s h o l d s  o f  n o r m a l  i n d i v i d u a l s  a n d  
d i a b e t i c s  w i t h  n o  r e t i n o p a t h y  o n  
o p h t h a l m o s c o p y .
G r a p h i c a l  r e p r e s e n t a t i o n  o f  c o n t r a s t  
t h r e s h o l d s  o f  n o r m a l  i n d i v i d u a l s  a n d  
d i a b e t i c s  w i t h  b a c k g r o u n d  a n d  
p r o l i f e r a t i v e  r e t i n o p a t h y .
G r a p h i c a l  r e p r e s e n t a t i o n  o f  a g e  a t  
d i a g n o s i s  o f  d i a b e t e s  i n  p a t i e n t s  w i t h  
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SUMMARY
2 3
T h i s  t h e s i s  r e p o r t s  t h e  r e s u l t s  o f  a n  i n v e s t i g a t i o n  
i n t o  s o m e  a s p e c t s  o f  d i a b e t i c  e y e  d i s e a s e .
T h e  f i r s t  t h r e e  c h a p t e r s  g i v e  a n  a c c o u n t  o f  t h e  p r e s e n t  
s t a t e  o f  k n o w l e d g e  o f  d i a b e t e s  m e l l i t u s  a n d  d i a b e t i c  
r e t i n o p a t h y .
I n  c h a p t e r  4 t h e  m u l t i f a c t o r i a l  a e t i o l o g y  o f  d i a b e t i c  
r e t i n o p a t h y  i s  d i s c u s s e d .  I n  r e l a t i o n  t o  t h i s  a  s t u d y  o f  t h e  
p o s s i b l e  r o l e  o f  b l o o d  a n d  p l a s m a  v i s c o s i t y  i n  t h e  p a t h o g e ­
n e s i s  o f  d i a b e t i c  r e t i n o p a t h y  i s  r e p o r t e d .  I t  w a s  f o u n d  
t h a t  i n  d i a b e t e s  b l o o d  a n d  p l a s m a  v i s c o s i t i e s  a r e  i n c r e a s e d .  
D i a b e t i c s  w i t h  p r o l i f e r a t i v e  r e t i n o p a t h y  w e r e  f o u n d  t o  h a v e  
h i g h e r  b l o o d  v i s c o s i t y ,  a t  b o t h  h i g h  a n d  l o w  s h e a r  r a t e s ,  
t h a n  d i a b e t i c s  w i t h  b a c k g r o u n d  o r  n o  r e t i n o p a t h y .
D i a b e t i c s  w i t h  s e r i o u s  f o r m s  o f  r e t i n o p a t h y  h a d  h i g h e r  
f i b r i n o g e n  l e v e l s  t h a n  c o n t r o l s .
C h a p t e r  5 r e p o r t s  r e s u l t s  o f  a  s t u d y  c a r r i e d  o u t  i n  
g e n e r a l  p r a c t i c e  t o  d e t e r m i n e  t h e  p r e v a l e n c e  o f  d i a g n o s e d  
d i a b e t e s  i n  t h e  W e s t  o f  S c o t l a n d .  7 1 3 9  f i l e s  o f  p a t i e n t s  
a t t e n d i n g  o n e  g r o u p  p r a c t i c e  w e r e  s e a r c h e d  f o r  e v i d e n c e  o f  
d i a b e t e s .  7 6  d i a b e t i c s  w e r e  f o u n d  t o  a t t e n d  t h i s  p r a c t i c e .  
T h i s  g a v e  a f i g u r e  f o r  t h e  p r e v a l e n c e  o f  k n o w n  d i a b e t i c s  o f
1 . 0 6  p e  r  c e n t .
I n  C h a p t e r  6 r e s u l t s  o f  a n  i n v e s t i g a t i o n  i n t o  t h e  m o s t  
p r a c t i c a l  m e a n s  f o r  t h e  s c r e e n i n g  a n d  d e t e c t i o n  o f  d i a b e t i c  
r e t i n o p a t h y  a r e  r e p o r t e d .  T h i s  w o r k  w a s  c a r r i e d  o u t  i n  
c o l l a b o r a t i o n  w i t h  o p h t h a l m o l o g i s t s ,  o p t i c i a n s ,  p h y s i c i a n s ,  
a n d  t e c h n i c i a n s  f r o m  t h e  T e n n e n t  I n s t i t u t e  o f  O p h t h a l m o l o g y  
a n d  G l a s g o w  R o y a l  I n f i r m a r y .  O p h t h a l m o s c o p y  w a s  f o u n d  t o
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b e  a  r e l i a b l e  t o o l  f o r  t h e  p u r p o s e  o f  s c r e e n i n g  f o r  d i a b e t i c  
r e t i n o p a t h y .  O p h t h a l m o l o g i s t s  a n d  t r a i n e d  a n d  i n t e r e s t e d  
p h y s i c i a n s  w e r e  e q u a l l y  e f f i c i e n t  i n  t h i s  r e s p e c t .  O t h e r  
i n v e s t i g a t i o n s  s u c h  a s  f l u o r e s c e i n  a n g i o g r a p h y ,  t e s t s  o f  
c o l o u r  v i s i o n ,  c o n t r a s t  s e n s i t i v i t y  t o  g r a t i n g  p a t t e r n s ,  
a n d  m e a s u r e m e n t  o f  v i s u a l  f i e l d s  w e r e  t i m e  c o n s u m i n g ,  
c o s t l y  a n d  n e e d e d  h i g h l y  s p e c i a l i s e d  i n s t r u m e n t s  w h i c h  
m i g h t  n o t  n e c e s s a r i l y  b e  a v a i l a b l e  i n  c e n t r e s  c o n c e r n e d  
w i t h  e a r l y  d e t e c t i o n  o f  s e r i o u s  d i a b e t i c  r e t i n o p a t h y .
D i a b e t i c  s u b j e c t s  h a d  l o w e r  c o n t r a s t  s e n s i t i v i t y  
t o  g r a t i n g  p a t t e r n s ,  c o m p a r e d  t o  n o r m a l  s u b j e c t s ,  a s  
m e a s u r e d  b y  t h e  A r d e n  g r a t i n g  t e s t .  C o n t r a s t  s e n s i t i v i t y  
w a s  i n v e r s l y  p r o p o r t i o n a l  t o  t h e  d e g r e e  a n d  s e v e r i t y  
o f  r e t i n o p a t h y .  T h e  s e v e r i t y  o f  d i a b e t i c  r e t i n o p a t h y  
a l s o  a f f e c t e d  c o l o u r  d i s c r i m i n a t i o n .  T h e  m o s t  s e r i o u s l y  
a f f e c t e d  w e r e  t h o s e  w i t h  e x u d a t i v e  r e t i n o p a t h y .  T h e  
s t u d y  a l s o  c o n f i r m e d  t h a t  m e a s u r e m e n t s  o f  v i s u a l  a c u i t y  
a r e  n o t  a  g o o d  i n d i c a t i o n  o f  t h e  s e v e r i t y  o f  r e t i n o p a t h y .
On t h e  b a s i s  o f  r e s u l t s  o f  t h e  a b o v e  s t u d y  f u n d u s c o p i c  
e x a m i n a t i o n  o f  4 0 0  c o n s e c u t i v e  d i a b e t i c s  a t t e n d i n g  a  l a r g e  
h o s p i t a l  d i a b e t i c  c l i n i c ,  G l a s g o w  R o y a l  I n f i r m a r y ,  w a s  p e r ­
f o r m e d  ( C h a p t e r  7 ) ,  T h i s  w o r k  w a s  c a r r i e d  o u t  t o  d e t e r m i n e  
t h e  p r e v a l e n c e  o f  d i a b e t i c  r e t i n o p a t h y  i n  t h i s  p o p u l a t i o n  o f  
d i a b e t i c  i n d i v i d u a l s .  3 2  p e r  c e n t  o f  t h e s e  p a t i e n t s  w e r e  
f o u n d  t o  h a v e  d i a b e t i c  r e t i n o p a t h y  a n d  o f  t h e s e  o n e  t h i r d  
h a d  " s e r i o u s "  r e t i n o p a t h y .  S e r i o u s  d i a b e t i c  r e t i n o p a t h y  
w a s  d e f i n e d  a s  a  s i g h t - t h r e a t e n i n g  r e t i n o p a t h y  w h i c h  
i n c l u d e d  c a s e s  w i t h  i s c h a e m i c ,  p r o l i f e r a t i v e ,  a n d  
m a c u l o p a t h y  ( e x u d a t i o n  a n d / o r  m a c u l a r  o e d e m a ) ;  t h i s  i s  
m o r e  c l e a r l y  d e f i n e d  i n  c h a p t e r  3 .  P a t i e n t s  who  h a d
d i f f e r e n t  s e v e r i t y  o f  d i a b e t i c  r e t i n o p a t h y  i n  t h e  t w o  e y e s
w e r e  c l a s s e d  a c c o r d i n g  t o  t h e  m o r e  s e v e r e  r e t i n o p a t h y .
M a l e s  d e v e l o p e d  d i a b e t e s  7 y e a r s  e a r l i e r  t h a n  f e m a l e s  
a n d  m e d i a n  a g e  o f  m a l e s  w i t h  d i a b e t i c  r e t i n o p a t h y  w a s  7 y e a r s  
y o u n g e r  t h a n  f e m a l e s  w i t h  r e t i n o p a t h y .  T h e  p r e v a l e n c e  o f  
d i a b e t i c  r e t i n o p a t h y  i n c r e a s e d  s t e a d i l y  w i t h  t h e  d u r a t i o n  
o f  d i a b e t e s  i n  b o t h  s e x e s .
B l o o d  p r e s s u r e  a n d  s m o k i n g  w e r e  f o u n d  t o  h a v e  n o  r e l a ­
t i o n  t o  t h e  p r e v a l e n c e  o f  d i a b e t i c  r e t i n o p a t h y  i n  t h i s  p o p u ­
l a t i o n  a n d  h y p e r t e n s i o n  h a d  a  s i m i l a r  p r e v a l e n c e  a m o n g  
d i a b e t i c s  a s  i n  t h e  r e s t  o f  t h e  p o p u l a t i o n  i n  t h e  W e s t  o f  
S c o t l a n d .
A s i m i l a r  s t u d y  w a s  c a r r i e d  o u t  o n  d i a b e t i c s  a t t e n d i n g  
g e n e r a l  p r a c t i c e  ( c h a p t e r  8 ) .  I d e n t i f i e d  d i a b e t i c s  w e r e  
a s k e d  t o  a t t e n d  f o r  a  f u l l  p h y s i c a l ,  i n c l u d i n g  a n  e y e  e x a m i ­
n a t i o n .  3 5  p e r  c e n t  o f  p a t i e n t s  w e r e  f o u n d  t o  h a v e  
o p h t h a l m o s c o p i c a l l y  r e c o g n i s a b l e  d i a b e t i c  r e t i n o p a t h y .  O n e  
t h i r d  o f  p a t i e n t s  w i t h  r e t i n o p a t h y  h a d  " s e r i o u s "  f o r m s  o f  
t h e  d i s e a s e .  T h i s  s u g g e s t e d  t h a t  a b o u t  1 0  p e r  c e n t  o f  t h e  
d i a b e t i c  p o p u l a t i o n  i n  t h e  W e s t  o f  S c o t l a n d  m i g h t  b e  
e x p e c t e d  t o  s h o w  t h e s e  c h a n g e s .
P a t i e n t s  w i t h  a  f a m i l y  h i s t o r y  o f  d i a b e t e s  w e r e  f o u n d  t o  
h a v e  d e v e l o p e d  d i a b e t e s  a b o u t  o n e  d e c a d e  e a r l i e r  t h a n  t h o s e  
wh o  d i d  n o t  h a v e  a  p o s i t i v e  h i s t o r y  o f  d i a b e t e s  i n  t h e i r  
f a m i l i e s .
I n  t h i s  p a r t  o f  t h e  s t u d y  g l y c o s y l a t e d  h a e m o g l o b i n  a n d  
r a n d o m  b l o o d  s u g a r  w e r e  m e a s u r e d .  No r e l a t i o n  w a s  f o u n d  
b e t w e e n  t h e  t y p e  o f  d i a b e t i c  r e t i n o p a t h y  a n d  t h e  l e v e l  o f  
g l y c o s y l a t e d  h a e m o g l o b i n .  A p o s i t i v e  a s s o c i a t i o n  w a s  
f o u n d  b e t w e e n  t h e  l e v e l  o f  r a n d o m  b l o o d  s u g a r  a n d  t h e  
p r e s e n c e  a n d  s e v e r i t y  o f  d i a b e t i c  r e t i n o p a t h y .
I t  i s  p o s s i b l e  t h a t  s h o r t  t e r r a  f l u c t u a t i o n s  o f  b l o o d  s u g a r  
a r e  m o r e  i m p o r t a n t  i n  t h e  p a t h o g e n e s i s  o f  d i a b e t i c  
r e t i n o p a t h y  t h a n  t h e  l e v e l  o f  h y p e r g l y c a e m i a  o v e r  t h e  l a s t  
f e w  w e e k s  o f  t h e  d i a b e t i c  i l l n e s s .
A s t u d y  o f  t h e  c a u s e s  o f  b l i n d  r e g i s t r a t i o n  w i t h  a  s p e ­
c i a l  r e f e r e n c e  t o  d i a b e t e s  -  i n d u c e d  b l i n d n e s s  w a s  c a r r i e d  
o u t  i n  t h e  " S o c i e t y  f o r  t h e  B l i n d  i n  G l a s g o w  a n d  t h e  W e s t  
o f  S c o t l a n d " .  2 1 1 8  B . P . l  F o r m s  w e r e  s t u d i e d .  F o r m s  
a v a i l a b l e  f r o m  t h e  y e a r s  1 9 6 0  a n d  1 9 8 0  w e r e  a n a l y s e d .
T h e  c o m m o n e s t  c a u s e s  o f  b l i n d n e s s  w e r e  s e n i l e  m a c u l a r  
d e g e n e r a t i o n ,  g l a u c o m a ,  c a t a r a c t ,  d i a b e t i c  r e t i n o p a t h y ,  
a n d  m y o p i a .  D i a b e t i c  r e t i n o p a t h y  w a s  f o u n d  t o  b e  t h e  f i r s t  
c a u s e  o f  b l i n d n e s s  i n  t h e  w o r k i n g  a g e  2 0 - 6 4 .  T h e  o n s e t  o f  
b l i n d n e s s  w a s  e a r l i e r  i n  d i a b e t i c  m a l e s  t h a n  f e m a l e s .  
D i a b e t i c s  w e r e  f o u n d  t o  b e  r e g i s t e r e d  a s  v i s u a l l y  h a n ­
d i c a p p e d  a t  a n  e a r l i e r  a g e  t h a n  t h e  n o n - d i a b e t i c  b l i n d  i n d i ­
v i d u a l s  ( C h a p t e r  9 ) .
I n  C h a p t e r  1 0  a n  a c c o u n t  i s  g i v e n  o f  t h e  i n d i c a t i o n s ,  
t e c h n i q u e s ,  a n d  a d v a n t a g e s  o f  p h o t o c o a g u l a t i o n  i n  t h e  t r e a t ­
m e n t  o f  d i a b e t i c  r e t i n o p a t h y .  V i s u a l  r e s u l t s  o f  m a j o r  s t u ­
d i e s  c a r r i e d  o u t  i n  t h i s  r e s p e c t  a r e  s u m m a r i s e d .
A s t u d y  o f  t h e  s h o r t - t e r m  e f f e c t s  o f  l a s e r  t h e r a p y  a n d  
e x p o s u r e  t o  h i g h  i n t e n s i t y  l i g h t  f r o m  o p h t h a l m i c  i n s t r u m e n t s  
w a s  c a r r i e d  o u t  o n  p a t i e n t s  a t t e n d i n g  t h e  T e n n e n t  I n s t i t u t e  
( C h a p t e r  1 1 ) .  N o r m a l  v o l u n t e e r s  a n d  d i a b e t i c  p a t i e n t s  w e r e  
e x p o s e d  t o  t h e  t u n g s t e n  l i g h t  o f  a  s l i t - l a m p  m i c r o s c o p e .
A l s o  d i a b e t i c s  wh o  r e c e i v e d  l a s e r  t r e a t m e n t  f o r  p r o l i f e r a ­
t i v e  d i a b e t i c  r e t i n o p a t h y  w e r e  s t u d i e d .  V i s u a l  a c u i t y  o n  
S n e l l e n ' s  C h a r t ,  c o l o u r  v i s i o n  a s  d e t e r m i n e d  by t h e  
F a r n s w o r t h - M u n s e 1 I l O O - H u e  t e s t ,  a n d  c o n t r a s t  s e n s i t i v i t y
m e a s u r e d  by  A r d e n  g r a t i n g  t e s t  w e r e  a l l  d e t e r m i n e d  b e f o r e ,
27
20  m i n u t e s ,  a n d  2 4  h o u r s  a f t e r  e x p o s u r e .  T h e s e  v i s u a l  
f u n c t i o n s  w e r e  n o t  f o u n d  t o  b e  s i g n i f i c a n t l y  a f f e c t e d  
b y  l a s e r  t h e r a p y  o r  e x p o s u r e  t o  o p h t h a l m i c  i n s t r u m e n t s  
d u r i n g  p h o t o c o a g u t a t i o n  o r  a  s l i t - l a m p  e x a m i n a t i o n  a l t h o u g h  
t h e  m a j o r i t y  o f  n o r m a l  a n d  d i a b e t i c  p a t i e n t s  s h o w e d  a 
t e m p o r a r y  d r o p  i n  v i s u a l  a c u i t y  2 0  m i n u t e s  a f t e r  l i g h t  
e x p o s u r e ,  i n  a l l  c a s e s  r e t u r n i n g  t o  w i t h i n  1 l i n e  o f  
S n e l l e n ' s  C h a r t .
I n  t h e  f i n a l  c h a p t e r  ( 1 2 )  v a r i o u s  c o n c l u s i o n s  f r o m  
t h e  p r o c e e d i n g  c h a p t e r s  a r e  d i s c u s s e d  a n d  s o m e  
r e c o m m e n d a t i o n s  a r e  m a d e  w i t h  r e g a r d  t o  t h e  d e s i r a b i l i t y  
a n d  d e s i g n  o f  s c r e e n i n g  p r o g r a m m e s  f o r  t h e  e a r l y  
d e t e c t i o n  o f  d i a b e t i c  r e t i n o p a t h y .
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D i a b e t i c  e y e  d i s e a s e  i s  o n e  o f  t h e  f o u r  c o m m o n e s t  
c a u s e s  o f  b l i n d n e s s  i n  E n g l a n d  a n d  W a l e s  ( S o r s b y  19 6 6 ) .  I t  
i s  now t h e  f i r s t  c a u s e  o f  b l i n d n e s s  i n  t h e  a g e  g r o u p  2 0 - 6 4  
( S o r s b y  1 9 7 2 ;  G h a f o u r ,  A l l a n ,  a n d  F o u l d s  1 9 8 3 ) ,
I t  i s  k n o w n  t h a t  i n  t h e  W e s t e r n  W o r l d  t h e  p r e v a l e n c e  
o f  d i a b e t e s  m e l l i t u s  i s - b e t w e e n  0 . 5  a n d  2 p e r  c e n t  o f  t h e  
p o p u l a t i o n  ( W e s t  1 9 7 8 1 ■  T h e  e x a c t  p r e v a l e n c e  o f  d i a b e t e s  i n  
S c o t l a n d  i s  n o t  k n o w n  n o r  i s  t h e  p r e v a l e n c e  o f  d i a b e t i c  
r e t i n o p a t h y  o r  t h e  i n c i d e n c e  o f  b l i n d n e s s  f r o m  t h i s  c a u s e .
A l t h o u g h  t h e  v a r i o u s  c l i n i c a l  f e a t u r e s  o f  d i a b e t i c  
r e t i n o p a t h y  w e r e  r e c o g n i s e d  a f t e r  t h e  i n t r o d u c t i o n  o f  t h e  
o p h t h a l m o s c o p e  by  H e l m h o l t z  i n  1 8 5 0  ( H e n k i n d  1 9 8 0 )  t h e r e  i s  
s t i l l  n o  c o n s e n s u s  o n  t h e  u n d e r l y i n g  p a t h o g e n e s i s  o f  t h e  
d i s o r d e r .  C o n s i d e r a b l e  a d v a n c e s  h a v e  o c c u r e d  i n  o u r  
u n d e r s t a n d i n g  o f  t h e  d i s e a s e  p r o c e s s  a s  a  r e s u l t  o f  t h e  
i n t r o d u c t i o n  o f  f u n d u s  f l u o r e s c e i n  a n g i o g r a p h y  ( N o v o t n y  a n d  
A l v i s  1 9 6 1 ) ,  v i t r e o u s  f l u o r o p h o t o m e t r y  ( C u n h a - V a z , d e  A b r e u ,  
C a m p o s ,  a n d  F i g o  1 9 7 5 ) ,  a n d  b y  t h e  a p p l i c a t i o n  o f  m o d e r n  
t e c h n i q u e s  o f  t i s s u e  p r e p a r a t i o n  ( A s h t o n  1 9 6 3 ) ,  l i g h t  a n d  
e l e c t r o n  m i c r o s c o p y  t o  d i s e a s e d  r e t i n a l  t i s s u e .
I t  a p p e a r s  l i k e l y  t h a t  d i a b e t i c  r e t i n o p a t h y  i s  m u l t i ­
f a c t o r i a l  i n  o r i g i n  a n d  s u c h  f a c t o r s  a s  a g e  o f  o n s e t ,  l e n g t h  
o f  d i a b e t i c  h i s t o r y ,  c o n t r o l  o f  d i a b e t e s ,  i n s u l i n  d e p e n ­
d e n c e ,  e n v i r o n m e n t a l ,  a n d  p o s s i b l y  h a e m a t o l o g i c a l  p a r a m e t e r s  
may  a l l  p l a y  a  r o l e  i n  i t s  g e n e s i s  ( G a r n e r  1 9 8 1 ) .
U n t i l  t h e  i n t r o d u c t i o n  o f  r e t i n a l  p h o t o c o a g u l a t i o n  
( M e y e r - S c h w i e k e r a t h  1 9 5 9 )  l i t t l e  c o u l d  b e  d o n e  t o  i n f l u e n c e  
t h e  p r o g r e s s  o f  p r o l i f e r a t i v e  d i a b e t i c  r e t i n o p a t h y .  I n  
s e v e r a l  m u l t i c e n t r e  c o n t r o l l e d  t r i a l s  i t  h a s  b e e n  c l a i m e d
t h a t  b o t h  e x u d a t i v e  a n d  p r o l i f e r a t i v e  f o r m s  o f  r e t i n o p a t h y  
m a y  b e  f a v o u r a b l y  i n f l u e n c e d  b y  r e t i n a l  p h o t o c o a g u l a t i o n  
( D i a b e t i c  R e t i n o p a t h y  S t u d y  1 9 7 6 ;  M u l t i c e n t r e  C o n t r o l l e d  
S t u d y  19  7 7 ) .
T h e s e  t r i a l s  h a v e  b e e n  c o n c e r n e d  w i t h  e f f i c a c y  o f  
l a s e r  o r  o t h e r  t y p e s  o f  - p h o t o c o a g u l a t i o n  i n  d i a b e t i c  
r e t i n o p a t h y ;  l i t t l e  a t t e n t i o n  h a s  b e e n  p a i d  t o  t h e  p o s s i b l e  
a d v e r s e  e f f e c t s  o f  t h e s e  f o r m s  o f  t h e r a p y .
T h i s  t h e s i s  s e t s  o u t  t o  d e t e r m i n e  a s  a c c u r a t e l y  a s  
p o s s i b l e  t h e  p r e v a l e n c e  o f  d i a g n o s e d  d i a b e t e s  i n  t h e  g e n e r a l  
p o p u l a t i o n  o f  t h e  W e s t  o f  S c o t l a n d  a n d  t h e  p r e v a l e n c e  o f  
d i a b e t i c  e y e  d i s e a s e  i n  t h i s  p o p u l a t i o n  a n d  i n  a  p o p u l a t i o n  
a t t e n d i n g  a  l a r g e  h o s p i t a l  d i a b e t i c  c l i n i c .  T h i s  i n c l u d e d  
t h e  r e l a t i o n  o f  s o m e  p a r a m e t e r s ,  s u c h  a s  t h e  i n f l u e n c e  o f  
c o e x i s t i n g  h y p e r t e n s i o n  a n d  s m o k i n g ,  t o  t h e  f r e q u e n c y  o f  
d i f f e r e n t  t y p e s  o f  d i a b e t i c  r e t i n o p a t h y .  T h e  r e l a t i o n  o f  
b l o o d  v i s c o s i t y  a n d  s o m e  o t h e r  r h e o l o g i c a l  f a c t o r s  t o  d i a b e ­
t i c  r e t i n o p a t h y  w a s  s t u d i e d  i n  a  g r o u p  o f  p a t i e n t s  w h o  w e r e  
m a t c h e d  f o r  a g e ,  s e x ,  d u r a t i o n  o f  d i a b e t e s ,  a n d  s m o k i n g  
h a b i t s .
F r o m  b l i n d  r e g i s t r a t i o n  s t a t i s t i c s  a n  a t t e m p t  i s  m a d e  
t o  a s s e s s  t h e  i n c i d e n c e  o f  b l i n d n e s s  f r o m  d i a b e t i c  e y e  
d i s e a s e  i n  r e l a t i o n  t o  o t h e r  c a u s e s  o f  b l i n d n e s s  i n  t h e  W e s t  
o f  S c o t l a n d .  F r o m  t h e s e  s t u d i e s  t h e  s i z e  o f  t h e  d i a b e t i c  
p o p u l a t i o n  a n d  n u m b e r s  o f  p a t i e n t s  w i t h  d i f f e r e n t  t y p e s  o f  
r e t i n o p a t h y  a r e  c a l c u l a t e d  a n d  t h e  r e l a t i v e  r i s k  o f  
d i a b e t e s - i n d u c e d  b l i n d n e s s  i s  e s t i m a t e d .
A s t u d y  w a s  a l s o  c a r r i e d  o u t ,  i n  c o l l a b o r a t i o n  w i t h  
s o m e  c o l l e a g u e s ,  o f  t h e  d i f f e r e n t  t o o l s  u s e d  f o r  t h e
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i d e n t i f i c a t i o n  o f  d i a b e t i c  r e t i n o p a t h y  a n d  a n  a s s e s s m e n t  i s  
m a d e  a s  t o  t h e  m o s t  p r a c t i c a l  o f  t h e s e  i n v e s t i g a t i o n s  f o r  
t h e  s c r e e n i n g  o f  d i a b e t i c  r e t i n o p a t h y .
An a c c o u n t  i s  g i v e n  o f  p h o t o c o a g u l a t i o n  t r e a t m e n t
w h i c h  i s  now t h e  m o s t  w i d e l y  u s e d  t h e r a p y  f o r  d i a b e t i c
r e t i n o p a t h y .
F i n a l l y  a  s t u d y  o f  t h e  p o s s i b l e  a d v e r s e  e f f e c t s  o f
l a s e r  t h e r a p y  o n  s o m e  v i s u a l  f u n c t i o n s ,  s u c h  a s  v i s u a l
a c u i t y ,  c o n t r a s t  s e n s i t i v i t y ,  a n d  c o l o u r  v i s i o n  i s  r e p o r t e d
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CHAPTER 2 
D I A B E T E S
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2 . 1 .  D e f i n i t i o n
D i a b e t e s  i s  a  d i s e a s e  w h i c h  a f f e c t s  b o t h  h u m a n s  a n d  s o m e  
a n i m a l s .  I n  m a n  i t  i s  t h e  t h i r d  m o s t  c o m m o n  m e t a b o l i c  d i s e a s e  
a f t e r  o b e s i t y  a n d  t h y r o i d  d i s o r d e r  a n d  may  b e  d i a g n o s e d  f o r  
t h e  f i r s t  t i m e  a t  a n y  a g e  ( M e i e r  1 9 6 0 ) ,
T h e  d i s o r d e r  i n  d i a b e t e s  c o n s i s t s  o f  a  m e t a b o l i c  a n d  
v a s c u l a r  c o m p o n e n t ,  w h i c h  a r e  p r o b a b l y  i n t e r r e l a t e d .  T h e  
m e t a b o l i c  s y n d r o m e  i s  c h a r a c t e r i s e d  by  a n  i n a p p r o p r i a t e  e l e ­
v a t i o n  o f  b l o o d  g l u c o s e  l e v e l ,  a s s o c i a t e d  w i t h  a l t e r a t i o n s  
i n  l i p i d  a n d  p r o t e i n  m e t a b o l i s m  f o r  w h i c h  a  r e l a t i v e  o r  
a b s o l u t e  l a c k  o f  i n s u l i n  i s  r e s p o n s i b l e .  T h e  v a s c u l a r  
s y n d r o m e  c o n s i s t s  o f  a c c e l e r a t e d  n o n - s p e c i f i c  a t h e r o s c l e r o ­
s i s  ( p r e m a t u r e  a g e i n g ) ,  a n d  a  m o r e  s p e c i f i c  m i c r o a n g i o p a t h y  
a f f e c t i n g  t h e  e y e  a n d  k i d n e y .
2 . 2 ,  H i s t o r y
D i a b e t e s  h a s  b e e n  r e c o g n i s e d  f o r  m o r e  t h a n  t w o  t h o u s a n d  
y e a r s .  I t  w a s  m e n t i o n e d  i n  C h i n e s e  m e d i c a l  w r i t i n g s  a s  a  
s y n d r o m e  o f  p o l y u r i a ,  p o l y p h a g i a  a n d  p o l y d i p s i a .  I t s  n a m e  
w h i c h  c o m e s  f r o m  a  G r e e k  r o o t  m e a n i n g  " T o  r u n  t h r o u g h "  w a s  
g i v e n  t o  i t  by  A r e t a e u s  ( A . D . 7 0 ) .  T h e  d i a b e t i c  u r i n e  w a s  
d e s c r i b e d  b y  T h o m a s  W i l l i s  " A s  i f  i m b u e d  w i t h  h o n e y " ,  a n d  
w a s  p r o v e d  t o  c o n t a i n  s u g a r  b y  D o b s o n  ( 1 7 7 6 ) ,  C l a u d  
B e r n a r d  i n  1 8 5 9  r e c o g n i s e d  h y  p e  r g  l y c a e m i  a  a s  t h e  c a r d i n a l  
s i g n  o f  t h e  d i s e a s e  a n d  L a n g e  r h a n s  i n  1 8 6 9  d e s c r i b e d  t h e  
i s l e t s  o f  t h e  p a n c r e a s  w h i c h  now b e a r  h i s  n a m e .
F i g u r e  1 .  D r a w i n g  o f  a  f u n d u s  b y  H i r s c h b e r g  ( 1 8 7 7 )
I m p o r t a n t  c o n t r i b u t i o n s  t o  t h e  m a n a g e m e n t  o f  d i a b e t e s  
w e r e  m a d e  b y  B a n t i n g  a n d  B e s t  w h e n  t h e y  m a n a g e d  t o  p r e p a r e  
a n  e x t r a c t  f r o m  d o g  p a n c r e a s  c a p a b l e  o f  r e d u c i n g  a n  e l e v a t e d  
b l o o d  g l u c o s e  l e v e l  ( B a n t i n g  a n d  B e s t  1 9 2 1 ) ,  b y  H a g e d o r n  wh o  
i n t r o d u c e d  t h e  f i r s t  l o n g - a c t i n g  i n s u l i n  i n  1 9 3 6 ,  a n d  N i c o l  
a n d  S m i t h  wh o  d e s c r i b e d  - t h e  c h e m i c a l  s t r u c t u r e  o f  h u m a n  
i n s u l i n  i n  1 9 6 0 .  I t  i s  i n t e r e s t i n g  t o  n o t e  t h a t  c a r -  
b u t a m i d e  w a s  a c c i d e n t a l l y  d i s c o v e r e d  b y  F r a n k e  a n d  F u c h s  i n  
G e r m a n y  i n  1 9 5 5  a n d  t h a t  t h i s  i n i t i a t e d  t h e  u s e  o f  
S u l p h o n y l u r e a s  a s  o r a l  h y p o g l y c a e m i c  a g e n t s .
2 . 3 .  D i a g n o s i s
T h e  d e g r e e  o f  h y  p e  r g  l y c a e m i  a  i s  p r o b a b l y  r e l e v a n t  t o  t h e  
d e v e l o p m e n t  o f  m i c r o a n g i o p a t h y ,  a s  s h o w n  m a i n l y  i n  t h e  e y e  
a n d  k i d n e y .  A t w o - h o u r  p o s t p r a n d i a l  c a p i l l a r y  w h o l e - b l o o d  
c o n c e n t r a t i o n  o f  g l u c o s e  g r e a t e r  t h a n  1 1  m m o l / L  h a s  b e e n  
i d e n t i f i e d  a s  t h e  p o i n t  a b o v e  w h i c h  t h e  r e l a t i v e  r i s k  o f  
r e t i n o p a t h y  r i s e s  a n d  a  t w o - h o u r  p o s t p r a n d i a l  c a p i l l a r y  
w h o l e  b l o o d  g l u c o s e  c o n c e n t r a t i o n  o f  7 . 5  m m o l / L  ( 1 3 5  m g / 1 0 0  
m l )  i s  t h e  v a l u e  a b o v e  w h i c h  a  d i a g n o s i s  o f  d i a b e t e s  b e c o m e s  
m o r e  l i k e l y  ( B e n n e t t ,  R u s h f o r d ,  M i l l e r ,  a n d  L e  C o m p t e  1 9 7 6 ;  
J a r r e t t  a n d  K e e n  1 9 7 6 ;  J a r r e t t ,  K e e n ,  F u l l e r ,  a n d  M c C a r t n e y  
1 9 7 9 ) .
T h e  f o l l o w i n g  p r o c e d u r e s  a r e  r e c o m m e n d e d  a s  d i a g n o s t i c  
t e s t s  f o r  d i a b e t e s .
A .  T e s t i n g  a  m o r n i n g  u r i n e  s p e c i m e n  f o r  s u g a r .
B .  M e a s u r i n g  b l o o d  g l u c o s e  l e v e l .
1 .  F a s t i n g  b l o o d  s u g a r .  A f a s t i n g  v e n o u s  p l a s m a
c o n c e n t r a t i o n  o f  8 m m o l / L  ( 1 4 4  m g / 1 0 0  m l )  o r  g r e a t e r  i s
r e g a r d e d  a s  d i a g n o s t i c  o f  d i a b e t e s .  I f  t h e  c o n c e n t r a t i o n
i s  b e l  ow 6 mmo 1 /  L ( 1 0  8 m g /  10 0 m l )  I: h e  d 1 ag  n o s  i s  i s  e x  c  l u  d e  d 
( W. H . O . 19 8 0 ) .
3 9
2 .  T h e r e  i s  a  g e n e r a l  a g r e e m e n t  t h a t  a  1 - h o u r  
p o s t p r a n d i a l  b l o o d  g l u c o s e  l e v e l  o f  11  m m o l / L  { 1 9 8  m g / 1 0 0  
m l )  o r  h i g h e r  i n d i c a t e s  d i a b e t e s .
C .  O r a l  g l u c o s e  t o l e r a n c e  t e s t .  A p a t i e n t  w h o s e  
f a s t i n g  b l o o d  s u g a r  i s  b e t w e e n  6 a n d  8 m m o l / L  i s  g i v e n  5 0  o r  
1 0 0  g  ( t h e  W . H . O .  1 9 8 0 - r e c o m m e n d s  7 5  g  ) o f  g l u c o s e  o r a l l y .  
V e n o u s  b l o o d  s a m p l e s  a r e  w i t h d r a w n  a t  1 / 2 ,  1 ,  1 . 1 / 2 ,  a n d  2 
h o u r  i n t e r v a l s .  I f  t h e  t w o  h o u r  v e n o u s  p l a s m a  c o n ­
c e n t r a t i o n  i s  g r e a t e r  t h a n  1 1  m m o l / L  t h e  t e s t  i s  d i a g n o s t i c  
o f  d i a b e t e s .
P a t i e n t s  wh o  h a v e  a  f a s t i n g  b l o o d  s u g a r  b e t w e e n  5 a n d  8 
m m o l / L  a n d  a  2 - h o u r  g l u c o s e  c o n c e n t r a t i o n  b e t w e e n  8 a n d  11  
m m o l / L  a f t e r  a  7 5  g  o r a l  g l u c o s e  l o a d  a r e  c a t e g o r i s e d  a s  
h a v i n g  i m p a i r e d  g l u c o s e  t o l e r a n c e  a n d  n e e d  t o  s h o w  a n o t h e r  
a b n o r m a l  v a l u e  a f t e r  a  7 5  g g l u c o s e  l o a d  ( f o r  e x a m p l e  a  o n e -  
h o u r  c o n c e n t r a t i o n  o f  1 1  m m o l / L  o r  g r e a t e r )  b e f o r e  a  d i a g n o ­
s i s  o f  d i a b e t e s  i s  m a d e .
D,  E s t i m a t i o n  o f  g l y c o s y l a t e d  h a e m o g l o b i n :  I n  d i a b e t e s ,
a b n o r m a l  c o n c e n t r a t i o n s  o f  v a r i o u s  g l y c o s y l a t e d  h a e m o g l o b i n s  
c a n  b e  i d e n t i f i e d .  H a e m o g l o b i n  A ^ ^  j^g ^  g l y c o s y l a t e d  
h a e m o g l o b i n  w h o s e  c o n c e n t r a t i o n  i n  d i a b e t i c  p a t i e n t s  
r e f l e c t s  t h e  m e a n  b l o o d  g l u c o s e  l e v e l  f o r  u p  t o  1 2 0  d a y s  
p r e v i o u s l y  ( D a y  1 9 8 1 )  -  a  v a l u e  e a s i l y  a s c e r t a i n e d  u s i n g
t h e  s t a n d a r d  i n d i c e s  o f  c a r b o h y d r a t e  m e t a b o l i s m .  U n l i k e  
b l o o d  a n d  u r i n e  s u g a r  m e a s u r e m e n t s ,  HbA^ g  d e t e r m i n a t i o n s  
a r e  h i g h l y  r e p r o d u c i b l e  a n d  r e q u i r e  l i t t l e  p a t i e n t  c o m p l i a n c e  
s i n c e  o n l y  o n e  b l o o d  s a m p l e  i s  n e e d e d  t o  a s c e r t a i n  m e a n  
g l u c o s e  l e v e l  f o r  t h e  p r o c e e d i n g  w e e k s  o r  m o n t h s .  D a t a  
may  b e  u s e d  t o  a s c e r t a i n  t h e  d e g r e e  o f  g l y c a e m i c  c o n t r o l  a n d ,  
t h u s ,  t h e  e f f e c t i v e n e s s  o f  a p a r t i c u l a r  t h a p e u t i c  r e g i m e n .
I t  h a s  b e e n  s u g g e s t e d  t h a t  b e t t e r  m a n a g e m e n t  o f  t h e  d i s e a s e
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i s  p o s s i b l e  a n d  t h e  p r e v e n t i o n  o r  a m e l i o r a t i o n  o f  c h r o n i c  
d i a b e t i c  c o m p l i c a t i o n s  i s  a n t i c i p a t e d  ( S c h a n z l i n ,  J a y ,  
F r i t z a n d ,  a n d  o t h e r s  1 9 7 9 ) ,  a n d  t h a t  H b A ^ c  d e t e r m i n a t i o n  
i s  a  c o n v e n i e n t  t o o l  w i t h  w h i c h  t o  s c r e e n  p a t i e n t s  f o r  
d i a b e t e s  ( B u n n ,  G a b b a y ,  a n d  G a l l o p  1 9 7 8 ;  G o n e n  a n d  
R u b i n s t e i n  1 9 7 8 ;  C o l e  1 9 7 9 ;  W a r d l e  1 9 8 2 ) .
2 . 4 .  C l a s s i f i c a t i o n
D i a b e t e s  c a n  b e  c l a s s i f i e d  a s  f o l l o w s :
( a )  G e n e t i c  t y p e :  D i a b e t e s  i n  t h i s  c a t e g o r y  i s
u s u a l l y  s u b d i v i d e d  i n t o  t y p e  I  i n s u l i n - d e p e n d e n t  d i a b e t e s  
w h i c h  i s  c o m m o n l y  d i a g n o s e d  b e f o r e  t h e  a g e  o f  3 0 ,  a n d  
t y p e  IX w h i c h  c a n  b e  m a n a g e d  b y  r e s t r i c t i o n  o f  d i e t ,  o r a l  
h y p o g l y c a e m i c  a g e n t s  o r  i n s u l i n  d e p e n d i n g  o n  t h e  
a c h i e v m e n t  o f  a n  a c c e p t a b l e  l e v e l  o f  b l o o d  s u g a r  a n d  t h e  
p r e s e n c e  o f  c o m p l i c a t i o n s  a n d  i s  n o t  i n s u l i n - d e p e n d e n t .
( b )  P a n c r e a t i c  d i a b e t e s  i n  w h i c h  t h e  c a r b o h y d r a t e  
i n t o l e r a n c e  may  b e  a t t r i b u t e d  d i r e c t l y  t o  d e s t r u c t i o n  o f  t h e  
p a n c r e a t i c  i s l e t s  b y  c h r o n i c  i n f l a m m a t i o n ,  c a r c i n o m a ,  
h a e m o c h r o m a t o s i s  o r  s u r g i c a l  r e m o v a l .
( c )  E n d o c r i n e  d i a b e t e s  w h i c h  i s  a s s o c i a t e d  w i t h  
e n d o c r i n o p a t h i e s  s u c h  a s  h y p e r p i t u i t a r i s m  ( a c r o m e g a l y ,  
b a s o p h i l i s m ) ,  h y p e r t h y r o i d i s m ,  h y p e  r a d  r e n a l  i  sm ( C u s h i n g ' s  
s y n d r o m e ,  p h e o c h r o m o c y t o m a ) ,  a n d  p a n c r e a t i c  i s l e t - c e l l  
t u m o u r  o f  A - c e l l  t y p e .  U n d e r  t h i s  c a t e g o r y  may  a l s o  b e  
i n c l u d e d  g e s t a t i o n a l  d i a b e t e s  a n d  t h e  v a r i o u s  f o r m s  o f  
s t r e s s  d i a b e t e s  l i s t e d  a b o v e .
( d )  I a t r o g e n i c  d i a b e t e s  -  p r e c i p i t a t e d  by  a d m i n i s t r a ­
t i o n  o f  c o r t i c o s t e r o i d s ,  c e r t a i n  d i u r e t i c s  o f  t h e  b e n -
z o t h i a d i a z i n e  t y p e  a n d  p o s s i b l y  a l s o  by o e s t r o g e n - p r o g e s t e r o n e  
c  o m b 1 n a  t  i o n s .
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T y p e  I ,  I n s u l i n - d e p e n d e n t  d i a b e t e s  ( I D D )
T h i s  t y p e  i s  c h a r a c t e r i s e d  b y  a  r a p i d  o n s e t ,  w i t h  s y m p ­
t o m s  s u c h  a s  p o l y d i p s i a ,  p o l y u r i a ,  p o l y p h a g i a ,  l o s s  o f  
w e i g h t  a n d  s t r e n g t ' h ,  a n d  i n  c h i l d r e n ,  f r e q u e n t l y ,  r e c u r r e n c e  
o f  b e d  w e t t i n g .  I t  i s  a p t  t o  b e  o f  t h e  u n s t a b l e  o r  b r i t t l e  
t y p e ,  b e i n g  q u i t e  s e n s i t i v e  t o  t h e  a d m i n i s t r a t i o n  o f  e x o g e ­
n o u s  i n s u l i n  a n d  e a s i l y  i n f l u e n c e d  b y  p h y s i c a l  a c t i v i t y .
T h e  p a t i e n t  i s  l i a b l e  t o  k e t o a c i d o s i s .
F o r  a d e q u a t e  t r e a t m e n t  d i e t  a n d  i n s u l i n  t h e r a p y  a r e  m a n ­
d a t o r y .
D i a g n o s i s  i s  u s u a l l y  n o t  d i f f i c u l t  a n d  d e a t h  c a n  o c c u r  
d u e  t o  c a r d i o v a s c u l a r  a n d  r e n a l  c o m p l i c a t i o n s  a l t h o u g t h  
t h e  m o r t a l i t y  r a t e  h a s  b e e n  f a v o u r a b l y  i n f l u e n c e d  b y  t h e  
i n t r o d u c t i o n  o f  i n s u l i n  t h e r a p y .
T y p e  I I ,  No n  i n s u l i n - d e p e n d e n t  d i a b e t e s  ( N I D D )
T h i s  t y p e  h a s  a  l e s s  s t o r m y  b e g i n n i n g ,  f r e q u e n t l y  s y m p ­
t o m s  a r e  m i n i m a l  o r  a b s e n t .  T h e  c h i e f  c o m p l a i n t  may  b e  
m o d e r a t e  l o s s  o f  w e i g h t  o r  o c c a s i o n a l l y ,  w e i g h t  g a i n .
T h e r e  may  b e  s o m e  n o c t u r i a .  V u l v a r  p r u r i t u s  i n  t h e  f e m a l e  
o r  v a s c u l a r  c o m p l i c a t i o n s  ma y  l e a d  t h e  p a t i e n t  t o  s e e k  m e d i ­
c a l  a d v i c e .  I t  ma y  o c c a s i o n a l l y  b e  d i a g n o s e d  a s  a  c o n ­
s e q u e n c e  o f  b l u r r e d  v i s i o n  r e s u l t i n g  f r o m  d i a b e t i c  
r e t i n o p a t h y  o r  a n  e a r l y  o n s e t  o f  s e n i l e  c a t a r a c t  ( C o t l i e r  1 9 8 1 )  
A n a e m i a  a n d  f a t i g u e  ma y  b e  a s s o c i a t e d  w i t h  f a i r l y  a d v a n c e d  
d i a b e t i c  n e p h r o p a t h y ;  a n d  t h e  d i s e a s e  i s  s o m e t i m e s  
d i a g n o s e d  a s  a  r e s u l t  o f  d i a b e t i c  n e u r o p a t h y  w h i c h  may  p r e ­
s e n t  a s  p a r e s t h e s i a ,  l o s s  o f  s e n s a t i o n ,  i m p o t e n c e ,  n o c t u r n a l  
d i a r r h o e a ,  p o s t u r a l  h y p o t e n s i o n  o r  n e u r o g e n i c  b l a d d e r .
T h e  p a t i e n t  w i t h  ma t  u r  i  t y - o n s  e  t  d i a b e t e s  u s u a l l y  d o e s  
n o t  p r e s e n t  t h e  d r a m a t i c ,  a c u t e  m e t a b o l i c  s y n d r o m e  o b s e r v e d  
i n  t h e  j u v e  n i l e - o n s e  t  p a t i e n t  b u t  r a t h e r  a c h r o n i c  v a s c u l a r
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s y n d r o m e .  I t  i s  t h e r e f o r e  i m p o r t a n t  t o  s u s p e c t  d i a b e t e s  a s  
a n  u n d e r l y i n g  d i s e a s e  i n  a  w i d e  v a r i e t y  o f  c i r c u m s t a n c e s .
2 . 5 .  T r e a t m e n t
C o r r e c t i o n  o f  t h e  u n d e r l y i n g  m e t a b o l i c  a b n o r m a l i t i e s  t o  
r e d u c e  s y m p t o m s ,  m a i n t a i n i n g  a n  i d e a l  b o d y  w e i g h t ,  p r e v e n ­
t i o n  o f  c o m p l i c a t i o n s  a n d  t h e  n o n s p e c i f i c  a c c e l e r a t e d  
a t h e r o s c l e r o s i s  t o  w h i c h  a  d i a b e t i c  p a t i e n t  i s  l i a b l e  s h o u l d  
b e  t h e  a i m s  o f  d i a b e t i c  m a n a g e m e n t .  T o  a c h i e v e  
t h e s e ,  d i e t a r y  r e s t r i c t i o n ,  o r a l  h y p o g l y c a e m i c  a g e n t s  a n d / o r  
i n s u l i n s  a r e  u s e d  f o r  t h e  t r e a t m e n t  o f  d i a b e t e s .
D i e t  : T h e  c h i e f  a i m s  o f  a  d i a b e t i c  d i e t  a r e :
1 .  T o  p r e v e n t  e x c e s s i v e  p o s t p r a n d i a l  h y p e r g l y c a e m i a .
2 .  T o  p r e v e n t  h y p e r g l y c a e m i a  i f  t h e  p a t i e n t  i s  o n  e x o g e ­
n o u s  i n s u l i n .
3 .  T o  o b t a i n  a n  i d e a l  b o d y  w e i g h t .
4 .  T o  n o r m a l i s e  s e r u m  c h o l e s t e r o l  a n d  t r i g l y c e r i d e s .
5 .  To  p r e v e n t  o r  d e l a y  p r e m a t u r e  a t h e r o s c l e r o s i s .
I t  h a s  r e c e n t l y  b e e n  r e p o r t e d  ( S i m p s o n ,  M a n n ,
C h a k r a b a r t i ,  a n d  o t h e r s  1 9 8 2  ) t h a t  a  h i g h  f i b r e  d i e t  h a s  a n  
e f f e c t  o n  l o w e r i n g  s o m e  c l o t t i n g  v a l u e s  a n d  t h e y  r e d u c e  t h e  
c a r d i o v a s c u l a r  m o r b i d i t y  a n d  m o r t a l i t y .
A c c o r d i n g  t o  i d e a l  b o d y  w e i g h t ,  p h y s i c a l  a c t i v i t y  a n d  
o c c u p a t i o n  o f  t h e  p a t i e n t  t h e  b a s i c  c a l o r i c  r e q u i r e m e n t  i s  
d e t e r m i n e d .  D e t a i l e d  c o n s i d e r a t i o n  o f  d i e t  w i l l  n o t  b e  
d i s c u s s e d  a s  i t  i s  b e y o n d  t h e  s c o p e  o f  t h i s  w o r k .
O r a l  h y p o g l y c a e m i c  a g e n t s
T h e s e  a r e  u s e d  i n  t h e  t r e a t m e n t  o f  NIDD i f  i t  i s  o f  
t h e  n o n k e t o t i c  t y p e  a n d  w h e n  d i e t a r y  t r e a t m e n t  a l o n e  i s  
u n s u c c e s s f u l  i n  a c h i e v i n g  a d e q u a t e  c o n t r o l .
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I n s u l i n
I n s u l i n  i s  a  p o l y p e p t i d e ,  a n d  i f  t a k e n  by  m o u t h  i s  
d i g e s t e d  t o  i t s  c o n s t i t u e n t  a m i n o  a c i d s .  A p a t i e n t  i s  
u s u a l l y  a d m i t t e d  t ' 6  h o s p i t a l  f o r  e d u c a t i o n  a n d  a d j u s t m e n t  o f  
t h e  d o s e  w h e n  i n s u l i n  i s  n e e d e d  f o r  t h e  t r e a t m e n t  o f  d i a b e ­
t e s  ( P e a c o c k ,  T a t t e r s a l l ,  T a y l o r ,  D o u g l a s ,  a n d  R e e v e s  1 9 8 3 ) .
2 , 6 .  C o m p l i c a t i o n s  o f  d i a b e t e s . F i g . 2 .
L i s t e d  b e l o w  a r e  t h e  c o m p l i c a t i o n s  t o  w h i c h  a  d i a b e t i c  i s  
s u s c e p t i b l e .  S o me  o f  t h e s e  c a n  a c t u a l l y  b e  t h e  p r e s e n t i n g  
s y m p t o m s  o f  t h e  d i s e a s e .
A .  A c u t e
1 .  D i a b e t i c  k e t o a c i d o s i s  a n d  c o m a  d u e  t o  l a c k  o f  
i n s u l i n .  I t  ma y  b e  s e e n  i n  a  p e r s o n  w i t h  a )  
u n d i a g n o s e d  d i a b e t e s ,  b )  k n o w n  d i a b e t e s ,  b u t  w h o  
f a i l s  t o  i n c r e a s e  h i s  i n s u l i n  d o s a g e  d e s p i t e  p o o r  
u r i n e  o r  b l o o d  t e s t s ,  c )  k n o w n  d i a b e t e s  who s u f f e r s  
f r o m  n a u s e a  and  v o m i t i n g  a n d  f a i l s  t o  t a k e  h i s  d a i l y  
i n s u l i n  b e c a u s e  h e  d o e s  n o t  e a t .
2 .  H y p e r g l y c a e m i c  n o n k e t o t i c  c o m a .
3 .  C o m p l i c a t i o n s  o f  i n s u l i n  t h e r a p y .
R e p e a t e d  u s e  o f  t h e  s a m e  s i t e  f o r  i n s u l i n  i n j e c t i o n s  
ma y  l e a d  t o  a  g r o s s  t h i c k e n i n g  o f  s u b c u t a n e o u s  t i s s u e  
c h i e f l y  f a t ,  s o  c a l l e d  l i p o h y p e r t r o p h y . T h e  
s u b c u t a n e o u s  f a t ,  o n  t h e  o t h e r  h a n d ,  may  r a p i d l y  
d i s a p p e a r  a t  t h e  s i t e  o f  i n j e c t i o n s  g i v i n g  r i s e  t o  
t h e  c o n d i t i o n  c a l l e d  l i p o a t r o p h y .  T h i s  may  b e  d u e  
t o  t h e  i n t r a d e r m a l  i n j e c t i o n  o f  i n s u l i n .
H y p o g  l y c a e m i  a  may  r e s u l t  f r o m  a n  i n s u l i n  o v e r d o s e  
c a u s e d ,  i n  t u r n ,  by  mi  s m e a s u r  eme n t  u s i n g  i n s u l i n
o f  t h e  w r o n g  s t r e n g t h  o r  t o o  r a p i d  a c t i o n  o f  i n s u l i n ,
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F i g u r e  2 .  R e l a t i o n  o f  d u r a t i o n  o f  d i a b e t e s  t o
i n c r e a s i n g  i n c i d e n c e  o f  c o m p l i c a t i o n s  
( F r o m  W e s t  1 9 7 8 )  .
f r o m  i n c r e a s e d  p h y s i c a l  a c t i v i t y  o r  f r o m  f a i l i n g  t o  
t a k e  a n  e x p e c t e d  m e a l ,  u s u a l l y  t h e  m i d - d a y  s n a c k .
B . C h r o n i c
1 .  D i a b e t i c  r e t i n o p a t h y .  T h i s  i s  t h e  t o p i c  o f  t h i s
T h e s i s  a n d  w i l l  b e  d i s c u s s e d  i n  d e t a i l  i n  t h e  
f o l l o w i n g  c h a p t e r s .
2 .  D i a b e t i c  n e p h r o p a t h y .  I n t e r c a p i l l a r y  g l o m e r u l o ­
s c l e r o s i s  ( K i m m e l s t i e l  -  W i l s o n  d i s e a s e ) ,  
c h a r a c t e r i s e d  b y  p r o t e i n u r i a  a n d  h y p e r t e n s i o n  i s  
t h e  r e s u l t  o f  a  d i s t i n c t i v e  n o d u l a r  g l o m e r u l a r  
l e s i o n  o f  t h e  k i d n e y s  w i t h  a  t y p i c a l  b a s e m e n t  
m e m b r a n e  ( R o o t ,  P o t e ,  a n d  F r e h n e r  1 9 5 4 ) .
3 .  D i a b e t i c  n e u r o p a t h y ,  A l t h o u g h ^ m o s t  f r e q u e n t l y
i n v o l v e s  p e r i p h e r a l  n e r v e s ,  i t  may  i n v o l v e  a n y  
p o r t i o n  o f  t h e  n e r v o u s  s y s t e m .  I f  a n  i n t r a c r a n i a l  
a n e u r y s m  c a n  b e  r u l e d  o u t  by  a n  a n g i o g r a m  t h e n  
d i a b e t i c  n e u r o p a t h y  i s  m o s t  p r o b a b l y  t h e  
u n d e r l y i n g  c a u s e  f o r  a n  o c u l a r  p a l s y  i n  a  k n o w n  
d i a b e t i c  p a t i e n t .
I t  i s  d i f f i c u l t  t o  a s s e s s  t h e  d e g r e e  o f  n e u r o p a t h y  a n d  
f i g u r e s  v a r y  w i d e  l y & c o n s  i d e  r a b  l y  i n  d i f f e r e n t  c l i n i c a l  s u r ­
v e y s  ( B r u y n  a n d  G a r l a n d  1 9 7 0 ) .
D i a b e t i c  n e u r o p a t h y  may  b e  p r i m a r i l y  v a s c u l a r  w h i c h  i s  
p o t e n t i a l l y  r e v e r s i b l e  o r  p r i m a r i l y  m e t a b o l i c  w h i c h  i s  l e s s  
a m e n a b l e  t o  t r e a t m e n t  ( T h o m a s  a n d  W a r d  1 9 7 5 ) .
C l i n i c a l l y  d i a b e t i c  n e u r o p a t h y  may  p r e s e n t  w i t h  
p e r i p h e r a l  a n d / o r  a u t o n o m i c  m a n i f e s t a t i o n s .
P e r i p h e r a l
S e n s o r y  : L o s s  o f  v i b r a t i o n  s e n s e ,  p a r e s t h e s i a ,  p a i n ,  
l o s s  o f  p a i n  s e n s a t i o n .
4 2
N e u r o m u s c u l a r  : W e a k n e s s ,  p a r a l y s i s ,  d i a b e t i c  
a m y o t r o p h y ,  e x t r a o c u l a r  p a l s i e s .
A u t o n o m i c
E y e  : P u p i l l a r y  c h a n g e s
G a s t r o i n t e s t i n a l  : D e l a y e d  g a s t r i c  e m p t y i n g ,  g a l l  
b l a d d e r  d y s f u n c t i o n , "  n o c t u r n a l  d i a r r h o e a .
G e n i t o u r i n a r y  : S e x u a l ,  i m p o t e n c e ,  a t o n i c  u r i n a r y  
b l a d d e r ,  r e t r o g r a d e  e j a c u l a t i o n .
V a s c u l a r  : O r t h o s t a t i c  h y p o t e n s i o n .
B o n e s  a n d  J o i n t s  ; N e u r o p a t h i c  j o i n t  ( C h a r c o t ) .
S k i n  : N e u r o g e n i c  u l c e r ,  a b s e n t  s w e a t i n g ,  d e p e n d a n t  
o e d e m a .
2 . 7 .  D e a t h  f r o m  d i a b e t e s
I t  i s  g e n e r a l l y  a c c e p t e d  t h a t  d i a b e t i c s  t e n d  t o  d i e  
a t  a n  e a r l i e r  a g e  t h a n  a  c o m p a r a b l e  g r o u p  o f  n o n d i a b e t i c  
i n d i v i d u a l s  i n  t h e  g e n e r a l  p o p u l a t i o n  ( S h a r m a ,  A r c h e r ,  
H a d d e n ,  a n d  o t h e r s  1 9 8 0 ) .
M y o c a r d i a l  i n f a r c t i o n  a n d  o t h e r  v a s c u l a r  d i s e a s e s ,  
r e n a l  c o m p l i c a t i o n s ,  k e t o a c i d o s i s ,  a n d  h y p e r g l y c a e m i a  
a r e  t h e  m a j o r  c a u s e s  o f  d e a t h  i n  a  d i a b e t i c  
p o p u l a t i o n  o f  a n y  a g e  g r o u p .  R e c e n t l y  t h e  M e d i c a l  
S e r v i c e s  S t u d y  G r o u p  a n d  B r i t i s h  D i a b e t i c  A s s o c i a t i o n  
c o n d u c t e d  a  s t u d y  o n  t h e  m o r e  i m p o r t a n t  c a u s e s  o f  d e a t h  
a m o n g  d i a b e t i c s  u n d e r  t h e  a g e  o f  5 0  i n  t h e  U n i t e d  K i n g d o m ,  
a n d  f o u n d  t h a t  m y o c a r d i a l  i n f a r c t i o n  a n d  l a r g e  v e s s e l  
d i s e a s e  w e r e  t h e  c a u s e  o f  d e a t h  i n  4 1  p e r  c e n t ,  r e n a l  
d i s e a s e  i n  19 p e r  c e n t ,  d i a b e t i c  k e t o a c i d o s i s  a n d  c o m a  
i n  1 5  p e r  c e n t ,  a n d  h y p o g l y c a e m i a  i n  4 p e r  c e n t .
A s s o c i a t e d  f a c t o r s  I n c l u d e d  s m o k i n g ,  h y p e r t e n s i o n ,  
o b e s i t y ,  a n d  p e r i p h e r a l  v a s c u l a r  d i s e a s e .  T h o s e  who
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d i e  b e f o r e  t h e  a g e  o f  5 0  d o  n o t  s m o k e  m o r e  h e a v i l y  t h a n  a  
c o m p a r a b l e  g r o u p  i n  t h e  g e n e r a l  p o p u l a t i o n  ( T u n b r i d g e  1 9 8 1 )  
D e p e n d i n g  o n  t h e  p r e v a l e n c e  o f  d i a b e t e s  i n  d i f f e r e n t  
c o m m u n i t i e s  o f  t h e  w o r l d  ( W e s t  1 9 7 8 )  d i a b e t e s  c o n t r i b u t e s  
v a r i a b l y  t o  m o r t a l i t y  c o m p a r e d  t o  o t h e r  c a u s e s  o f  d e a t h .  
L i s t e d  i n  A p p e n d i x  1 a r e  t h e  d e a t h  r a t e s  f r o m  d i a b e t e s  a n d  
i t s  c o m p l i c a t i o n s  i n  s o m e  c o u n t r i e s  ( W o r l d  H e a l t h  A n n u a l  
S t a t i s t i c s  1 9 7 6 )  f r o m  w h i c h  i t  c a n  p r o b a b l y  b e  n o t e d  t h a t  
r i c e  e a t i n g  c o m m u n i t i e s ,  i n  c o n t r a s t  t o  i n d u s t r i a l i s e d  
c o u n t r i e s ,  h a v e  l o w e r  r a t e s  o f  d e a t h  f r o m  d i a b e t e s .
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CHAPTER 3 
D I A B E T I C  RETINOPATHY
3 . 1 .  C L I N I C A L  FEATURES
S o me  o r  a l l  o f  t h e  f o l l o w i n g  a b n o r m a l i t i e s  a r e  f o u n d  i n  
t h e  f u n d u s  o n  c l i n i c a l  e x a m i n a t i o n ,
3 . 1 . a .  V e n o u s  c h a n g e s
D i l a t a t i o n  o f  t h e  r e t i n a l  v e i n s  i s  s a i d  t o  b e  a n  e a r l y  
f e a t u r e  b u t  e a r l y  v e n o u s  d i l a t a t i o n  i s  s o m e t i m e s  d i f f i c u l t  
t o  d e t e c t  o p h t h a l m o s c o p i c a l l y . As  t h e  d i l a t a t i o n  i n c r e a s e s  
h o w e v e r ,  e s p e c i a l l y  i f  i t  i s  a s s o c i a t e d  w i t h  i n c r e a s i n g  t o r -  
t o u s i t y ,  i t  w i l l  l e a d  t o  f u s i f o r m  d i l a t a t i o n s  w h i c h  s o m e t i ­
m e s  o c c u r  i n  c l o s e  p r o x i m i t y  a l o n g  t h e  v e i n  g i v i n g  i t  t h e  
a p p e a r a n c e  o f  a  " s t r i n g  o f  s a u s a g e s "  ( B a l l a n t y n e  a n d  
L o w e n s t e i n  1 9 4 3 ) ,  F i g u r e  3 .  T h e  b l o o d  i n  t h e  v e i n s  i s  
d a r k e r  i n  c o l o u r  t h a n  n o r m a l .
S e v e r e  c h a n g e s  a r e  s o m e t i m e s  s e e n  i n  t h e  v e i n s  w h e n  
i n t r a r e t i n a l  n e o v a s c u l a r i s a t i o n  i s  n o t  d e t e c t a b l e .  L o o p s  
ma y  f o r m ,  a n d  e v e n t u a l l y  b e c o m e  s o  e n g o r g e d  a n d  t w i s t e d  
a r o u n d  t h e  b a s e  t h a t  t h e y  s t r a n g u l a t e  a n d  s l o u g h .
F i n a l l y  w h e n  c o n t r a c t i o n  o f  f i b r o u s  t i s s u e  o c c u r s ,  ( t h i s  
a c c o m p a n i e s  o r  f o l l o w s  n e w v e s s e l  f o r m a t i o n )  F i g u r e  4 ,  t h e  
v e i n s  a r e  d i s p l a c e d  f r o m  t h e i r  o r i g i n a l  c o u r s e  a n d  l o o p s ,  
c o i l s ,  a n d  v a r i c o s e  c h a n g e s  b e c o m e  m o r e  f r e q u e n t .
T h e s e  v e n o u s  c h a n g e s  i n d i c a t e  a  s e r i o u s  d e v e l o p m e n t  i n  
t h e  c o u r s e  o f  d i a b e t i c  r e t i n o p a t h y  b e c a u s e  t h e y  a r e  u s u a l l y  
a s s o c i a t e d  w i t h  a r e a s  o f  c a p i l l a r y  n o n p e r f u s i o n  a n d  may  
p r e c e e d  new v e s s e l  f o r m a t i o n .
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Figure 3. Fundus photograph showing the "string of 
sausages" appearance of veins.
Figure 4. Fundus photograph . Advanced proliferative 
diabetic retinopathy ; formation of fibrous tissue and
traction on the macula.
Figure 5. Fundus photograph. Simple diabetic background 
retinopathy ;only a few microaneurysms are seen 
This was the fundus appearance of a woman with 
a 34 years history of diabetes.
3 . 1 . b ,  M i c r o a n e u s y s m s
M i c r o a n e u r y s m s  c a n  d e v e l o p  i n  d i a b e t i c  a n i m a l s  ( B a r n e t t  
1 9 8 1 ) .  I n  1 9 6 2  P a t z  a n d  M a u m e n e e  d e m o n s t r a t e d  
m i c r o a n e u r y s m s  i n  ' à  s p o n t a n e o u s l y  d i a b e t i c  d o g .  H a u s l e r ,  
S i b a y ,  a n d  C a m p b e l l  ( 1 9 6 4 )  d e m o n s t r a t e d  t h e i r  p r e s e n c e  i n  a  
d o g  r e n d e r e d  d i a b e t i c  b y  t h e  a d m i n i s t r a t i o n  o f  g r o w t h  h o r ­
m o n e ,  a n d  r e t i n a l  c h a n g e s  s i m i l a r  t o  t h o s e  o c c u r  i n g  i n  m a n  
h a v e  b e e n  o b t a i n e d  i n  a  d o g  r e n d e r e d  d i a b e t i c  by  a l l o x a n  o r  
m e t a s o m a t o t r o p i n  b y  E n g e r m a n  a n d  B l o o d w o r t h  ( 1 9 6 5 ) ,  a n d  by  
B l o o d w o r t h  a n d  M o l i t o r  ( 1 9 6 5 ) .
T h e  p r e s e n c e  o f  m i c r o a n e u r y s m s  ( N e t t l e s h i p  1 8 8 2 )  i n  a  
d i a b e t i c  e y e ,  i n  t h e  a b s e n c e  o f  o t h e r  v a s c u l a r  c h a n g e s ,  i s  
h i g h l y  s u s p i c i o u s  o f  d i a b e t e s .  T h e y  a r e  t h e  f i r s t  u n e ­
q u i v o c a l  s i g n ,  a l t h o u g n  n o t  p a t h o g n o m o n i c  o f  t h e  r e t i n o p a t h y  
o f  d i a b e t e s .
T h e y  r a n g e  i n  s i z e  f r o m  a  f e w  t o  1 0 0  m i c r o n s  w i t h  a n  
a v e r a g e  o f  5 0  m i c r o n s  ( F i g .  5 ) ,  T h o s e  2 0 - 3 0  m i c r o n s  i n  
d i a m e t e r  c a n  b e  s e e n  w i t h  t h e  o p h t h a l m o s c o p e  e s p e c i a l l y  i f  
t h e  p u p i l  i s  w e l l  d i l a t e d .  T h e  s m a l l e r  o n e s  a r e  n o t  s e e n .  
H o w e v e r ,  f l u o r e s c e i n  a n g i o g r a p h y  s h o w s  t h e m  a l l  a n d  may  
d i s c l o s e  a  t e n f o l d  i n c r e a s e  i n  t h e i r  n u m b e r  ( S c o t t ,  D o l l e r y ,  
H i l l ,  H o d g e ,  a n d  F r a s e r  1 9 6 3 ) .  M i c r o a n e u r y s m s  may b e  s e e n  
o n  f l u o r e s c e i n  a n g i o g r a p h y  e v e n  i f  t h e  f u n d u s  i s  c l i n i c a l l y  
n o r m a l  ( T a n i  1 9 7 6 ) .
M i c r o a n e u r y s m s  d o  n o t  a f f e c t  v i s i o n  i n  t h e  a b s e n c e  o f  
o t h e r  c h a n g e s  a l t h o u g h  i n  o n e  f u n d u s  t h e r e  may b e  a f e w  
h u n d r e d  o f  t h e m .  T h e y  may  d i s a p p e a r  f o l l o w i n g  s t r i c t  
d i a b e t i c  c o n t r o l  ( D o l l e r y  a n d  O a k l e y  19 6 5 )  o r  may r e m a i n
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u n c h a n g e d  f o r  y e a r s .  W i t h  t i m e  t h e y  f a d e  a n d  s o m e  may 
d i s a p p e a r  a l t o g e t h e r .  S o m e t i m e s  t h e i r  p r e v i o u s  e x i s t e n c e  i s  
i n d i c a t e d  b y  w h i t i s h  s p o t s  i n  t h e  f u n d u s .  T h i s  i s  b e c a u s e  
t h e y  f o r m  a s  a  b l o w  o u t  o f  t h e  c a p i l l a r y  w a l l  w h i c h  i s  l a t e r  
f i l l e d  i n  by  e n d o t h e l i a l  c e l l  p r o l i f e r a t i o n  a n d  l a t e r  w i t h  
b a s e m e n t  m e m b r a n e  m a t e r i a l .
M i c r o a n e u r y s m s  a r e  r o u n d  i n  s h a p e ,  c l e a r l y  o u t l i n e d  
s o m e t i m e s  b y  a  s i n g l e  l a y e r  o f  e n d o t h e l i a l  c e l l s  a n d  s o m e t i ­
m e s  b y  a  t h i n  b u t  d o u b l e  c o n t o u r e d  w a l l .  T h e y  may a s s u m e  a  
s a c c u l a r  f o r m  a r i s i n g  f r o m  t h e  s i d e  o f  a  c a p i l l a r y  o r  a n  
a m p u l l i f o r u m  s h a p e  ( A s h t o n  1 9 4 9 ) ;  i n  t h e i r  e a r l y  s t a g e  
t h e i r  w a l l s  ma y  b e  t h i n  s o  t h a t  e r y t h r o c y t e s  may  p a s s  
t h r o u g h  t h e m  ( B l o o d w o r t h  19  6 2 ) ,  b u t  a s  t h e y  d e v e l o p  t h e y  
t e n d  t o  a c q u i r e  t h i c k e n e d  l a m i n a t e d  c o a t s  f o r m e d  by  t h e  
d e p o s i t i o n  o f  P A S - p o s i t i v e  m a t e r i a l .  A t  a  l a t e r  s t a g e  t h e y  
t h r o m b o s e  a n d  t h e i r  l u m i n a  a r e  o c c l u d e d  b y  l a m i n a t e d  h y a l i n e  
m a t e r i a l .
Two m e c h a n i s m s  f o r  t h e  f o r m a t i o n  o f  m i c r o a n e u r y s m s  h a v e  
b e e n  s u g g e s t e d .  T h e  f i r s t  i s  a  l o c a l i s e d  o u t p o u c h i n g  
o f  c a p i l l a r y  w a l l .  I t  c o u l d  b e  d u e  t o  f o c a l  w e a k n e s s  
o f  t h e  w a l l  d u e  t o  p e r i c y t e  d e g e n e r a t i o n  ( C o g a n  1 9 6 1 ) ,  
c a p i l l a r y  o b l i t e r a t i o n  t o  l e a v e  a  r e s i d u a l  s t u m p  a n d / o r  
a b o r t i v e  a t t e m p t s  a t  n e o v a s c u l a r i s a t i o n  o f  a r e a s  o f  
c a p i l l a r y  c l o s u r e  ( Y a n o f f  1 9 6 9 ) .  An a l t e r n a t i v e  
s u g g e s t i o n  f o r  t h e  f o r m a t i o n  o f  c a p i l l a r y  m i c r o a n e u r y s m s  
i s  b y  f u s i o n  o f  t h e  o p p o s e d  s i d e s  o f  a  c a p i l l a r y  l o o p  
( A s h t o n  1 9 5 8 ) .  A l t h o u g h  A s h t o n  ( 1 9 7 4 )  h a s  w i t h d r a w n  
t h i s  s u g g e s t i o n ,  h e  o r i g i n a l l y  t h o u g h t  t h a t  t h i s  t y p e  
i s  p r o c e e d e d  by v a r i c o s i t y  a n d  k i n k i n g  o f  t h e  c a p i l l a r y .
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Figure 6. Formation of microaneurysms. From Ashton 1963.
9Figure 7. Histological section of the layers of a normal
primate retina( Courtesy of N. McKechnie).
Nerve fibre. 
Ganglion cell. 
Inner plexiform. 
Inner nuclear.
5. Outer plexiform.
6. Outer nuclear.
7. Rods and cones.
8. Pigment epithelium.
9. Choriocapillaris.
T h e  s t a r t  may b e  a  l i m i t e d  h y p e r p l a s i a  c a u s i n g  b o t h  c i r c u m ­
f e r e n t i a l  d i l a t i o n  a n d  l o n g i t u d i n a l  g r o w t h  w h i c h  w o u l d  
r e s u l t  i n  t o r t o u s i t y  a n d  k i n k i n g  f u s i o n  o f  t h e  o p p o s e d  w a l l s  
o f  t h e  r e s u l t i n g  l o o p .  T h i s  l e a d s  t o  t h e  d e v e l o p m e n t  o f  a n  
a n e u r y s m  w h i c h  a p p e a r s  t o  b e  a n  o u t p o u c h i n g  o f  t h e  w a l l  o f  
t h e  a f f e c t e d  c a p i l l a r y  ( F i g .  6 ) .
M i c r o a n e u r y s m s  a l w a y s  o c c u r  i n  a r e a s  w h e r e  a t  l e a s t  o n e  
o r  t w o  c a p i l l a r i e s  a r e  n o n p e r f u s e d .  T h e y  a r e  p a r t i c u l a r l y  
n u m e r o u s  a t  t h e  e d g e  o f  m i c r o i n f a r c t s  i n  t h e  n e r v e  f i b r e  
l a y e r  ( c o t t o n  w o o l  s p o t s ) .
3 . I . e .  R e t i n a l  H a e m o r r h a g e s
H a e m o r r h a g e s  i n  d i a b e t i c  r e t i n o p a t h y  o c c u r  i n  t h e  m i d ­
r e t i n a  f r o m  t h e  d e e p  c a p i l l a r y  p l e x u s  o r  i n  t h e  n e r v e  f i b r e  
l a y e r  f r o m  t h e  s u p e r f i c i a l  c a p i l l a r y  p l e x u s  ( F i g .  7 ) .  T h e  
f o r m e r  a r e  t y p i c a l l y  r o u n d .  T h e y  may  b e  o f  t h e  " d o t  a n d  
b l o t "  t y p e  o r  " s p o n g e  m a r k "  w h i c h  l o o k s  l i k e  a  b l o o d  s o a k e d  
s p o n g e  i m p r i n t .  T h e y  a r e  u s u a l l y  l o c a t e d  a t  t h e  p o s t e r i o r  
p o l e  o f  t h e  r e t i n a  b u t  h a v e  r e c e n t l y  ( R o y  a n d  M c C u l l o c h  1 9 8 2 )  
b e e n  d e s c r i b e d  i n  t h e  p e r i p h e r y  o f  t h e  r e t i n a  n e x t  t o  t h e  
o r a  s e r r a t a .  M o r e  s u p e r f i c i a l  h a e m o r r h a g e s  a r e  l e s s  c o m m o n  
a n d  a r e  f l a m e - s h a p e d .  T h e s e ,  h o w e v e r ,  may  s o  d o m i n a t e  
t h e  p i c t u r e  t h a t  s o m e  o p h t h a l m o l o g i s t s  h a v e  a p p l i e d  t h e  t e r m  
" h a e r a o r r h a g i c  r e t i n o p a t h y "  t o  d e s c r i b e  t h e  d i a b e t i c  f u n d u s  
i n  w h i c h  t h e y  f e a t u r e .
I t  i s  u n u s u a l  f o r  h a e m o r r h a g e s  i n  t h e  d i a b e t i c  f u n d u s  
t o  h a v e  t h e  s t r i a t e  o r  l i n e a r  f o r m  w h i c h  i s  c h a r a c t e r i s t i c  
o f  h a e m o r r h a g e s  i n  t h e  n e r v e  f i b r e  l a y e r ,  a n d  t h i s  
a p p e a r a n c e  s h o u l d  s u g g e s t e d  a n o t h e r  a e t i o l o g y  s u c h  a s  
s y s t e m i c  h y p e r t e n s i o n .
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T h e  i n d i v i d u a l  h a e m o r r h a g e  t a k e s  6 - 8  w e e k s  t o  d i s a p p e a r  
a n d  may  b e  r e p l a c e d  by  o t h e r s .  T h e  s p o n t a n e o u s  r e s o l u t i o n  
o f  r e t i n a l  h a e m o r r h a g e  m a k e s  t h e  i n t e r p r e t a t i o n  o f  t h e r a ­
p e u t i c  m e a s u r e s  d i f f i c u l t .
H a e m o r r h a g e s  may b r e a k  t h r o u g h  t h e  c o n f i n e s  o f  M u l l e r  
c e l l s  a n d  b e c o m e  l a r g e  a n d  c o n f l u e n t .  T h e  may  a l s o  b r e a k  
t h r o u g h  t h e  i n t e r n a l  l i m i t i n g  m e m b r a n e  i n t o  t h e  s u b h y a l o i d  
s p a c e .
3 . 1 . do H a r d  e x u d a t e s
T h e s e  h a v e  w e l l  d e f i n e d  e d g e s  a n d  a r e  c o m p o s e d  o f  l i p i d  
m a t e r i a l .  T h e y  a r e  s e e n  i n  t h r e e  f o r m s .
A c l u s t e r  o f  s m a l l  e x u d a t e s ,  may  b e  s e e n  i n  m o r e  t h a n  
o n e  a r e a  a n d  ma y  o r  may  n o t  b e  a s s o c i a t e d  w i t h  h a e m o r r h a g e s .  
F l u o r e s c e i n  a n g i o g r a p h y  a l w a y s  s h o w s  t h e  p r e s e n c e  o f  
m i c r o a n e u r y s m s  i n  t h e  s a m e  a r e a .  H a r d  e x u d a t e s ,  i n  
c o n t r a s t  t o  m i c r o a n e u r y s m s  d o  n o t  f l u o r e s c e .
H a r d  e x u d a t e s  ma y  a l s o  b e  s e e n  a s  a  r i n g  o r  c i r c i n a t e  
a r r a n g e m e n t  c a l l e d  c i r c i n a t e  r e t i n o p a t h y  ( F i g .  8 ) .
E x u d a t e s  may  f o r m  a  r i n g  e n c l o s i n g  a n  a r e a  o f  v i s i b l e  v a s c u ­
l a r  d i s t u r b a n c e  s u c h  a s  a  c o l l e c t i o n  o f  v a r i c o s e  
c a p i l l a r i e s ,  m i c r o a n e u r y s m s ,  o r  h a e m o r r h a g e s  ( H o u s t o n  a n d  
W i s e  1 9 5 7 ) .  On o t h e r  o c c a s i o n s  h a r d  e x u d a t e s  may  f o r m  
l a r g e r  l e s i o n s  w i t h  a  w r e a t h - l i k e  s t r u c t u r e  w h i c h  may  b e  
m o r e  t h a n  t w o  d i s c  d i a m e t e r  a c r o s s .  T h e s e  a r e  u s u a l l y  
s i n g l e  a n d  e n c l o s e  t h e  m a c u l a .  R i n g - s h a p e d  e x u d a t e s  a r e  
m o r e  s t a b l e  a n d  may  r e m a i n  u n c h a n g e d  f o r  m o r e  t h a n  t w o  y e a r s .
A t h i r d  t y p e  o f  h a r d  e x u d a t e  i s  t h e  s o l i t a r y  p l a q u e .  I t  
i s  u s u a l l y  f o u n d  a t  t h e  p o s t e r i o r  p o l e  a n d  may  l i e  q u i t e  c l o s e  
t o  t h e  m a c u l a  w h i c h  i s  u s u a l l y  o e d e m a  t o u s  ( m a c u l a r  o e d e m a ) .  
T h e y  may  t a k e  s o m e  y e a r s  t o  a b s o r b  a n d  s h o u l d  t h e y  d o  s o ,  
f i n e  s h i n i n g  c h o l e s t e r o l  c r y s t a l s  a r e  l e f t  b e h i n d .
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F i g u r e  8 .  F u n d u s  p h o t o g r a p h .  E x u d a t i v e  d i a b e t i c
r e t i n o p a t h y .  F o r m a t i o n  o f  a  r i n g  o f  h a r d  
e x u d a t e s .  T h i s  i s  a  d a n g e r o u s  s i g n ;  i t  
m a y  c a u s e  s e v e r e  l o s s  o f  v i s u a l  a c u i t y .
v;
Figure 9. Fundus photograph. Ischaemic diabetic 
retinopathy with normal blood pressure. Note absence 
of blood vessel changes characteristic of 
hyper tension.
T h e s e  p l a q u e s  a r e  s e r i o u s  s i g h t  t h r e a t e n i n g  l e s i o n s .
E v e n  i f  t h e y  a r e  a b s o r b e d  t h e y  l e a v e  a  s c o t o m a  i n  
t h e  v i s u a l  f i e l d  ( K i n g ,  D o b r e e ,  Kok a n d  o t h e r s  1 9 6 3 ) .
T h e  e x u d a t e s  o'f d i a b e t i c  r e t i n o p a t h y  a r e  s i t u a t e d  f o r  
t h e  m o s t  p a r t  i n  t h e  o u t e r  r e t i c u l a r  l a y e r  ( B a l l a n t y n e  a n d  
M i c h a e l s o n  1 9 6 2 ) ,  i n  t h e  f i r s t  p l a c e  f i l l i n g  i n d i v i d u a l  
c y s t i c  s p a c e s  a n d  f o r m i n g  c o m p a c t  m a s s e s  w h i c h  a r e  k n o w n  
c l i n i c a l l y  a s  " w a x y " p a t c h e s .  D u k e - E l d e r  ( 1 9 6 7 )  s t a t e s
t h a t  d i a b e t i c  e x u d a t e s  d i f f e r  f r o m  h y p e r t e n s i v e  e x u d a t e s  
w h i c h  a r e  p r e d o m i n a n t l y  f i b r i n o u s  a n d  w h e n  c o n f l u e n t  
a r e  g r a n u l a r  i n  a p p e a r a n c e  a n d  o f  s i l v e r y  g r e y  c o l o u r .
Wa x y  d i a b e t i c  e x u d a t e s  a r e  s m o o t h  a n d  o f  h o m o g e n o u s  t e x t u r e .  
F r o m  my own l i m i t e d  e x p e r i e n c e  i n  h i s t o p a t h o  l o g y  t h e  
s u g g e s t e d  d i f f e r e n c e s  a r e  n o t  a t  a l l  o b v i o u s .
F l a t  p r e p a r a t i o n s  s h o w  t h a t  h a r d  e x u d a t e s  h a v e  f i n g e r ­
l i k e  p r o c e s s e s  w i n d i n g  t h r o u g h  t h e  o u t e r  p l e x i f o r m  l a y e r  b u t  
a s  t h e y  e n l a r g e  a l l  t h e  r e t i n a l  l a y e r s  a r e  e v e n t u a l l y  
i n v a d e d  a n d  d e p o s i t s  a r e  a l s o  f o u n d  a s  a  l o c a l i s e d  s h e a t h i n g  
a l o n g  t h e  a d v e n t i t i a  o f  l a r g e r  v e s s e l s .  T h e  f a t t y  m a t e r i a l  
i s  p a r t l y  i n t r a c e l l u l a r  a n d  p a r t l y  e x t r a c e l l u l a r .  T h e  
i n t r a c e l l u l a r  f a t  i s  c o n t a i n e d  i n  l a r g e  r o u n d e d  c e l l s  w i t h  
s m a l l  n u c l e i ,  p h a g o c y t i c  i n  f u n c t i o n  a n d  m i c r o g l i a l  i n  o r i ­
g i n .  T h e s e  c e l l s  a r e  s t u f f e d  w i t h  f a t  a n d  o c c u r  i n  
c l u s t e r s .  Some w o r k e r s  b e l i e v e d  t h a t  h a r d  e x u d a t e s  w e r e  
d e p o s i t s  f r o m  t h e  b l o o d  s t r e a m  b u t  t h e  f a c t  t h a t  t h e s e  w a x y  
p l a q u e s  a r e  a l w a y s  f o u n d  i n  a r e a s  o f  n e u r o n a l  d e g e n e r a t i o n  
s u g g e s t s  t h a t  t h e y  a r e  b r e a k d o w n  p r o d u c t s  o f  d e g e n e r a t e  n e r ­
v o u s  t i s s u e  w h i c h  i s  g r a d u a l l y  r e m o v e d  b y  t h e  p h a g o c y t i c  
a c t i o n  o f  t h e  m i c r o g l i a l  c e l l s  ( B l o o d w o r t h  19 6 2 ) .  H o w e v e r  
p a r t  o f  t h e i r  c o n t e n t  may  e m a n a t e  f r o m  a b n o r m a l l y  t h i n -  
w a l l e d  m i c r o a n e u r y s m s .
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3 . 1 . e .  C o t t o n  w o o l  s p o t s
C o t t o n  w o o l  s p o t s  p r e v i o u s l y  k n o w n  a s  s o f t  e x u d a t e s  a r e  
g r e y i s h  y e l l o w  i n  c o l o u r  w i t h  a n  i n d i s t i n c t  m a r g i n  d i f f e r e n t  
f r o m  t h e  s h a r p l y  d e m a r c a t e d  e d g e s  o f  h a r d  e x u d a t e s  ( F i g .  9 ) .
T h e y  a r e  c o m m o n l y  r e l a t e d  t o  a r e a s  o f  a c u t e  f o c a l  
i s c h a e m i a  a n d  a r e  n o t  s p e c i f i c  t o  h y p e r t e n s i v e  r e t i n o p a t h y  
a s  t h e i r  p r e s e n c e  h a s  b e e n  d e m o n s t r a t e d  i n  n o r m o t e n s i v e  
d i a b e t i c s  ( K o h n e r ,  D o l l e r y ,  a n d  B u l p i t t  1 9 6 9 ) .  P a t h o l o ­
g i c a l l y  t h e y  c o n s i s t  o f  a r e a s  o f  s w o l l e n  d e g e n e r a t e  a x o n s  
i n  t h e  n e r v e  f i b r e  l a y e r  o f  t h e  r e t i n a .  T h i s  s w e l l i n g  o f  
t h e  i n d i v i d u a l  a x o n s  o f  t h e  n e r v e  f i b r e  l a y e r  o f  t h e  r e t i n a  
i s  d u e t o  i n t r a c e l l u l a r  o e d e m a  a n d  a l s o  t o  f a i l u r e  o f  
a x o p l a s m i c  t r a n s p o r t  w h i c h  i s  d e p e n d e n t  o n  l o c a l  e n e r g y  p r o ­
v i s i o n  ( M c L e o d ,  M a r s h a l l ,  K o h n e r ,  a n d  B i r d  19 7 7 ) .  T h e  
f a i l u r e  o f  a x o p l a s m i c  t r a n s p o r t  r e s u l t s  i n  a n  a c u m m u l a t i o n  o f  
a x o p l a s m i n  i n  t h e  a f f e c t e d  a r e a  a n d  i s  l a r g e l y  r e s p o n s i b l e  
f o r  t h e  g r o s s  s w e l l i n g  o f  a f f e c t e d  a x o n s .  H i s t o l o g i c a l l y  
t h e s e  s w o l l e n  a x o n s  l o o k  l i k e  c e l l s  a n d  h a v e  b e e n  c a l l e d  
c y t o i d  b o d i e s .
5 . 1 . f .  M a c u l a r  o e d e m a
D i a b e t i c  m a c u l a r  o e d e m a  i s  t h e  m o s t  s e r i o u s  o f  t h e  m a n i ­
f e s t a t i o n s  o f  n o n p r o l i f e r a t i v e  r e t i n o p a t h y  ( R u b i n s t e i n  a n d  
M y s k a  1 9 7 2 ;  B . J . O . ,  E d i t o r i a l  1 9 7 4 ;  R u b e n s t e i n  a n d  M y s k a  
1 9 7 4 ) .  I f  i t  i n v o l v e s  t h e  m a c u l a r  a r e a  d i f f u s e l y ,  o e d e m a  
i s  l i k e l y  t o  h a v e  a  g e n e r a l  o r i g i n  a n d  r e s u l t s  f r o m  a b n o r m a l  
c a p i l l a r y  p e r m e a b i l i t y  ( K e a r n s ,  H a m i l t o n ,  a n d  K o h n e r  1 9 7 9 ) .  
T h e  o e d e m a  may a l s o  c o m e  f r o m  t h e  s u b j a c e n t  c h o r o i d a l  
c i r c u l a t i o n  d u e  t o  a  b r e a k d o w n  i n  t h e  b l o o d - r e t i n a l  b a r r i e r  
p r e s e n t e d  b y  t h e  p i g m e n t  e p i t h e l i u m  ( T s o ,  C u n h a - V a z , S h i h ,  
a  n d  J o n e s  19 8 0 ) .
L o c a l i s e d  m a c u l a r  o e d e m a  p r o b a b l y  r e s u l t s  f r o m  l e a k a g e  
o f  p l a s m a  f r o m  m i c r o a n e u r y s m s  a n d  s h u n t  v e s s e l s  a n d  may 
b e  a c c o m p a n i e d  b y  h a r d  e x u d a t e s  ( l i p i d ) ,  c y s t o i d  m a c u l o p a t h y  
o r  b o t h .
T h e  o e d e m a  f l u i d  a c c u m u l a t e s  i n  t h e  o u t e r  p l e x i f o r m  l a y e r  
a n d  f i n a l l y  s p r e a d s  t o  a d j a c e n t  r e t i n a .  T h e  a c c u m u l a t i o n  o f  
e x t r a c e l l u l a r  f l u i d  i n  t h e  o u t e r  p l e x i f o r m  l a y e r  a n d  t h e  
p e c u l i a r  a r r a n g e m e n t  a t  t h e  m a c u l a  o f  t h e  f i b r e s  i n  t h i s  l a y e r  
ma y  g i v e  t h e  a p p e a r a n c e  o f  c y s t o i d  m a c u l o p a t h y  ( S c h a t z  a n d  P a t z  
1 9 7 6 ;  T i c h o  a n d  P a t z  1 9 7 3 ) .
3 . 1 . g .  P r o l i f e r a t i v e  v e s s e l s  ( F i g u r e  1 0 ) .
I n  t h e  n o r m a l l y  d e v e l o p i n g  r e t i n a  t h e  v a s c u l a r  n e t w o r k  
i s  f o r m e d  b y  a  p r o c e s s  o f  b u d d i n g  f r o m  e m b r y o n i c  m e s o d e r m .
I n  t h e  f o e t u s  t h e  n e w v e s s e l s  n o r m a l l y  d e v e l o p  f r o m  a n  
a d v a n c i n g  m a t r i x  o f  v a s o f o r m a t i v e  m e s e n c h y m e  w h i c h  f o r m s  
s o l i d  c o r d s  o f  e n d o t h e l i a l  c e l l s  t h a t  b u d  o u t  f r o m  t h e  
p a r e n t  v e s s e l s .  T h e  s a m e  b a s i c  o r i g i n  i s  f o u n d  i n  
n e o v a s c u l a r i s a t i o n  i n  t h e  r e t i n a .  V a s o p r o l i f e r a t i o n  i s  
a l m o s t  n e v e r  s e e n  i n  d i s e a s e s  w h e r e  t o t a l  a n o x i a  o c c u r s ,  f o r  
e x a m p l e ,  i n  c e n t r a l  r e t i n a l  a r t e r y  o c c l u s i o n .
I n  d i a b e t i c  r e t i n o p a t h y ,  n e o v a s c u l a r i s a t i o n  i s  a l m o s t  
a l w a y s  f o u n d  p o s t e r i o r  t o  t h e  e q u a t o r ,  c h a r a c t e r i s t i c a l l y  o n  
t h e  o p t i c  d i s c  a n d  a l o n g  t h e  c o u r s e  o f  t h e  m a j o r  r e t i n a l  
v e s s e l s ,  u s u a l l y  w i t h i n  t h r e e  d i s c  d i a m e t e r s  o f  t h e  d i s c .
T h e s e  b l o o d  v e s s e l s  d o  n o t  s h a r e  t h e  p e r m e a b i l i t y  c h a r a c ­
t e r i s t i c s  o f  n o r m a l  r e t i n a l  v e s s e l s  ( H e n k i n d  1 9 8 1 ;  G a r n e r
1 9 8 1 ) .  T h u s ,  t h e y  l e a k  f l u o r e s c e i n ,  s o m e t i m e s  s o  p r o f u s e l y  
a s  t o  r a p i d l y  o b s c u r e  r e t i n a l  d e t a i l s  d u r i n g  a n g i o g r a p h y .
T h e y  u s u a l l y  r e m a i n  f l a t  a n d  d o  n o t  b l e e d  b u t  c o n t r a c t i o n  o f  
t h e  v i t r e o u s  a n d  d e t a c h m e n t  o f  t h e  p o s t e r i o r  h y a l o i d  p r o d u c e s
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e l e v a t i o n  o f  t h e  n e w l y  f o r m e d  f  i b r o v a s c u l a  r  t i s s u e  ( W a l l o w ,  
G r e a s e r ,  a n d  S t e v e n s  1 9 8 1 ;  F o o s , K r e i g e r ,  F o r s y t h ,  a n d  
Z a k  k a  19 8 0 ) .
New v e s s e l s  a p p e a r  o n  t h e  v e n o u s  s i d e  o f  t h e  c i r ­
c u l a t i o n .  T h e y  a r e  u s u a l l y  s e e n  a t  t h e  e d g e  o f  a r e a s  o f  
c a p i l l a r y  n o n p e r f u s i o n  a n d  t h e y  g r o w  o n  t h e  s u r f a c e s  o f  t h e  
r e t i n a  a n d  o f  t h e  v i t r e o u s  w h i c h  p r o v i d e  a  s c a f f o l d i n g  o n  
w h i c h  t h e  v e s s e l s  c a n  s p r e a d .
I n  a d d i t i o n  t o  t h e i r  a b n o r m a l  p e r m e a b i l i t y ,  w h i c h  i s  
a s s o c i a t e d  w i t h  f e n e s t r a t i o n s  i n  t h e  b a s e m e n t  m e m b r a n e  a n d  
a b s e n c e  o f  t h e  t i g h t  e n d o t h e l i a l  c e l l  j u n c t i o n s  w h i c h  
c h a r a c t e r i s e  m a t u r e  r e t i n a l  v e s s e l s  ( C o h e n ,  M c M e e l ,  a n d  
F r a n k s  1 9 7 9 ) ,  new v e s s e l s  a r e  p r o n e  t o  b l e e d .
I n i t i a l l y  new f o r m e d  b l o o d  v e s s e l s  a r e  u n a c c o m p a n i e d  b y
a  f i b r o u s  t i s s u e  s u p p o r t  b u t  b e f o r e  l o n g  f i b r o b l a s t i c  a c t i ­
v i t y  l a y s  d o w n  a  c o l l a g e n o u s  f r a m e w o r k  a r o u n d  v e s s e l s  
a t t a c h i n g  t h e m  t o  t h e  t i s s u e  a t  t h e  p o s t e r i o r  p o l e  o f  t h e  
e y e  a n d  t o  t h e  p o s t e r i o r  h y a l o i d  w h i c h  i s  u s u a l l y  d e t a c h e d  
( B e e t h a m  1 9 6 3 ;  D o b r e e  1 9 6 4 ) ,  F i g .  1 1 .  T h e  e v o l u t i o n  o f  
v a s o p r o l i f e r a t i o n  i s  a l w a y s  a s s o c i a t e d  w i t h  c h a n g e s  i n  t h e  
v i t r e o u s  w h i c h  c o n s i s t  o f  c o n t r a c t i o n  o f  t h e  v i t r e o u s  b o d y  
a n d  d e t a c h m e n t  o f  t h e  p o s t e r i o r  h y a l o i d  s u r f a c e  a n d
t h i c k e n i n g  o f  t h e  p o s t e r i o r  h y a l o i d  m e m b r a n e .  P r o g r e s s i v e
t r a c t i o n  o n  t h e  f i b r o v a s c u l a r  t i s s u e  may  e v e n t u a l l y  l e a d  t o  
a  l o c a l i s e d  a r e a  o f  r e t i n a l  d e t a c h m e n t .  V i t r e o u s  t r a c t i o n  
o n  t h e  n e o v a s c u l a r  m e m b r a n e  o r  u p p e r  r e t i n a l  v e s s e l s  f r e ­
q u e n t l y  c a u s e s  a v u l s i o n  o f  t h e  v e s s e l s  a n d  v i t r e o u s  
h a e m o r r h a g e  .
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3 . 2 .  C L A S S I F I C A T I O N
D i f f e r e n t  t y p e s  o f  d i a b e t i c  r e t i n o a t h y  may  h a v e  a  
d i f f e r e n t  p r o g n o s i s  ( K o h n e r  1 9 7 8 ) .  I t  i s  t h e r e f o r e  
i m p o r t a n t  t o  c l a s s i f y  t h e s e  r e t i n a l  p i c t u r e s .  E a c h  f o r m  
o f  r e t i n o p a t h y  may  v a r y  g r e a t l y  i n  s e v e r i t y  a n d  i t  i s  
a l s o  i m p o r t a n t  i n  t h e  a s s e s s m e n t  a n d  f o l l o w - u p  o f  d i a b e t i c  
r e t i n o p a t h y  t o  g r a d e  t h e  s e v e r i t y  o f  t h e  c h a n g e s  p r e s e n t .
B e c a u s e  t h e  s i g n s  ma y  v a r y  g r e a t l y  f r o m  o n e  a r e a  o f  t h e  
f u n d u s  t o  a n o t h e r  a n d  v a r y  g r e a t l y  i n  t h e i r  r e l a t i v e  
p r o p o r t i o n ,  i t  i s  d i f f i c u l t  t o  d e v i s e  a  w h o l l y  s a t i s f a c t o r y  
c l a s s  i f  i c a t  i o n .
T h e r e  a r e  d i f f i c u l t i e s  i n  d e v i s i n g  a  c l a s s i f i c a t i o n  
o f  d i a b e t i c  r e t i n o p a t h y  w h i c h  t a k e s  f u l l  a c c o u n t  o f  t h e  
l a c k  o f  u n i f o r m i t y  a n d  o f  t h e  v a r i a b i l i t y  i n  t h e  v a r i o u s  
s i g n s  w h i c h  may  b e  p r e s e n t  i n  t h e  e y e .  A f u n d u s  w h i c h  m i g h t  
b e  d e s c r i b e d  a s  s h o w i n g  n o  r e t i n o p a t h y  o n  t h e  m o s t  d e t a i l e d  
o p h t h a l m o s c o p i c  e x a m i n a t i o n  c o u l d  d e m o n s t r a t e  m a n y  a n a t o m i c a l  
a n d  f u n c t i o n a l  c h a n g e s  i f  f u r t h e r  s o p h i s t i c a t e d  m e t h o d s  o f  
e x a m i n a t i o n  a r e  u s e d  e . g .  f l u o r e s c e i n  a n g i o g r a p h y ,  c o n t r a s t  
s e n s i t i v i t y  t e s t i n g ,  a n d  c o l o u r  v i s i o n  a s s e s s m e n t  ( T a n i  
1 9 7 6 ;  G h a f o u r ,  F o u l d s ,  A l l a n  a n d  M c C l u r e  1 9 8 2 ;  Y a m a z a k i ,  
A d e c h i - U s a m i , a n d  C h i b a  1 9 8 2 ;  L a k o w s k i ,  A s p i n a l l ,  a n d  
K i n n e a r  1 9 7 2 ;  R o t h  1 9 6 9 ) .
Ma n y  d i f f e r e n t  s y s t e m s  o f  c l a s s i f i c a t i o n  b a s e d  o n  
d i f f e r e n t  m e t h o d s  o f  e x a m i n a t i o n  h a v e  b e e n  p r o p o s e d .
H i r s c h b e r g  ( 1 8 9 1 )  a t t e m p t e d  t h e  f i r s t  c l a s s i f i c a t i o n  
w h e n  h e  d e s c r i b e d  t h r e e  c l i n i c a l  s i g n s  n a m e l y  i n f l a m m a t o r y ,  
h a e m o  r  r h a g  i  c  , a n d  p i g m e n t a r y  c h a n g e s .  P r o l i f e r a t i v e
c h a n g e s  w e r e  n o t  d e s c r i b e d  a l t h o u g h  c l e a r l y  i l l u s t r a t e d  
( F i g .  1 ) .  I n  t h e  f i r s t  g r o u p ,  i n f l a m m a t i o n  o f  t h e  c e n t r a l  
p a r t  o f  t h e  r e t i n a  w i t h  s m a l l  c l e a r  s p o t s  a n d  p u n c t a t e
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h a e m o r r h a g e s  w e r e  i n c l u d e d ;  " r e t i n i t i s  p u n c t a  d i a b e t i c a " .  
T h e  s e c o n d  g r o u p  w a s  d e s c r i b e d  w i t h  r e t i n a l  h a e m o r r h a g e s  
a n d  c o n s e q u e n t  i n f l a m m a t i o n  a n d  d e g e n e r a t i o n ,  " r e t i n i t i s  
h a e m o r r h a g i c a  d i a b e t i c a " ' .  T h e  l a s t  g r o u p  i n c l u d e d  t h o s e  
w i t h  i n f l a m m a t i o n  a n d  d e g e n e r a t i o n  o f  t h e  r e t i n a  a n d  
w h o s e  c o n n e c t i o n  w i t h  d i a b e t e s  r e q u i r e d ,  h e  t h o u g h t ,  
f u r t h e r  i n v e s t i g a t i o n .  He s t a t e d  t h a t  " a  s i n g l e  s m a l l  
h a e m o r r h a g e  i n  t h e  r e t i n a  p e r m i t s  u s  t o  r e c o g n i s e  
g l y c o s u r i a "  { H i r s c h b e r g  1 8 9 1 ) .
B a l l a n t y n e  a n d  L o w e n s t e i n  ( 1 9 4 3 )  c l a s s i f i e d  d i a b e t i c  
r e t i n o p a t h y  i n t o  f i v e  s t a g e s :
1 .  M i c r o l e s i o n s  w i t h  m i c r o a n e u r y s m s  w i t h  o r  w i t h o u t  
h a e m o r r h a g e s  a n d  p u n c t a t e  e x u d a t e s .
2 .  M a c r o l e s i o n s :  w a x y  e x u d a t e s  w h i c h ,  s o m e t i m e s ,  c a n  b e  
c i r c i n a t e  b u t  n e v e r  f o r m  a  m a c u l a r  s t a r .
3 .  V e n o u s  c h a n g e s :  a m o n g  w h i c h  v a r i a t i o n  -  i n  b l o o d  v e s s e l  
c a l i b r e ,  i n  t h e  c o u r s e  o f  t h e  m a i n  v e i n s ,  w a s  t h e  e a r l i e s t  
c h a n g e .  I t  t a k e s  t h e  f o r m  o f  i n t e r m i t t e n t  e n l a r g e m e n t  
r a t h e r  t h a n  i n t e r m i t t e n t  c o n s t r i c t i o n .  T h e s e  t w o  a u t h o r s  
a l s o  d e s c r i b e d  i n c r e a s i n g  t o r t o u s i t y  a n d  t h e  f o r m a t i o n  o f  
l o o p s  a s  w e l l  a s  p l e x u s e s  a n d  l e a s h e s  o f  n e w l y  f o r m e d  
v e s s e l s .  I n  t h i s  c a t e g o r y  a l s o  i n c l u d e d  w e r e  p e r i p h l e b i t i s ,  
p h l e b o s c l e r o s i s ,  a n d  i n c r e a s e  i n  h a e m o r r h a g e s  i n  t h e  r e t i n a .
4 .  D e s t r u c t i v e  c h a n g e s :  I n t r a o c u l a r  h a e m o r r h a g e s ,  r e t i n i ­
t i s  p r o l i f é r o n s ,  d e t a c h m e n t  o f  t h e  r e t i n a  a n d  v i t r e o u s ,  a n d  
s e c o n d a r y  g l a u c o m a  c o n s t i t u t e d  t h i s  s t a g e .
5 .  M i x e d  f o r m  i n  w h i c h  t h e  c h a n g e s  o f  a r t e r i o s c l e r o s i s  a n d  
h y p e r t e n s i o n  a r e  a d d e d  t o  t h e  d i a b e t i c  o n e s .
B a l l a n t y n e  a n d  L o w e n s t e i n  t h o u g h t  t h a t  t h e  a b o v e  
c h a n g e s  a p p e a r  i n  a  s e q u e n c e  o f  e v e n t s  i n  t h a t  m a n n e r .
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S c o t t ' s  c l a s s i f i c a t i o n  ( S c o t t  1 9 5 1 ) ,  w h i c h  i s  s t r i c t l y  a  
g r a d i n g  s y s t e m ,  t a k e s  i n t o  c o n s i d e r a t i o n  t h e  d i f f e r e n t  
c o u r s e  d i a b e t i c  r e t i n o p a t h y  m i g h t  t a k e ,  a s  f o l l o w s :
S t a g e  1 . a  : C a p i l l a r y  m i c r o a n e u r y s m s
1 . b  : C h a n g e s  i n  t h e  l a r g e r  v e i n s  l i k e
p h l e b o - s c  l e r o s  i s ,  l o o p s ,  c o i l s ,  a n d  
d  i ' s t e n s  i o n .
S t a g e  2 . a  : P u n c t a t e  h a e m o r r h a g e s  w i t h  o r  w i t h o u t  
d i s c r e t e  f l e c k s  o f  e x u d a t e s .
2 .  b  : L a r g e r  r o u n d  o r  ' b l o t '  h a e m o r r h a g e s
w i t h  c o n f l u e n t  e x u d a t e s .
S t a g e  3 . a  : M o r e  n u m e r o u s  h a e m o r r h a g e s  a n d  
e  x u d a t e s .
3 .  b  : H a e m o r r h a g e s  i n t o  t h e  v i t r e o u s .
S t a g e  4 : R e t i n i t i s  p r o l i f e r a n s ,  r e t i n a l
d e t a c h m e n t  a n d  g r o s s  d e g e n e r a t i v e  
c h a n g e  s .
I n  L e e ' s  ' c l a s s i f i c a t i o n '  ( L e e ,  M c M e e l ,  S c h e p e n s ,  a n d
F i e l d  1 9 6 6 )  f o u r  t y p e s  o f  c h a n g e s  a r e  d e s c r i b e d  :
A n g i o p a t h i c  , e x u d a t i v e ,  p r o l i f e r a t i v e ,  a n d  v i t r e o u s
h a e m o r r h a g e .  An a t t e m p t  w a s  m a d e  t o  c l a s s i f y  a n d  g r a d e
t h e  s e v e r i t y  o f  d i a b e t i c  r e t i n o p a t h y  b y  t a k i n g  a c c o u n t
o f  t h e  a r e a  o f  f u n d u s  a f f e c t e d  b y  e a c h  o f  t h e  r e c o g n i s a b l e
o p h t h a l m o s c o p i c  s i g n s  w h i c h  ma y  b e  p r e s e n t ,  f o r  e x a m p l e
v a s c u l a r  c h a n g e s ,  e x u d a t i o n ,  p r o l i f e r a t i o n  a n d  h a e m o r r h a g e .
E a c h  o f  t h e  s i g n s  w a s  g r a d e d  a s  n o t  p r e s e n t  ( 0 ) ,  m i l d  ( 1 ) ,
m o d e r a t e  ( 2 ) ,  a d v a n c e d  ( 3 ) ,  f a r  a d v a n c e d  ( 4 ) ,  a n d  e n d
s t a g e  ( 5 ) .  T h i s  g r a d i n g  w a s  s p e c i f i c a l l y  d e s i g n e d  f o r
b i n o c u l a r  i n d i r e c t  o p h t h a l m o s c o p y ,  w i t h  i t s  l a r g e  f i e l d
o f  o b s e r v a t i o n ,  a n d  a i m e d  a t  s p e c i f i c a l l y  d e s c r i b i n g  t h e
c o m p o n e n t s  o f  r e t i n o p a t h y  r a t h e r  t h a n  o f  t h e  f u n d u s  a s
a  w h o l e .  T h u s  a  m o r e  m e a n i n g f u l  d e s c r i p t i o n  o f  t h e
s t a t u s  o f  t h e  r e t i n o p a t h y  c o u l d  b e  o b t a i n e d .  I t  a p p e a r s
t o  b e  a n  a d m i r a b l e  g r a d i n g  s c h e m e  f o r  r e c o r d i n g  t h e  
s e v e r i t y  o f  r e t i n o p a t h y  i n  r e l a t i o n  t o  r e s p o n s e  t o
5 7
t r e a t m e n t .  I t  i s  u n d o u b t e d l y  t o o  c o m p l e x  f o r  u s e  i n  a  
s c r e e n i n g  p r o g r a m m e .
I n  h i s  " S y s t e m  o f  O p h t h a l m o l o g y " ,  D u k e - E l d e r  ( 1 9 6 7 )  
c l a s s i f i e s  d i a b e t i c  r e t i n o p a t h y  a s  f o l l o w s :
1 .  P r e - p r o l i f e r a t i v e  s t a g e  c o m p r i s i n g
a .  C h a n g e s  i n  v e i n s  a n d  v e s s e l s  : D i s t e n s i o n  o f  t h e  
l a r g e r  v e i n s  a n d  t h e i r  m a i n  b r a n c h e s .
b .  O t h e r  v i s i b l e  e v i d e n c e  o f  d i a b e t i c  r e t i n o p a t h y  may  
o r  may n o t  b e  p r e s e n t ,
c .  N o r m a l  r e t i n a l  f u n c t i o n s  o t h e r  t h a n  a  d e c r e a s e  o f  
r e t i n a l  a c t i v i t y .
T h e  a r t e r i o - v e n o u  s  r a t i o  c h a n g e s  f r o m  3 : 4  t o  2 : 4 ,  
f u l l n e s s  o f  v e i n s  i s  e s p e c i a l l y  s e e n  i n  y o u n g  d i a b e t i c s  a n d  
c o u l d  b e  r e v e r t e d  w h e n  t h e i r  d i a b e t i c  s t a t e  i s  w e l l  
c o n t r o l l e d  ( L a r s e n  1 9 6 0 ) .
S i m p l e  d i a b e t i c  r e t i n o p a  t h y , c o m p o s e d o f  :
a  • C a p i l l a r y  m i c r o a n s u r y s m s .
b . R e t i n a l  h a e m o r r h a g e s .
c . R e t i n a l  e x u d a t e s .
d . L a t e  c h a n g e s  i n  t h e  r e t i n a l v e i n s .
e  . H y p e r t e n s i v e  a n d  a r t e r i o s c  l e r o t  i c l e s  i o n s .
f  . L i p a e m i a  r e t i n a l i s .
g • X a n t h o s i s  r e t i n a e .
h . P i g m e n t a r y  c h a n g e s .
P r o l i f e r a t i v e  d i a b e t i c r e t i n o p a t h y i  n wh i c h t h e
g r o w i n g  b l o o d v e s s e l s  p a s s i  n t o t h r e e s t a g e s  o f e v o
D o b r e e  19 6 4)  :
3 . 0 N a k e d  v e s s e l s .
b , C o n d e n s a t i o n  o f  c o n n e c t i v e  t i s s u e a  r o u n d  t h e s e
v e s s e I s .
c .  C i c a t r i s a t i o n  a n d  r e c t r a c t i o n  of  f i b r o u s  t i s s u e
V e n o u s  c h a n g e s  w e r e  c o n s i d e r e d  b y  s o m e  t o  o c c u r  a f t e r  
b a c k g r o u n d  r e t i n o p a t h y  i s  r e l a t i v e l y  a d v a n c e d  ( B a l l a n t y n e  
a n d  L o w e n s t e i n  1 9 4 3 ) ,  w h i l e  o t h e r s  n o t e d  t h a t  v e n o u s  c h a n g e s  
m a y  o c c u r  e a r l y  i d  t h e  c o u r s e  o f  r e t i n o p a t h y  o r  e v e n  a s  t h e  
f i r s t  d e t e c t a b l e  s i g n  o f  r e t i n o p a t h y  ( B r o w n  a n d  J o n e s  1 9 6 4 )  
a n d  i n d e p e n d e n t l y  f r o m  o t h e r  b a c k g r o u n d  c h a n g e s  ( S c o t t  
1 9 5 1 ) .  B u r d i t t ,  C a i r d ,  a n d  D r a p e r  ( 1 9 6 8 )  n o t e d  t h a t  v e n o u s  
c h a n g e s  t e n d  t o  r e g r e s s  s p o n t a n e o u s l y  a n d  o c c a s i o n a l l y  
e v o l v e  i n t o  b a c k g r o u n d  r e t i n o p a t h y  b u t  n e v e r  i n t o  p r o l i f e r a ­
t i v e  r e t i n o p a t h y .
A l e s s  c o m p l e x  c l a s s i f i c a t i o n  a n d  o n e  w h i c h  m i g h t  b e  
u s e f u l  f o r  c l i n i c a l  g r a d i n g  w a s  p r o p o s e d  b y  S c u d e r i  ( 1 9 7 3 )  
a s  f o l l o w s :
I  B a c k g r o u n d  r e t i n o p a t h y :
A .  E a r l y .
1 ,  M i c r o a n e u r y s m s ,  p u n c t a t e  h a e m o r r h a g e s .
2 .  P u n c t a t e  r e t i n i t i s .
B .  A d v a n c e d .
1 .  H a e m o r r h a g i c .
2 .  E x u d a t i v e .
C . S e v e  r e .
1 .  R e t i n a l  a n d  p r e r e t i n a l  h a e m o r r h a g e s ,  v e n o u s  
c h a n g e s .
2 .  V i t r e o u s  h a e m o r r h a g e s ,
3 .  V e n o u s  t h r o m b o s i s .
I I  P r o l i f e r a t i v e  r e t i n o p a t h y :
I I I  M i x e d  r e t i n o p a t h y :
A .  D i a b e t i c  a n d  a t h e r o s c l e r o t i c .
B .  D i a b e t i c  a n d  r e n a l .
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Figure 10. Composite fundus photographs. Early
proliferative diabetic retinopathy.
advanced
Figure 11. Composite fundus photograph showing 
advanced proliferative diabetic retinopathy. 
Same patient as in Figure 10, ten months later.
Figure 12. Fundus fluorescein angiography. Areas 
of advanced capillary nonperfusion with proliferation 
of new vessels (leaking fluorescein) at the edge of 
the ischaemic area. Note also leakage of dye (staining)
of blood vessel walls indicated by an arrow.
Figure 13(a). A photograph of iris neovascularisation 
(rubeosis iridis).
F i g u r e  1 3 ( b ) .  F l u o r e s c e i n  i r i d o g r a m ( l a t e  s t a g e ) o f  t h e
s a m e  p a t i e n t  i n  F i g u r e  1 3 ( a )  . S e e  l e a k a g e  
o f  t h e  d y e  f r o m  t h e  i r i s  n e w  v e s s e l s .
Many s y s t e m s  o f  c l a s s i f i c a t i o n  a r e  b a s e d  o n  g r a d i n g  o f  
t h e  c h a n g e s  w h i c h  a r e  s e e n  e i t h e r  o p h t h a l m o s c o p i c a l l y  o r  by  
c o l o u r  p h o t o g r a p h s .
I n  t h e  H a m m e r s m i t h  g r a d i n g  s y s t e m  ( O a k l e y ,  H i l l ,  J o p l i n ,  
K o h n e r ,  a n d  F r a s e r  19  6 7 )  t w e n t y  c o l o u r  p h o t o g r a p h s  s e r v e  a s  
s t a n d a r d s  t o  d e f i n e  f o u r -  d e g r e e s  o f  s e v e r i t y  (A t o  D)  f o r  
e a c h  o f  t h e  f i v e  c o m p o n e n t s  o f  r e t i n o p a t h y .  P a t i e n t ' s  
c o l o u r  p h o t o g r a p h s  a r e  o b t a i n e d  i n  n i n e  p r e - d e t e r m i n e d  p h o ­
t o g r a p h i c  f i e l d s  a r o u n d  a n d  i n c l u d i n g  t h e  o p t i c  d i s c .  
P h o t o g r a p h s  a r e  t h e n  g r a d e d  f o r  e a c h  c o m p o n e n t  o f  r e t i n o ­
p a t h y  b y  c o m p a r i s o n  w i t h  f o u r  d e g r e e s  o f  s e v e r i t y  i n  t h e  
s t a n d a r d  p h o t o g r a p h s .  T h e s e  c o m p o n e n t s  a r e :
1 .  M i c r o a n e u r y s m s  a n d  h a e m o r r h a g e s ;  t h e i r  n u m b e r  i s  
d i r e c t l y  c o u n t e d  i n  t h e  p h o t o g r a p h i c  f i e l d  r e g a r d l e s s  o f  
t h e i r  s i z e .
2 .  E x u d a t e s  -  H a r d  e x u d a t e s  o n l y  a r e  a s s e s s e d  a c c o r d i n g  
t o  t h e  a r e a  o f  r e t i n a  i n v o l v e d  r a t h e r  t h a n  t h e i r  n u m b e r .  
C o t t o n  w o o l  s p o t s  ( s o f t  e x u d a t e s )  a r e  i g n o r e d .
3 .  New v e s s e l s .  T h e s e  a r e  g r a d e d  a c c o r d i n g  t o  t h e  
a r e a  o f  f i e l d  i n v o l v e d .  A l l  a b n o r m a l  v a s c u l a r  c h a n n e l s  
a r e  i n c l u d e d ,  e x c e p t  t h o s e  f o r m i n g  i n  r e l a t i o n  t o  
p r e v i o u s l y  e s t a b l i s h e d  f i b r o u s  r e t i n i t i s  p r o l i f e r a n s ,
4 .  V e n o u s  i r r e g u l a r i t i e s .  D i l a t a t i o n ,  s e g m e n t a l  
i r r e g u l a r i t i e s ,  a n d  s a u s a g i n g  a r e  a s s e s s e d  a c c o r d i n g  t o  
t h e  p e r c e n t a g e  o f  v e i n ,  i n  a  p a r t i c u l a r  f i e l d ,  t h o u g h t  
t o  b e  i n v o l v e d  a n d  g r a d e d  1 - 3 ,  G r a d e s  4 a n d  5 a r e  
r e s e r v e d  f o r  f i e l d s  i n  w h i c h  a l l  t h e  v e i n  i s  t h o u g h t
t o  b e  a b n o r m a l  a c c o r d i n g  t o  t h e  s e v e r i t y  o f  i n v o l v e m e n t  
o f  t h e  v e i n .
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5 .  R e t i n i t i s  p r o l i f e r a n s .  R e g a r d l e s s  o f  t h e  a m o u n t  o f  
i t s  v a s c u l a r  c o m p o n e n t ,  a n y  f i b r o t i c  l e s i o n  i n  f r o n t  o f  
t h e  r e t i n a  i s  g r a d e d  a c c o r d i n g  t o  t h e  a r e a  i n v o l v e d  i n  
a  p a r t i c u l a r  p h o t o g r a p h i c  f i e l d .
G r a d i n g  i n  t h i s  s y s t e m  w a s  d e f i n e d  a s  f o l l o w s ;
G r a d e  0 . . . .  No l e s i o n  -
G r a d e  1 . . . .  L e s s  t h a n  s t a n d a r d  " A " .
G r a d e  2 . . . .  E q u a l  o r  w o r s e  t h a n  "A"  b u t  b e t t e r  t h a n
s t a n d a r d  " B " ,
G r a d e  3 . . . .  E q u a l  o r  w o r s e  t h a n  " B "  b u t  b e t t e r  t h a n  
s t a n d a r d  " C " .
G r a d e  4 . . . .  E q u a l  o r  w o r s e  t h a n  " C "  b u t  b e t t e r  t h a n
s t a n d a r d  " D " .
G r a d e  5 . . . .  E q u a l  o r  w o r s e  t h a n  " D " .
I n  t h e  i n i t i a l  a s s e s s m e n t  o f  t h i s  g r a d i n g  s y s t e m  
o b s e r v e r s  w e r e  d e s i g n a t e d  t h e  " i n s i d e  g r o u p "  i f  t h e y  w e r e  
f a m i l i a r  w i t h  t h e  s y s t e m ,  o r  t h e  " o u t s i d e  g r o u p "  a n d  t h e s e  
w e r e  a s s o c i a t e d  w i t h  L o n d o n  d i a b e t i c  c l i n i c s  o t h e r  t h a n  
H a m m e r s m i t h  H o s p i t a l .  T h e r e  w a s  a  " s a t i s f a c t o r y "  
c o n s i s t e n c y  b e t w e e n  t h e  t w o  g r o u p s  i n  t h e  a s s e s s m e n t  o f  
m i c r o a n e u r y s m s ,  h a e m o r r h a g e s ,  a n d  e x u d a t e s .  A f a i r  
c o n s i s t e n c y  w a s  o b s e r v e d  i n  t h e  a s s e s s m e n t  o f  new v e s s e l s ;  
t h e  o u t s i d e  g r o u p  o f  o b s e r v e r s  m a d e  t w i c e  a s  m a n y  e r r o r s  
t h a n  t h e  i n s i d e  g r o u p  i n  t h i s  r e s p e c t .  T h e  c o n s i s t e n c y  
w a s  h o w e v e r  u n s a t i s f a c t o r y  i n  t h e  a s s e s s m e n t  o f  v e n o u s  
c h a n g e s  a n d  t h e  o u t s i d e  g r o u p  e x p e r i e n c e d  p a r t i c u l a r  
d i f f i c u l t i e s  i n  t h i s  r e s p e c t  ( O a k l e y ,  J o p l i n ,  K o h n e r ,  
a n d  F r a s e r  19 6 8 ) .
I n  my o p i n i o n  t h e  H a m m e r s m i t h  s y s t e m  i s  u s e f u l  p r o v i d e d  
t h e  o b s e r v e r  i s  s a t i s f a c t o r i l y  t r a i n e d .  I t ,  h o w e v e r ,  
r e q u i r e s  a  l o t  o f  t e c h n i c a l  b a c k u p  a n d  f i n a n c i a l  s u p p o r t .
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T h e  A i r l i e  g r a d i n g  s y s t e m  r e p r e s e n t e d  a  j o i n t  e f f o r t  
f r o m  b o t h  t h e  U n i t e d  S t a t e s  a n d  t h e  U n i t e d  K i n g d o m  t o  f i n d  a  
c o m p r e h e n s i v e ,  g e n e r a l l y  a c c e p t e d  c l a s s i f i c a t i o n  a n d  g r a d i n g  
s y s t e m  f o r  d i a b e t i c  r e t i n o p a t h y  ( D a v i s ,  N o r t o n  a n d  M y e r s  
1 9 6 8 ) .  T h e  A i r l i e  s y s t e m  p r o p o s e s  m o r e  e x t e n s i v e  r e c o r d i n g  
m e t h o d s  a n d  p a t i e n t  e v a l u a t i o n  t h a n  a n y  o t h e r  s y s t e m  ( d i r e c t  
a n d  i n d i r e c t  o p h t h a l m o s c o p y ,  s l i t - l a m p  b i o m i c r o s c o p y  o f  t h e  
r e t i n a ,  f u n d u s  d i a g r a m s ,  a n d  w h e r e  i n d i c a t e d ,  d e t a i l e d  w r i t t e n  
d e s c r i p t i o n s ) .  T h e  l i s t  o f  c o m p o n e n t s  o f  r e t i n o p a t h y  
f o r  g r a d i n g  i s  m o r e  c o m p r e h e n s i v e  t h a n  t h a t  o f  a n y  o t h e r  
s y s t e m .  C o m p o n e n t s  a m e n a b l e  t o  p h o t o g r a p h i c  a s s e s s m e n t  a r e  
g r a d e d  b y  r e f e r e n c e  t o  o n e  s t a n d a r d  c o l o u r  p h o t o g r a p h ;  g r a d e  
2 ,  c o m p o n e n t s  m o r e  s e v e r e  t h a n  s t a n d a r d  p h o t o g r a p h .  O t h e r  
c o m p o n e n t s  a r e  g r a d e d  b y  r e f e r e n c e  t o  s t a n d a r d  w r i t t e n  
d e s c r i p t i o n s .
T h i s  s y s t e m  w a s  f u r t h e r  m o d i f i e d  ( D i a b e t i c  R e t i n o p a t h y  
S t u d y  R e s e a r c h  G r o u p  1 9 8 1 )  b y  t h e  a d d i t i o n  o f  s u b d i v i s i o n s  
t o  t h e  o r i g i n a l  g r a d i n g ;  i t  w a s  u n c e r t a i n  w h e t h e r  a l l  c o m ­
p o n e n t s  l i s t e d  i n  t h i s  s y s t e m  c o u l d  b e  a c c u r a t e l y  g r a d e d  by  
d i f f e r e n t  o b s e r v e r s  ( K o h n e r  19  6 8 ) .  T h i s  s y s t e m  h a s  h o w e v e r ,  
e n a b l e d  t h e  p e o p l e  i n v o l v e d  i n  t h e  a s s e s s m e n t  o f  t h e  e f f e c t s  
o f  p h o t o c o a g u l a t i o n  t h e r a p y  o n  d i a b e t i c  r e t i n o p a t h y  t o  
p e r f o r m  a c c u r a t e  s t a t i s t i c a l  a n a l y s e s  o f  t h e i r  r e s u l t s .
W i t h o u t  t h i s  s y s t e m  i t  w o u l d  p r o b a b l y  n o t  h a v e  b e e n  p o s s i b l e  
t o  r e a c h  t h e  c o n c l u s i o n  t h a t  p h o t o c o a g u l a t i o n  i s  o f  v a l u e  
i n  t h e  t h e r a p y  o f  d i a b e t i c  r e t i n o p a t h y .  F o r  s o m e  p u r p o s e s  
I a n d  i n  p a r t i c u l a r  t h e  s c r e e n i n g  o f  d i a b e t i c  p a t i e n t s  f o r  
t h e  p r e s e n c e  o r  a b s e n c e  o f  s i g h t - t h r e a t e n i n g  r e t i n o p a t h y  
a  s i m p l e r  c l a s s i f i c a t i o n  a n d  g r a d i n g  s y s t e m  may  b e  
a p p r o p r  i a t e .
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F o r  s c r e e n i n g  p u r p o s e s  t h e  f o l l o w i n g  c l a s s i f i c a t i o n  
w h i c h  i s  u s e d  i n  t h e  T e n n e n t  I n s t i t u t e  o f  O p h t h a l m o l o g y  h a s  
b e e n  f o u n d  s a t i s f a c t o r y .
1 .  No r e t i n o p a t h y .  ■ P a t i e n t s  w i t h  g o o d  v i s u a l  a c u i t y  i n  
whom n o  d i a b e t i c  r e t i n o p a t h y  i s  f o u n d  o n  f u n d u s c o p y  
a n d  w h o  f a i l  t o . s h o w  c h a n g e s  o n  f l u o r e s c e i n  a n g i o ­
g r a p h y  a r e  i n c l u d e d  u n d e r  t h i s  h e a d i n g .
2 .  B a c k g r o u n d  r e t i n o p a t h y .  C h a r a c t e r i s e d  b y  t h e  p r e s e n c e  
o f  o n e  o r  a  c o m b i n a t i o n  o f  m i c r o a n e u r y s m s ,  s c a t t e r e d  
s m a l l  h a r d  e x u d a t e s ,  a n d  s c a t t e r e d  h a e m o r r h a g e s  w i t h  
r e t e n t i o n  o f  g o o d  v i s u a l  a c u i t y .
3 .  E x u d a t i v e  r e t i n o p a t h y .
( a )  Ma n y  s m a l l  o r  l a r g e  h a r d  e x u d a t e s  e n c r o a c h i n g
u p o n  t h e  m a c u l a  a n d  c a u s i n g  d e t e r i o r a t i o n  o f
v i s u a l  a c u i t y  o r  t h r e a t e n i n g  t o  d o  s o .
( b )  D i a b e t i c  m a c u l a r  o e d e m a ;  i n  t h e  f o r m  o f
f o c a l  o f  c y s t o i d  o e d e m a  c a u s i n g  d e t e r i o r a t i o n
o f  v i s u a l  a c u i t y ,
4 .  I s c h a e m i c  r e t i n o p a t h y  ( F i g .  1 2 ) .  C o t t o n  w o o l  s p o t s ,  
l a r g e  a r e a s  o f  c a p i l l a r y  n o n p e r f u s i o n  o n  f l u o r e s c e i n  
a n g i o g r a p h y ,  p r e s e n c e  o f  g h o s t  v e s s e l s ,  r u b e o s i s  
i r i d i s  ( F i g .  1 3 ) ,  v e n o u s  l o o p s  o r  b e a d i n g  a n d  
m u l t i p l e  a r e a s  o f  i n t r a r e t i n a l  m i c r o v a s c u l a r  
a b n o r m a l i t i e s  ( I R M A ) .  T h i s  m i g h t  b e  a s s o c i a t e d  w i t h  
r e t e n t i o n  o f  g o o d  v i s u a l  a c u i t y .
5 .  P r o l i f e r a t i v e  r e t i n o p a t h y .  D e t e c t e d  o n  o p h t h a l m o s c o p y  
a n d / o r  f l u o r e s c e i n  a n g i o g r a p h y .  P r o l i f e r a t i n g  b l o o d  
v e s s e l s  a r e  s e e n  o n  t h e  o p t i c  d i s c  a n d / o r  t h e  r e t i n a  
w i t h  o r  w i t h o u t  r u b e o s i s  o f  t h e  i r i s .  T h i s  a l s o  
m i g h t  b e  a s s o c i a t e d  w i t h  r e t e n t i o n  o f  g o o d  v i s u a l  
a c u i t y .
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6 .  E n d - s t a g e  r e t i n o p a t h y .  M a n i f e s t e d  b y  a n  u n r e s o l v i n g  
v i t r e o u s  h a e m o r r h a g e ,  p r o l i f e r a t i o n  o f  f i b r o u s  t i s s u e ,  
r e t i n a l  d e t a c h m e n t ,  o r  r u b e o t i c  g l a u c o m a .
T h i s  c l a s s i f i c a t i o n  i n c l u d e s  a n  " i s c h a e m i c "  c a t e g o r y  w h i c h  
w o u l d  o b v i o u s l y  n e c e s s i t a t e  a  c l o s e  w a t c h  o n  t h e  p r o g r e s s  o f  
t h e  r e t i n o p a t h y  b e c a u s e  - i t  i s  i n  t h i s  g r o u p  o f  p a t i e n t s  t h a t  
a  b e t t e r  c o n t r o l  o f  t h e  d i a b e t i c  s t a t e  m i g h t  c a u s e  a r r e s t  
o r  e v e n  r e v e r s a l  o f  t h e  c h a n g e s  ( I r s i g l e r ,  K r i t z ,  N a j e m n i k ,  
a n d  F r e y l e r  1 9 7 9 )  w h i l e  a  p e r s i s t e n t  h y  p e  r g l y c a e m i  a  m i g h t  
l e a d  t o  a  r a p i d  d e t e r i o r a t i o n  o f  t h e  r e t i n o p a t h y  a n d  
a p p e a r a n c e  o f  n e o v a s c u l a r i s a t i o n .
F o r  s c r e e n i n g  p u r p o s e s  a  v e r y  s i m p l e  g r a d i n g  s y s t e m  w a s  
u s e d  n a m e l y  d i v i s i o n  o f  p a t i e n t s  i n t o  s e r i o u s  a n d  n o n -  
s e r i o u s  r e t i n o p a t h y .  T h e  p u r p o s e  o f  t h i s  g r a d i n g  w a s  t o  
m a k e  i t  s i m p l e  f o r  r e l a t i v e l y  u n t r a i n e d  o b s e r v e r s  t o  d e c i d e  
w h e t h e r  o r  n o t  a  p a t i e n t ' s  r e t i n o p a t h y  w a s  a  " s i g h t -  
t h r e a t e n i n g "  r e t i n o p a t h y  a n d  n e e d e d  f u r t h e r  i n v e s t i g a t i o n  
w i t h  a  v i e w  t o  p o s s i b l e  l a s e r  t h e r a p y .
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3 . 3 .  NATURAL HI S TORY OF D I A B E T I C  RETINOPATHY
3 . 3 . a .  I n t r o d u c t i o n
T o  s t u d y  t h e  n a t u r a l  h i s t o r y  o f  u n t r e a t e d  d i a b e t i c  r e t i ­
n o p a t h y ,  i t  ma y  b e  c o n v e n i e n t  t o  c o n s i d e r  s o m e  o f  t h e  v a r i a b l e s  
w h i c h  may  c o n t r i b u t e  t o  t h e  f r e q u e n c y  a n d  e v o l u t i o n  o f  
d i a b e t i c  r e t i n o p a t h y .
I n  s p i t e  o f  t h e  v a s t  a m o u n t  o f  l i t e r a t u r e  o n  d i a b e t i c  
r e t i n o p a t h y  i t  i s  n o t  e x a c t l y  k n o w n  w h a t  p r e c i s e  r o l e  t h e  
d u r a t i o n  o f  m e t a b o l i c  d i s o r d e r ,  t h e  a g e  a t  w h i c h  t h e  
d i s o r d e r  f i r s t  a p p e a r s ,  t h e  l i n e  o f  m a n a g e m e n t  a d o p t e d  f o r  
e a c h  d i a b e t i c  p a t i e n t ,  t h e  s e v e r i t y  o f  t h e  d i a b e t i c  s t a t e ,  
o r  t h e  e x i s t e n c e  o f  h i g h  b l o o d  p r e s s u r e ,  p r e g n a n c y ,  a n d  
o t h e r  f a c t o r s ,  l i k e  s m o k i n g ,  p l a y  i n  t h e  a p p e a r a n c e  a n d  
p r o g r e s s i o n  o f  d i a b e t i c  r e t i n o p a t h y .
3 . 3 . b .  V a r i a t i o n  w i t h  S e x
No s t u d y  s h o w s  a n y  s u b s t a n t i a l  s e x  d i f f e r e n c e  i n  t h e  
p r o p o r t i o n  o f  d i a b e t i c s  w i t h  r e t i n o p a t h y .  A p a r t i c u l a r l y  
l o w  f r e q u e n c y  a n d  s e v e r i t y  o f  r e t i n o p a t h y  i n  d i a b e t i c  m a l e s  
o v e r  59  y e a r s  o f  a g e  h a s ,  h o w e v e r ,  b e e n  r e p o r t e d  ( N i l s s o n ,  
N i l s s o n ,  F r o s t b e r g ,  a n d  o t h e r s  1 9 6 7 ) .  S e f t e l  a n d  W a l k e r  
( 1 9 6 6 )  a l s o  f o u n d  t h a t  r e t i n o p a t h y  i s  m o r e  c o m m o n  i n  w o m e n .  
B l i n d n e s s  f r o m  d i a b e t e s  i s  f a r  m o r e  c o m m o n  a m o n g  b l a c k  w o m e n  
i n  t h e  U n i t e d  S t a t e s ,  t h a n  a m o n g  b l a c k  m e n  a l t h o u g h  m u c h  o r  
a l l  o f  t h i s  d i f f e r e n c e  may  b e  d u e  t o  h i g h e r  f r e q u e n c y  o f  
d i a b e t e s  a m o n g  b l a c k  w o m e n  ( K a h n  a n d  B r a d l e y  1 9 7 5 ) .  I n  
s o m e  c o m m u n i t i e s  ( G h a f o u r ,  A l l a n ,  a n d  F o u l d s  19 8 3 )  w o m e n  may 
p r e d o m i n a t e  a m o n g  t h e  d i a b e t i c  b l i n d  p e r h a p s  o n l y  b e c a u s e  
w o m e n  f o r m  a  g r e a t e r  p r o p o r t i o n  o f  o l d e r  d i a b e t i c s  a m o n g  
whom r e t i n o p a t h y  i s  m o r e  c o m m o n .  T h i s  p e r h a p s  i s  d u e  t o
t h e  f a c t  t h a t  d i a b e t i c  m e n  d i e  a t  a n  e a r l i e r  a g e  t h a n  
d i a b e t i c  w o m e n .
3 . 3 . C .  E f f e c t  o f  a g e  a t  d i a g n o s i s  a n d  d u r a t i o n  o f  d i a b e t e s
I t  h a s  b e e n  a c c e p t e d  t h a t  d i a b e t i c  r e t i n o p a t h y  i s  
i n f r e q u e n t  i n  p e r s o n s  w i t h  j u v e n i l e - o n s e t  i n s u l i n - d e p e n d e n t  
d i a b e t e s ,  w i t h i n  t ' h e  f i r s t  f e w  y e a r s  a f t e r  t h e  o n s e t  o f  t h e  
d i s e a s e ,  b u t  b e c o m e s  m o r e  p r e v a l e n t  w i t h  i n c r e a s i n g  d u r a t i o n  
( C a i r d ,  G a r r e t t  1 9 6 3 ;  C a i r d ,  P i r i e ,  a n d  R a m s e l l  1 9 6 9 ;  M i k i ,  
F u k u d a ,  K u z u y a ,  a n d  o t h e r s  1 9 6 9 ) ,  I n  a  r e c e n t  s t u d y  ( D o r f ,  
E l m e r ,  B a l l i n t i n e ,  a n d  o t h e r s  1 9 7 6 )  n o  r e l a t i o n  b e t w e e n  t h e  
a g e  o f  o n s e t  o f  d i a b e t e s  a n d  t h e  f r e q u e n c y  o f  d i a b e t i c  
r e t i n o p a t h y  h a s  b e e n  f o u n d ,
M a l o n e ,  v a n  C a d e r ,  a n d  E d w a r d s  ( 1 9 7 7 )  r e p o r t e d  t h a t  6 7  
p e r  c e n t  o f  j u v e n i l e  p a t i e n t s  h a d  r e t i n o p a t h y  w i t h i n  o n e  
y e a r  o f  t h e  d i a g n o s i s .  T h e i r  s t u d y  w a s  b a s e d  o n  
o p h t h a l m o s c o p y .  O t h e r  s t u d i e s  b a s e d  o n  o p h t h a l m o s c o p y  h a v e  
s u g g e s t e d  t h a t  o v e r  t h e  a g e  o f  4 0  r e t i n o p a t h y  c a n  s o m e t i m e s  
b e  o b s e r v e d  a t  t h e  t i m e  o f  d i a g n o s i s  o f  d i a b e t e s  ( C a i r d  e t  
a l  1 9 6 9 ) .  T h e r e  a r e  a  f e w  s t u d i e s  o f  p a t i e n t s  o v e r  6 0  
a t  t h e  t i m e  o f  d i a g n o s i s  o f  d i a b e t e s ,  b u t  h e r e  t h e  
f r e q u e n c y  i n  t h e  f i r s t  5 y e a r s  a f t e r  d i a g n o s i s  i s  h i g h e r  
t h a n  i n  j u v e n i l e - o n s e t  d i a b e t e s  a n d  i n c r e a s e s  t o  r e a c h  
6 0  p e r  c e n t  o r  s o  a f t e r  1 5  y e a r s  ( B u r d i t t ,  C a i r d ,  a n d  D r a p e r  
1 9 6 8 )  .
S t u d i e s  b a s e d  o n  t h e  u s e  o f  f l u o r e s c e i n  a n g i o g r a p h y  h a v e  
f o u n d  l o w e r  r a t e s  o f  r e t i n o p a t h y  i n  t h e  e a r l y  y e a r s  a f t e r  
t h e  o n s e t  o f  d i a b e t e s ;  p r e v e l a n c e  r a t e  o f  z e r o  p e r  c e n t  
a f t e r  z e r o  t o  f o u r  y e a r s ,  27  p e r  c e n t  f o r  f i v e  t o  n i n e  
y e a r s ,  a n d  71 p e r  c e n t  f o r  m o r e  t h a n  t e n  y e a r s  ( P a l m b e r g ,  
W a l t m a n ,  K r u p i n ,  a n d  o t h e r s  19 7 9 ;  F r a n k ,  H o f f m a n ,  P o d g o r ,  
a n d  o t h e r s  1 9 8 0 ) .
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C o m m e n t
I t  d o e s  n o t  s e e m  t h a t  a  l a r g e  p r o p o r t i o n  o f  d i a b e t i c  
p a t i e n t s  w o u l d  h a v e  d i a b e t i c  r e t i n o p a t h y  w i t h i n  a t  l e a s t  
t h e  f i r s t  f e w  y e a t ' s  a f t e r  t h e  d i a g n o s i s  o f  d i a b e t e s  i s  m a d e .
T h e  o b s e r v a t i o n  o f  M a l o n e  e t  a l  ( 1 9 7 7 )  w a s  s h o w n  t o  b e  
i n v a l i d  ( F r a n k  e t  a l  1 9 8 0 )  s i n c e  t h a t  s t u d y  w a s  c a r r i e d  o u t  
b y  i n e x p e r i e n c e d  p h y s i c i a n s  w h o  w e r e  n o t  q u i t e  c a p a b l e  o f  
i n t e r p r e t a t i o n  o f  m a n y  f u n d u s  c h a n g e s .  M a l o n e  e t  a l  ( 1 9 7 7 )  
i n t e r p r e t e d  m i n o r  r e t i n a l  c h a n g e s ,  n o t  d u e  t o  d i a b e t e s ,  a s  
b e i n g  s i g n s  o f  d i a b e t i c  r e t i n o p a t h y .  T h i s  w o r k  i s  a n  
i n d i c a t i o n  o f  t h e  b e n e f i t s  o f  p r o p e r l y  t r a i n i n g  i n d i v i d u a l s  
i n v o l v e d  i n  t h e  s c r e e n i n g  a n d  d e t e c t i o n  o f  d i a b e t i c  r e t i n o p a t h y  
D i a b e t i c  m i c r o a n g i o p a t h y  i s  b e l i e v e d  t o  b e  a  f u n c t i o n  o f  
t h e  d u r a t i o n  o f  t h e  m e t a b o l i c  d i s o r d e r  i n  d i a b e t e s  ( G a r n e r
1 9 8 2 ) .  A l m o s t  a l l  s t u d i e s  o n  t h e  p r e v a l e n c e  o f  d i a b e t i c  
r e t i n o p a t h y  h a v e  s t r e s s e d  t h e  i n f l u e n c e  o f  t h e  d u r a t i o n  o f  
d i a b e t e s  o n  t h e  d e v e l o p m e n t  a n d  p r o g r e s s  o f  d i a b e t i c  
r e t i n o p a t h y ,  i r r e s p e c t i v e  o f  t h e  r a c i a l ,  e n v i r o n m e n t a l ,  
d i e t a r y  h a b i t s  o r  o t h e r  f a c t o r s  a m o n g  t h e  s a m p l e  o f  
p a t i e n t s  s t u d i e d .
A p o s i t i v e  r e l a t i o n  b e t w e e n  t h e  p r e v a l e n c e  o f  
d i a b e t i c  r e t i n o p a t h y  a n d  t h e  d u r a t i o n  o f  d i a b e t e s  w a s  
r e p o r t e d  i n  J a p a n e s e  d i a b e t i c s  ( M i k i  e t  a l  1 9 6 9 ) ,  P i m a  
I n d i a n s  ( D o r f  e t  a l  1 9 7 6 ;  W e s t ,  E r d r e i c h ,  a n d  S t o b e r  1 9 8 0 ) ,  
A m e r i c a n s  ( K a h n  a n d  B r a d l e y  1 9 7 5 ;  F r a n k  e t  a l  1 9 8 0 ) ,  
a n d  P o r t u g e s e  ( C u n h a - V a z , F o n s e c a ,  d e  A b r e u ,  a n d  R u a s  1 9 7 8 ) .
A p r e v a l e n c e ,  i n c o r r e c t l y  t e r m e d  i n c i d e n c e ,  a s  l o w  a s  
4 . 6  p e r  c e n t  w a s  r e p o r t e d  a m o n g  N i g e r i a n  d i a b e t i c s  
( O s u n t o k u n  1 9 6 9 )  a n d  w a s  r e l a t e d  n o t  o n l y  t o  d u r a t i o n  o f  
d i a b e t e s  b u t  i n  a d d i t i o n  t o  a  p o s s i b l e  a l t e r a t i o n  i n  t h e  
i m m u n o l o g i c a l  s y s t e m  o r  t o  d i e t a r y  h a b i t s  o f  t h e  p o p u l a t i o n
i n  t h a t  c o u n t r y  w h i c h  i n c l u d e  f o r  a n  a v e r a g e  N i g e r i a n  m u c h  
u n s a t u r a t e d  v e g e t a b l e  f a t s  a s  w e l l  a s  a  l i b e r a l  q u a n t i t y  o f  
c a r b o h y d r a t e s ,  v e g e t a b l e s ,  a n d  p u l s e s  b u t  l i t t l e  p r o t e i n  a n d  
i t  w a s  t h o u g h t  t h a t  t h i s  d i e t  a l s o  c o n t r i b u t e d  t o  t h e  l o w  
s e r u m  c h o l e s t e r o l  f o u n d  i n  m o s t  N i g e r i a n  d i a b e t i c s .
V e g e t a b l e  f a t s  h a v e  b e e n  f o u n d  t o  c a u s e  a  d e c r e a s e  i n  t h e  
n u m b e r  a n d  s i z e  o f  h a r d  e x u d a t e s  i n  p t i e n t s  w i t h  d i a b e t i c  
r e t i n o p a t h y  ( K i n g ,  D o b r e e ,  K o k , a n d  o t h e r s  19 6 3 ) .
I n  t h e  U n i t e d  K i n g d o m ,  t h e  r e l a t i o n  b e t w e e n  d u r a t i o n  
o f  d i a b e t e s  a n d  d i a b e t i c  r e t i n o p a t h y  h a s ,  a s  w o u l d  b e  
e x p e c t e d ,  b e e n  d o c u m e n t e d  a n d  i n  a  s t u d y  c a r r i e d  o u t  b y  
t h e  a u t h o r  a  l i n e a r  a n d  p o s i t i v e  c o r r e l a t i o n  b e t w e e n  t h e  
p r e v a l e n c e  o f  d i a b e t i c  r e t i n o p a t h y  a n d  d u r a t i o n  o f  t h e  
d i s e a s e  a m o n g  d i a b e t i c s  a t t e n d i n g  a  G e n e r a l  H o s p i t a l  d i a b e t i c  
c l i n i c  h a s  b e e n  f o u n d  ( s e e  C h a p t e r  7 ) .
3 . 3 . d ,  I n f l u e n c e  o f  d i a b e t i c  c o n t r o l
R e p o r t s  i n  t h e  l i t e r a t u r e  o n  t h e  e f f e c t s  o f  g o o d  
d i a b e t i c  c o n t r o l  o n  t h e  p r e v a l e n c e  o f  d i a b e t i c  r e t i n o p a t h y  
a n d  o n  i t s  p r o g r e s s i o n  a r e  c o n f l i c t i n g .
O b s e r v a t i o n  o f  4 , 4 0 0  d i a b e t i c s  f o r  m o r e  t h a n  2 0  y e a r s  
h a s  s u g g e s t e d  t h a t  b e t t e r  c o n t r o l  o f  d i a b e t e s  f a v o u r a b l y  
i n f l u e n c e s  t h e  c h a n c e s  o f  d e v e l o p m e n t  o f  d i a b e t i c  
r e t i n o p a t h y  ( P i r a r t  1 9 7 7 ) .  G o o d  c o n t r o l  o f  t h e  d i a b e t i c  
s t a t e ,  s p e c i a l l y  d u r i n g  t h e  f i r s t  5 y e a r s  a f t e r  d i a g n o s i s ,  
h a s  a l s o  b e e n  c l a i m e d  t o  d e l a y  t h e  o n s e t  o f  r e t i n o p a t h y  by  
a p p r o x i m a t e l y  t w o  a n d  a  h a l f  y e a r s  e s p e c i a l l y  i n  y o u n g  
d i a b e t i c s  ( C a i r d  e t  a l  1 9 6 9 ) .
I n  r e c e n t  y e a r s  t h e r e  h a s  b e e n  i n c r e a s i n g  e v i d e n c e  t h a t  
m a i n t a i n i n g  a  p a t i e n t  i n  a  n e a r  n o r m o g l y c a e m i c  s t a t e ,  w h e t h e r  
b y  c o n t i n u o u s  s u b c u t a n e o u s  i n s u l i n  i n f u s i o n ,  C S I  I  ( P i c k u p  
19 8 2 ) ,  o r  o t h e r  m e a n s  f o r  a s  l o n g  a s  p o s s i b l e  may r e t a r d  t h e
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a p p e a r a n c e  o f  d i a b e t i c  r e t i n o p a t h y  ( C a h i l l ,  E t z w i l e r ,  a n d  
F r i e n k e l  1 9 7 6 ;  J o n e s ,  C a r t e r ,  H a i t a s  a n d  M a n n  1 9 8 3 )  a n d  i m p r o v e  
e y e  a n d  k i d n e y  f u n c t i o n  ( S t e n o  S t u d y  G r o u p  1 9 8 2 ) .  I n  a  s t u d y  
i n v o l v i n g  2 8 9  J a p a ' h e s e  d i a b e t i c s ,  M i k i  a n d  c o - w o r k e r s  f o u n d  
t h a t  p r o g r e s s i o n  o f  r e t i n o p a t h y  w a s  s i g n i f i c a n t l y  m o r e  f r e ­
q u e n t  i n  t h e  f a i r  a n d  p o o r  c o n t r o l  g r o u p  t h a n  i n  t h e  g o o d  
c o n t r o l  g r o u p  ( M i k i  e t  a l  1 9 6 9 ) .  O t h e r  w o r k e r s  r e p o r t e d  
a n  a l m o s t  l i n e a r  c o r r e l a t i o n  b e t w e e n  t h e  s e v e r i t y  o f  
r e t i n o p a t h y  a t  t h e  t i m e  o f  e x a m i n a t i o n  a n d  m e a n  b l o o d  s u g a r  
l e v e l  ( H a r d i n ,  J a c k s o n ,  J o h n s t o n ,  a n d  K e l l y  19 5 6 ;  S z a b o  
1 9 7 0 ) ,  a n d  s t u d i e s  b y  v i t r e o u s  f  l u o r o p h o t o m e  t r y  C u n h a - V a z ,  
d e  A b r e u ,  C a m p o s ,  a n d  F i g o  1 9 7 5 )  o n  b l o o d  r e t i n a l  b a r r i e r  
h a v e  s h o w n  t h a t  t h e  d e g r e e  o f  b r e a k d o w n  o f  t h e  b l o o d  
r e t i n a l  b a r r i e r ,  n o t  o n l y  c o r r e l a t e d  w i t h  t h e  d u r a t i o n  
o f  t h e  d i a b e t e s  b u t  w a s  a c c e l e r a t e d  by  p o o r  m e t a b o l i c  
c o n t r o l  ( C u n h a - V a z ,  F o n s e c a ,  d e  A b r e u ,  a n d  R u a s  1 9 7 8 ) .
E v e n  a  r e v e r s a l  o f  s o m e  s e r i o u s  f o r m s  o f  d i a b e t i c  r e t i ­
n o p a t h y  a f t e r  s t r i c t  c o n t r o l  o f  h y p e r g l y c a e m i a  h a s  b e e n  
r e p o r t e d .  T h u s  m a c u l o p a t h y  d i s a p p e a r e d  i n  a  p a t i e n t  6 5  d a y s  
a f t e r  C S I I  ( W h i t e ,  K o h n e r ,  P i c k u p ,  a n d  K e e n  1 9 8 1 ) ,  a n d  a  
r e v e r s a l  o f  f l o r i d  p r o l i f e r a t i v e  c h a n g e s  h a s  b e e n  n o t e d  
a f t e r  a  f e w  m o n t h s  o f  s t r i c t  d i a b e t i c  c o n t r o l  ( I r s i g l e r  
e t  a l ,  1 9 7 9 ) ,  a l t h o u g h  t h i s  h a s  b e e n  c h a l l e n g e d  r e c e n t l y  
( L a w s o n ,  C h a m p i o n ,  C a n n y  e t  a l  1 9 8 2 ) .
I t  h a s  a l s o  b e e n  f o u n d  t h a t  p o o r  c o n t r o l  o f  d i a b e t e s  i s  
a s s o c i a t e d ,  i n  a d d i t i o n  t o  h y p e  r g  l y c a e m i  a ,  w i t h  h i g h e r  
l e v e l s  o f  p l a s m a  l i p i d s  ( S o s e n k o ,  B r e s l o w ,  M i e t t i n e n ,  a n d  
G a b b a y  1 9 8 0 ) ,  a n d  t h a t  r e s t o r a t i o n  o f  n o r m a l  l i p i d  a n d  a m i -  
n o a c i d  m e t a b o l i s m  w a s  a c h i e v e d  by  t h e  e s t a b l i s h m e n t  o f  a  
n e a r  n o r m o g l y c a e m i c  s t a t e  ( T a m b o r l a n e ,  S h e r w i n ,  G e n e l ,  a n d  
F e l i g ,  1 9 7 9 ) .
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S o m e  a n i m a l  s t u d i e s  s u p p o r t  t h e  v i e w  t h a t  p o o r  d i a b e ­
t i c  c o n t r o l  i s  i m p o r t a n t  i n  t h e  i n i t i a t i o n  a n d  e v o l u t i o n  o f  
d i a b e t i c  r e t i n o p a t h y  ( E n g e r m a n ,  B l o o d w o r t h ,  a n d  N e l s o n  
1 9 7 7 ) ,
S o me  o t h e r  r e p o r t s  h a v e  h o w e v e r  f a i l e d  t o  e s t a b l i s h  t h e  
b e n e f i c i a l  e f f e c t s  o f  g o o d  d i a b e t i c  c o n t r o l  o n  t h e  
p r e v a l e n c e  a n d  p r o g r e s s i o n  o f  d i a b e t i c  r e t i n o p a t h y  ( C o n s t a r n  
1 9 6 5 ) .
C o m m e n t
T h e r e  i s  l i t t l e  d o u b t  t h a t  m a i n t e n a n c e  o f  a  n e a r  n o r m o -  
g l y c a e m i c  s t a t e  i n  a  d i a b e t i c  s u b j e c t  d e l a y s  t h e  a p p e a r a n c e  
a n d  p r o g r e s s i o n  o f  d i a b e t i c  r e t i n o p a t h y .  T h i s  s h o u l d  n o t ,  
h o w e v e r ,  b e  a c h i e v e d  a t  t h e  e x p e n s e  o f  t h e  d i a b e t i c  
i n d i v i d u a l ' s  w e l l b e i n g ;  a  d i a b e t i c  s h o u l d  n o t  b e  s u b j e c t e d  
t o  t h e  a d v e r s e  e f f e c t s  n e a r  n o r m o g l y c a e m i  a  m i g h t  c a u s e  
n a m e l y  f r e q u e n t  h y p o g l y c a e m i c  e p i s o d e s .
3 . 3 . e .  C o - e x i s t i n g  h i g h  b l o o d  p r e s s u r e
S o me  a u t h o r s  h a v e  t h o u g h t  t h a t  d i a b e t i c s  h a v e  a n  i n c r e a s e d  
l i a b i l i t y  t o  h y p e r t e n s i o n  a n d  t h a t  d i a b e t i c  h y p e r t e n s i v e s  
a r e  m o r e  l i a b l e  t o  d e v e l o p  r e t i n o p a t h y  t h a n  n o r m o t e n s i v e  
d i a b e t i c s  e s p e c i a l l y  p a t i e n t s  o v e r  t h e  a g e  o f  4 0 .
B a l l a n t y n e  a n d  L o w e n s t e i n  ( 1 9 4 3 )  f o u n d  h y p e r t e n s i o n  i n  5 0  
p e r  c e n t  o f  d i a b e t i c s  s h o w i n g  r e t i n a l  c h a n g e s .  K o r n e r u p  
( 1 9 5 7 )  c o m p a r i n g  a  l a r g e  s e r i e s  o f  d i a b e t i c s  w i t h  n o r m a l  
i n d i v i d u a l s  f o u n d  t h a t  i n  a  g r o u p  u n d e r  t h e  a g e  o f  4 0 ,  
h y p e r t e n s i v e  r e t i n a l  c h a n g e s  w e r e  p r e s e n t  i n  17  p e r  c e n t  o f  
d i a b e t i c s  a n d  i n  6 p e r  c e n t  o f  n o r m a l s .
A r e c e n t  s t u d y  o f  r i s k  f a c t o r s  a m o n g  P i m a  I n d i a n s  o f  
O k l a h o m a  s u b - d i v i d e d  s u b j e c t s  i n t o  t h o s e  wh o  h a d  a  
s y s t o l i c  b l o o d  p r e s s u r e  o f  1 7 0  mm Hg a n d  wh o  d i d  n o t  h a v e
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Figure 14. Fundus photograph. Ischaemic diabetic 
retinopathy in a hypertensive patient 
aged"46 . Many cotton wool spots are 
seen. Retinal arterioles are narrow and 
numerous linear haemorrhages are noted.
proteinuria and those whose systolic blood pressure was 
greater than this. On ophthalmoscopy it was found that 
the prevalence of retinopathy was significantly higher among 
those with raised systolic blood pressure (West and Stober 
1978; West et al 1980). Pima Indians might however not 
represent the diabetic population elsewhere; this might be 
due to the very high prevalence rate among Pima Indians,
It does not seem, however, that either hypertension or 
arteriosclerosis have a "direct" influence on diabetic reti­
nopathy (Oakley, Pyke, Tattersall and others 1974) although 
the retina may become affected by the addition of a hyper­
tensive retinopathy, in which case the components of retino­
pathy referrable to the diabetes and hypertension can be 
separately identified. Cotton wool spots which are 
commonly related to areas of acute ischaemia are not exclu­
sive to hypertensive diabetics (Larsen 1960) since they have 
been shown to exist in normotensive diabetics as well 
(Kohner, Dollery, and Bullpitt 1969). Harrold found that 
increased systemic blood pressure made little difference to the 
appearance of the retina in diabetics with retinopathy 
beyond altering the incidence of linear haemorrhages 
(Harrold 1971), Fig. 14. Others (Knowler, Bennett, and 
Ballantine 1980) reported an increase in hard exudates 
among hypertensive diabetics not treated by insulin.
3.3.f. Pregnancy and diabetic retinopathy
F e m a l e s  w h o  d e v e l o p  d i a b e t e s  d u r i n g  t h e  f i r s t ,  s e c o n d ,  o r  
e v e n  t h e  t h i r d  d e c a d e  o f  t h e i r  l i v e s  a r e  s u s c e p t i b l e  t o  t h e  
d e v e l o p m e n t  o f  d i a b e t i c  r e t i n o p a t h y ,  f o r  t h e  f i r s t  t i m e  
d u r i n g  t h e i r  c h i l d - b e a r i n g  l i f e .
P r e g n a n c y  a n d  d i a b e t e s  c e r t a i n l y  c o m p l i c a t e  e a c h  o t h e r  
I n  m a n y  w a y s .  T h e  s e v e r i t y  o f  c o m p l i c a t i o n s  i n c r e a s e s  w i t h
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the duration of the diabetes and the lack, of consistent 
control. It has been stated that retinopathy and its severity 
correlate with the presence of angiopathy elsewhere in the 
body, and the outcome of pregnancy is related to the pre­
sence of retinopathy and its severity (Caird, et al, 19 69; 
Moloney and Drury 1982).' Beetham ( 19 50) found that during 
63 pregnancies in 44 patients with simple retinopathy, 
there were only 8 instances of marked progression with 
the development of "malignant" retinopathy, and 4 instances 
of progression in 18 pregnancies in 12 women with "malignant" 
ret inopathy.
Since the introduction of photocoagulation and other 
forms of treatment this unfavourable prognosis was altered.
In order to allow most women the option of motherhood, there 
is now agreement (Cassar, Kohner, Hamilton, and others 1978; 
Johnston 1980; Hovart, Maclean, Goldberg, and Crock 1980; 
Singerman 1981) that:
1. Diabetic women should undergo planned pregnancies early 
in life.
2. If proliferative retinopathy is seen prior to 
pregnancy, prompt laser treatment is indicated until the 
disease is quiescent.
3. Treatment should continue during the pregnancy because 
it minimises the risk of severe visual loss.
4. Women whose proliferative retinopathy is in spontaneous 
or laser-induced remission before pregnancy may undertake 
pregnancy and maintain good vision provided that careful 
observation and appropriate laser therapy are available.
5. If proliferative diabetic retinopathy is seen, for the 
first time during pregnancy, prompt laser therapy is indi­
cated.
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6. Consideration of therapeutic abortion is restricted to 
women with progressive proliferation despite treatment.
3.3.g. Effect of smoking
It is not, yet, certain if smoking plays any role in the 
development of diabetic retinopathy.
Because many blood values, including blood viscosity, 
are said to be increased by cigarette smoking {Dintenfass 
1975) and blood viscosity has been found to be increased in 
diabetics with and without retinopathy (Lowe, Lowe,
Drummond, and others 1980), diabetics are therefore advised 
not to smoke.
It has been claimed that the risk of development of 
diabetic retinopathy might be enhanced by cigarette smoking, 
and that it increases relative to the number of cigaret­
tes smoked per day. The same study (Paetku, Boyd, Winship, 
and Grace 1977), which involved 181 patients, of whom 65 
were long-dur at ion cases of twenty or more years, reported 
a significant association between smoking and proliferative 
retinopathy in diabetes of long duration.
Another study on the relation of microangiopathy to 
HLA-associated genetic factors (Gray, Starkey, Rainbow, and 
others 1982) has suggested that smoking is a risk factor in 
the development of diabetic retinopathy and this agrees 
with the finding (Christiansen 1978) that smoking is more 
prevalent among diabetics with microangiopathy than among 
those who did not have signs of angiopathy.
On the other hand, however, an examination of the rela­
tionship between retinopathy and cigarette smoking in a con­
secutive series of 695 Oklahoma Indians with adult-onset 
diabetes (West and Stober 1978) showed strikingly negative
results both for retinopathy and proliferative retinopathy.
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Although smokers had slightly lower levels of blood pressure 
and blood glucose, it did not seem likely that these differ­
ences were sufficient to hide an effect of smoking on retino­
pathy. Similar results were also reported in another study 
which involved 973 diabetics (West, Erdreich, and Stober 1980). 
Summary
It would appear that the development of diabetic retino­
pathy is related to the duration of diabetes, age at diagnosis, 
and the state of diabetic control. It may be made worse by 
pregnancy and possibly systemic hypertension. The roles of 
diet (particularly dietary fat) and smoking are unclear.
3.3.h, Prognosis of untreated diabetic retinopathy
It can be seen from the previous account that it is not 
exactly known what determines the onset, rate of progression, 
or regression, of diabetic retinopathy once diabetes is 
established.
It seems that the presence and site of diabetic retino­
pathy are probably more important than its extent in deter­
mining the prognosis for vision (Caird and Garrett 19 63;
Beetham 19 63; Tamura and Tamura 19 82).
Background retinopathy is the earliest clinically 
recognisable form of diabetic retinopathy; only a small 
proportion of eyes with mild background changes advance 
to the sight threatening forms of retinopathy. Over 
a 5 year period 36 per cent of eyes with microaneurysms 
alone will show spontaneous disappearance of all clinically 
visible lesions and 50 per cent will develop haemorrhages 
and/or exudates (Caird and Garrett 1962). In Bedford,
England, 116 diabetics were discovered in 1962 and were re­
examined in 1967; no microaneurysms were observed initially
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in 26 persons with two hour post load glucose levels of 
2 0 0-239 mg/100 ml (11.1 - 13.3 mmol/L), but 3 had 
microaneurysms five years later. In those with still 
higher blood glucose levels about one quarter had 
microaneurysms after 5 years (Keen 1972). Keen also 
reported that about 8 per cent of the newly discovered 
diabetics with two hour glucose level greater than 13.3 
mmol/L had microaneurysms at the time of discovery of diabe­
tes. In the entire group of 116, 3 developed impairment of 
vision from retinopathy during the first five years of known 
diabetes. Arrest or very slow progression of background 
retinopathy has also been reported by other observers.
Kohner ( 1978) found that 12 out of 106 eyes studied over a 
5-year period deteriorated in vision and the majority did so 
due to the development of cataract rather than worsening of 
the retinopathy itself.
In a large series of patients Burditt, et al. ( 1968) 
observed 3907 eyes of 2184 patients; they showed that in 
patients with microaneurysms alone, the chances of progression 
with the development of haemorrhages or exudates increase, 
with increasing age at diagnosis, from about 40 per cent in 
those 29 and under at diagnosis to over 60 per cent in those 
aged 30 to 59. Regression, on the other hand, of retinopathy 
in these patients with disappearance of all microaneurysms 
to leave normal fundi was less common in older patients than 
in the young. When haemorrhages or exudates were present 
progression with the development of "malignant" retinopathy 
occured in less than 20 per cent of patients and was least 
common in the oldest patients. Regression with disappearance 
of all haemorrhages and exudates to leave either microaneurysms
alone or normal fundi was again commoner in the youngest group
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(40 to 50 per cent), but not infrequent, in the older (15 to 
30 per cent) (Burditt, Caird, and Draper 1968).
Both small hard exudates and haemorrhages may be reduced 
in number and appearance with a better control of the 
hyperglycaemic state or when a co-existing high blood pressure 
is adequately treated (Tamborlane et al 19 79; Knowler et al 
1980; Sosenko et al 1980), Larger hard exudates may take 
many years to resolve (King et al 19 63; Kaback and 
Tanenbaum 1974).
Certain clinical signs indicate that a patient with mild 
retinopathy is in danger of development of the more serious 
forms of retinopathy. An increase in the number of 
haemorrhages, increase in the number and size of hard 
exudates, encroachment of hard exudates upon the fovea, 
appearance of cotton wool spots, venous beading, and clinical 
or subclinical collection of fluid in the macular region all 
herald deterioration of visual acuity and indicate a worse 
prognos is.
The development of diabetic maculopathy with even minor 
damage to vision is a danger sign and tends to involve both 
eyes. It is more common in patients with onset of diabetes 
after the age of 40 and in only about a quarter of those 
with maculopathy is diabetes diagnosed before this age 
(Sigelman 19 80) .
Maculopathy is more commonly seen with Type II than 
with Type I diabetes. In the Hammersmith Hospital, 75 per 
cent of patients with maculopathy had their disease diagnosed 
after the age of 40. In 30 per cent of these patients, the 
known duration of diabetes was 10 years or less. In 25 per 
cent of patients with maculopathy, diabetes was diagnosed 
under the age of 40 (Kohner 1978).
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Kohner (1978) suggested that these younger patients 
fall into three distinct groups. The largest sub-group is 
composed of type I patients with a long duration of diabetes 
(over 15 to 20 years). Most of these patients have impaired 
renal function and in most of them maculopathy decreases 
vision, though rarely beyond 6/36. The final cause of 
visual loss in these patients is usually haemorrhage from new 
vessels.
The second group is composed of either type I or type II 
diabetics who develop maculopathy after diabetes of 
relatively short duration that commonly is poorly controlled. 
Their visual loss is usually not severe, and impeccable 
diabetic control may have marked beneficial effect.
The third sub-group is the smallest. In these patients 
there is a form of macular oedema with little in the way of 
obvious lesions. In contrast to the more common type of 
retinopathy in which leakage becomes more marked in the 
late frames of the angiograms, these patients' capillaries 
all leak fluorescein profusely, even in the capillary stage. 
This type of maculopathy does not usually respond to any 
form of treatment and carries a very bad prognosis for vision 
(Kearns, Hamilton, and Kohner 1979) because neovascularisat ion 
is very soon added to the picture making the outcome even 
worse.
Recently a simpler classification (Blach, Whitelocke, 
and Hamilton 1981) of diabetic maculopathy has been proposed:
1. Focal diabetic maculopathy; This consists of usually 
circinate exudates, microaneurysms, and haemorrhages. 
Oedema is at the centre of the ring exudates and may 
often be present at the macula. Fluorescein angiography 
demonstrates adequate capillary perfusion but areas of
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leakage are seen.
2, Cystoid diabetic maculopathy: This has marked oedema
with cystic changes at the macula. Exudates are not 
a feature, but ’ microaneurysms and haemorrhages occur 
with a marked increase in permeability of the 
capillaries on fluorescein angiography.
3. Ischaemic diabetic maculopathy: This consists of
microaneurysms, haemorrhages, and a few exudates - 
often with macular oedema and cystoid changes together 
with deep retinal haemorrhages. Fluorescein angiography 
reveals areas of capillary nonperfusion in the para­
macular area.
An important factor in further progression, stabilisa­
tion, or regression of diabetic maculopathy is the state of 
perfusion of the perifoveal network ; progression of 
capillary nonperfusion in the perifoveal zone correlated 
with poor visual prognosis (Tamura and Tamura 1982), Good 
final visual acuity without treatment was recorded in 63 
per cent of eyes with diabetic maculopathy and good 
perfusion while poor results were obtained in 100 per cent 
of centrally nonperfusing eyes (Ticho and Patz 19 73).
The appearance of capillary nonperfusion and cotton wool 
spots is a dangerous sign since it signals the development 
of new vessel formation. Cotton wool spots should always 
be regarded as an indicationthat neovascularisation is likely 
to develop in 6 to 12 months.
In addition to capillary nonperfusion other signs of 
retinal ischaemia are large blot haemorrhages, sheets and 
clusters of haemorrhages, sheathed vessels and white lines 
replacing blood vessels. Venous loops (Whittington 19 64) 
may be an additional sign. Regression of venous loops
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however can sometimes occur (Joplin, Oakley, Hill, and 
others 19 67).
New vessels may develop on the disc or in the retinal 
periphery. Those on the disc carry a worse prognosis than 
those in the retina which may remain flat and hardly advance 
at all over a period of "5 years (Beetham 1963).
Haemorrhages complicate disc vessels more readily and 
the subsequent advance to fibrosis makes the prognosis worse 
than in the case of retinal vessels (Diabetic Retinopathy 
Study 1976). Out of 21 untreated eyes followed for 5 
years, 13 lost vision while of 17 eyes with retinal vessels 
only 5 lost vision in 5 years (Kohner 1978). A follow-up 
of patients with moderate and severe proliferative diabetic 
retinopathy for an average of 4 4.3 months showed that one 
third of the patients retained a good level of vision, 
another third were left with a moderate visual acuity of 
6/60 or better, and the rest were almost blind (Spencer, 
McMeel, and Frank 1981).
Regression of neovascularisation has, however, been seen 
in some patients. Gerritzen (1973), see Table 1, in an 8 
year follow-up of 459 diabetic patients with different forms 
of retinopathy, including cases with neovascularisation, 
reported the disappearance of new vessels in some cases.
Proliferative retinopathy more commonly progresses to 
advanced disease if untreated. This depends on changes in 
the vitreous and internal limiting membrane of the retina. 
Neovascularisation passes through three stages of evolution 
(Dobree 1964) in the first of which the newly formed 
vessels, whether on the disc or in the retina are naked; 
fibrous tissue then starts to invest the vessels, second 
stage, and may be seen extending on the detached vitreous;
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recurrent vitreous haemorrhage may take place in this stage 
causing sudden partial or complete loss of vision. A small 
vitreous haemorrhage usually clears up but a severe 
haemorrhage may not be absorbed and may leave permanent 
blindness (Diabetic Retinopathy Study 1979). Ziemianski, 
McMeel, and Franks ( 1980) followed up eighty five eyes with 
severe vitreous haemorrhage at the initial visit and found 
that vision improved in 30 per cent of cases, was unchanged 
in 28 per cent, and worsened in 42 per cent. When, in the 
third stage, the fibrous tissue contracts retinal tears, trac­
tion retinal detachment, and blindness result. Thrombotic 
glaucoma resulting from new vessels growing at the anterior 
chamber angle usually associated with rubeosis of the iris 
is another dangerous development and there are usually areas 
of retinal capillary nonperfusion. These patients have new 
blood vessels at the disc at the same time. Severe visual 
loss occurs and only rarely is a patient left with a visual 
acuity of 6/60 or better.
Period 
(years ) Progression Stationary Amelioration
2 14-29 60-69 7-17
4 32-39 47-57 10-12
6 39-50 40-47 10-1 4
8 48 38 14
Table 1, Follow-up results of untreated diabetic
retinopathy shown as percentages of patients 
with different clinical outcome. From 
Gerritzen 1973.
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CHAPTER 4
PATHOGENESIS OF DIABETIC RETINOPATHY
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4.1. INTRODUCTION ■
The pathogenesis of diabetic retinopathy is poorly 
understood. It is an extremely complex series of changes in 
which many factors contribute to the final picture.
The changes that occur in diabetic retinopathy are not 
unique to diabetes and some are found in other diseases. 
However, it is only in a diabetic fundus that all the 
following features can exist at the same time : Venous dila­
tation, capillary nonperfusion, focal retinal ischaemia, 
proteinaceous and lipid exudates, microaneurysms, retinal 
oedema, haemorrhages, and retinal and optic disc neovascu­
larisation.
Retinal hypoxia seems to be the insult common to diabe­
tic retinopathy and similar diseases (Ashton 1963, 1980).
The suggested mechanisms by which retinal hypoxia is pro­
duced in diabetes are as follows;
1. There is impaired ability of red blood cells to release 
oxygen. This is caused by reduced levels of 2, 3 - 
diphosphoglycerate in erythocytes, which results from 
lowered plasma inorganic phosphate in poorly controlled 
diabetics; this reduction is associated with impaired 
release of oxygen by haemoglobin and may be found in recently 
diagnosed diabetics (Ditzel, Anderson, and Daugaard 1973; 
Standi and Kolb 1973; Ditzel, Hau, and Daugaard 1977),
2. There is an abnormal distribution of haemoglobin A in 
diabetics with increased haemoglobin Ap^. This has a 
greater than normal binding power for oxygen, further 
impairing the diffusion of oxygen to tissue.
3. Insulin insufficiency or insulin-insensitive cells lead 
to shunting of glucose into polyol pathways with accumula­
tion of sorbitol and fuctuse (Gabbay 1973; Rossio,
Morrison, and Winegrad 1-972), Increased osmotic pressure 
from intracellular sorbitol causes cellular oedema, probably 
including oedema of endothelial cells. This may further 
contribute to tissue hypoxia by impaired diffusion.
4, There are changes in blood consisting of altered 
plasma proteins, increased red cell aggregation, altered 
platelet function, and impaired fibrinolytic response.
These changes possibly play a significant role in
the pathogenesis of diabetic retinopathy by impairing blood 
flow in the microcirculation, particularly in the presence 
of thickened capillary basement membrane with a narrowed 
lumen (Ditzel 1967; Little, Sacks, Vassiliades, and Greer
1977) ,
The pathogenesis of diabetic retinopathy will be 
discussed in this chapter under the following headings : 
Microangiopathy, the influence of genetic factors and car­
bohydrate metabolism, the role of growth hormone, and the 
role of some rheological factors.
4.2. MICROANGIOPATHY
Blood vessels in most parts of the body are subject to 
disease as a function of the duration of the metabolic 
defect in diabetes and are at the root of the renal compli­
cations, neuropathy, and tendency to gangrene, as well as 
the retinal disturbance. Largely because the vascular 
complications are far less amenable to therapy that lowers 
the blood sugar than is the metabolic disorder, it was
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suggested that these are distinct aspects of the diabetic 
process under the control of related but separated genes 
(Sabour, MacDonald, and Robson 1962; Siperstein, Unger, and 
Madison 1968). It is difficult to sustain this view 
because angiopathy can also develop in diabetes of other 
types in which genetic factors are not involved 
(Duncan, Macfarlane, and Robson 1958) and is also seen in 
artificially induced diabetes in animals (Bloodworth and 
Molitor 1965), Moreover, microangiopathy develops after 
the onset of diabetes mellitus and may be delayed if the 
carbohydrate metabolism is kept under rigid control (Caird 
et al 1969). Consequently there is good reason to attri­
bute the small vessel involvement to the metabolic abnor­
mality, but the mechanism by which this is brought about 
is still not entirely clear.
Apart from microangiopathy, the larger vessels of 
arterial size are prone to develop excessively severe 
atherosclerosis, and there is evidence that plaque 
formation at the origin of the ophthalmic artery may 
aggravate an established diabetic retinopathy (Garner and 
Ashton 1972), There is however, little that is absolutely 
specific to diabetes in either small or large vessels.
Venous, capillary, and arteriolar changes are early 
manifestations of the diabetic retinopathy process,
4,2.a. VENOUS CHANGES
Dilatation of the veins is one of the early changes in 
the process of diabetic retinopathy and may amount to about 
10% in some patients (Skovborg, Nielson, Lauritzen, and
Hartkopp 1969). Initially, the dilatation appears to be 
functional since it may be reversed with improved control of 
the diabetic state (Larsen 1960), but eventually the abnor­
mality is likely to become fixed as sclerotic changes take 
place within the wall.
At one time it was usual to regard the venous dilatation 
as indicating a venous stasis retinopathy. If this is the 
case, failure to detect any sign of structural impediment to 
outflow would mean that any stasis must be due to a func­
tional disturbance, such as hyperviscosity or sluggish per­
fusion due to arteriolar inadequacy in a manner comparable 
to the venous stasis retinopathy associated with carotid 
artery disease (Kearns and Hollenhorst 1963). Demonst­
rations of increased blood flow in early diabetic 
retinopathy (Kohner, Hamilton, Saunders, Sutcliff, and 
Bulpitt 1975), however, are opposed to any concept of stasis 
from whatever cause and the mechanism of venous dilatation 
remains unexplained. There is a distinct possibility, 
nevertheless, of its being a reflection of the increased 
blood flow shown to be prominent in early diabetic retino­
pathy ,
4.2.b. CAPILLARY CHANGES
The capillary changes which can be recognised clinically 
are, dilatation, which can be generalised or localised, 
and capillary closure.
[Capillary dilatation
Capillary dilatation is evidenced by the finding of an
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increase of blood flow in minimal and preclinical retino­
pathy and in recently diagnosed diabetes (Kohner et al
1975). It is also found in maculopathy and sometimes in 
young diabetics with early proliferative retinopathy and 
is usually associated with capillary closure.
Capillary dilatation on fluorescein angiography is an 
early change in diabetic retinopathy and may occur in the 
absence of other signs.
It is possible that vasodilatation and increased blood 
flow are both autoregulatory mechanisms to compensate for an 
abnormal metabolsim and/or increased hypoxia since it has been 
found that increased retinal blood flow is associated with 
raised levels of blood glucose (Atherton, Hill, Keen, Young, 
and Edwards 1980), and with lactic acid accumulation (Keen and 
Chlouverakis 1965). It is also possible that raised whole 
blood viscosity could play some part in the process of 
dilatation. (Trope, Lowe, Ghafour, Foulds, and Forbes 1983).
Localised capillary dilatations appear in the form of 
microaneurysms and, like generalised dilatation, are usually 
associated with one or more areas of capillary nonperfusion.
Capillary dilatation is not associated with visual 
deterioration unless other changes like increased per­
meability are present as in macular oedema, when visual loss 
is a common result. Increased capillary permeability, again, 
is possibly an autoregulatory response to tissue hypoxia 
secondary to insulin dependent intraretinal metabolic processes 
[and perhaps increased levels of glycosylated haemoglobin 
(HBA^c) and hyperglycaemia (Hill and Atherton 1979).
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D i l a t a t i o n  o f  t h e  c a p i l l a r i e s  i s  a s s o c i a t e d  w i t h  t h e  
f o l l o w i n g  s t r u c t u r a l  c h a n g e s  : B a s e m e n t  m e m b r a n e  t h i c k e n i n g ,  
p e r i c y t e  d e g e n e r a t i o n ,  m i c r o a n e u r y s m s ,  a n d  i n t r a r e t i n a l  
m i c r o v a s c u l a r  a b n o r m a l i t i e s  ( I R M A ) .
Basement membrane changes
The hallmark of capillary abnormality in diabetes is 
thickening of the basement membrane (Siperstein, Raskin, and 
Burns 1973), a development that accompanies the metabolic 
disturbance and occurs in many tissues. It can be detected 
in renal glomeruli and appears to be secondary to the meta­
bolic abnormality and is a feature of secondary diabetes.
It is retarded by therapeutic prevention of hype rg lycaemi a 
and can be reversed by grafting of pancreatic islet cells in 
experimentally induced diabetes in animals (Lee, Mauer, 
Brown, Sutherland, Michael, and Najarian 1974). The normal 
width of the basement membrane is of the order of 80-1 20 nm ; 
in diabetes it may be up to five times this and is due to an 
accumulation of collagenous glycoprotein distinguished by an 
increased proportion of hydroxylysine-rich subunits. Two 
mechanisms for increased synthesis are suggested (Spiro
1976) :
1. The high levels of growth hormone (Somatotrophin) 
common in diabetes induce both increased synthesis of pep­
tides and subsequent hydroxylation of the lysine residue.
2. Hype rg lycaemi a is associated with metabolic pathways 
which are independent of insulin and involve glycosyl and 
galactosyl transferases. This could result in the linking 
of disaccharide units to the hydroxylysine-peptide units and 
the formation of basement membrane protein.
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It has been suggested that a humoral factor might be 
involved in basement membrane synthesis in experimental 
work on the lens of diabetic rats (Fisher 1979). However, 
it is doubtful whether this is important in the development 
of retinal lesions since there is a barrier to protein 
movement across the capillary wall provided mainly by the 
capillary endothelium.
Ashton's comment (19 74) on the presence of recognisable 
haematogenous elements such as lipid, fibrin, haemosiderin, 
and even cellular constituents within the thickened membrane 
supports the view that part of the thickening represents 
insudation through an unduly permeable endothelium. Such 
elements are, however, by no means invariable, and commonly 
the thickening appears to be caused by accumulation of true 
basement membrane material. It is possible, therefore, 
that both insudation and increased synthesis are involved.
The thickened membrane can also include cellular rem­
nants presumed to originate from degenerate pericytes, giving 
the membrane a laminated appearance in electron micrographs; 
an alternative hypothesis is that the laminated appearance 
of the thickened membrane could be caused by waves of 
endothelial cell degeneration and renewal, each new layer of 
endothelium secreting its own membrane (Vracko 1974).
Added to the thickening of the amorphous component of 
the basement membrane is an increase in the network of reti- 
culin fibres normally demonstrable around the vessels on 
their external aspects (Ashton and Tripathi 1975). Reticulin 
is argyrophilic and is a collagenous protein with a fibrillar 
[organisation, individual fibres measuring about 10 nm in 
diameter. It possibly has the same origin as does the 
[basal lamina. Fibres of this type may frequently be
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observed extending into the interstices of the adjacent 
neural tissue and when present in large amounts appear to 
contribute to the formation of capillary loops (Ashton 19 61)
Pericyte degeneration
The increased permeability of the capillaries was postu­
lated (Ballantyne 1948) -to be a result of endothelial 
injury, and a specific and differential decrease in the 
number of pericytes of the capillary wall (Cogan, Toussaint, 
and Kuwabara 1961) which might be proceeded by an increase 
in the size of these cells (Fisher 1980) is a persistent 
change of the capillary wall in diabetic retinopathy.
Pericytes are normally wrapped about the outer circum­
ference of the vascular channel; they probably function to 
provide structural integrity to the vessel (Yanoff 1969).
The ratio of pericytes to capillary endothelial cells in a 
normal young individual is approximately 1:1. In a normal 
ageing process, there is a relative decrease of capillary 
endothelial cells. This is reversed, however, in diabetic 
retinopathy in which there is a gradual loss of retinal 
capillary pericytes or mural cells. The small number of 
pericytes may create a weakness in the wall that would pre­
dispose to the formation of aneurysms and the tendency to 
fluid leakage or haemorrhage.
Microaneurysms
Capillary aneurysms are a constant feature of diabetic 
retinopathy and are commonly its presenting clinical sign.
The propensity for microaneurysm formation is a feature 
not so much of diabetes as of the retinal capillaries, since 
(on the one hand, they occur in several other retinal disor-
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ders and, on the other, are rare in the capillaries of 
diabetic patients elsewhere in the body. They are someti­
mes found in the conjunctiva, kidney, and heart (Factor,
Okun, and Minase 1980). They predominate on the venous 
side of the circulation in the posterior retina and are 
usually most frequent around foci of closed capillaries.
They begin as saccular outpouchings from a capillary wall.
The wall of the aneurysm consists of an endothelial lining 
and a relatively thin basement membrane. Patent 
microaneurysms show positive fluorescence on fluorescein 
angiography; some gradually hyalinise due to thickening 
of their walls by deposition of PAS -positive material.
They then appear as yellow or white spots that do not 
fluoresce and may give a misleading impression of regression.
The importance of microaneurysms lies in their excessive 
permeability and liability to rupture, resulting in focal 
serous exudation and haemorrhage. Accumulated thrombus 
within the aneurysmal sac causes many aneurysms to be obli­
terated, the life of individual lesions being of the order 
of several months (Kohner and Dollery 1970).
Intraretinal microvascular abnormalities (IRMA)
The closure of precapillary arterioles and capillaries 
creates a state of relative ischaemia and hypoxia. Later 
formation of intraretinal vascular shunts and the process of 
neovascularisation characteristic of proliferative diabetic 
retinopathy occur in relation to ischaemic retina. Formation 
of non-leaking or very slowly leaking intraretinal vascular 
channels (intraretinal microvascular abnormalities: IRMA)
can be demonstrated by fluorescein angiography. These s h u n t  
vessels often show a retarded rate of flow. Apple (1981)
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suggests that these represent a compensatory response to a 
hypoxic stimulus. It is important that IRMA should be 
distinguished from proliferating blood vessels on one hand 
and from shunt vessels on the other to avoid photocoagulating 
an area with shunt" blood vessels or delay photocoagulation 
of an area with proliferative vessels which must be treated 
as soon as their presence is confirmed by careful 
ophthalmoscopy and angiography (Henkind 1981).
Capillary closure
Capillary closure or nonperfusion is the most important 
development in the course of diabetic retinopathy. It pre­
disposes to neovascularisation and other serious complica- 
t ions.
Ashton (19 53) first demonstrated multiple small foci of 
nonperfused capillaries in diabetes using Indian ink injec­
tion of the blood vessels in enucleated eyes. He found 
capillary closure to be a predominant pathological feature 
of diabetic retinopathy.
Clinical evidence supporting the role of focal retinal 
ischaemia in diabetic retinopathy include the presence of 
ischaemic retinal infarcts (cotton-wool spots) in all stages 
of retinopathy (Esmann, Lundbaeck, and Madsen 19 63) and the 
presence of capillary nonperfusion in both early and late 
stages of retinopathy (Kohner et al 1975). These findings 
may suggest (Little 1981) that focal ischaemia and nonperfusion 
proceed from areas of microinfarction to large zones of 
macroinfarction and influence the development of retinal 
neovascularisation, since zones of capillary nonperfusion 
are always found in association with neovascularisation.
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It is not exactly known what causes capillary closure 
but abnormalities of blood coagulation and changes in the 
endothelial lining of the capillaries are important asso- 
c iations.
Blood retinal barrier
The blood retinal barrier is located at two different 
levels. In the outer barrier the main structure involved is 
the retinal pigment epithelium. The inner blood retinal 
barrier is composed of the endothelial membrane of the reti­
nal vessels. In both of these membranes the constituent 
cells have tight junctions of the "non-leaky" type.
At present, abnormal function of the blood retinal 
barrier is widely accepted as one of very important changes 
in the development of retinal vascular disease and macular 
pathology. Vitreous fluorophotometry (Cunha Vaz et al 19 75) 
has demonstrated that a breakdown in the blood retinal 
barrier takes place early in the disease process before any 
clinical change in the retina is detectable (Cunha Vaz 1976; 
Krupin, Waltman, Osterich, Santiago, Ratzan, Kilo, and Becker
1978). Krogsaa, Lund-Andersen, Mehlsen, Sestoft, and 
Larsen (1981) reported that the degree of blood retinal 
barrier permeability correlates with the degree of retinopathy, 
being higher in those with proliferative diabetic retinopathy 
and lowest in diabetics who had simple background retinopathy. 
In all cases the permeability was higher than in normal 
controls. In the human eye, the amount of fluorescein 
entering the vitreous after injection into the systemic 
circulation in early diabetes is increased and it was 
suggested that this is due to an increased permeability of 
the retinal vessels (Cunha Vaz 1978), A fault in the
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pigment epithelium which allows the diffusion of fluorescein 
into the vitreous was also suggested by other workers 
(Tso, Cunha Vaz, Shih, and Jones 1980), Support for this 
view comes from the finding of an increase in vitreous 
fluorescein in streptozotocin induced diabetes in the 
guinea pig since these animals are devoid of retinal 
vessels (Klein, Engerman, and Ernest 1980). Fresh 
photocoagulation burns, by damaging the pigment epithelium 
of the retina, also allow the diffusion of fluorescein into 
the vitreous until the burns have healed (Foulds, Moseley, 
Edie, and McNaught 1980).
4 . 2 . C .  ARTERIOLAR CHANGES
Arteriolar hyalinosis (Ashton 19 53) of the type commonly 
identified with the benign phase of hypertension is a common 
feature in diabetes. It is likely to represent the insi­
dious insudation of plasma through an abnormally permeable 
endothelial lining. The leakage may be enhanced by the 
increased transmural pressure gradient associated with the 
arteriolar dilatation characteristic of early diabetic reti­
nopathy (Skovborg, Nielson, Lauitzen, and Hartkopp 1969).
4.3. RETINAL ISCHAEMIA AND PROLIFERATIVE CHANGES
Vasoproliferation is almost never seen in diseases 
where total anoxia occurs, for example, in central retinal 
artery occlusion; however, in diabetic retinopathy and other 
diseases mimicking it hypoxia plays a major role in the 
pathoge nes is.
As a r t e r i o l a r  a n d  c a p i l l a r y  c h a n g e s  p r o g r e s s  t h e r e  i s  
a n  a s s o c i a t e d  i n c r e a s e  i n  t h e  e x t e n t  o f  i n a d e q u a t e  p e r f u s i o n  
o f  t h e  r e t i n a l  v a s c u l a r  b e d ;  t h e  i n c r e a s e d  b l o o d  f l o w  n o t e d
94
in early diabetic retinopathy is replaced by a decrease.
This decrease of retinal perfusion may be so much that the 
retinal circulation becomes below normal (Cunha Vaz 1978) 
and, at this stage, new blood vessels start to appear on 
the venous side of the circulation from the previously 
dilated vessels (Mlchaelson 1948; Ashton, Ward, and 
Serpell 1954).
It is presumed that a viable but metabolically impo­
verished retina liberates a diffusable angiogenic factor 
which is capable of accumulation in the vitreous space and 
which may also stimulate endothelial proliferation on the 
retinal surface (Glaser, D'Amore, Michels, Brunson,
Fenselau, Rice, and Patz 1980). This hypothetical factor 
has not been isolated but some ocular tissues have been 
proved to possess angiogenic activity while extracts of ske­
letal muscle, cardiac muscle, and liver have not (Glaser,
D'Amore, Michels, Patz, and Fenselau 1980; Chen and Chen 
1980). Cartilage (Langer, Brem, Falterman, Klein, and 
Falkman 1976), aortic extracts (Eisenstein, Goren, Shumacher, 
and Choromokos 1979), and vitreous (Patz 1980) were found, 
on the other hand, to have an inhibitory effect on 
neovascularisation.
E v i d e n c e  o f  a  c a u s a l  r e l a t i o n s h i p  b e t w e e n  i s c h a e m i c  
r e t i n a ,  p r o d u c i n g  a  v a s c u l o g e n i c  d i f f u s a b l e  " f a c t o r " ,  a n d  
n e o v a s c u l a r i s a t i o n  i s  a l s o  d e r i v e d  f r o m  t h e  f o l l o w i n g  c l i n i ­
c a l  o b s e r v a t i o n s .
1. Fluorescein angiography frequently demonstrates 
areas of capillary nonperfusion before the development of 
retinal neovascularisation.
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2. The conditions associated with retinal neovasculari­
sation such as retrolental fibroplasia, sickle cell disor­
ders, retinal vein occlusion and, of course, diabetic reti­
nopathy, always include areas of retinal capillary nonper-
fus ion.
3. Retinal neovascularisation occasionally occurs at a 
distance from the ischaemic areas, such as when disc 
neovascularisation occurs after branch vein occlusion.
4. The iris rubeosis seen with diabetic retinopathy 
appears to respond to ablative photocoagulation of the 
retina (Kohner, Shilling, and Hamilton 1976; Henkind 1978; 
Merin, Ber, and Ivry 1978; Tasman, Magargal, and 
Augsburger 1980).
4.4. ROLE OF GROWTH HORMONE
Growth hormone (Ganong 1979) is produced by the 
pituitary gland and its secretion is controlled via the 
hypothalamus. It has a molecular weight of 21,500 and can 
now be synthesised. Radioimmuno-assay is used to measure 
the plasma levels of growth hormone, the normal basal level 
of which in adults is less than 3 ng/ml; metabolism of 
growth hormone takes place, at least in part, in the liver.
It promotes growth, is a protein anabolic hormone, and 
affects electrolyte, fat, and carbohydrate metabolism.
Growth hormone has a diabetogenic effect. 25% of 
patients with growth hormone-secreting tumours of the 
pituitary gland have diabetes and human growth hormone makes 
diabetes worse. Hypophysectomy ameliorates diabetes and
increases sensitivity to insulin. It decreases glucose 
uptake into some tissue (anti-insulin action), increases
96
h e p a t i c  g l u c o s e  o u t p u t  a n d  ma y  d e c r e a s e  t i s s u e  b i n d i n g  o f  
i n s u l i n .  G r o w t h  h o r m o n e  m a y  s t i m u l a t e  i n s u l i n  s e c r e t i o n  
i n d i r e c t l y ,  a n d  t h e  h y p e r g l y c a e m i a  i t  p r o d u c e s  s e c o n d a r i l y  
s t i m u l a t e s  t h e  p a n c r e a s  a n d  m a y  e v e n t u a l l y  e x h a u s t  t h e  B 
c e l l s .
It was reported (Campbell, Lei, and Davidson 19 51) that 
within 3 to 7 days of daily injection of growth hormone, dogs 
developed hyperg lycaemi a and glycosuria.
Serum growth hormone levels three to four times greater 
in diabetic subjects than in nondiabetics have been found 
(Johansen and Hansen 1969) and exercise (Lundback 1973) 
accentuates the abnormally high secretion of human growth 
hormone in diabetics.
Evidence indicates that the relationship of abnormal 
carbohydrate metabolism to the development of diabetic reti­
nopathy hinges on growth hormone. Hansen (19 71) showed 
that following rigid control of blood sugar levels, the 
hypersecretion of growth hormone in juvenile diabetics was 
neutralised. This observation was made on hospitalised 
patients from whom blood sugar was measured three times 
daily and on whom growth hormone determinations during exer­
cise were made in the course of regulatory metabolic 
control. Increasing dosage of soluble insulin and isophane 
insulin suspension were given by three to four injections 
daily. After several days of strict diabetic control with 
[blood sugar levels ranging between 4.4 to 6,6 mmol/L (80 
[to 120 mg/100 ml), no rise of serum growth hormone occured 
luring exercise, and fasting serum growth hormone levels 
'ere normalised. It was, hence, concluded that abnor- 
lalities of serum growth hormone in juvenile diabetics are 
letabolic in origin.
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4.5. ROLE OF GENETIC FACTORS AND CARBOHYDRATE METABOLISM
There is a disagreement about the contribution of car­
bohydrate metabolism and genetic factors to the development 
of diabetic retinopathy. Some workers believe that it is 
the disturbance of carbohydrate metabolism, rather than a 
genetic factor, that determines the onset of retinopathy, 
while others studying, for example, diabetic twins concluded 
that genetics play an essential role in the development of 
the diabetic retinal changes.
Caird, et al (1969) found, in diabetic retinopathy, 
no greater similarity among diabetic siblings than among 
unrelated diabetics, although on the other hand, Pyke 
and Tattersall (1972) reported significant similarities 
in the development and pattern of retinopathy between many 
pairs of identical diabetic twins with duration of diabetes 
of more than 15 years.
A higher incidence of vascular complications among 
poorly controlled juvenile diabetics than among well 
controlled subjects was found and it was concluded that to 
achieve a better control of carbohydrate metabolism many 
patients require more than one insulin injection daily 
(Paz-Guevara, Hsu, and White 1975). Also experimental 
models of diabetic retinopathy have shown a statistically 
significant greater number of microaneurysms, acellular 
capillary zones, and pericyte cell loss in dogs that were 
poorly controlled than in those which had a better control 
( Engerma n 19 76),
In the absence of genetic diabetes, microangiopathy was 
[produced in rats (Cohen, Michaelson, and Yanko 19 72) which 
[were fed a 72% sucrose diet for 12 months, again stressing
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the importance of carbohydrate in the pathogenesis of diabe­
tic retinopathy.
Thickening of the perivascular basement membrane is a 
common development in the course of diabetic vaseulopathy.
It is also noted in advancing age, and is related to 
hydrostatic pressure (Ashworth, Erdmann, and Arnold 1960; 
Ashton 1974); although it is inconstant and nonspecific for 
diabetes it, undoubtedly, is most common and pronounced in 
this condition and has been described in the diabetic kid­
ney, skin, muscle, and nerve (Fagerberg 19 56; Aagenaes and 
Moe 1961). It has also been seen in prediabetics and very 
early after the onset of diabetes and has not been found to 
occur in hyperglycaemia in the absence of genetic diabetes 
mellitus even after many years suggesting that the 
thickening is a basic genetic defect rather than a complica­
tion of diabetes (Sabour, MacDonald, and Robson 1962; 
Siperstein, Unger, and Madison 1968) although it has been 
noted in many types of diabetes including experimentally 
produced diabetes in dogs and that due to haemochromatosis, 
pancreatitis (Duncan, MacFarlane and Robson 19 58; Bloodworth, 
Engerman, and Power 1969; Walsh and Malins 1978), and randomly 
selected diabetics (Gray, Starkey, Rainbow and others 1982).
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4.6. ROLE OF HAEMATOLOGICAL FACTORS
4.6.a. Introduction
Prostaglandins : Prostaglandins are a series of closely
related 20-carbon 'ünsaturated fatty acids containing a 
cyclopentane ring. They were first isolated from semen but 
have been shown to be synthesised in all organs of the body. 
Three main groups of prostaglandins are identified, PGA,
PGE, and PGP; the common biologically active prostaglandins 
are PGAi, PGEi, PGEa, PGFi^, and P G F ^  The biologically
im p o r ta n t  p r o d u c t s  s y n t h e s i s e d  a r e  PGE2, thromboxanes ,  and 
p r o s t a c y c l i n  which i s  c a l l e d  PGIg.
Prostaglandin synthetases are enzymes that catalyse 
prostaglandin formation. The first of these enzymes 
involved in this process is called eyelooxygenase; it cata­
lyses the conversion of arachidonic acid to a cyclic endo- 
peroxide. This process is inhibited by aspirin, indometha- 
cin and various other drugs (Lewis 1982).
Prostaglandin PGE^ inhibits platelet aggregation while 
PGE 2 augments aggregation.
Prostaglandins may play a role in regulating the capacity 
of red blood cells to undergo deformation in passing through 
capillaries. They also stimulate renin secretion.
Prostacyclin, PGI 2 , inhibits blood clotting and stimu- 
|lates renin secretation.
Thromboxane A 2 promotes clotting, and clot formation 
apparently depends on the balance between it and PGI 2 .
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Thromboxane is a vasodilator and stimulator of platelet 
aggregation.
The clotting mechanism: When a blood vessel is damaged,
the exposed layer of collagen attracts platelets which 
liberate serotonin and adenosine diphosphate (ADP). The 
ADP rapidly attracts other platelets and a loose plug of 
aggregated platelets is formed. The aggregated platelets 
are bound together and converted into the definitive clot by 
f ibrin.
The insoluble fibrin is formed from the soluble plasma 
protein fibrinogen and this process is catalysed by thrombin 
which, in turn, is formed from its circulating precursor 
prothrombin by the action of activated factor X. Factor X 
is activated through two pathways, an intrinsic and an 
extrinsic pathway. The initial reaction in the intrinsic 
pathway is conversion of factor XII to active factor XII 
which then activates factor XI. Factor XI then activates 
factor IX. In the presence of factor VIII and platelets, 
active factor IX activates factor X which in the presence of 
platelets, Ca ions, and factor V, catalyses the conversion 
of prothrombin to thrombin. The extrinsic pathway involves 
the activation of factor VII by tissue thromboplastin, a 
protein-lipid complex released from damaged blood walls. 
[Active factor VII activates factor X which catalyses the 
[conversion of prothrombin to thrombin.
inti-clotting mechanism: Reactions that tend to prevent
lotting inside the blood vessels and to break down any clot 
hat may form include formation from activated factor X of
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an antithrombin and removal of some activated clotting fac­
tors from the circulation by the liver. There is also a 
reduction in the supply of clotting factors because of their 
use during clotting.
Thromboxane A 2 promotes platelet aggregation and hence 
clotting but its action -is opposed by the simultaneous for­
mation of PGI 2 (prostacyclin) which inhibits aggregation.
Reduction of prostacyclin level might upset the 
balance which it maintains with platelet thromboxane which 
is a vasodilator and stimulator of platelet aggregation 
and hence the action of the latter would be enhanced.
There is in addition a fibrinolytic system that limits 
clotting, the active components of which is plasmin or 
fibrinolysin. This enzyme lyses fibrin and fibrinogen pro­
ducing fibrinogen degradation products (FOP) that inhibits 
thrombin. Plasmin is formed from its inactive precurser, 
plasminogen, by the action of thrombin and possibly substan­
ces in the tissue. There is also an activator in plasma 
that normally circulates as inactive proactivator. 
Proactivator is converted into activator by the action of 
proteolytic fragments of active factor XIX called pre- 
kalkrein activators which are also involved in the for­
mation of kinins; they are formed by the action of plasmin 
on active factor XIX.
4.6.b. Abnormal prostacyclin levels
Reduced levels of prostacyclins, which tend to increase 
fter the administration of insulin, but not to normal levels 
ave been found in diabetic animals (Harrison, Reece, and 
ohnson 1978), Prostacyclin levels have also been found 
o be reduced in diabetic patients, the reduction being
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most marked in those with proliferative retinopathy (Webster, 
Lewis, McDermot, Hensby, Porta, and Kohner 1980), In 
vessels of amputated legs of diabetic subjects a reduced 
prostacyclin activity was reported by Johnson and co—workers 
(Johnson, Harrison, Raferty, and Elder 1979).
4 . 6 . C .  Plasmin activator
Although plasmin activator was not found to be signif­
icantly reduced in diabetic subjects without or with only 
minimal retinopathy, a slight reduction however could play 
a role in the reduction of plasmin, the active fibrinolytic 
agent (Aimer, Pandolfi, and Nilsson 1975).
4.6.d. Red blood cells
Increased red blood cell aggregation was found in the 
conjunctival vessels of diabetic dogs (Ditzel 1967) . In 
humans an increase of erythrocyte aggregation, reflected 
in increases in erythrocyte sedimentation rate, has been 
reported. Increased aggregation was associated with the 
severity of diabetic retinopathy in the patients studied 
(Little 1976).
In addition to red cell aggregation, the deformabili ty 
of these cells was noted to be reduced (McMillan, Utterback, 
and LaPuma 19 78).
For circulation to occur, red cell aggregates must be 
disrupted in order that blood flows through the microcir­
culation. When blood flow is sludged, transfer of oxygen is 
probably impaired; when aggregates are not disrupted then 
focal areas of ischaemia occur. Impaired blood flow by 
rigid and clumped red cells is probably exacerbated in the
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presence of a narrowed lumen and rigid cells caused by 
the thickened capillary basement membrane (Little 1981).
4.6,e. Platelets
It has been shown that about ninety per cent of adult- 
onset diabetics have platelet aggregation-enhancing activity 
(Dobbie, Kwaan, Colwell, and Suwanwela 1974). The same 
study also showed a positive association between platelet 
aggregation-enhancing activity and nephropathy or retino­
pathy and with the duration of diabetes.
von Willebrand factor VIII (vW-VIII) - related protein 
and antihaemophilic factor (AHF) - activity in diabetics 
with retinopathy were found to be higher than in those 
without retinopathy and generally higher in diabetics than 
in a nondiabetic group (Pandolfi, Aimer, and Holmberg 1974), 
Since the vW-VIII factor is involved in the mechanism of 
platelet adhesion and aggregation, these findings may 
contribute to an explanation of the increased platelet 
stickiness known to occur in diabetics and especially in 
those with retinal changes (Colwell, Sagel, Crook, Chambers, 
and Laimins 19 77; Burrows, Chavin, and Hockaday 19 78;
Creter, Pavlotzky, and Savir 1978),
4.6.f. Abnormal fibrinolytic system 
Longstanding diabetics of ten or more years who did not
develop retinopathy were shown to have a significantly 
higher and almost norma 1 fibrinolytic response to venous 
[occlusion and also a higher spontaneous fibrinolytic act i- 
Ivity than those who have developed retinopathy (Aimer et al 
Il 9 7 5 ) . The fibrinogen and alpha-2 macroglobulin levels were 
higher in the retinopathy group. There have, however, been
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other reports on elevated concentrations of fibrinogen or 
reduced fibrinolytic activity in patients with diabetic 
retinopathy (Jones and Peterson 1979).
4.6.g. Blood and plasma viscosity
Skovborg, Nielson, Schlichtkrull, and Ditzel (1966) 
reported a twenty per cent increase in whole blood viscosity 
in diabetics when compared, with control patients. They cor­
related increased viscosity with concentrations of serum pro­
teins and observed that the average concentrations of fibrin­
ogen and alpha-2 globulin were higher in the diabetic group.
Blood viscosity was found to be higher in diabetic 
children, in groups of diabetics with various durations of 
diabetes, and in patients with increasing severity of reti­
nopathy (McMillan 1974; Lowe, Lowe, Drummon and others 1981; 
Trope, Lowe, Ghafour, Foulds and Forbes 1983).
Factors such as trauma which are known to increase 
blood viscosity could cause an acceleration of the retino- 
pathic changes (Dintenfass 1975; Alexander, Kearns, Kohner, 
and Asplin 1979). Reduction of blood viscosity, on the 
other hand, may reduce the occurrence of retinopathy 
(Ariga, Oshiba, and Tamada 1981; Kobayashi, Hirai, Terano, 
Hamazaky, Tamura, and Kumagai 19 81).
Blood viscosity was studied, by the author and others, 
in a group of 18 patients with proliferative diabetic reti­
nopathy confirmed by fluorescein angiography. The group 
Icoraprised 12 males and 6 females aged 29-73 years with a 
jnean age of 53 ± 3 years. The duration of diabetes ranged 
rom 2 to 31 years with a mean of 17 ± 2 years. 9 of the 
'atients were insulin-dependent, type I diabetics; the 
ither 9 were non-insulin dependent. The group was matched
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for age, sex, smoking habits, duration, type, and treatment 
of diabetes with another group of 18 diabetics of whom 8 had 
no clinically detectable retinopathy and 10 had background 
retinopathy.
Venous blood was sampled between 2 and 5 pm after 10 
minutes’ rest from a forearm vein with a 19 gauge ’butterfly 
needle (Abbott) without a tourniquet. Blood was anti­
coagulated with edetic acid (EDTA, 1.5 mg/ml) for viscosity 
studies, which were performed within 2 hours of vene­
puncture. Whole blood viscosity was measured at a high 
shear rate (94 s“l ) and at a low shear rate (.0.94 s"^) 
in a Contraves LS 30 rotational viscometer at temperature 
37°C. Haematrocrit (Hawksley microhaeraatrocrit 13,000 g 
for 5 minutes), plasma viscosity (Coulter-Harkness capillary 
viscometer, 25°C ) were measured-
Table 2 shows the blood whole blood viscosity, at high 
and low shear rates, of the group of diabetics with 
proliferative retinopathy and of those with a milder form 
of/or no retinopathy. Significant differences were found 
btween the two groups. Plasma viscosity, also, was 
significantly different when the two groups were compared 
( P C  0 . 0 0 1 )  .
The mean plasma fibrinogen level of the group with proli­
ferative diabetic retinopathy was 3.69 ± 0.25 g/L and of the 
control group, 3.07 ± 0.17 g/L. The difference was 
found to be significant (P<0.05).
There is controversy about the role of increased 
viscosity in the pathogenesis of diabetic retinopathy. In
this study different parameters which could contribute to 
the differences in blood and plasma viscosity have bee 
[excluded; subjects ages, smoking habits, duration of
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Proli ferative 
group
Blood viscosity 
(m Pa.s)
- High shear 
94 s e c ~ l
- High shear 
PCV = 4 5
- Low shear
0 . 9 4  s e c " l
- Low shear 
PCV = 4 5
Plasma
viscosity (m Pa.s) 
Fibrinogen (g/L)
6.12 ± 0.18 
6.25 ± 0.15
20.8 i 1.2
21.7 i 0.8
1.89 i 0.03 
3.69 dL 0.25
Background 
or no 
retinopathy 
group
5.35 ± 0.21 P< 0.01 
5.57 ± 0.15 P < 0.01
17.8 ± 0 . 9  P < 0.05
19.3 ± 0 . 6  P< 0.05
1.71 ± 0.02 P< 0.001
3.07 ± 0.17 P < 0.05
Table 2. Comparison of blood viscosity at high and low 
shear rates, plasma viscosity, and fibrinogen 
levels of diabetics with different severity of 
retinopathy.
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diabetes, type, and treatment of diabetes were similar.
In an earlier study ( Lowe et al 1981 ) it was shown 
that whole blood and plasma viscosities were higher in 
established diabetics than in matched normal controls. It 
would however be interesting to see if these values were 
raised in recently diagnosed diabetics.
4.6.h. SUMMARY AND CONCLUSION
Blood and blood vessel changes occur in diabetic 
patients. These changes include;
1. Increased erythrocyte aggregation and rigidity.
2. Increased blood and plasma viscosity.
3. Altered platelet activity with increase of their 
aggregation and stickiness, with increased release of throm­
boxane and prostaglandin E.
4. Increased levels of plasma fibrinogen.
5. Changes in the blood vessel wall.
6. Changes in the blood-retinal barriers.
These changes may be related to altered carbohydrate
metabolism in the presence of insufficient insulin and/or 
hyperg lycaemi a, and growth hormone.
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CHAPTER 5
THE IDENTIFICATION OF DIABETIC RETINOPATHY
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As for other diseases of the retina^ many clinical 
investigatory tools can be used for the identification of 
diabetic retinopathy.
In a joint effort with other Ophthalmologists, 
Physicians, Opticians, and Technicians a study was carried 
out to assess the usefulness of the following ophthalmic 
parameters in the diagnosis and assessment of diabetic reti­
nopathy .
1. Assessment of structure by:
a. Ophthalmoscopy
b . Fluorescein angiography
2. Assessment of function as shown by
measurement of
a. Visual acuity
b. Quantitative perimetry
c. Colour vision using the Farnsworth- 
Munsell 100 Hue Test
d . Contrast sensitivity using the Arden 
grating test
5.1. OPHTHALMOSCOPY
Although fluorescein angiography gives a higher rate of 
detection of diabetic retinopathy (Klemen, Freyler, 
Scheimbauer, and Prskavec 1980) than ophthalmoscopy, 
ophthalmoscopy in a darkened room with the patient's pupils 
well dilated has been found useful in the diagnosis and 
grading of retinopathy in cases with clinically detectable 
[diabetic changes of the retina (Barrie, Scobie, Green, 
IMacCuish, and Foulds 1981). This is especially true if 
[strict criteria for the definition of the different types 
if retinopathy are used.
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To determine the accuracy of identification of diabetic 
retinopathy by ophthalmoscopy and to compare ophthalmoscopy 
performed by trained general Physicians with that carried 
out by Ophthalmologists two groups of patients were examined:
1. A group of 182 diabetics seen by both 
Ophthalmologists and Physicians, each being unaware 
of the results of the other.
2, 349 diabetics examined by Physicians using 
direct ophthalmoscopy and 635 by Ophthalmologists 
using both direct and indirect ophthalmoscopy.
In each case patients were those referred from the 
general diabetic clinic of Glasgow Royal Infirmary for 
an annual eye examination.
On the basis of ophthalmoscopic examination patients 
were sub-divided into those without retinopathy, those 
with background retinopathy, and those with serious 
retinopathy as defined on page 6 3
The same patients were examined separately by a 
Physician and an Ophthalmologist.
There was reasonable agreement in the total amount of 
retinopathy diagnosed (Physicians 23 per cent, Ophthalmologists 
25 per cent). There was however, some disparity in the 
numbers thought to have serious retinopathy (Physicians 4 
per cent, Ophthalmologists 10 per cent).
The results of a study on group 2 composed of separate 
)ut comparable patients examined by either Physicians or 
)phthalmologists are detailed in Table 4.
Comment
I n  t h e  s t u d y  o n  g r o u p  1 t h e r e  i s  a  d i s p a r i t y  b e t w e e n
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the prevalence of serious retinopathy diagnosed by the 
Physicians and that diagnosed by the Ophthalmologists.
The Physicians involved in this study included an 
experienced Consultant Diabetologist and a Senior Registrar 
in general medicine who had attended the retina clinic at 
the Tennent Institute. - The Ophthalmologists included a 
Senior Ophthalmic Registrar and a recently appointed 
Research Registrar in ophthalmology. In retrospect it 
is possible that judgements made by the less experienced 
observer were not as accurate as they might have been.
In the study on group 2 where separate but comparable 
groups of diabetic patients were examined by observers who 
were by then experienced in the application of the diagnostic 
criteria to diabetic fundi, better agreement was found 
between the two sets of observers although some disparity 
remained.
Although the numbers of patients in group 2 (984) is 
large there remains a definite possibility that the 
prevalence of diabetic retinopathy was different in the 
group examined by the Physicians from that examined by the 
Ophthalmolegists.
To test the accuracy of diagnosis by Physicians or 
Ophthalmologists all patients labelled as having serious 
retinopathy were re-examined in the Tennent Institute of 
[ophthalmology using, in addition to ophthalmoscopy, bio- 
licroscopy with a diagnostic contact lens, colour fundus 
hotography, and fluorescein angiography.
On the basis of this further examination, the diagnosis 
f serious retinopathy was confirmed in 72 per cent of 
atients referred by Physicians and 63 per cent of patients 
[eferred by Ophthalmologists.
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Physician Ophthalmologi st
No retinopathy 141 (77) 136 (75)
Background
retinopathy 33 (18) 28 (15)
Serious retinopathy 8 (4) 18 (10)
Total 18 2 182
Table 3. A compa rison of prevalence of retinopathy as
determined by Ophthalmologists and Physicians 
using conventional ophthalmoscopy (percentages) 
are shown in brackets).
Physician Ophthalmologist
No retinopathy 259 (74) 511 (80)
Background
retinopathy 55 (16) 88 (14)
Serious retinopathy 35 (10) 36 (6)
Total 349 635
Table 4. Prevalence of different types of diabetic
retinopathy of two groups of patients examined 
by either Ophthalmologists or Physicians using 
conventional ophthalmoscopy (percentages are 
shown in brackets).
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No
retinopathy
Prevalence of 
retinopathy in 72
the random sample
Prevalence of 
retinopathy as 75
found by 
Physicians
Prevalence of 
retinopathy as 79
found by
Ophthalmologists
Background
retinopathy
Serious
retinopathy
17
17
14
11
Table 5. A comparison of the percentages of different 
categories of retinopathy between a random 
sample of 9 3 diabetics fully investigated, 
and ophthalmoscopic findings in 1166 patients 
examined by Physicians and Ophthalmologists.
Category
No. Range of corrected Mean corrected 
of eyes. visual acuity visual acuity
No retinopathy
Background
retinopathy
Exudative
retinopathy
Ischaemi c 
retinopathy
Proli ferative 
retinopathy
242
79
13
12
34
6/5
6/5
6/9
6 / 6
6/9
6/9
6/60
6 / 1 2
6/6 - 6/18
6 / 6
6 / 6
6/18
6/9
6/9
T a b l e  6 .  V i s u a l  a c u i t i e s  o f  d i a b e t i c  p a t i e n t s  w i t h  
d i f f e r e n t  g r a d e s  o f  r e t i n o p a t h y .
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It appeared that both Ophthalmologists and Physicians 
were overdiagnosing serious retinopathy on the basis of 
ophthalmoscopy alone, but both were comparable in the 
accuracy of their -assessment.
Having identified a false positive rate of around 24 
per cent it was important to estimate what proportion of 
patients with serious retinopathy were being wrongly 
classified as having non-serious retinopathy. This 
figure could only be determined indirectly as patients 
classified as having non-serious retinopathy were not 
routinely investigated in the Tennent Institute. However, 
extrapolating from the prevalence of serious retinopathy 
found in a group of diabetic patients randomly selected 
from the diabetic clinic and fully investigated in the 
Tennent Institute whether or not there was any visual 
problem it again appeared (Table 5) that there was 
comparability between the prevalence of serious and 
background retinopathy diagnosed by Physicians or 
Ophthalmologists in the total population of diabetic 
patients examined (1166 patients) but both sets of 
observers appeared to be underdiagnosing serious 
retinopathy by around 3 per cent as compared with the 
prevalence found in the randomly selected group.
In addition to the interobserver error estimated 
in these studies it would undoubtedly have been of 
value to have estimated the intraobserver error by 
having the same observer to classify and grade the same 
patients for example on the basis of retinal photography; 
the author carried out such a study.
F i f t y  c o l o u r  f u n d u s  p h o t o g r a p h s  o f  d i a b e t i c  i n d i v i d u a l s  
[ w e r e  r a n d o m l y  s e l e c t e d  t o  t e s t  t h e  r e p e a t a b i l i t y  o f
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grading by one observer.
A slide viewer which enlarged the view x 3 was used.
The type of retinopathy was classed as indicated in Chapter 3 
of this Thesis. The slides were then mixed up and the 
classification of photographic signs of diabetic retinopathy 
was repeated.
In 13 instances (26 per cent) there was inconsistency 
in the grading of retinopathy. In most of the cases (10 
cases) the difference in grading occurred when a photograph 
showed an abundance of hard exudates (diabetic maculopathy).
A d i f f i c u l t y  w a s  p a r t i c u l a r l y  e x p e r i e n c e d  i n  c l a s s i n g  t h e  
c h a n g e s  a s  a n  e x u d a t i v e  r e t i n o p a t h y  o r  a s  a  d i a b e t i c  
m a c u l a r  o e d e m a .
It is re assuring however that most of the inconsistencies 
were related to cases of diabetic maculopathies. This 
perhaps stresses the occasional need for further investigation, 
for example by fluorescein angiography, in such cases since 
a reasonable degree of certainty should be obtained before 
a decision can be made as to whether a diabetic patient with 
such changes would benefit from photocoagulation therapy.
5.2. FLUORESCEIN ANGIOGRAPHY
Fundus fluorescein angiography (Novotny and Alvis 19 61) 
is used for the display of anatomical, physiological, and 
pathological features of the fundus in vivo. It offers an 
opportunity for independent and objective measurements, and 
[evaluation of data collected from different centres. It 
[also makes possible re-evaluation and revision of methods and 
riteria during the course of a study, if this proves 
lesirable. Fluorescein angiography gives an opportunity to 
lake subsequent measurements and assessments not requiring
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the presence of the subject (Wetzig and Jepson 19 66; Kahn 
and Hiller 1974; ffytch. Shilling, Chisholm, and Federman 
1980) .
3 ml of a 2 0 % 'or 5 ml of a 10% solution of the soluble 
dye sodium fluorescein are injected into an arm vein and a 
series of fundus photographs are taken, usually at 1-2 
second intervals. During photography the fundus is illumi­
nated by a flash of blue light of 420-490 nm which maximally 
excites the fluorescence in the sodium fluorescein as it 
passes through the tissue. Sodium fluorescein fluoresces at 
510-530 nm and the emitted fluorescence is photographed on 
black and white film via a barrier filter transmitting maxi­
mally at 510 nm. The time the dye takes to first appear in 
the retinal arteries is called the dye-arrival or arm to 
retina time, and the interval between its appearance in the 
arteries and the veins is the intraretinal circulation time.
In the blood fluorescein is bound to albumin the large 
molecules of which can not cross the endothelial barrier of 
the retinal capillaries so that in health fluorescein in the 
retinal circulation remains intravascular. Although it 
escapes readily from the capillaries of the choroid it is 
prevented from entering the retina from this source because 
of the barrier function of the retinal pigment epithelium. 
Any increase in retinal capillary permeability may allow 
intravascular albumin-bound fluorescein to diffuse into the 
retinal tissue (Scott, Dollery, Hill, Hodge, and Fraser 
1963; Rosen 1977). The amount of unbound fluorescein in 
the plasma, also, plays a role in the penetration of syste- 
mically administered fluorescein sodium into the eye and 
this concentration has been found to differ from person to 
[person (Palestine and Brubaker 1982).
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Fluorescein angiography is superior to many other 
investigations (Wisznia, Liberman, and Leopold 1971) in the 
detection of very early diabetic retinopathy; in more than 
one third of diabetics with apparently normal fundi 
fluorescein angiography may show hyperpermeability, occlu­
sion of the capillaries^ and arterio-venous shunts (Klemen 
et al 1980).
Not only is the technique capable of demonstrating 
abnormality of retinal capillary permeability, it may reveal 
pathological changes such as capillary abnormalities 
including capillary microaneurysms, fine neovascularisation, 
or areas of capillary underperfusion not readily detected by 
ophthalmoscopy. Of 181 eyes of 93 patients selected at ran­
dom from a diabetic clinic, 28 per cent showed no visible 
retinopathy on ophthalmoscopy. However, fluorescein 
angiography revealed the presence of simple diabetic changes 
in 20 per cent of this proportion. No case was shown to 
be without retinopathy on fluorescein angiography when 
on ophthalmoscopy the presence of diabetic retinopathy was 
suspected (see Chapter 7),
Although retinal colour photography was used routinely 
in the assessment of all patients initially classified as 
being serious retinopathy, it was not used in the initial 
screening of diabetic patients attending the diabetic clinic, 
These patients were examined in a general medical unit which 
did not have any sophisticated ophthalmic equipment and in 
any case retinal photography was not considered suitable for 
the screening of a large number of diabetic subjects by 
general physicians.
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5.3. VISUAL ACUITY
The visual acuity of 438 eyes (219 patients) was 
measured using Snellen's test chart. Patients were diabe­
tics attending fof investigation or screening from the 
following sources: 93 randomly selected for a pilot study
into the prevalence of diabetic retinopathy among diabetics 
attending Glasgow Royal Infirmary, 54 consecutive patients 
attending Woodside Health Centre for a study of the preva­
lence of diabetes in general practice (see Chapter 6 and 
8), and 72 diabetics attending the Tennent Institute of 
Ophthalmology for assessment of the state of their retino­
pathy or for treatment and follow-up. 58 eyes with 
cataract or other pathology had to be excluded because fun­
dus details could not be seen so that the presence or degree 
of retinopathy could not be determined. The visual 
acuities of the remaining 380 eyes in relation to the dif­
ferent stages of retinopathy present are shown in Table 6.
As expected, patients without retinopathy or other 
pathology had unimpaired vision. Patients showing 
background, ischaemic, or even proliferative retinopathy, 
if this was not complicated by vitreous haemorrhage or 
rubeotic glaucoma, tended also to have normal acuities 
so that the use of visual acuity measurment was not a 
useful guide to the presence of these forms of diabetic 
retinopathy. Only in patients with exudative maculopathy 
[was reduced visual acuity a common finding.
[5 .4 . PERIMETRY
Roth (1969) reported that all diabetics with retinopathy 
howed central visual field defects and that approximately 
alf of the diabetic patients without retinopathy also had
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visual field defects. King and others (1963) found that 
scotomata persisted even after disappearance of exudates 
from some diabetic fundi following the use of certain 
dietary regimes. Arcuate field defects which are similar 
to those found in glaucoma have also been reported to occur 
in some diabetic subjects with preproliferative retinopathy 
(Wisznia et al 1971).
To investigate the usefulness of testing the visual 
field in the screening of diabetic retinopathy quantitative 
perimetry was carried out using the ocuius Tubinger peri­
meter and it was found that of 150 ophthalmoscopically nor­
mal eyes 126 gave a normal result, and 24, 16 per cent, 
showed scotomata. 5 out of 58 eyes with background retino­
pathy, 9 per cent, showed visual field defects. 7 out of 9
eyes with exudative retinopathy, 78 per cent, had field
defects. When eyes with retinal ischaemia were tested it 
was found that only 2 eyes of 6 tested showed any field 
defect. The results are summarised in Table 7.
The high false normal results in patients with serious 
forms of retinopathy together with the number of patients 
without retinopathy showing visual field defects makes peri­
metry unreliable in the identification and assessment of 
severity of diabetic retinopathy.
|5.5. COLOUR VISION
Colour discrimination may be adversely affected in 
ongenital colour defects (Palmer 1977; Pokorny, Smith,
nd Verriest 1979). The ability to discriminate colours has
Iso been found to deteriorate in many acquired disorders 
[ffecting the eye (Lakowski 19 62; Foulds 19 69; Chisholm, 
onte-Stewart, and Awduche 1970; Weale 1970; Birch 1981).
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Measurement of colour vision is thought to be a sen­
sitive index of visual function.
In diabetes, an acquired dyschromatopsia of the tritano­
pia type (blue defect) affecting the discrimination of blues 
from reds, yellows, and greens is said to be commonly pre­
sent and, sometimes, to preceed the appearance of clinically 
detectable diabetic retinopathy (Kinnear, Aspinall, and 
Lakowski 1972). It has also been found that among a diabe­
tic population those with retinopathy perform worse on 
colour vision testing than those without op h thalmoscop ical ly 
detectable retinopathy (Lakowski, Aspinall, and Kinnear 
1972/73). Some diabetics have been reported to have dif­
ficulty in accurately measuring their blood and urine sugar 
(Taylor 1972).
To establish whether assessment of colour vision was 
useful for the screening of diabetic retinopathy and par­
ticularly for differentiating serious from non-serious reti­
nopathy, colour vision in 98 eyes of 57 diabetics was 
tested. In addition 24 eyes from 14 normal individual from 
the Department's staff were tested for comparison of colour 
vision performance with the diabetic group; these were 
found to have normal colour vision as defined by Verriest, 
Van Laethem, and Uvijls (1982).
Colour vision testing was carried out using the 
Farnsworth-Munsel1 100 Hue Test (Farnsworth 1943) under 
standard conditions of artificial daylight. The 
[test consists of 85 coloured "caps" arranged in four sets. 
iThe first set contains 22 caps and the other three contain 
|21 caps each. The caps are 1.25 cm in size. All colours 
re of equal luminosity and saturation and can be so 
rranged that they f o r m  a continuous sequence of hues. At
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the ends of each set, coloured reference caps are placed and 
the patients' task is to arrange the caps, which are pre­
sented in a predetermined random manner, in order of hue to 
form a colour seqdènce between the reference hues in each 
set. Each coloured cap has a number on its reverse side and 
if perfectly arranged the caps will form a numerical 
sequence from 1 to 85. Departures from the correct order 
are indicated by errors in this sequence and the total error 
score gives a measure of the colour loss and the particular 
wavelengths affected can be seen in a graphical represen­
tation. A normal untrained observer can rarely attain the 
perfect sequence but the few errors made are usually distri­
buted randomly around the hue circle. Fig. 15. The colour 
defective will make numerous errors but usually cocentrated 
in two parts of the hue circle (Voke 1981).
Of the 98 diabetic eyes tested 27 eyes (16 patients) had 
normal visual acuity and no diabetic retinopathy on 
ophthalmoscopy, 27 eyes (16 patients) had background retino­
pathy and good vision, 15 eyes (9 patients) had diabetic 
exudative retinopathy with low visual acuity, and finally 29 
eyes (16 patients) had ischaemic or proliferative retino­
pathy. The patients were obtained from the following 
sources: Those with background or no retinopathy were
diabetics attending Woodside Health Centre or Glasgow Royal 
Infirmary; patients with exudative or proliferative diabe­
tic retinopathy were subjects attending for laser treatment 
lor were referred by the author, other Ophthalmologists, or 
[physicians from Woods ide Health Centre and Glasgow Royal 
nfirmary for investigation and photocoagulation. An eye
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which had already received photocoagulation or other forms 
of therapy was excluded from the study.
No time limit was given to the patient for the completion of 
the test and patients used their available spectacle correc­
tion where appropriate.
Total error scores from each of the eyes tested are 
shown in Appendix 2. It was found that 63 per cent (17/27 
of eyes without retinopathy on ophthalmoscopy showed abnor­
mal total error scores. Two thirds of the defective eyes 
had a diffuse type of dyschromatopsia, the other third 
showed an abnormality of the blue/yellow axis. Similar 
figures were obtained from those with background retinopathy;
70 per cent of eyes had abnormally high scores. More than 
a half of these had a diffuse dyschromatopsia (Pig. 16).
87 per cent and 79 per cent respectively of eyes with 
exudative or proliferative retinopathy demonstrated poor 
colour discrimination (Fig. 17). In most cases the faulty 
colour discrimination was of a diffuse type. In only 10 
per cent of instances was it a blue/yellow defect.
The results are summarised in Table 8.
In Table 9 are shown the mean, median, standard 
deviation, and square roots of total error scores from the 
individual groups. Figure 18 shows the mean square 
roots and standard deviation of each of the groups tested. 
Significant statistical differences, at the level of 
P = 0.05, were found when figures from normal individuals 
(were compared with figures from different groups of 
iabetics except on Mann-Whitney test when normal
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Category
No. No. of No. of
of eyes eyes with eyes with
tested normal results abnormal results
No
retinopathy 150 126 24
Background
retinopathy 58 ' 53 5
Exudative
retinopathy 9 2 7
Ischaemic
retinopathy 6 4 2
Table 7. Results of visual field tests of 223 diabetic 
eyes.
Category
of
subjects
No .of 
eyes 
tes ted
No.of 
eyes 
wi th 
high 
scores
No.of 
eyes 
wi th 
di ffuse 
chroma t 
opsia
No.of 
eyes 
wi th 
poor blue/ 
- yellow axis
No.of 
eyes 
wi th
red/green 
normali ty
Norma1 
subjects 24 8
(33)
7
(29)
1
(4)
—
No
retinopathy 27 17
(63)
12
(44.5)
5
(18.5)
-
Background
retinopathy 27 19
(70)
11
(40)
8
( 30)
-
Exudative
retinopathy 15 13
(87)
13
(87)
- -
Proli ferative 
retinopathy 29 23
(79)
19
(65)
3
( 10)
1
(4)
T a b l e  8 .  A b n o r m a l i t i e s  o f  c o l o u r  v i s i o n  i n  n o r m a l  a n d  
d i a b e t i c  s u b j e c t s .  ( P e r c e n t a g e s  a r e  s h o w n  i n  
b r a c k e t s ) .
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Mean Median
Standa rd 
devi ation
Normals 88.6 83 31
(24 eyes, 14 patients) (9.41) (9.11) (5.56)
No retinopathy 110 98 43
(27 eyes, 16 patients) (10.48) (9.89) (6.55)
Background ret inopathy 138 106 78
(27 eyes, 16 patients) (11.74) (10.29) (8.83)
Exudative retinopathy 305 322 117
(15 eyes. 9 patients) (17.46) (17.94) (10.81)
Proliferative retinopathy 190 184 117
(29 eyes, 16 patients) (13.78) (13.56) (10.81)
Table 9. Different parameters of error scores of the 
groups of individuals examined on the 
Farnsworth-Munsel1 100-Hue test. The square 
roots are in brackets.
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t-test
Mann- 
Whitney 
tes t
Normal Vs no retiriOpathy
Normal Vs background retinopathy
Normal Vs exudative retinopathy
Normal Vs proliferative retinopathy
No retinopathy Vs background 
retinopathy
No retinopathy Vs exudative 
retinopathy
No retinopathy Vs proliferative 
retinopathy
Background retinopathy Vs 
exudative retinopathy
Background retinopathy Vs 
proliferative retinopathy
P=0,0426 
P=0 .0049 
P=0.0000 
P=0.0000
P=0.1165 *
P=0.0000
P=0.0015
P=0.0000
P=0.1129 * 
P=0.0165 
P=0.0000 
P=0.0004
P=0 ,2 39 4 *
P=0.0000
P=0.0059
P=0.0000
P=0.0538 * P=0.1117 *
Exudative retinopathy Vs 
proliferative retinopathy P=0.0044 P=0,0024
Table 10. Comparison of mean scores frcm different 
groups of individuals. Non-significant 
differences of mean scores are indicated
vs. the no retinopathy group were compared (P = 0,1129) 
although the Student t-test showed significant differences 
(P = 0.0426), Table 10, On comparing figures from the 
diabetic groups with each other the only non-significant 
result was found when the background retinopathy group was 
compared with the proliferative group, see Table 9.
The sguare root was used because it has been 
found that the square root of the Farnsworth-Munsel1 
100 Hue-test error score is statistically more informative 
than either the total error score or its logarithm 
(Kinnear 1970; Aspinall 1974). In addition it makes 
graphical representation of the data easier.
Because no particular attention was paid to the age 
factor in this study, the relatively high scores from 
"normal" eyes might be due to age distribution among the 
sample studied; age has been shown to affect colour vision 
steadily with advancing years (Lakowski 19 58; Verriest 1963; 
Pinkers 1980), Table 11, Colours are perceived and 
discriminated most accurately between the age of 16 and 35, 
and after 55 years there is a rapid deterioration in fine 
colour discrimination which affects mainly blue/yellow 
or violet/blue/green discrimination. Red/green 
discrimination which is characteristically affected in for 
xample tobacco amblyopia (Chisholm et al 19 70) remains 
easonably stable and is the least affected by age. 
ige should also contribute, to some extent, to the 
igh error scores of the diabetic subjects 
[specially the older ones with severe exudative
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retinopathy. Patients with exudative retinopathy 
tend to be older than other groups of diabetics at the 
time of diagnosis of diabetes (Bodonsky, Cudworth,
Whitelocke, and Dobree 1982) and would thus be more affected 
by the age factor than others and it might be true that the 
deterioration of colour-vision of diabetics is an acce­
lerated version of loss of colour discrimination associated 
with ageing (Kinnear, Aspinall, and Lakowski 1972). Further 
work in progress suggests that this may be the case.
In conclusion, colour vision of diabetic subjects seems 
to be affected to a significant extent. Even before the 
appearance of ophthalmoscopically detectable retinopathy 
high error scores are found on the Farnsworth-Munsel1 
100-Hue test. Because of the large overlap in the total
error scores of patients with and without retinopathy and
with serious as compared to non-serious retinopathy the
test was found not to be of value for screening purposes.
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Age range (years) 95th Percentile
16-20 100
21-25 74
26-30 92
31-35 106
36-40 120
41-45 134
46-50 144
51-55 154
56-60 164
61-65 174
Table 11. Upper limit of error scores (9 5th
percentile) made by normal trichromats of 
different ages. From Verriest (1963): 
Further studies on acquired deficiency of 
colour discrimination. J.Opt.Soc.Am. 53: 
185-19 5.
Mean values Arden's figures
Plate 2 
Plate 3 
Plate 4 
Plate 5 
Plate 6 
Plate 7
11.96 (2.27) 11.50
10.26 (1.89) 10.00
11.33 (2.08) 11.50
10.90 (1.98) 11.50
9.08 (2.25) 10.00
9.19 (2.56) 9.00
Table 12. Results of contrast sensitivity measurements, 
Mean values for normal controls in this 
study are compared with those of Arden and 
Jacobson ( 19 78) .
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F i g u r e  15.  F a r n s w o r t h - M u n s e l l  100-Hue t e s t  t r a c e  o f  a 
normal u n t r a i n e d  s u b j e c t .  Random d i s t r i b u t i o n  o f  e r r o r
s c o r e .
Figure 16. Fanrsworth-Munsell 100-Hue test trace 
of a diabetic patient with background retinopathy 
Diffuse dyschromatopsia.
F i g u r e  17.  F a r n s w o r t h - M u n s e l l  100-Hue t e s t  t r a c e  o f  
a d i a b e t i c  w i t h  m a c u l o p a t h y .  High t o t a l  e r r o r  s c o r e
wi th  a b s e n c e  o f  a d é f i n i t  p o l a r i t y .
a:
§
21
19
17
15
O
Q
(K 13
NORMALS NO RETINO- B A C K - EXUD A- PROLIFE- 
PATHY GROUND TIVE RATIVE
Figure 18. Sguare roots of means of total error scores 
of normal individuals and diabetics with 
different types of retinopathy. Vertical lines 
represent standard deviations.
5.6 . CONTRAST SENSITIVITY
Contrast sensitivity is an important visual function 
which is sometimes neglected in everyday clinical practice.
The ear acts as a frequency analyser and splits any 
complex sound into its harmonic components which are 
transmitted separately to higher levels of the nervous 
gystem and it is a matter of controversy whether a similar 
process occurs in the visual system {Spekeijse and van der 
Tweed 1977) because there is no obvious basis in retinal 
anatomy which would enable the eye to act as a spatial fre­
quency analyser as there is in the structure of the cochlea. 
However, it has been established that single cells in the 
visual cortex do respond to narrow bands of spatial frequen­
cies and may respond more vigorously to a sinusoidal grating 
of optimal frequency than to a square wave grating or to any 
single line, bar, or edge (Maffei, Fiorentini, and Bisti 
1974; Glezer, Cooperman, Ivanov, and Tscherbach 19 76; 
Glezer, Kostelyanets, and Cooperman 1977), and that maximum 
grating acuity is at 30 to 40 cycles per degree. It has, 
therefore, been postulated that there exist visual 
"channels" each handling information about bands of spatial 
frequency. Separate channels have also been postulated for 
the processing of luminance and colour information (Regan 
1977).
Isolated losses of contrast sensitivity have been 
demonstrated in certain diseases, and in many others loss 
of contrast sensitivity is more prominent and disturbing 
to the patient than the loss of visual acuity. It 
has been reported that contrast sensitivity is reduced in 
cases of glaucoma before the patient notices impairment
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of vision (Arden 1978), in macular and paramacular 
diseases even when foveolar function remains unaltered 
and the optotype acuity is normal (Sjostrand and Frisen 
1977). It has also been shown that measurements of 
contrast sensitivity are a more sensitive indication of 
demyelination of the optic nerve than other psychophysical 
tests (Arden and Gucukogla 1978). Canavan and Archer 
(1980) reported loss of contrast sensitivity following 
contusional eye injury and noted that there was a significant 
difference in this aspect of visual function between the 
injured and uninjured eyes; the defect in contrast sen­
sitivity could be demonstrated in the injured eye even 
when no structural abnormality could be detected on 
full clinical examination.
Although gratings such as those of the Arden test are 
unfamiliar as they are never seen in nature, they are 
a powerful investigatory tool. The Arden grating test 
has been shown to be useful in North West Iran (Minassian, 
Jones, and Zargarizadeh 1981) and Australia (Singh et al 
1981) as a screening test. It also appeared to be the 
most sensitive of three tests, VER acuity, Snellen 
acuity, and Arden test scores, equalling VER performance 
in optic nerve diseases, and surpassing it in macular 
[diseases and was, thus, recommended for use as a screening 
[test in central visual disturbances (Skalka 1980), glaucoma 
[(Arden, Siegel, and Scher 1977), retrobulbar neuritis,
Lrden and Gucokogla 19 78), families of glaucoma patients 
Hitchings, Powell, Arden, and Carter 1981), Minamata 
isease (Mukuno, Ishikawa, and Okamura 1981), and in 
letinitis pigmentosa (Lindberg, Fishman, Anderson, and 
jasquez 1981).
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A study was conducted by the author to determine whether
diabetic subjects have a normal or an elevated threshold
for different grating frequencies using the Arden grating
book, by comparing" a group of diabetics with normal
individuals matched for age, and also to establish the
usefulness of this test-as a screening tool in a diabetic
eye clinic and whether it can be used to differentiate
serious from non-serious retinopathy.
Recently, Arden and Jacobson (19 78) introduced a
grating test which has been used for the evaluation and
follow up of certain diseases of the eye. It consists
of a book with seven plates. The first plate is used for
quick initial screening of contrast sensitivity. Plate 2
is the first plate usually used. It shows a sinusoidal
grating, in which the contrast varies in the Y dimension,
being low at the top of the page and highest at the bottom
of the page. The contrast changes in a logarithmic
sequence, being 0.088 units per division.
The distance between the patient's eye and the plates is
about 57 cm, and the spacing between the periods of the
grating is nominally 0.2 cycles/degree. The successive
plates show gratings of periods 0.4, 0.8, 1.6, 3.2, and 6.4
eye les/degree.
In conducting the test the examiner covers the plate
with a card of roughly similar albedo to the test pattern
progressively
iand then moves it to expose the/^highercontrast port ions (scale 
reading 20 to 15). The patient, seated, looks at the 
[plate, and follows with his eye as the card is moved slowly 
iown the page and is instructed to report the moment he sees 
he grating bars. For a subject performing the test for 
he first time an initial run is usually permitted on the
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first, low frequency, plate. The position of the card is 
read from the scale at the side of the plate and this is 
called the score. A reading of 25 is arbitrarily assigned 
if the grating could not be seen by the subject.
The Arden grating test is a subjective test requiring 
active participation by "the patient, and to administer the 
test it was necessary that, a range of values from normal 
individuals should be obtained. Eighty normal volunteers 
from the Department’s staff, the author's relations, and 
relatives of patients were examined and informed of the 
nature of the study. The right eye from each of the normal 
individuals was used. Standard artificial daylight was 
used (Verivide Cabinet, Leslie Hubble Limited) and, when 
necessary, the subjects were wearing their appropriate near 
vision correction.
The subject's ages ranged between 24 and 68 years, mean 
age 4 6 and median 4 5 years.
Individuals with ocular diseases were excluded by 
checking for eye symptoms, visual acuity measurement using 
Snellen's test chart, slit lamp biomicroscopy, applanation 
tonometry, and ophthalmoscopic examination. No effort was 
imade to perform the Arden grating test if a lens opacity, 
elevated intraocular pressure, or retinal disease was pre- 
Isent.
Ninety nine diabetics ranging in age between 27 and 
0 years (mean age 47, median 49 years) were also tested, 
qain the right eye was used and, like the control group, 
iabetics had no lens opacities or increased intraocular 
ressure but, of course, varying degrees of retinal diabetic 
Involvement were present. Included in this series were 42
'es with oph thalmoscop ical ly no retinopathy, 28 eyes with
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background retinopathy. The last group consisted of 29
eyes with proliferative diabetic retinopathy confirmed 
by fluorescein angiograms. Visual acuities among this 
group of di abet ics" ranged from 6/5 to 6/36 with mean and 
median levels of 6/9,
The mean results for the various plates and also the total 
scores from the normal controls and the different groups of 
diabetic subjects were compared using the Student t-test and 
F“test (Figs. 19 & 20). Normal probability plots confirmed
that the data were essentially normally distributed. Mean 
scores on the individual plates from 80 normal eyes with 
standard deviation (in brackets) of each together with the 
original figures as suggested by Arden and Jacobson ( 1978) 
are shown in Table 12, see also Figure 21.
Assuming that Arden and Jacobson’s figures were the 
result of a few hundred observations, as opposed to eighty 
subjects in this study, there were no statistically signi­
ficant differences between Arden and Jacobson's mean 
readings and the mean readings from the present normal con­
trols on plates 2, 3, 4, and 7 (P> 0.1, 0.2, 0.2, and 0.2
Respectively), but differences were found to exist between 
[the mean scores on plates 5 and 6 (P< 0,001 on both plates). 
When mean contrast thresholds for plates 2 to 7 from 
he 99 right eyes of all diabetic subjects, irrespective 
>f the presence or degree of retinopathy, are compared 
[Table 13) it is noted that as the grating frequency of the 
[uccessive plates increases, the mean increases together with 
le standard deviation, i.e. large variances were noted, 
g . 22. Significant statistical differences were found 
tween these readings and both Arden and Jacobson's 
[gures for normals and the present series of 80 normal
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controls at all spatial grating frequencies ( P < 0.001 on 
all plates).
Mean scores on the six plates of the grating book 
of 4 2 diabetics who showed no retinopathy on ophthalmoscopy 
are as shown in Table 14. No significant differences could 
be detected between this group and normal individuals at 
low frequency spatial gratings viz plates 2 through 5 but 
mean thresholds on plates 6 and 7 were statistically 
different (P< 0.001), patients in this category having a 
higher threshold (lower contrast sensitivity) for high 
frequency patterns. Figures 23 a & b. The same conclusion 
results when these "no retinopathy" figures are compared 
with Arden and Jacobson’s original means.
The group of diabetics with background retinopathy (28 
right eyes) demonstrated significantly high thresholds for 
grating patterns along the whole spectrum whether the mean 
values were compared with normal controls or with Arden and 
Jacobson's means. Table 15.
The most strikingly high scores on all plates were 
obtained from the 29 patients with proliferative diabetic 
retinopathy, Figure 20, Again, highly significant dif- 
iferences were found between the mean values of contrast 
[threshold, Table 16, and those of both present normal 
controls and Arden and Jacobson's normals. A wide 
ange of scores was obtained on all plates especially 
lates 6 and 7 (3.2 and 6,4 cycles/ degree respectively).
(omment
Scores of normal controls were comparable to Arden and 
icobsons figures on plates 2, 3, 4, and 7 but different
'om those on plate 5 and 6, Figures from a recent work
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(Singh, Cooper, Alder, Crawford, Terrell, and Constable 1981) 
using plates 6 and 7 only. Table 17, did not differ from 
figures from the normal individuals in this work but showed 
significant differences when compared with the original 
figures of Arden and Jacobson.
The individuals who"participated in the present study, 
whether normals or diabetics represented a wide range of 
ages so that it is unlikely that the mean scores were 
biased by age. The variation in the test results with 
age in normals is only slight (Arden 1978), although 
a significant increase in test scores with increasing age 
was noted by Arundale (1978) and Skalka (1980) who found 
that contrast threshold increased with age despite 
excellent Snellen acuity.
Differences in mean thresholds of normal subjects for 
plates 6 and 7 between the present study and that 
reported by Arden and Jacobson (1978) are likely to 
reflect minor differences in testing techniques such as 
the illumination used, the distance of subject from the 
test plate, and the rate at which the obscuring card 
[was moved. It was thought important that comparisons 
[between diabetic and normal subjects should be made only 
nder the same test conditions.
The test was conducted by one examiner using the same 
tandard illumination. This excluded the possibility of 
n interobserver difference in recording and judgement.
[he test was also carried out at different times of the 
|ay so that any effects of fluctuation of blood sugar 
lusing varying errors of refraction and possible 
.anges in test scores should average out.
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Mean Standard deviation
Plate 2 13.42 3.72
Plate 3 11.17 3.39
Plate 4 13.37 3.54
Plate 5 13.73 3.99
Plate 6 13.91 6.39
Plate 7 15.80 7.31
Table 13 Figures obtained from 99 diabetic eyes 
with different grades of retinopathy on 
Arden grating test.
Mean Standard deviation
Plate 2 12.86 4.03
Plate 3 9.53 2.99
Plate 4 11.73 3.32
Plate 5 11.60 3.50
Plate 6 12.40 7 .28
Plate 7 13.26 8.07
Table 14. Mean of contrast threshold on the Arden
book from 42 diabetic eyes without clinically 
detectable retinopathy.
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Mean Standard deviation
Plate 2 13.60 2.87
Plate 3 12.00 2.23
Pla te 4 13.33 3.06
Plate 5 13.13 2.64
Plate 6 12.66 4.33
Plate 7 14.86 5.20
Table 15. Mean values and standard deviation of 
figures obtained from diabetes eyes 
with background retinopathy.
Mean Standard deviation
Plate 2 13.80 4,31
Plate 3 12.00 4.22
1 Plate 4 15.06 3.65
1 Plate 5 16 .46 4.18
1 Plate 6 16 .66 6.65
1 Plate 7 19 .26 7.43
Table 16 . Mean threshold figures fron 29 diabetic 
subjects with proliferative diabetic 
retinopthy on the Arden grating test.
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Normal s u b j e c t s
P r e s e n t  s tu dy  
mean v a l u e s
Arden and 
J a c o b s o n ' s 
mean v a l u e s
S i ngh ' s 
mean v a l u e s
P l a t e  6 9 . 0 8
( 2 . 2 5 )
10.00
(2.00)
9 . 5 0
( 2 . 2 9 )
P l a t e  7 9 . 1 9
( 2 . 5 6 )
9 . 0 0
(2.00)
9 . 4 4
( 2 . 3 2 )
Tabl e  17-  A com pa r i so n  of  d i f f e r e n t  mean 
t h r e s h o l d  r e a d i n g s  from normal  
o f  t h i s  work,  Arden & J a c ob s on  
Si ngh  e t  a l  ( 1 9 8 1 ) .  S tandard  
a r e  shown i n  b r a c k e t s .
c o n t r a s t  
i n d i v i d u a l s  
( 19 78) and 
d e v i  a t i o n s
P l a t e 2 3 4 5 6 7
Mean 1 1 . 9 6 1 0 . 2 6 1 1 . 3 3 1 0 . 9 0 9 . 0 8 9 . 1 9
+ 1 . 9 6  X SD 4 . 4 5 3 . 7 0 4 . 0 8 3 . 8 8 4 . 4 1 5 . 0 2
g i v i n g  normal 16 . 41 1 3 . 9 6 1 5 . 4 1 1 4 . 7 8 1 3 . 49 1 4 . 2 1
range of t o t o to t o to t o
7 . 5 1 6 . 5 6 7 . 2 5 7 . 0 2 4 . 6 7 4 . 17
Table  18 .  95% l i m i t s  (mean + 1 . 9 6  SD) of  normal
range of  c o n t r a s t  s e n s i t i v i t y  o b t a i n e d  
from normal i n d i v i d u a l s  i n  t h i s  s t u d y .
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The highest total scores for any one of the normal 
controls did not exceed 81 but with diabetics, especially 
those with well advanced retinopathy, much higher total 
scores were obtained; actually a few of those with back­
ground retinopathy and many with proliferative retinopathy 
were unable to see some -of the grating patterns especially 
when the higher frequency plates 6 and 7 were used. They 
were, thus, assigned an arbitrary score of 25 for that 
particular plate.
Learning does not play a role in this test (Fiorentini 
and Berardi 1981). In the present study all patients were 
shown the plates only once after an initial run on plate 2 
and consequently learing did not influence the results.
Using electronically generated sinusoidal gratings 
Fiorentini and Berardi (1981) concluded that the spatial 
frequency discrimination does not improve with repetition.
When scores from normal subjects were compared with 
the various groups of diabetics it was found that there 
were significant differences on all plates and from all 
igroups except that diabetics without retinopathy only 
differed from normals in respect of plate 6 and 7.
|ln fact almost the same conclusion resulted when Arden's 
lOrmals were used; significant differences being found 
n plates 2, 6, and 7. This would suggest that a 
unctional deficit for higher frequencies may preceed 
jphthalmoscop ical ly visible retinopathy and indeed 
joss of visual acuity.
It has been claimed (Arden and Jacobson 19 78) that the 
:st measures retinal integrative function and it would 
Ipear that in diabetes this aspect of retinal function
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may be abnormal when visual acuity and some other aspects 
of function such as colour vision are still unaffected.
Although reduced contrast sensitivity on the Arden 
grating test is more marked in those with more advanced 
retinopathy than in those with background or no retinopathy 
the overlap in results between groups makes the test 
unsuitable for screening for retinopathy requiring treatment. 
The overlap arises from the variance of scores within 
groups. Thus using the standard range of ± 2 SD to 
categorise the results within each group would result in 
50 per cent of diabetics in the no retinopathy group 
being classed as normals on plates 6 and 7 although as 
a group the mean scores for those plates are significantly 
different in these two groups. Even using the slightly 
less broad 95% confidence limits (1.96 x SD) considerable 
overlap remains between each group tested.
As already indicated this broad overlap between groups 
prevents the tests being useful for the routine clinical 
screening of diabetic retinopathy.
141
Plate 2 3 4 5 6 7 Comparison
*
Normal Controls v. 
Arden Normals
* * * * *
Arden Normals v. 
All Diabetics
* * * * * *
Arden Normals v. 
No Retinopathy
* * * * *
Arden Normals v. 
Background Retinopathy
* * * * *
Arden Normals v. 
Proliferative Retinopathy
* * * * *
Normal Controls v. 
All Diabetics
* * * * * *
Normal Controls v. 
No Retinopathy
* * * *
Normal Controls v. 
Background Retinopathy
* * * * * *
Normal Controls v. 
Proliferative Retinopathy
* *
No Retinopathy v. 
Background Retinopathy
*
No Retinopathy v. 
Proliferative Retinopathy
* * * *
Background Retinopathy v. 
Proliferative Retinopathy
F i g u r e  19.  A t - t e s t  c o m p a r i s o n  o f  mean c o n t r a s t  
t h r e s h o l d s ,  on d i f f e r e n t  p l a t e s  o f  t h e  Arden g r a t i n g  
book ,  b e tw ee n  d i f f e r e n t  g r o u p s  o f  i n d i v i d u a l s  t e s t e d .  
S i g n i f i c a n t  d i f f e r e n c e s  a r e  i n d i c a t e d  by an a s t e r i s k  (*)
Pla te 2 3 4 5 6 7
..  ......- v,«
Comparison
* *
Normal Controls v. 
Arden Normals
* * * * *
Arden Normals v. 
All Diabetics
* * *
Arden Normals v. 
No Retinopathy
* * * * *
Arden Normals v. \ 
Background Retinopathy
* * * * * *
Arden Normals v. 
Proliferative Retinopathy
* * * * * *
Normal Controls v. 
All Diabetics
* *
Normal Controls v. 
No Retinopathy
* * * * * *
Normal Controls v. 
Background Retinopathy
* * * * * *
Normal Controls v. 
Proliferative Retinopathy
* * *
No Retinopathy v. 
Background Retinopathy
* * * * *
No Retinopathy v. 
Proliferative Retinopathy
* * *
Background Retinopathy v. 
Proliferative Retinopathy
Figure 20. An F-test comparison of mean contrast 
thresholds, on different plates of the Arden grating 
book, between different groups of individuals tested. 
Significant differences are indicated by an asterisk (*)
Contra»t
threshold
20
2 3 4 5 0 7
P la te  num ber
Figure 21. Mean contrast thrshold on the Arden grating 
book of :
______  Normal individuals in this series.
   Normal individuals in Arden and Jacobson's series (1978)
Contrast
threshold
10
3 4 52 6 7
P la te  n u m b er
Figure 22. Mean contrast threshold on the Arden grating 
book of :
Normals in this series.
Arden and Jacobson's normals.
All diabetics irrespective of presence 
or type of retinopathy.
Vertical lines indicate standard deviation.
C ontrast
threshold
20
3 5 62 4 7
P la te  n u m b er
Figure 23(a). Contrast threshold of normal individuals 
and diabetic patients with no retinopathy 
______ Normals.
-----  Diabetics ; no retinopathy.
V e r t i c a l  l i n e s  r e p r e s e n t  s t a n d a r d  d e v i a t i o n
02
4
6
8
C o n tra s t
threshold,
10
12
14
16
18
20
2 3 4 5 6 7
P la te  num ber
Figure 2 3 (b). Mean contrast threshold of :
______ Normal subjects.
  Diabetics with background retinopathy.
  Diabetics with proliferative retinopathy.
Vertical lines represent standard deviation.
CHAP TER 6
PREVALENCE OF DIABETES IN THE WEST OF SCOTLAND
1 4 2
6.1 INTRODUCTION
Diabetes is a disease which shows a great variation of 
frequency in different areas of the world and, depending on 
the criteria used for the diagnosis of diabetes in different 
surveys, the available figures show a wide range of preva­
lence rates in different countries. Factors such as 
race, environment, and socio-economics all play parts in 
modifying the rates.
To obtain up to date information on the prevalence of 
diabetes and diabetic blindness in different countries, a 
letter , see appendix 3,was sent to diabetic societies and 
to blind welfare bodies in 22 countries. Figures were 
received from the following countries: Canada; four states
in the USA; Denmark; France; Italy; and Spain; India;
Tunisia; and Barbados. No replies were received from East 
European countries.
In the United States of America it is estimated that 
there are 4.5 million diabetics, one third of whom are 
unaware that they have the disease. In terms of total 
population in America, slightly more than 2 per cent have 
diabetes (Amos 1974).
In Canada diabetes affects nearly one million people, or 
one in every twenty persons (CNIB 1981).
Several tribes of American Indians were shown to have 
very high frequencies of glycosuria and diabetes. Amongst 
the tribes of Pima, Cocopah, Cherokee, and Seneca, almost 50 
per cent of those over the age of 30 had a venous plasma level 
of more than 8.8 mmol/L (160 mg/100 ml) 2 hours after a 7 5g
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glucose load (Bennett, Burch, and Miller 1971). By contrast, 
the Athabaskan Indians and the racially dissimilar Eskimos 
in Alaska both have a very low prevalence of clinical diabetes; 
both groups also show a high degree of tolerance to a glu­
cose load in comparison with all other population groups 
within the United States. The Eskimos of Greenland, like 
those of Alaska, have a very low prevalence of diabetes.
Using population sampling and defining diabetes as a 
blood sugar level of over 8.3 mmol/L (149 mg/100 ml) 2 hours 
after a glucose load. West and Kalbfleisch (1966) provided 
reasonably exact comparisons of the prevalence of diabetes 
in some countries of the world in those over 35 years of age. 
Their comparative prevalence rates were 2.0 per cent in East 
Pakistan, 3.3 per cent in Malaya, 4.1 per cent in Central 
America, 6.9 per cent in Uruguay, 7 per cent in Venezuela,
17 per cent in Bangor, Pennsylvania, and 25 per cent in 
Cherokee Indians,
Studies in South Africa have suggested that diabetes is 
excessively common among those of Indian origin. Indians 
|showed a prevalence rate of 10.4 per cent, Malays of 6.6 per 
:ent, and African blacks 3.6 per cent. No factor other 
han racial was found that might have explained this great 
variation. The same difference in prevalence rate was found 
Lo exist between the Busselton Whites of Australia, 2.3 per 
lent, and Davenport Aboriginals where the rate was found to 
|e 19 per cent (Jarrett 1976).
Population sampling was used for the study of preva- 
■nce of diabetes in Bedford and in Birmingham, England, in
ich of which the prevalence of known plus new-found diabetes
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a t i o n P r e v a l e n c e  o f  d i a b e t e s (%) C o m m e n t R e f e r e n c e
d States 
erica
Cocopah, 
kee,and 
a Indians
askan Indians 
ska Eskimos, 
Land Eskimos
Pakistan
I
il America
ly
iela
,Pennslvania 
lee Indians
ifrica 
ans 
lys
.can blacks 
ia 
:es
inpor t 
liginals
About 4.5 million 
have diabetes
A m o s (1974)
>rd
.ngham
a th
irgh
50
Very low !
2
3.3
4.1
6.9
7
17
25
10.4 
6 . 6 
3.6
2.3
19
4-5
1-3
1 .06
0.6
Studied are those Bennett(1971)
over 30 who had
venous level of
more than 8.8 mmol
/L after 2 hour of
a 75 g glucose load
Jarrett(1976)
All had a blood 
sugar level of 
over 8.3 mmol/L
West and
Kalbfleisch
(1966)
Jarrett(1976)
C N I B  (1981 : 
(personal com­
munication )
Sharp et al 
(1964)
Clark et al 
(1965)
Falconer et al 
(1971)
Table 19. Different prevalence rates of 
diabetes in some countries .
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in all age-groups was in the order of 1-3 per cent (Sharp, 
Butterfield, and Keen 1964). In the United Kingdom, the 
incidence of diabetes in the first 26 years of life is about 
one tenth of these figures (Wadsworth and Jarrett 1974).
In Scotland (Clark, "Taylor, Tocher, and Tocher 1965) a 
survey of glycosuria and diabetes was undertaken on the 
population of Arbroath, on the Angus coast of Scotland with 
a population of around 20,000, and showed that 3.8 per cent of 
the population, above 5 years of age, had glycosuria.
Further investigations showed that 28 per cent of these were 
diabetics. By calculation this gives a prevalence rate of 
diabetes in this part of Scotland of 1.06 per cent (see 
Table 19). Falconer, Duncan, and Smith (19 71) reported a 
prevalence of 0.6 per cent in Edinburgh.
A study was carried out to discover the prevalence of 
diagnosed diabetes in a general practice in the West of 
Scotland (Woodside Health Centre, Glasgow). The frequency 
of complications of diabetes, other than diabetic retinopathy 
(see the following chapter), was also studied as was the state 
|of diabetic control using random blood sugar and glycosylated 
aemoglobin levels.
.2. MATERIALS & METHOD
7139 medical records of patients attending one group 
iractice, in which three general practitioners were involved, 
lere searched for information indicative of diabetes, 
cords were analysed in batches of 150-200 selected 
.phabe t ical ly. Doctor's letters, hospital replies, urine
id blood investigations, and medical prescriptions were
)Oked at and a letter was sent to every identified diabetic
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under the care of the group explaining the nature of the 
survey and requesting his/her attendance.
Special clinics for the examination of identified 
diabetic subjectd'were arranged. These clinics were held 
from 2 to 5 in the afternoon.
At these clinics a note was taken of the name, age, 
sex, duration of diabetes, age at which diabetes was first 
diagnosed, family history, smoking habits, type and fre­
quency of treatment, treating body (whether general prac­
titioner or hospital), history of chest pain, intermittent 
claudication, gangrene, or cardiovascular accident. Blood 
pressure was recorded (sitting) and samples of blood taken for 
random blood sugar and glycosylated haemoglobin measurements.
A computer input was prepared from the information obtained 
and the results analysed on the Edinburgh University Computer.
6.3. RESULTS & DISCUSSION
Counts of diabetes in general practice of sample 
physicians is a recognised epidemiological procedure and 
has been used in previous studies (Adelstein 1975),
The age/sex distribution of people on the practice list
lis shown in the Appendices. 798 records (10 per cent) could
|not be inspected because more than 200 records of students
>n the practice list were kept at Baird Hall, a student's
•esidence, about 250 records were usually withdrawn daily
.or consultant clinics, repeat prescriptions and surgery
jppointments, and about 200 files were permanently withdrawn
ïcause of patients moving or dying. The rest, about 150,
instituted the missing files" common to many clinics
lannay and Maddox 1977; Scobie, Rafferty, Pranks, and 
>nksen, 1983) .
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6 . 3 . a .  P r e v a l e n c e  a n d  s e x  r a t i o
Of 7139 records inspected, 76 diabetics were identified 
These comprised 30 males and 46 females. Regardless of the 
type of diabetes, whether adult or juvenile - onset, this 
gives a male-female sex ratio of 1:1.55.
Comment
The male:female ratio in the general population of the 
West of Scotland is 1:1.1 (Registrar General, Scotland 1981) 
In Scotland and in England-Wales the male;female sex ratio 
in cases with "adult"-onset diabetes is 1:2 (World Health 
Organisation 1964).
Ratios with female predominance have been found in some 
countries e.g. Central America (West and Kalbfleisch 1970), 
Europe and the Soviet Union (World Health Organisation 1964) 
and Libya where the male:female ratio was reported to be 1:4 
(Mekkawi and Aswad 1972). On the other hand, high 
male:female ratios were reported from some other parts of 
the world including Nigeria (Osuntokun 1971), Ethiopia 
(Belcher 1970), and Iraq and Jordan (W.H.O. 1964).
There is a possibility that in some countries social 
(customs may make it more likely that men are diagnosed 
learlier than women.
ittendance rate
The number of people who were willing to participate in 
he study and who actually attended the clinic was 54 giving 
n attendance rate of 71 per cent. A search into the notes 
(f those who defaulted showed that there was no specific 
ason for their failure to attend the clinic. Diabetics
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are required, sometimes, to attend so many general and spe­
cialised clinics that some probably feel unwilling to 
undergo further tests; also some of the patients requested 
to attend had moved to other areas without notifying the 
Health Centre of their new address, a recognised bias in this 
sort of epidemiological survey (Hannay and Maddox 1977).
18 of the 30 diabetic males and 36 of the 46 females 
were able to attend the clinic, making the total number of 
persons examined 54. The default rate was 4 0 and 22 per 
cent among males and females respectively.
Comment
The number of patients studied is relatively small to 
draw conclusions about the default rate, but it will be 
seen from the next chapter that, on an average, diabetic 
males tend to be around 7 years younger than diabetic 
females and this could, perhaps, mean that relatively more 
males were at work at the time of the clinic and probably 
found it inconvenient to be available, the clinic being an 
"additional" one and not one of the routine clinics they 
usually visited.
The prevalence of diagnosed diabetes among the popula- 
|tion of the practice studied is accordingly 1.06 per cent.
’his is similar to that found in Arbroath (Clark and others 
965) but higher than that in Edinburgh in which a prevalence 
‘ate of 0.6 per cent was found. In the Edinburgh survey 
[he characteristics of 2932 diabetics were studied (Falconer 
Ind others 1971).
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b.j.b. Age at time of examination
Patients' ages ranged between 21 and 86 years with a 
mean age of 62 and a median of 64 years. Table 20.
About 50 per cent of all diabetics examined were 66 
years of age or more, see Table 21. A p p e n d i x  5 shows the 
age distribution of patients on the practice lists of Woodside 
Health Centre. It can be. seen that the over 65 year olds 
constitute about 20% of the practice studied. Those over 
65 years of age formed 14 per cent of the total Health Centre 
list.
6 . 3 . C .  Duration of diabetes
Duration of diabetes of the sample studied ranged bet­
ween 6 months and 34 years with a median of 6.6 years. In 
Table 2 2 are shown the minimum, maximum, mean, and median 
duration of the diabetic illness. This range of duration 
of diabetes is similar to the range found in a recent study 
also carried out in Britain (Bodansky, Cudworth, Whitelocke, 
and Dobree 1982).
6.3.d. Age at diagnosis of diabetes 
One patient, a female, had developed diabetes at the age
if 11 and one, also a female, was diagnosed at the age of
3. However, the median age at diagnosis in males was 60 
nd in females 55 years (Table 23). No significant difference 
n the age at diagnosis of diabetes in males as compared with 
(Omales was demonstrated (P = 0.1142, Mann-Whitney comparison 
|f medians).
)mment
The failure to demonstrate a difference in age of onset
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Ages in years All patients Males Females
Minimum age 21 21 28
Maximum age 86 76 86
Mean age 62 59 63
Median age 64 64 66
Standard deviation 14 16 13
Table 20. Age and sex of the 5 4 diabetics studied.
Age
group No. Percent No.
Males 
Percent No.
Females
Percent
0-20 0 0 0 0 0 0
21-40 5 9.2 3 16.6 2 5.5
41-65 23 42.6 7 38.8 16 44.4
66 4- 26 48.1 8 44.4 18 50.0
TOTAL 5 4 18 36
Table 21. Actual numbers and percentages of the total of 
diabetics examined at different age groups, 
subdivided into male and female groups.
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Duration All Patients Male Female
Minimum 6 months 6 months 6 months
Maximum 34 years - 14 years 34 years
Mean 8.2 years 7.1 years 8. 8 years
Median 6.6 years 7.9 years 6. 0 years
Standard
deviation 7.3 years 4.6 years 8. 4 years
Table 22. Details of 
the sample
known duration of 
studied.
diabetes in
Age at diagnosis
in years All Male Female
Minimum 11 18 11
[Maximum 83 68 83
|4ean 54 52 55
iledi an 60 60 55
Table 23. Age at diagnosis of diabetes
1 5 2
ALL MALE FEMALE
Age Group No. of per No. of per No. of per 
(years) patients, cent patients, cent patients, cent
0-20 2' 3.7 1 5.5 1 2.7
21-40 7 12.9 3 16.6 4 11.1
41-65 29 53.7 10 55.5 19 52.7
6 6 + 16 29.6 4 22.2 12 33.3
Table 24. Age at time of diagnosis of 
groups.
different age
Age at diagnosis 
(years )
With positive 
family history 
(24 cases ) .
wi thout 
family history 
(30 cases).
Minimum age 11 20
Maximum age 68 83
Mean age 50 57
Maximum age 50 60
Table 25. Ages at diagnosis of patients with and 
without a positive family history of 
diabetes.
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of diabetes in males as compared with females may relate to 
the small sample size. The results differ from those of a 
study of 400 diabetics attending a general hospital diabetic 
clinic in which significant statistical differences in the 
age at diagnosis of diabetes was found between the two sexes 
(P = 0.0001), see Chapter 7.
In Table 24 it is noted that in more than half of the 
patients the diagnosis was made between ages 41-65 years and 
that more females, (33 per cent), experienced the onset of 
diabetes after the age of 6 5 than did males in the same age 
category. 16.6 per cent of males and 11.1 per cent of fema­
les were diagnosed between the ages of 21 and 40 years.
6.3.e. Family history of diabetes
Twenty four individuals, 44 per cent of the total, had a 
positive family history of diabetes. In twenty cases, 37 
per cent, the father, the mother, a sister or a brother or 
both plus one of the parents or a grandparent, were 
diabetic; the rest, 4 cases, had one or more second degree 
relatives affected with the illness.
The median age at onset of diabetes tends to be about 
me decade earlier in those with a family history, as seen 
n Table 25 and Figure 24.
Five out of 24 subjects (21 per cent) who came from
amilies with a positive history of diabetes were diagnosed
[jfter the age of 65, while 11 out of 30 ( 36 per cent) with
family history of diabetes were actually found to be
[Labetic after this age, see Table 26. This could be
lother indication that diabetic patients with a positive
[mily history of diabetes tend to develop the illness at 
earlier age .
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30
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20
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\
J
.W ith family history of diabetes
.No
30 40 50
AGE AT DIAGNOSIS
60 70 80 90
Figure 24. Different parameters of age at diagnosis 
of diabetes in 24 patients with and 30 
patients without family history of diabetes.
Age at
ons et (+)ive family history (-) ive family history
(ye ars ) Numbe r Percent Number Percent
0- 20 1 4.0 1 3.3
21- 40 3 12.5 4 13.3
41- 65 15 62.5 14 46.6
6 6 + 5 21.0 11 36.6
TOTAL 24 30
Table 26. A comparison of ages at diagnosis of subjects 
with and without a history of diabetes in the 
family. Woodside Health Centre.
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C o m m e n t
"Heriditability" rates of diabetes as high as 35-50 per 
cent were reported' in some studies (Falconer 19 67; Simpson 
1969) and these figures related more to juvenile-onset than 
to adult-onset cases of-diabetes. Simpson (1969) also 
reported that when diabetes was discovered after age 40, the 
risk for siblings and children was increased by a factor of 
2-3; but when diabetes was discovered before age 20, risk 
was increased about 12-fold in siblings, and more than 
30-fold in offspring of the diabetic.
It was not possible to study the age at the onset of
diabetes in cases with juvenile diabetes because of the 
small number of patients studied. It is, however, 
reported that the incidence is about 6 times more frequent 
in the second five years than the first five years of life 
and that the incidence in the young onset patients rises 
with age reaching a peak at age 11 and there is, then, a 
decline in incidence after age 14. Recent data (Bloom,
Hayes, and Gamble 19 75) from a survey in Britain and
Ireland suggest a plateau in incidence before the fourth 
[and eighth years before a sharp rise with a peak during 
ige 10-13.
There is no information in the present work of the fre- 
uency of diabetes in the offspring of the individual diabe- 
ics studied but nevertheless, the study showed that around 
|0 per cent of diabetics had a positive family history, 
lether genetic or environmental factors such as fatness or 
>cio-economic status (West 19 78) determined these rates 
s not considered.
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6.3.f, Smoking habits
Among the 54 patients 17 were smokers (32 per cent), 30 
non-smokers (55 per cent), and 7 ex-smokers (13 per cent).
Of the smokers, 14 smoked 10-2 5 cigarettes per day, 1 smoked 
pipe tobacco, and 2 had the habit of smoking cigars. I have, 
unfortunately, not been able to compare these figures with 
prevalence rates of smoking among the general population as 
these are, as yet, not available.
6.3.g. Blood pressure
As already mentioned, blood pressure readings were made 
with the patient seated. Diastolic blood pressure was 
taken as the pressure at which there was a change in the tone 
of the sound.
A systolic blood pressure of more than 18 0 mm Hg and/or 
a diastolic pressure higher than 95 mm Hg was arbritrarily 
considered to be elevated at the time of examination.
Although one might ordinarily accept higher values for 
normal blood pressure among older subjects, the criteria 
used in this study were chosen so that a comparison could 
be made with a large population study (Beevers 19 78) in 
which these were the criteria selected.
It can be noted from Table 27 that 7 out of 36 females,
|19 per cent, but none of the 18 males had a systolic 
ressure of more than 180 mm Hg, and that 9 of the females,
5 per cent, and only 1 male, 5.5 per cent, had a diastolic 
treasure higher than 95 mm Hg.
tomment
Among the population of Renfrew, West of Scotland, an 
[tensive study which included 3001 subjects the frequency
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of diastolic blood pressure of more than 95 mm Hg was found 
to be around 25 per cent (Beevers 1978). It seems, thus, 
that elevated blood pressure was not higher among the 
sample of diabetics under consideration than its prevalence 
in the general population. This is in agreement with some 
other recent studies in which blood pressure levels of 
diabetic twins were not significantly different from those 
of none diabetic twins (Pyke, Smith, Nelson, and others 
1977) or in diabetics who have survived forty years or more 
(Oakley, Pyke, and Tattersall 1974).
6.3.h. Relation of smoking to blood pressure
No positive relationship was found between smoking 
habits and systolic and/or diastolic blood pressure 
readings. Seven out of thirty non-smokers, 23.3 per cent, 
had a diastolic pressure higher than 95 mm Hg, while 2 out 
of 17 smokers, 11.7 per cent, had a high diastolic pressure 
as defined.
When the systolic blood pressure is measured it can be 
seen from Table 28 that 16.6. per cent of the non-smokers 
and 5.8 per cent of the smokers had a systolic pressure 
[higher than 180 mm Hg.
.3.1. Type of treatment
35 per cent of patients were on dietary restriction
inly, 50 per cent on oral hypogylcaemic agents (35 per cent
|n one daily dose of the drugs and 15 per cent on more than
|nce daily dose), and the rest, 15 per cent, on insulin (11
r cent on one injection and 4 per cent on two injections
r day). Thus the great majority (55%) were cases of non-
^sulin dependent diabetes (NIDD) while only 15 per cent had
su li n depe nd en t dia be tes (IDD). These figures are
Imonstrated in Figure 25.
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Systolic Diastoli c
All M M
pat- A All A
ients'' L Female Patients L Female
E E
Less than 47 18 29 Less than 44 17 27
180 mm Hg - 9 5 mm Hg
More than 7 0 7 More than 10 1 9
180 mm Hg 9 5 mm Hg
TOTAL 54 18 36 TOTAL 54 18 36
Table 27 . Systolic and diastolic blood pressure
measureme nts.
Systolic Diastoli c
T T
Smo­ Non- Ex- 0 Smo­ Non- Ex- 0
kers smo­ smo­ T ke rs Smo­ Smo - T
kers kers A ke rs kers A
L L
Less Less
than than
180 16 25 6 47 95 15 23 6 44
mm Hg mm Hg
More More
than than
180 1 5 1 7 95 2 7 1 10
TOTAL 17 30 7 54 TOTAL 17 30 7 54
Table 28. Normal and high systolic and diastolic blood 
pressure as related to smoking habits.
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Diet once twice once twice TOTAL
only O.H. O.H. Insulin Insuli n
G. P. 15 '12 4 1 1 33
patients
(46) (36) (12) (3) (3)
Hospital 4 7 4 5 1 21
patients (19) (33) (19) (24) (5)
Table 29. A comparison between treatment policies of 
General Practice and Hospital clinics. 
Percentages are shown in brackets 
O.H. : Oral Hypoglycaemic agents. 
Percentages are in brackets.
Number of patients 
affected with one 
or more of the 
listed complications
Percent of 
incidence.
1 Angina 13 24
1 Infarct ion 8 15
^Intermittent
■claudication
15 28
fcangrene 0 0
■ardiovascular 
mccide nt
2 4
Table 30. Incidence of some diabetic complications 
excluding retinopathy.
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Figure 26, A comparison between treatment of diabetics 
attending general practice and a hospital 
diabetic clinic. Numbers of patients are shown 
in Table 2 9 (page 160 ).
6.3.]. G.P. and Hospital patients
61 per cent of the patients were exclusively looked 
after by their own general practitioners. The rest, 39 per 
cent, attended a hospital for the management of their diabe­
tes but visited their own doctors only sometimes for routine 
check-up and repeat prescriptions.
Treatment policy was noted to be different among the two 
groups. Slightly less than a half of the patients who were 
under the general practitioners' care were on oral hypogly­
caemic agents, 46 per cent on dietary restriction 
and only 6 per cent were insulin dependent while 29 per 
cent of hospital attending subjects were on insulin therapy 
and only 19 per cent were managed by dietary restriction 
alone. Table 29 and Figure 26 show a comparison of these 
f igures.
This may be due to the fact that patients with milder 
NIDD usually attend medical practitioners and are referred 
to hospital once insulin therapy is required for one reason 
or another. (Thorn and Russell 1973). See Chapter 7.
6.3.k. Frequency of complications other than retinopathy
Questions were asked about the presence and/or a history 
if certain complications of diabetes. As seen in Table 30, 
loronary heart disease (39 per cent) and intermittent 
laudication headed the list of systemic complications.
[here was no case of gangrene and only two instances (4 per 
lent) of cerebrovascular accident, one male and one female, 
e also Table 31 for the incidence of occurrence of com- 
nations of these complications.
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Of patients with one or more systemic complications 
one was on insulin therapy (out of 11 patients with IDD).
No significant difference was found in the prevalence of 
systemic complications between insulin dependent diabetics 
and non-insulin dependent ones.
Figures in this section are similar to those reported by 
others workers (Lewis and .Symons 19 58) and confirm 
that diabetes is one of the major causes of mortality in 
many communities. Diabetes has killed more people than the 
two world wars combined (West 1978).
6.3.1. Control of diabetes 
Random blood sugar
None of the usual tests which are used in the diagnosis 
of diabetes was used here. Rather reliance was laid on the 
clinic records for the diagnosis. All cases studied were 
"labelled" as diabetic and treated by their physicians as 
such. A level of 11 mmol/L was considered the dividing 
line between normal and abnormal levels of blood sugar at 
the time patients attended the clinic and the samples of 
blood withdrawn.
In the West of Scotland lunch is usually taken about 
noon. Blood samples were taken between 2 p.m. and 3 p.m. 
so that patients in general were two to three hours post­
prandial. As already noted the majority of patients had 
NIDD in whom a 2 hour post-prandial blood sugar level of 
111 mmol/L would be grossly abnormal. Such a post-prandial 
[blood sugar level would also be considered abnormal in 
[insulin-dependent diabetics.
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TaDle 32 shows that 19 patients (35 per cent) had a high 
blood sugar.
Random blood sugar levels of over 11 mmol/L were found in 
30 per cent of the NIDD and in 65 per cent of the IDD. The 
difference however may be due to the small sample size and to 
the known difference in behaviour of post-prandial blood 
sugar levels in the two ’types of diabetes.
10 of 33 diabetics treated by their general practitioner 
and 9 of 21 individuals attending hospitals for their 
follow-up (30 and 43 per cent respectively) showed high 
blood glucose levels; this is shown in Table 34.
4 patients out of 6 treated at hospital with insulin had 
high glucose levels and in one of general practitioners' 
patients on insulin was the level high; the other patients 
had normal blood glucose. This makes the total number of 
subjects on insulin therapy 8.
No firm conclusion could be drawn from these figures 
since the number of patients was small. However, no 
great differences existed between the levels of blood sugar 
in patients attending general practice or hospital diabetic 
ic li nic.
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Glycosylated haemoglobin
Corning Electrophoresis (Glytrac) set was used for the 
quantitative determination of glycosylated haemoglobin. 
Samples of blood were examined within 24 hours. The normal 
range was taken as 4.1 - 8.1 per cent.
21 patients were found to have high levels of glycosy­
lated haemoglobin (38.8 per cent); 13 were general 
practitioners' patients and 8 were hospital attenders.
In Table 35 the levels of HbA^Q are related to hospital 
and practitioners' care. About 35 per cent in each group 
had abnormal levels of HbAig. m  Table 36 the sex 
distribution of individuals with normal and abnormal levels 
of HbAic is shown; 30 per cent of males and 45 per cent 
of females had abnormal HbAg<-, levels.
27 individuals were on oral hypoglycaemic agents and 
of these 17 (63 per cent) had abnormal HbAqc while only 
25 per cent of those on insulin had HhAq^ levels within 
(normal limits, see Table 37.
Including patients on diet alone 30 per cent of non- 
insulin dependent diabetics showed abnormal HbAg^ levels 
s compared to 75 per cent of patients with insulin 
iependent diabetes.
jomment
It appears that more than 35 per cent of the diabetics
ider consideration are not well controlled whether random
-ood sugar or glycosylated haemoglobin levels were used
»r the assessment of control and further that on HbA^c
tiraation IDD were less well controlled than NIDD. HbA^c
isurements give an indication of long-term control in
ID but in I D D  HbAj^^ probably reflects the degree of control 
r the proceeding few weeks.
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Number of 
complications
Numbe r of patients Percentage
One complication 15 28 .0
Two complications 10 18 .5
Three complications 1 2.0
TOTAL 26 48 .5
Table 31 . Frequency of occurrence of one or more of the 
systemic complications in a sample of 54 
patients studied at Woodside Health Centre,
Male Female All
Normal 13 22 35
Above normal 5 14 19
TOTAL 18 36 54
Table 32, Normal and abnormal random blood glucose 
levels of the 54 diabetics studied.
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Glucose 
leve 1
Oral/ 
Diet Once
Oral/ Insulin/ Insulin/
Twice Once Twice Total
Normal 12 16 4 1 2 35
High 7 3 4 5 0 19
Totals 19 19 8 6 2 54
Table 33 . Normal 
rela ted
and high random blood sugar levels as 
to type and frequency of treatment.
G.P, Patients Hospital Patients Total
Normal 23 12 35
High 10 9 19
Totals 33 21 54
Table 34 . General practitioners'and Hospital's patients
with normal and high random blood glucose 
leveIs ,
1 6 6
HbAlc G.P.'s Hospital Totals
Normal 20 13 33
Above normal 13 8 21
Totals 33 21 54
Table 35. Different levels of HbAlc related to 
and general practitioner attenders.
hospital
HbAlc All Male Female
Normal 33 13 20
Above normal 21 5 16
Totals 54 18 36
Table 36. Levels of HbAlc as related to sex. Normal
range of HbAlc: 4.1 - 8.1 per cent.
1 6 7
HbAlc level Diet
O.H.
/Once
O.H.
/Twice
Insulin
/Once
Insuli n 
/Twice Totals
Normal 14 '■ 13 4 1 1 33
Above normal 5 6 4 5 1 21
Totals 19 19 8 6 2 54
Table 37. This table shows that 3 2 per cent of
patients with non-insulin dependent diabetes 
(NIDD) had abnormal HbAlc while 75 per cent 
of insulin-dependent diabetics (IDD) 
abnormal levels (normal range of 
4.1 - 8.1 per cent).
s howe d 
HbAlc
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CHAPTER 7 
PREVALENCE OF DIABETIC RETINOPATHY 
IN A GENERAL HOSPITAL DIABETIC CLINIC
1 6 9
7.1 INTRODUCTION
Diabetes has been shown to be the commonest systemic 
disease causing blindness (Michaelson 1969) and diabetic 
retinopathy, one of the most dangerous complications of 
diabetes to be the cause of blindness in more than 80 per 
cent of cases of blindness due to diabetes (Nielson 1982).
In England and Wales, where it was estimated that there were 
8,700 blind diabetics (9.6 per cent of all blind people)
6,200 were blind from diabetic retinopathy alone; the 
rest, 2,500 from other causes with diabetic retinopathy as 
a contributory cause (Sorsby 1966).
Studies have been carried out (Lewis and Symons 19 58; 
Osuntokun 19 69; Cullen and Town 19 75; Donovan 19 78;
Mitchell 1980; Scobie, MacCuish, Barrie, Green, and Foulds 
1981; Jarah 1982; Bodansky, Cudworth, Whitelocke, and 
Dobree 1982) to determine the prevalence of diabetic retino­
pathy and, sometimes other complications of diabetes in 
general and special diabetic clinics. Results varied 
depending on many variables including the geographical 
isituation of the clinic and whether it was a general diabetic 
(clinic or one to which only selected cases of diabetes 
fere referred including in some instances those with known 
et inopathy.
The prevalence of diabetic retinopathy is likely to be 
ifferent among hospital patients as compared with those 
[eing cared for in general practice. Having ready access 
|o a large hospital diabetic clinic it was decided in the 
li rs t instance to establish the prevalence of retinopathy 
|i a hospital clinic and subsequently to compare this with 
study based on a general practice population. The aims
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of the study were:
1. To determine the prevalence of diabetic retinopathy 
in a hospital diabetic clinic (Glasgow Royal Infirmary) 
in the West of Scotland.
2. To determine the frequency of different types of 
retinopathy.
3. To identify the different factors which might contribute 
to the development of diabetic retinopathy in diabetic 
subjects, for example age at examination, age at which 
diabetes was first recognised, and the duration of diabetes 
and its treatment and to relate these factors to the 
relative frequency of occurrence of retinopathy of different 
types and severity.
4. To identify patients requiring further ophthalmological 
examination and/or laser treatment.
7.2. MATERIALS AND METHODS
The study was carried out during the period 1st May to 
31st December 1981 at the Glasgow Royal Infirmary diabetic 
clinic. Patients from this clinic who show serious forms of 
retinopathy or other diabetic eye complications are usually 
ireferred to the Tennent Institute of Ophthalmology for 
[further assessment and treatment where appropriate.
In a previous work by diabetic physicians of Glasgow 
loyal Infirmary and Ophthalmologists from the Tennent 
nstitute during the period August 1978 - March 1981, a cer- 
ain proportion of patients was seen by each group of clini- 
ians (Barrie, Scobie, Green, MacCuish, and Foulds 19 81),
In the present study there was no selection of cases because 
|he author alone examined 400 consecutive diabetic subjects 
tending for their annual eye test.
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A note was taken of the patients' diabetic clinic number 
for future reference, age at time of examination, duration 
of diabetes, type of treatment, frequency of intake of oral 
hypoglycaemic agents or administration of insulin, presence of 
or a history of hypertension, and smoking habits. Pupils were 
dilated using Tropicamide and a dark room was used for the 
ophthalmoscopic examination. A careful examination of the 
fundus was then carried out. In those who showed signs of
diabetic retinopathy the retinopathy was classified as 
previously described. In addition a note was made of which 
abnormal features were most in evidence (microaneurysms, 
haemorrhages, exudates, cotton-wool spots, new vessels).
The presence of cataract glaucoma as indicated by an operation 
or a history of taking drugs for its control, or other 
complications of diabetes was also recorded. A computer 
input (see Appendix 6) was prepared and the results analysed 
on the Edinburgh University Regional Computer.
7.3. RESULTS AND DISCUSSION
400 patients were examined. This figure comprised 190 
males, 47.5 per cent of the total, and 210 females, 52.5 per 
cent, giving a maletfemale ratio of 1:1.1. This ratio is 
[similar to that reported in a previous study in England 
[(Caird and Garrett 1963) in which 1750 diabetics attending a 
leneral hospital diabetic clinic were examined. The 
\ale: female ratio in the community of the West of Scotland 
s also 1:1.1 (Registrar General, Scotland 1981).
,3.a. Influence of age and duration of diabetes
The oldest of the patients was 85 and the youngest 13 
[ears of age. The median age of all patients was 60 years 
16) .
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Table 38 shows the minimum, maximum, mean, and median 
duration of age of the two sexes and Figure 27 demonstrates 
the age distribution of the patients.
29 per cent of patients were between 57.5 and 67.5 years 
of age and two thirds, 65.5 per cent, of them were within 
the working age, 21-65 years old. 75 per cent of men and 
57 per cent of women fell within this age range and 85 per 
cent of patients were over 40. Ages of patients were 
comparable to the age range reported by Lewis and Symon 
( 1958) who studied the frequency of different vascular 
diseases among 654 diabetics from the Royal Free and 
Hampstead General Hospitals. 90 per cent of their patients 
were over 4 0 years of age.
Median age of the 190 males was 55 years and of the 210 
females was 62 years, see Tables 39 and 40 in which the age 
range is split up into the following categories: 0-20,
21-4 0, 41-6 5, and over 6 5 years. The majority of males 
(64 per cent) were in the age range 41-65 at the time of 
[examination. In females 45 per cent were in this age 
ange while 4 0 per cent were over 6 5 years of age.
3.b. Age at diagnosis of diabetes.
In Table 43 the ages at the time diabetes was first 
lecognised are shown. There was a 7 year difference 
[etween the median age at diagnosis of male and female 
ibjects. Males tended to develop diabetes at an earlier 
;e than females; median ages being 49 and 56 years 
ispectively and this was found to be statistically significant 
= 0.0001, Mann Whitney test). This can also be seen 
|om Figures 29 and 30. In males the peak frequency of
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age at diagnosis was at age 60 and in females at age 70. 
Again females generally developed diabetes a decade later 
than males.
Table 44 showd other interesting figures. About one 
tenth of men but almost a quarter of all women were 
diagnosed after age 65.-
Comment
Bennett, Rushford, Miller, and LeCompte (1976) in a 
study of diabetes among Pima Indians found that the inci­
dence of diabetes peaked at age 30 in men and at age 40 in 
women. Although much earlier than the median age of 
diagnosis obtained frcm the sample under consideration, 
their data also shows that males tend to develop diabetes at 
a younger age than females.
In this study the incidence of diabetes continued to 
rise with increasing age. This is in agreement with that 
reported by Gamble and Taylor (19 69) and by Falconer and co­
workers (1971), (Figure 31), but in contrast to the findings 
|of Belcher ( 1973) in Ethiopian diabetics in whom the peak 
[incidence of onset of diabetes was around age 30 followed 
)y a continuous decline of incidence till the age of 60 
round which the rate was lowest, Figure 32. More than one 
xplanation for these differences have been offered the most 
robable of which is the lack of exercise and fatness among 
[he relatively more prosperous communities (West 19 78). In 
jhese communities old people also have more tests and this 
ly contribute to the discovery of more diabetics. The 
hiopian figures may also reflect a high mortality from 
abe tes.
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Figure 27. Distribution of ages,at the time of 
ophthalmic examination,of diabetics attending a 
Hospital Diabetic Clinic,
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Figure 28. Distribution of duration of diabetes among 
patients attending Glasgow Royal Infirmary Diabetic 
Clinic.
Ages (years ) All patients Male Females
Maximum 85 81 85
Minimum 13 14 13
Mean 57 54 59
Median 60 55 62
Standard 
devi ation
16 15 16
Table 38. Different age parameters of males 
females. It is noted that females 
be 7 years older than males at the 
examination.
and
tend to 
time of
Age (years) Number of patients Percentage
0-20 13 3.3
21-40 46 11.5
41-65 216 54.0
6 6 + 125 31.2
Table 39. Age distribution of 400 diabetics at time of 
e xami nation.
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Male
Age (years) Number Percentage
Female 
Number Percentage
0-20 8 '' 4.2 5 2.4
21-40 21 11.0 25 11.9
41-65 121 - 63.7 95 45.2
6 6 + 40 21.1 85 40.5
Table 4 0. Age distribution by sex at examination.
Duration All patients Male Females
Minimum 1 month 1 month 1 month
Maximum 40 years 3 5 years 4 0 years
Mean 7 " 7.2 " 6.8 "
Median 4 " 4.8 " 4.0 "
Standard
deviation
8 " 7.7 " 7.8 "
Table 41. Different parameters of known duration of 
diabetes in the sample studied.
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All patients Male Female
Duration 
(years )
N o . Percentage No. Percentage No. Percentage
0-1 89 22.2 43 22.6 46 21.9
1 + -2 43 10.8 18 9.5 25 11.9
2+-5 93 23.2 43 22.6 50 23.8
5 + -10 88 22.0 41 21.6 47 22.5
10+-15 42 10.5 23 12.1 19 9.0
15+-20 13 3.3 5 2.6 8 3.8
2 0+ 32 8.0 17 9.0 15 7.1
Total 400 19 0 210
Table 42. Distribution of known duration 
by sex, of patients examined at 
Royal Infirmary Diabetic Clinic
of diabetes, 
Glasgow
Age (years) All Male Female
Minimum 2 2 5
Maximum 83 77 83
Mean 50 47 52
lied 1 an 53 49 56
Btanda rd 
■  evi at ion
17 16 17
Table 43. Ages at diagnosis of diabetes of 400 diabetic 
i ndividuals.
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7.3.C. D u r a t i o n  o f  d i a b e t e s .
There was a wide range of durations of diabetes amongst 
the subjects. The shortest was one month and the longest 
(in a female) 40 years. Table 41 depicts the different 
durations of diabetes in all patients split up according to 
sex and in Table 42 the duration of diabetes is subdivided 
into zero to 1 year, more than 1 up to 2 years, more than 
2 and up to 5 years, more than 5 and up to 10 years, more 
than 10 years and up to 15 years, more than 15 and up to 
20 years, and finally more than 20 years. The numbers of 
patients encountered in each of these duration categories 
are shown in the Appendices.
In Figure 28 the distribution of durations is shown.
The data show a biphasic distribution with a peak at 0-1 
years and a second peak at around 5 years. This probably 
results from the fact that the diabetic clinic is composed 
of a population of patients with recently diagnosed 
diabetes referred for confirmation and initial stabilisation
and a second group of patients who for various reasons
.continue to attend the clinics. As the average age at 
examination was 57 years and the average age at diagnosis 
|S0 the average duration of diabetes among this population 
rould be expected to be 7 years which agrees with the peak 
requency of the second peak of the bimodal frequency 
furve in Figure 28.
.3.d. Age, duration of diabetes, and type of diabetes
101, 73, and 126 subjects constituting 25, 43, and
per cent respectively were on dietary restriction, 
al hypoglycaemic agents, and insulin i.e. approximately 
per cent had NIDD and 32 per cent were IDD. These
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Figure 29. Distribution of age at diagnosis of diabetes
in 190 diabetic males.
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Figure 30. Distribution of age at diagnosis of diabetes 
in 210 diabetic females.
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Figure 31. Increasing incidence of diagnosis of diabetes 
with age. From Falconer et al (1971).
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Figure 33. Relation of duration to treatment of
diabetes. Number of patients in each category 
is listed in Appendix 8
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Figure 34. Shows higher prevalence of diabetic retino­
pathy with increasing duration of diabetes. Data from
400 patients.
100
90
80
IO
Z
60
g  50
ïO
40
30
20
10
M a i e
F e m a l e
1 „ 2  2 _ 5  5 - 1 0  10-15 1 5 - 2 0  2 0 +
D U R A T I O N
Figure 35. Maies and females with diabetic retinopathy. 
Relation to duration of diabetes.
figures are relatively different from those found in general 
practice where a smaller population were IDD, Table 45.
7.3.e. Duration of diabetes and type of treatment
Diabetics on diet alone had a shorter duration of 
diabetes (median 1.8 years) than the NIDD on oral 
hypoglycaemic agents(median 3.1 years). IDD had longer 
duration of diabetes than did the NIDD patients (median 
10 years). Figure 33. This is expected and has been 
reported in a previous study (Nilsson, Nilsson, and 
Frostberg 1967) .
Non insulin dependent diabetes tends to present at a 
later age than does insulin dependent diabetes so that 
the duration of the disease in a mixed population containing 
both types of diabetics would be likely to show a prevalence 
of longer durations among the insulin dependent group. It 
may also be the case that increasing complication rate in 
longer standing diabetics might result in insulin therapy 
being instituted for these patients. The influence of 
age of onset of IDD as compared with NIDD is confirmed by a 
[correlation of the age at examination and type of diabetes 
[in the present data where it can be seen (Table 47) that the 
lean age at diagnosis of those on diet or oral hypoglycaemic 
igents was 61 years while insulin dependent patients had a 
jean age at examination of 46 years.
No patient whose age fell within the 0-20 years group 
,s non insulin dependent while 10 per cent of subjects on 
[isulin therapy fell within this age category. 16 per cent 
insulin dependent patients were above 65 years of age and 
is figure is about a third and a half of those on diet 
oral hypoglycaemic agents within this age bracket. This 
shown in Table 48.
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Male Female
( years ) Numbe r Percentage Number Percentage
0-20 20 " 10.5 16 7.6
21-40 41 21.5 31 14.8
41-65 111 ' 58.5 113 53,8
66 + 18 9.5 50 23.8
Total 190 100.0 210 100.0
Before 40 61 32 47 22
After 40 129 68 163 78
Table 44, Age at diagnosis of diabetes for both sexes. 
More males are diagnosed at an earlier age 
than females (Glasgow Royal Infirmary).
Treatment and Number of 
frequency patients. Percentage
Percentage in 
General Practice
Diet 101 25 35
bral hypoglycaemic
pgents - once 101 ) 25 ) 50
) 173 ) 43
1 - twice 72 ) 18 )
Insulin - once 58 ) 15 ) 15
1 ) 126 ) 32
1 - twice 68 ) 17 )
Table 45, Form of treatment.
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Duration Diet O.H. Insulin
Minimum 1 month 1 month 1 month
Maximum 40 years 2 8 4  years 4 0 years
Mean 3.5 " 5 " 12.4 "
Median 1 . 8  " 3.1 " 1 0 . 0  "
Standard
deviation
5.7 " 5.0 " 9.3 "
Table 46. Comparison of different parameters of 
of diabetes and types of treatment, 
table shows that patients on insulin 
have longer duration of diabetes (O.H 
oral hypoglycaemic agents).
duratior 
This 
tend to
Age (years) Diet O.H. Insulin
Minimum 29 29 13
Maximum 82 84 85
Mean 61 61 46
Median 62 62 48
Standard
deviation
1 2 1 1 19
Table 47. Treatment related to age at examination.
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Age at 
exami nation 
(years)
Percentage 
on diet
Percentage on 
oral hypogly­
caemic agents
Percentage 
on insulin
0-20 0 0 10
21-40 6 4 26
41-65 54 58 48
6 6 + 40 37 16
Table 48. Percentages of diabetics of different age 
groups at time of examination on different 
treatment regimens.
All Patients Male Female
No. Percent N o . Percent N o . Percent
Smokers 110 27.5 63 33.2 47 22.4
Non Smokers 260 65.0 106 55.8 154 73.3
Ex Smokers 30 7.5 21 11.0 9 4.3
TOTAL 400 100.0 190 100.0 210 100.0
Tab le 49. Smoking habits of 
at Glasgow Royal I
the 400 patient 
nf i rma ry .
studied
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7.3.f. Smoking habits
The majority of patients were non smokers (65 per 
cent). Smoking was more prevalent among men than women, the 
percentages of those who smoked among men and women were 
33 and 22 respectively. Table 49 depicts the smoking habits 
of the 400 diabetic patients.
7.3.g. Hypertension
A patient who was on antihypertensive treatment or who 
had high blood pressure using the same criteria as before, 
(Chapter 6),was considered to be hypertensive. The 
prevalence of hypertension is seen in Table 50. A higher 
percentage of females had a high blood pressure than 
males. Median age at time of examination and duration 
of diabetes of those with and without hypertension did 
not differ much and were as follows - 6 0 and 4; 59 and 5
years respectively.
Comment
Lewis and Symons ( 19 58) defined hypertension as blood 
pressure of over 165/95 and reported that the prevalence of 
hypertension among diabetics was 36 per cent in men and 56 
[per cent in women and in those over 60 years of age 70 per 
[cent of women and 5 0 per cent of men were hypertensive.
’hey found no relation between duration of diabetes and 
lype rtens ion. In this work I have been unable to 
lemonstrate a relationship between the "presence" of diabe- 
es and hypertension on one hand or between the "duration" 
if diabetes and hypertension on the other but, unlike Lewis 
tnd Symons ( 19 58), have in addition failed to show any rela- 
jionship between increasing age of patients and the presence 
hypertension. It is difficult to define hypertension
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(Beevers 1978) and there is a trend toward high blood 
pressure with age. It is possible, perhaps that older 
patients are not treated as "hypertensives" if their blood 
pressure is found,to be relatively higher than younger 
people, and this might explain the failure to recognise 
higher rates of "hypertension" with increasing age of 
the patients. Table 51.
In Beever's study (1978) 20 per cent of normal 
subjects over the age of 6 5 had blood pressure of over 
170/95. This is similar to the results presented in 
this study (19.2 per cent of diabetic patients). Table 51.
Table 52 shows that there was no increase in the frequen­
cy of hypertension with increasing duration of diabetes.
There is thus no support for the view that diabetes 
predisposes to systemic hypertension.
7.3.h. Prevalence of ocular abnormality among diabetics
During examination of the eye for the presence of diabe­
tic retinopathy a note was made of any other ocular abnor­
mality such as catarct, glaucoma, or extraocular palsy.
Table 53 shows the numbers and prevalence rates of different 
ocular findings in all patients and in the two sexes separa­
tely. Some patients had more than one pathology in one eye. 
i83 patients (21 per cent) had one or a combination of the 
[listed eye disorders. More females had lens opacities than 
tales, 22,8 and 8.4 per cent respectively. This was probably 
lue to the older age composition of females. Median ages of 
hose with and without cataracts were 70 and 56 years 
espectively; the median duration of diabetes in those with 
ataract was 6,5 years and in the other group 4 years, 
his is shown in Table 54.
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It is seen that about a fifth of all patients had ocular 
conditions other than diabetic retinopathy some of which, 
at least, could have been related to the diabetic process.
A comparison'of figures of duration and age at diagnosis 
of diabetes from subjects with and without cataracts showed 
that, taken alone, the role of duration of diabetes was not 
significant in relation to the development of cataract 
(P = 0.0655, Mann-Whitney comparison of medians; P = 0.0916, 
two sample t - test comparison of means) but the age at 
diagnosis of diabetes was important. Cataract being 
significantly associated with a late age at diagnosis 
(P = 0.0001, both tests comparing median and mean ages).
It has been suggested (Cotlier 1981) that diabetes 
accelerates the development of senile catarct. The 
present study does not support this view; no association 
between duration of diabetes and prevalence of cataract 
being found.
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Blood All patients Male Female
Pressure No. Percent No. Percent No. Percent
High 71 " 17.8 26 13.7 45 21.4
Normal 329 82.2 164 86.3 165 78.6
Table 50. Blood pressure measurements.
Number of Numbe r Percentage
Age patients wi th wi th
group studied hypertens ion hype rtens ion
0-20 13 0 0
21-4 0 46 6 13.0
41-65 216 41 18 .9
6 6 + 125 24 19 .2
Table 51. Relation of age to blood pressure.
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N o . of 
Duration patients 
(years) examined
Numbe r 
wi th 
hy pe rtens ion
Percentage 
wi th 
hype rtens ion
0-1 89 " 21 23.6
1 + —2 43 5 11.6
2+-5 93 - 18 19 .3
5+-10 88 17 19 .3
10+-15 42 6 14.3
15+-20 13 1 7.7
2 0+ 32 3 9.4
Table 52. Relation between 
and hypertension.
known duration of diabetes
All Patients Male Female
No. Percent No. Percent No. Percent
Cataract 64 16 16 8.4 48 22.8
Glaucoma 4 1 1 0.5 3 1.4
Other
conditions 22 5.5 10 5.3 12 5.7
Table 53. Prevalence of some eye conditions among the 
400 clinic patients.
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Years with cataract without cataract
Median age at 
exami nation
Median age at 
diagnosis of 
diabetes
70
63
56
50
Mean age at 
diagnosis of 
diabetes
Median duration 
of diabetes
Mean duration 
of diabetes
61
6.5
8.6
48
4.0
6.6
Table 54. Different parameters from 400 diabetic patients 
with and without lens opacities.
With retinopathy
Without retinopathy
All patients Male Female
129 76 53
(32) (40) (25)
271 114 157
(68) (60) (75)
Table 55. Prevalence of diabetic retinopathy from a 
series of 400 consecutive diabetics.
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7.3.1, Diabetic retinopathy in the clinic
129 patients (32 per cent) had diabetic retinopathy 
in one or both eyes. Recently, Donovan (19 78) reported 
a prevalence of 35.5 per cent among diabetics attending 
a general hospital diabetic clinic but higher rates 
have been found by others; 49 per cent among a diabetic 
clinic population and 36 per cent in a town hospital in 
Australia (Mitchell 1980).
Of the 129 diabetics with retinopathy 76 were males and 
53 females; 40 per cent of the male and 25 per cent of 
female population, a difference of 15 per cent, see Table 55.
In spite of being relatively younger, with a median age 
of 55, a higher percentage of males had diabetic retinopathy 
than females whose median age was 62 years. This is pro­
bably because men had been diabetics for longer periods.
The median duration of diabetes was 4.8 years in males and 
4 years in females. It is known that the duration of 
(diabetes is a more decisive factor than age at examination 
'r age at onset of diabetes in those with retinopathy,
'able 56, Bodansky and others ( 1982) examined 100 
lonsecutive diabetic patients with severe retinopathy 
Ind reported a significant association between male 
|ex and proliferative retinopathy which was also 
)sitively related to type I insulin dependent diabetes 
DD) . It is well known that type I diabetes is more 
[equently related to early-onset which is usually 
[sociated with longer duration.
Slightly more than a fifth of the clinic population 
idied had only background retinopathy and 11 per cent 
(wed what could be categorised as serious forms of retino- 
Ihy. Similar figures were found from a study of diabetic
89
retinopathy in general practice (Chapter 8) and are com­
parable to figures reported by Donovan (1978) from a study 
of 704 diabetic patients attending a district general 
hospital in England,
7.3.j. Relative frequency of different types of retinopathy 
66 per cent of patients with retinopathy had simple
background retinopathy. The other third had more serious 
types of retinopathy viz exudative, ischaemic, and 
proliferative. It can be seen from Table 57 that of those 
with diabetic retinopathy 15 per cent had proliferative 
retinopathy. Proliferative retinopathy also constituted 
45 per cent of patients with serious retinopathy, Table 58.
The prevalence rates of all forms of diabetic retinopathy 
and proliferative retinopathy in some recent studies are 
listed in Table 59.
7.3.k. Duration of diabetes in patients with and without 
retinopathy
Diabetic retinopathy was seen in patients who had diabe- 
|tes ranging between 1 month and 40 years. It is probable 
hat those in whom diabetes was diagnosed only during the 
lonth prior to ophthalmoscopy had had "occult" diabetes for 
ometime (Anderson 1966).
When the number of patients with diabetic retinopathy in 
[ifferent duration categories was compared with the actual 
imber of diabetics who fell within that category a steady 
icrease in the prevalence of retinopathy was found; 12 per 
nt of those who had diabetes for one year or less 
(owed retinopathy. This figure rose to 35 per cent 
[ter 5-10 years and to more than 80 per cent among 
ients with a duration of more than 20 years. This is 
)wn in Table 60 and Figures 34 and 35.
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F u n d u s c o p y A c t u a l  n u m b e r P r e v a l e n c e  i n  t h e  c l i n i c
Background 85 21.2
Maculopathy 8 2.0
Ischaemic 16 4.0
Proli ferative 20 5.0
Total number 129 32.2
No retinopathy 271 67.8
Table 56, Prevalence of different 
in the clinic.
types of retinopathy
Retinopathy
Actual number 
of patients
Percentage among 
retinopathy patients
Background 85 65.9
Maculopathy 8 6.2
Ischaemic 16 12.4
Proli ferative 20 15.5
Total 129 100.0
Table 57. Frequency of different types of retinopathy.
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Percentage among patients 
with serious retinopathy
Exudative 18 (8)
Ischaemic 37 (16)
Proli ferative 45 (20)
Total (44)
Table 58. Relative frequency of different types of 
serious retinopathy among 400 diabetics. 
Actual numbers of patients in each 
category are shown in brackets.
Prevalence of 
retinopathy 
(per cent)
Prevalence of proliferative 
retinopathy in the clinic 
(per cent) Reference
21.7 ? Lewis & Symons 
(1958)
35.5 4.4 Donovan ( 19 78)
49 ) 
)
36 )
7 ) 
)
3 )
Mi tchel1 
( 1980)
26.7 3.8 Scobie & 
others (19 81)
32 5 This series
Table 59. A comparison of prevalence rates of diabetic 
retinopathy in different studies.
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An almost similar pattern of increase in prevalence 
of retinopathy was noted in the two sexes but a higher 
population of men developed retinopathy within the first 
5 years of diabetes. After 5 years 3 7 per cent of men 
but only 10 per cent of women had retinopathy. This is
demonstrated in Table 61-.
7.3.1. Comparison of duration and age at onset of diabetes
in subjects with and without retinopathy
Patients with retinopathy had longer durations of diabe­
tes than those who did not have retinopathy. Median 
duration was 9 and 3 years respectively in the two groups.
This difference was found to be statistically significant 
(P < 0.0001, Mann-Whitney test). These figures are shown 
in Table 62.
Mean age at diagnosis of diabetes in those with reti­
nopathy was 49 years and in those without retinopathy 55 
years, a difference of 6 years, which was also found to be 
[significant (P = 0.0105, Mann-Whitney test).
Males with retinopathy had longer duration of diabetes 
han males without retinopathy; median duration being 9 and 
.5 years respectively. In females those with retinopathy 
ad duration of 10 years and those without retinopathy 3 years 
ihese differences were statistically significant (P <■ 0.001). 
Ihis relationship between duration of diabetes and prevalence 
|f retinopathy was present in both males and females.
Males with retinopathy had a median age at onset of 
abetes of 45 years while males without retinopathy had a 
idian age of 48 years. Females with retinopathy had a 
dian age at onset of 54 and those with no retinopathy a 
Idian age of 57 years. There was a significant relation- 
lip between the age of onset and prevalence of retinopathy
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in females (P 0.0001) but not in males (P = 0. 1508).
When the mean duration of diabetes in patients with no 
retinopathy (4.7 years) was compared with the duration in 
patients with different severities of diabetic retinopathy, 
Table 63, significant results were obtained; no 
retinopathy versus background retinopathy, no retinopathy 
versus exudative retinopathy, no retinopathy versus 
ischaemic retinopathy, no retinopathy versus proliferative 
retinopathy (P = 0.001 in all cases). The mean age at 
onset for patients without retinopathy did not differ 
significantly from that of patients with any of the 
various types of retinopathy found (P = 0.1 in all 
instances).
It seems, therefore, that the duration of diabetes was 
of significant importance in relation to whether a patient 
would have retinopathy. There was no difference whether all 
patients with retinopathy were lumped together or whether 
males and females were compared separately. Younger onset 
goes with a greater tendency to develop retinopathy but this 
is less clear cut than the effect of duration especially in 
males.
7.3,m. Referrals
All patients classed as serious retinopathy were 
reffered to the Tennent Institute of Ophthalmology for 
[further investigation and assessment for possible laser 
[therapy with the exception of those patients who had 
Iready been so referred.
30 patients (7.5 per cent of the total) were referred 
or further assessment. In 22 (74 per cent) serious 
etinopathy was confirmed.
19 4
Duration of 
Diabetes 
(years)
Number of 
di abetics 
exami ned
Number with 
diabetic 
retinopathy
Prevalence of 
retinopathy in the 
duration category
0-1 89 11 12.3
iH— 2 43 8 18 .6
2 + -S 93 21 22.5
5+-10 88 31 35.2
10+-15 42 23 54.7
15+-20 13 9 69.2
2 0+ 32 26 81.2
Table 60. A steady increase of prevalence of 
retinopathy with increasing known 
diabetes. Data frcan 400 patients.
diabetic 
duration of
Duration 
(years )
Percentage of men 
with retinopathy.
Percentage of women 
with retinopathy
0-1 9.3 (4) 15.2 (7)
l4— 2 27 .7 (5) 12.0 (3)
2 + -S 37 .2 (16) 10.0 (5)
5 +—1 0 43.9 (18) 27.6 (13)
10+-15 65.2 (15) 42.1 (8)
15+-20 40.0 (2) 87.5 (7)
!
I2 O+ 94.1 (16) 66.6 (10)
iTotal (76) (53)
Table 61. Prevalence rates of diabetic retinopathy in
males and females with varying known duration 
of diabetes. Actual numbers are shown in 
bracke ts.
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RETINOPATHY NO RETINOPATHY
All Male Female
129 76 53
Years patient patient patient
All Male Female
271 114 157
patient patient patient
Mean
duration 11.6 11.5 11.7 4.7 4.3 5.1
Medi an .
duration 9.0 9.0 10.0 3.0 2.5 3.0
Mean age
at onset 47 45 49 51 48 53
Median
age at 49 46 54 55 51 57
onset
Table 62. Comparison of mean and median durations and ag
at onset of diabetes, of the two sexes, in
patients with and without diabetic retincpathy
Mean Medi an Mean age Median age
Retinopathy duration duration at onset at onset
Back­ All (85) 12.4 10.0 45 46
ground Male (49) 12.0 9.0 45 44
Female(36) 12.9 10.5 48 52
Exud­ All (8) 8.7 6 54 64
ative Male (3) 14.8 14.0 43 36
Female (5) 5 3.1 60 65
Isch­ All (16) 9.3 8.2 49 50
aemic Male (10) 8.6 8.2 48 48
Female (6) 10.3 8.5 51 56
3
trol- All (20) 11.1 8.8 49 60
b ferat- Male (14) 10.9 7.8 50 60
Ive Female (6) 11.6 9.6 46 52
Table 63. Duration and age at diagnosis of patients 
with varying severity of retinopathy. 
Numbers of patients are shown in brackets,
196
Patients All Male Female
Number referred 46 22 24
Did not need referral 343 160 183
Already attending 11 8 3
Total 400 190 210
Table 64. Disposal of patients.
Groups of 
Patients
Number of 
patients
Percent of 
referrals
Proved to be 
non-serious 8 26
Serious - need 
no treatment 11 37
Serious - need 
laser 11 37
Total 30 100
Table 65. Frequency and outcome of referrals.
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On fluorescein angiography 8 patients failed to show 
any form of serious changes and were, therefore, returned 
to the Royal Infirmary Diabetic Clinic. Of the remaining 
22 diabetics, 11 Were found to have serious retinopathies 
which needed no treatment at the time of examination but 
for whom arrangements were made to be seen at regular 
intervals. The other 11 diabetics (37 per cent of the 
referrals) needed laser therapy; see Tables 64 and 65.
In 16 instances diabetics were referred for 
conditions other than diabetic retinopathy.
As 11 patients in the group of 400 (Table 64) had 
already been identified previously as having serious 
retinopathy and had been treated where appropriate the 
number of potential referrals was reduced by this amount.
In a diabetic clinic where no routine eye examination 
had been previously carried out one would expect a referral 
rate of 10 per cent of whom some 5 0 per cent would require 
laser treatment.
1 98
C HAP T E R  8
PREVALENCE OF DIABETIC RETINOPATHY 
IN GENERAL PRACTICE
1 9 9
8.1 INTRODUCTION;
Many studies have been conducted in different 
countries to determine the prevalence of diabetic retinopathy 
in a given community.
The Pima Indians of Arizona have the highest rate of 
diabetes in the world, up to 50 per cent {Bennett, Rushford, 
Miller, and LeCompte, 1976). A survey of 1640 Pima Indian
diabetics aged 15 years and over has shown that 18 per cent
of those with a 2-hour postload plasma glucose level equal 
to or greater than 200 mg/100 ml (11 mmol/L) had some 
evidence of diabetic retinopathy. Of those with diabetic 
retinopathy 7 per cent were found to have proliferative or 
neovascular changes, the remaining having microaneurysms 
and/or exudates. The frequency of retinal changes was 
higher in those with higher glucose levels especially 
beyond the age of 35 years (Dorf, Ballintine, Bennett, 
and Miller 1976; Knowler, Bennett, Hamman, and Miller 1978).
Diabetic retinopathy ranks third, next to macular 
[degeneration and glaucoma, as a leading cause of blind- 
[ness in the United States; it is the responsible cause 
‘f blindness in 1 out of every 15 blind persons (7 per 
lent of the total number of the blind in the country)
NSPB 1980). At age 52-64 the prevalence of diabetic
etinopathy is almost 2 per cent rising to about 3 per
|ent at age 65-74 years and 7 per cent at age 75-85 (Kini, 
ibowitz, Colton, and others 1978; Kahn and Bradley 19 75).
Racial and ethnic factors are important in the deter- 
jnation of the frequency in the same community. The
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Population Studied Prevalence of diabetic 
retinopathy and comment
Reference
De nma rk 3/4 of patients who had 
survived 15-25 years of 
diabetes
Lundbaeck 
( 1953)
Sweden 46.8%, A study of 
1800 diabetics
Kornerup 
( 1957)
Nigeria 4.6% Osuntok un 
(1969)
Kristians tad, Sweden 34.3% Nilson and 
others 
(1967)
Pima Indians 21% of those with a 2-hour 
postprandial glucose level 
of more than 200 mg/100 ml
Dorf and 
others 
. (1976)
Japan 33.9% Kojima and 
others 
(1971)
Japan 45% (duration more than 
7 years)
Seftel and 
Walker 
(1966)
[Oxford, England Diabetes of 5 or less years; Burditt 
4% in those younger than and 
30 years others 
22% in those 30-59 years old (1968) 
3 4% in those over 59 years 
old
Igypt 11.4% Osman and 
others 
(1971)
g a c k  South African 45% (duration more than 
7 years )
Seftel and 
Walke r 
(1966)
Table 66. Prevalence rates of diabetic retinopathy 
in some studies.
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white diabetics of South Africa show a prevalence of diabe­
tic retinopathy of 34 per cent while the prevalence for black 
South Africans is 45 per cent. In contrast, Nigerians show 
a prevalence of diabetic retinopathy of only 4.6 per cent 
(Osuntokun 1969). In Egypt, also in Africa, 11.4 per cent 
of 1140 diabetics showed signs of retinopathy, 1.7 per cent 
only was of the proliferative type (Osman, Seiam, and Mekkawi 
1971). Low rates of diabetic retinopathy were reported in 
Libyans except in fat females in whom a high frequency of 
retinal exudates was found (Mekkawi and Aswad 19 72).
Mann and Potter (1969) examining 333 Maoris of New 
Zealand found 9 diabetics, 4 of whom had retinopathy.
In a study of the prevalence of diabetic retinopathy in 
untreated Japanese diabetics it was found that in those with 
a fasting blood sugar higher than 170 mg/100 ml (9.4 mmol/L) 
and a duration of more than 5 years, 50 per cent showed 
evidence of retinopathy when first examined (Miki, Fukuda, 
Kuzuya and others 1969).
In Table 66 some prevalence rates from different stu­
dies are listed.
Although information on the prevalence of different 
[types of diabetic retinopathy among hospital diabetic clinic 
latients in the West of Scotland has become available 
ecently (Scobie, MacCuish, Barrie, and others 19 81), data 
m  the prevalence of diabetic retinopathy in the general 
lopulation of this part of Scotland has not previously 
een available. In the study by Scobie et al (1981) it was 
[uggested that the diabetic patients attendinng the Glasgow 
>yal Infirmary were representative of diabetics in general
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but obviously such patients form a selected group and 
prevalence figures for retinopathy and its various types 
might well differ from those in the general population.
It was thought useful to conduct a pilot study of all the 
diabetics in one general practice to see whether the 
prevalence of retinopathy and its various categories 
resembled or differed from the hospital based group.
8.2. MATERIALS & METHODS;
Diabetics attending a general practice clinic were 
examined for the prevalence of diabetic retinopathy which 
was subdivided into serious and nonserious subgroups as 
before.
The severity of diabetic retinopathy was related to 
measurements of random blood sugar and glycosylated haemoglo­
bin at the time of ophthalmoscopic examination. It has 
been claimed recently (Schanzlin, Jay, Fritz, and others 
19 79) that levels of glycosylated haemoglobin are directly 
related to the severity of diabetic retinopathy especially 
in patients in whom diabetes was diagnosed before 30 years 
(of age .
Ocular fundi were examined by direct ophthalmoscopy in 
darkened room after dilating the pupil with cyclopentolate 
% and/or phenylephrine 10%, Visual acuities were measured 
[sing Snellen's test chart before dilating the pupils.
Ltients were informed of the nature of the study.
3. RESULTS & DISCUSSION;
The 54 patients examined included 18 males and 36 females
|ere was no statistically significant difference between
|e male : female ratio In this study and that encountered
the study of diabetics of Glasgow Royal Infirmary 
apter 7), P = 0.05.
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8 . 3 . a .  D i a b e t i c  r e t i n o p a t h y
19 patients (35 per cent) showed ophthalmoscopically 
recognisable retinopathy. Among these were 5 males and 14 
females constituting 28 and 39 per cent of males and females 
included in this study.
Background retinopathy
13 patients had background retinopathy, 24 per cent 
of the total diabetic population and 68 per cent of those 
with retinopathy. In no instance was it found necessary 
to refer any of these patients for further investigation.
Exudative retinopathy
Two patients, 10.5 per cent of subjects with retino­
pathy fell into this category.
Ischaemic retinopathy
In this category 3 patients were recognised, two of 
whom had laser treatment later.
Proliferative retinopathy
Only one patient had neovascularisation of the optic 
[disc and he was already attending an ophthalmologist for pho- 
■ ocoagulat ion.
Table 67, depicts the above figures and also the rela- 
ive frequency in a diabetic population of different types 
f retinopathy.
,. 3,b. Other ocular changes
10 patients (18,5 per cent) had ocular abnormality 
her than diabetic retinopathy (cataract, glaucoma, or 
:traocular muscle palsy). Table 68. In 6 cases the 
[normality was unilateral.
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Type of 
retinopathy
Numbe r 
of
patients
Percentage 
of the 
total number 
with 
retinopathy
Percentage of 
freq uency 
amo ng all 
di abetics 
frequency
Background 13 68.4 24
Exudative 2 10.5 3,7
Ischaemic 3 15.8 5.5
Proli ferative 1 5.3 1.8
Total 1.9 100.0 35.0
Table 67. Prevale
General
nee of diabetic retinopathy 
Pract ice.
in
All patients (54)
Cataract 5
Glaucoma 2
Extraocular
palsy 3
Males (18) Females (36)
Percentage 
of the total 18 .5 16.6 19 .4
Table 68. Frequency of ocular abnormalities other than 
diabetic retinopathy found in a study of 54 
diabetic patients attending a Group Practice 
(Woodside Health Centre),
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8 . 3 . C .  Association of systemic complications and retinopathy
Of patients with diabetic retinopathy 6 were on treatment
for angina, 3 had had one or more attacks of myocardial 
infarction, and 7 suffered from intermittent claudication.
Although the number of patients studied was small, the 
frequency of occurrence of these vascular complications 
(Table 69) was generally higher in patients with diabetic 
retinopathy than those without it. Table 70 shows that the 
concurrent association of two or more systemic complications 
in patients who had diabetic retinopathy was higher than in 
those without it.
8.3.d. Age at examination
A comparison was made between the ages at the time of 
examination of patients with and without retinopathy. Table 
71 depicts the different parameters of age at examination of 
the two groups. There was no significant difference between 
the mean or median ages in the two groups (P = 0.2127, two 
sample t - test comparison of means; P = 0.6120, Mann-Whitney 
comparison of medians).
8.3.e. Duration of diabetes
Median duration of diabetes of the 19 patients who had 
diabetic retinopathy was 10.2 years and of the 35 patients 
without retinopathy was 4,0 years. Mean duration of diabetes 
jwas 12.6 and 5,9 years respectively. This is shown in Table 
i72. As expected the effect of the duration of the diabetic 
illness on the presence of retinopathy was statistically 
significant when these figures were compared (P = 0.0045,
- test comparison of means; P = 0.0011, Mann-Whitney 
lomparison of medians).
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Number of patients with 
Intermi ttent 
Angina Infarction Claudication Gangrene CVA
Patients with 6 
retinopathy (31V5)
Pat ients
without
retinopathy
7
(20.0)
3
(15.7)
5
(14.2)
7
(36.8)
8
(22.8)
0 0
0 2 
(5.7)
Table 69. Association of systemic vascular disease in
patients with and without retinopathy. Note 
that there are higher percentages of com­
plications in diabetics with retinopathy than 
in those without diabetic retinal involvement
Number of associated 
complications
None 1 2 3 Total
Number of patients with 9 5 4 1 19
retinopathy (47.3)(26.3)(21.0) (5.2)
Number of patients without 
retinopathy
19
(54.2)
10 6 
(28.5)(17.1)
0 35
Table 70. Multiplicity of systemic involvement with 
diabetic retinopathy.
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Patients with retinopathy without retinopathy 
(Ages in years) (Ages in years)
Minimum age 45 21
Maximum 85 86
Mean 65 60
Median 67 62
Standa rd 
devi ation
10 16
Table 71. Ages at examination (54 patients attending 
Woodside Health Centre).
Diabetics with 
retinopathy 
(Duration in years)
without retinopathy 
(Duration in years)
Minimum duration 1.5 0.5
Maximum 34 22
Mean 12.6 5.9
Median 10.2 4.0
(Standard deviation 8.4 5.5
Table 72. Comparison of known duration of diabetes with 
and without retinopathy.
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with retinopathy without retinopathy
(Age in years) (Age in years)
Minimum age
Maximum
Mean
Median
Standard
deviation
22
71
62
55
13
11
83
55
59
17
Table 73. A comparison of age at diagnosis of
diabetes of the two groups.
Retinopathy group 
(19 patients)
No retinopathy group 
(35 patients)
Mean blood
sugar
(mmol/L)
12.0 8.86
Median
blood
sugar
12.4 7.60
Standard 
idevi at ion
5.31 4.42
Mean HbAlc 
l(per cent)
8.67 7.08
lledian HbAlc 8.20 7.1
Btanda rd 
Bevi at ion
2.86 2.56
Table 74. Values of random blood sugar and glycosylated 
haemoglobin from two groups of diabetics.
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8.3.f, Age at diatnosis of diabetes
Table 73 depicts the ages at which the diagnosis of 
diabetes was first made in the two groups (those with and 
those without retinopathy). Differences in mean and median 
ages were not significant (P = 0.6031 and 0.4202 on two 
sample t - test and Mann-Whitney comparing means and medians 
respect ively).
8.3.g. Degree of hyperglycaemia
Random blood sugar levels and HbA]^^ levels in the 19 
patients with retinopathy were compared with similar 
measurements in the 35 patients without retinopathy.
Results are shown in Table 74. There were significant 
statistical differences between the two groups when 
values of random blood sugar were compared (P = 0.0355, 
t - test comparison of means; P = 0.0331, Mann-Whitney 
comparison of medians) but no significant differences were 
found when values of HhAp^ were compared (P = 0.0 515, t - 
test comparison of means; P = 0.0572, Mann-Whitney comparison 
of medians).
These results were also used to determine whether 
leasurements of levels of random blood sugar and glycosylated 
aemoglobin relate to the presence and severity of diabetic 
etinopathy. Patients were therefore divided into three 
[roups: 1. Patients who had no retinopathy, 2. Patients
[ith simple background retinopathy, and 3. those with 
lerious" retinopathy. Mean values of the two blood tests 
re compared. Table 75. It was found, again, that values 
mean blood sugar were significantly different among the 
Iree groups. The group with no retinopathy had the lowest 
Ian values (0.05 > P > 0.01 one way analysis of variance)
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but mean values of glycosylated haemoglobin did not show 
significant differences between any two groups (0.1 > p
> 0.05, one way anaylsis of variance).
The significance of these results is fully discussed 
in Chapter 12.
21 1
No
retinopathy
Background
retinopathy
Serious
retinopathy
Mean
blood
sugar
(mmol/L)
8.86 12.98 10.33
Standard 
devi ation
4.42 4.99 5.80
Mean HbAlc 
(per cent)
7.08 9.02 8.06
Standard 
devi ation
2.56 3.30 1.99
Table 75. Mean values of random blood sugar and of
glycoslated haemoglobin of patients who had 
no retinopathy on ophthalmoscopy, and of 
those who had different severity of 
retinopathy.
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CHAPTER 9 
BLINDNESS FROM DIABETIC RETINOPATHY 
IN THE WEST OF SCOTLAND
2 1 3
9.1 I NTRODUCTI ON
One of the problems of surveys on blindness is the 
great variation in its definition adopted by studies from 
different countries. The World Health Organisation (1966) 
accepts 65 definitions of blindness.
In the United States, for example, a person is certified 
blind if the best obtainable visual acuity in the better eye 
is 20/200 (6/60), or less, whether or not associated with 
limitation of the visual field to 20° while in the United 
Kingdom blindness is broadly defined as a vision too poor 
to allow any work for which eyesight is essential and is 
generally accepted as a corrected visual acuity of 3/60 in 
the better eye and/or a field of vision of less than 10° in 
its widest diameter.
Causes of blindness have been studied in many countries 
of the world. In the Western world, however, few of the 
causes were found to interchange places as the leading ones. 
Thus glaucoma, cataract, atrophy of the optic nerve, senile 
degenerations of the macula, and diabetic retinopathy were 
[always reported as the commonest blinding offenders.
Whatever the definition of blindness was, all studies on 
he causes of blindness have concluded that diabetes is the 
lommonest blinding disease among all systemic disorders.
A study of the causes of legal blindness in the United 
Itates for the year 1978 (National Society to Prevent 
[lindness 1980) showed that glaucoma caused 12,5 per cent 
the total number of new blind registrations, macular
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degeneration 11.7 per cent, senile cataract 8.3 per cent, 
optic atrophy 7.0 per cent and diabetes 7.9 per cent. 
Diabetic retinopathy alone caused 6.6 per cent of all blind 
registrations and was, after glaucoma, the second leading 
cause of blindness among the 45-64 and 65-74 years old. It 
also was the fourth commonest cause of blindness in females 
but not among the first five causes in males. Its preva­
lence rate among the population was 4.8 per 100,000. A 
previous work (Kahn and Hiller 1974) estimated that about 
10 per cent of new cases of blindness in the United States 
was due to diabetes and that this proportion was substan­
tially higher in persons under 70 years of age. In persons
45-74 diabetes accounts for about 20 per cent. This study
also suggested that American non-white women have very high 
rates of blindness from diabetic retinopathy and that the 
incidence of diabetes-related blindness in 1969-19 70 based 
on registry data in States with reporting systems was about 
1.5 cases per 100,000 per year. The prevalence rate of 
(diabetes-related blindness among all the blind in the 
inited States was about 2.4 per 100,000 population (Kahn 
nd Hiller 1974) which is different from the rate reported 
ecently (N.S.P.B. 1981).
In Canada a survey on the different epidemiological 
[spects of blindness is carried out annually by the 
nadian National Institute for the Blind, CNIB . In the 
ar 1979 the total number of cases registered with the 
istitute was 3142. Of these, 36.3 per cent were blind
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from senile macular degeneration, 9.2 per cent from diabetic 
retinopathy, 8.1 per cent from glaucoma, 6.3 per cent from 
optic nerve atrophy, and 4.7 per cent from cataract.
Diabetes caused 315 cases of blindness and of these 289 were 
blind from diabetic retinopathy alone. Diabetic retino­
pathy was also responsible for the highest number of 
registrations among the 40-49 and 50-64 years old. Some of 
the important causes of blindness in Canada are listed in 
Table 76 (CNIB 1981).
Chronic simple glaucoma, by causing 60 per cent of cases 
of blindness was found to be the commonest cause of blind­
ness in Iceland (Bjornsson 1955); prevalence of diabetic 
retinopathy was zero per cent. In Denmark (Michaelson 
1969) diabetic retinopathy accounts for 22.8 per cent of new 
blind registrations. It is the commonest blinding cause 
among adults at the age of 20-50 years (Rosenberg 19 81, 
personal communication).
A study of 3557 adult Swedes with onset of blindness 
before age 60 showed that optic atrophy and retinal dege­
neration of genetic origin were the commonest causes, 16.1 
per cent, and that diabetic retinopathy was the blinding 
cause in 412 instances, 11.6 per cent of the total blindness 
in that category of patients (Lindstedt 1969).
Dama to (1960) from a study of 6 38 blind people of the 
[altese Islands reported that myopia caused 18.6, cataract 
8, glaucoma 17.2, diabetes 15.9 and trachoma 12.3 per cent 
f all blindness respectively. Dama to also found that the 
lajority of cases of diabetes-related blindness occurred in 
Ihe age group above 50 and that diabetic blindness was 3
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N o .  o f  c a s e s
Age Group SMD DR
Optic 
nerve 
Glaucoma atrophy Cataract
Ret. 
pig . Myop i a
5 & under 3 0 0 ■ 27 8 0 2
6-15 11 0 2 39 21 12 11
16-19 2 1 1 16 2 6 2
20-29 11 38 1 22 15 21 5
30-39 11 22 3 13 4 31 2
40-49 10 29 5 6 7 23 10
50-64 62 94 34 28 9 41 25
65-80 502 95 115 36 32 10 30
81 & ove r 5 29 10 94 12 50 0 60
Totals 1, 141 289 255 19 9 148 144 103
Incidence 36.3% 9.2% 8.1% 6.3% 4.7% 4,6% 3 .3%
1 Table 76. Important causes of blindness in Canada 
From CNIB 19 81.
•
Cause Prevalence
Cataract 22.2
Myopia 14.2
H Senile macular degeneration 9.8
Glaucoma 9.2
External eye disease 7.4
Diabetic retinopathy 7.4
Optic a trophy 4,9
Table 77. Prevalence rates of blinding causes in 
England and Wales. From Sors by ( 19 6 6)
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greater In females than in males.
In Barbados diabetes is a common systemic disease although 
diabetic retinopathy is rarely seen among diabetics in 
this Island and is seldom a problem (Connell 1981, personal 
communication).
On the Island of Pals ter primary glaucoma was the most 
frequent cause of blindness, 29 per cent, followed by senile 
macular degeneration, 22 per cent. It was also noted that 
diabetic retinopathy and excessive myopia were among the 
relatively frequennt causes of blindness being represented 
by 10 and 9 per cent respectively (Norskov 1968).
In the United Kingdom results of many surveys have been 
reported, the best known of which is the comprehensive sur­
vey on the prevalence and incidence of causes of blindness 
in England and Wales reported by Sorsby (1966). Sorsby 
listed macular degeneration, cataract, glaucoma, myopia, and 
diabetic retinopathy as the most frequent causes in that 
order, see Table 77.
9.2. MATERIAL AND METHODS
The present study aims at the investigation of the 
common causes of blindness and visual handicap in the West 
[of Scotland with a special reference to diabetic retino- 
athy. Such a survey would make possible as estimation of 
he number of diabetic blind persons in this part of Scotland 
nd the approximate number of diabetics who could probably be 
[aved through the application of the current preventative 
asures for example photocoagulation. It would also be of 
inefit in making recommendations as to the cost effectiveness 
screening programmes for the detection of diabetes and 
tabetic retinopathy in the West of Scotland.
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Blind registration is not compulsory in Britain.
However a person registered blind is eligible for special 
services and certain opportunities offered through such 
organisations as the Society for the Blind in Glasgow and the 
West of Scotland like the availability of talking books and 
other teaching materials, the supply of guide dogs, free 
transport and certain tax exemptions.
In Scotland a special form, Form B P l , is completed by 
an Ophthalmologist to certify a person as blind or partially 
sighted , see Appendix 10.
Completed forms BPl are returned to a central office in 
Edinburgh but a copy of all forms completed for persons 
resident in the West of Scotland goes to the Society for the 
Blind in Glasgow.
Forms BPl held by the Society for the Blind in Glasgow 
and the West of Scotland were studied. These forms relate 
to people from the whole Strathclyde region. This area 
corresponds to that covered, before government reorgan­
isation by the Area Health Boards of Greater Glasgow, 
irgyll and Clyde, Ayrshire and Arran, and Lanarkshire.
A total of 2118 forms were personally studied by the
uthor. This number was composed of people who were
•egistered with the Society as blind or partially
ighted as shown in Table 78.
It is unfortunate that only 141 forms from the year
60 were available for analysis. 619 forms of the total
imber of 760 registrations had earlier been destroyed or
)st. However, the data studied are likely to be represen-
tive of all registrations because the forms were not
[ l e c t e d  b y  a n y  s p e c i f i c  c r i t e r i a .  A n a l y s i s  o f  t h e
i l a b l e  i n f o r m a t i o n  a l s o  s h o w e d  s o m e  e x p e c t e d  r e s u l t s  s u c h
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as the male : female ratio which gives some confirmation of the 
unselect ive destruction of forms.
The study is mainly concerned with the analysis of the 
141 forms of 1960 and 772 forms of the year ended 31st 
December 1980. The other forms, which relate to the year 
1970 and part of 1981, were studied in less detail, prin­
cipally to see if the number of people registering with the 
Society every year was changing. Parameters were, however, 
similar to those reported for the year 1980.
Of the 772 forms completed till the end of the year 
1980, 125 forms, 16 per cent, had to be excluded from 
further analysis because of lack of essential information. 
Some forms contained nothing other than the name of the 
Ophthalmologist and the person's name. It is believed 
that these exclusions do not invalidate the findings; all 
the rejected forms came from one general Ophthalmologist in 
an area with no apparent abnormal incidence of causes of 
blindness so that no particular cause should have been dif­
ferentially excluded from the study.
Computer input was prepared , Appendix 10a,from the 788
141 of the year 1960 and 647 of 1980) forms, summarising
[the most important available data from the BPls. The
[factors considered were the age and sex of the person,
he visual acuity and visual field for each eye and the
primary and secondary blinding cause in each eye. Two
ifferent ages for the same person were considered, the
ge at registration as visually handicapped and the age
t onset of the visual impairment, i.e. the age at which
[he person first became severely visually handicapped.
.e data were analysed on the Edinburgh Regional Computer
:l 2980 using some of the standard data handling
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Y e a r N u m b e r  r e g i s t e r e d  w i t h  t h e  S o c i e t y
1960 760
1970 786
1980 772
1981 (first 6 months) 419
Table 7 8 Number of visually 
registered with the 
in Glasgow and the
handicapped people 
! Society for the Blind 
West of Scotland,
All registered 
(141 persons, 282 eyes)
Legally blind 
(81 persons, 162 eyes)
Causes NO. --- No. of eyes. Percent
Cataract 71 25.1 36 22.2
Myopia 45 15.9 23 14.2
Senile macular 
degeneration 25 8.8 16 9.8
External eye 
disease 19 6.7 12 7.4
Glaucoma 19 6.7 15 9.2
Diabetic
retinopathy 17 6.0 11 6.8
Optic nerve 
a trophy 15 5.3 8 4.9
Uveitis 10 3.5 4 2.5
Table 79 Causes of visual handicap. The year 1960.
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f a c i l i t i e s  o f  t h e  M I N I T A B  p r o g r a m m e  p a c k a g e .
In the analysis a distinction is drawn between the 
"registered" blind who are all those for whom a BPl Form has 
been completed, and the "legally" blind who are those whose 
vision satisfied the United Kingdom criteria of legal blind­
ness. Patients were also divided into the following age 
groups 0-4, 5-19, 20-44, 45-64, 65-74, 75-84, and 85 and 
over. This age grouping has been used in a previous study 
(NSPB 1980) .
People who had visual handicap due to cerebrovascular 
accidents were also excluded from the category of "legal" 
blind but were included among the "all registered" because 
some Ophthalmologists had completed Forms BPl for them 
classing them as "partially" sighted.
Additional information about the prevalence and causes 
of blindness in a number of overseas countries was obtained 
in response to a letter sent to Blind Societies, Welfare 
Authorities etc. as indicated in the introduction to 
Chapter 6. This information was used in making comparisons 
with the West of Scotland.
I9 .3 . RESULTS AND DISCUSSION 
|9 . 3 .a . The Year 1960
Among the 141 Forms studied there were 56 males, 40 per 
lent, and 85 females, 60 per cent; a male;female ratio of 
: 1.5. Their ages at the time of registration with the 
[ociety ranged between 1 and 99 years with a median age of 
[2 years.
The highest incidence of registration occurred in age 
oup 45-64, 34 .7 per cent, followed by the 65-74 years old 
oup, 27.6 per cent, and the lowest incidence of registra- 
p n  was among the 0-4 and the over 85, one case in each
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Secondary cause Per cent
No cause 
Cataract 
Myopia
Senile macular degeneration 
Optic nerve atrophy
42.9
12.4
6.7
5.7 
5.0
Table 80. Contributory causes of blindness. 
The year 1960.
Cause No. of eyes. Percent.
Congenital cataract 11 28.9
External eye disease 6 15.8
Optic atrophy 4 10.5
Congenital abnormality 
of the eye 4 10.5
Uveitis 3 7.9
Table 81. Important blinding causes among the 0-4 
years old.
223
Cause No. of eyes Percent
Optic atrophy 8 44
Congenital cataract 6 33
Glaucoma 2 11
External eye disease 2 11
Table 82, Frequency 
5-19 years
of blinding causes among 
o l d .
the
Cause No. of eyes Percent
Myopia 17 36.9
Cataract 10 21.7
External eye disease 4 8.7
Diabetic retinopathy 2 4.3
Glaucoma 2 4.3
[Retinal detachment 2 4.3
Uveitis 2 4.3
Retinitis pigmentosa 2 4.3
Table 83, Causes of blindness among the 20-24 years 
old.
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Cause No. of eyes. Percent
Cataract 16 57.1
Senile macular 
degeneration 8 28 .6
Glaucoma 2 7.1
Myopia 2 7.1
Table 86. Causes 
o l d .
of blindness among the 7 5-84 years
Patient Age at onset Sex
1 31 Male
2 45 Male
3 49 Female
4 50 Female
5 53 Female
6 62 Female
l7 66 Female
IB 70
71
Female
Female
l o 72 Female
l l 73 Female
Table 87. Age and sex distribution of the individual 
diabetics.
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Cause No. of eyes Percent
Cataract 16 17 .4
Myopia - 16 17 .4
Diabetic retinopathy 8 8.7
External eye disease 8 8.7
Glaucoma 7 7.6
Senile macular degeneration 7 7.6
Table 84. Causes of blindness 
old.
among the 4 5-64 years
Cause No. of eyes Percent
Cataract 28 42.4
Senile macular degeneration 10 15.1
Diabetic retinopathy 7 10.6
Glaucoma 6 9.1
Table 85. Causes of blindness among the 65-74 years 
o Id.
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category, but there were 19 cases in which the "onset" of 
blindness had occurred before 5 years of age, 13.5 per cent. 
Figure 36 (p. 237 seq) shows a histogram of the numbers of 
persons at onset of blindness and at registration for 
different age groups.
81 persons were legally blind, 57 per cent, and of these 
32 were males and 49 females; again a malexfemale ratio of 
1:1.5.
Analysis of the more common causes of blindness, all 
registered and legally blind, is presented in Table 79 which 
shows that, by far the commonest cause of visual handicap 
was cataract accounting for a quarter of the total number of 
all registered and more than a fifth of the legally blind.
It was also the commonest secondary cause when other causes 
were the primary ones, see Table 80.
Blindness among different age groups 
Age group 0-4 (38 eye s )
Nineteen people, 13,5 per cent, were found to have had 
itheir "onset" of blindness during this period of life; Table 
[b 1 shows the number and percentage of eyes blinded at this 
leriod by different causes.
Lge group 5-19 (18 eyes)
Table 82 shows that only 9 people were registered at this 
ige group in the sample studied and that optic atrophy was 
[he leading cause of visual disability.
[e group 20-44 ( 46 e y e s )
Myopia, cataract, and external eye disease lead the 
luses of legal blindness in this age group constituting 
.9, 21.7, and 8.7 per cent respectively. Table 83.
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Age group 45-64 (92 e y e s )
Cataract and myopia share the first place in this age 
group causing blindness in 16 eyes each. Diabetic retino­
pathy makes its first appearance as a major cause of blind­
ness here forming 8,7 per cent of blind eyes, Table 84,
Age group 65-74 (66 e y e s )
Once again cataract was the major cause of blindness 
in this age group.
Age group 85 years and over
Only one BPl was found for this age. The person was 
blinded by corneal opacity in the right eye and by cataract 
in the left.
Diabetics I960
Of the 141 people there were 11 diabetics, 7.8 per 
cent and of these 9 were females and 2 males; a male:female 
ratio of 1:5. They ranged in age between 31 and 7 8 years 
with a median age of 6 2 years. The two males were 31 and 
45 years old.
The highest incidence of blindness in diabetics, 
[whether by age at registration or at onset was among age 
145-64.
Of the 11 diabetics registered with the Society, 6 (2 
tales and 4 females) had become visually handicapped before 
ige 65. The other 5 were 66 to 73 years old and all were
I'emales. Table 87 shows the age at onset of visual impair-
|ent and sex of the diabetics in this sample.
Six of these diabetics, 1 male and 5 female, were
igally blind and constitute 7.4 per cent of the legally 
■ ind in the whole sample. Diabetic retinopathy was the
228
Patient Age at onset Sex
1 31 Male
2 50 Female
3 53 Female
4 70 Female
5 71 Female
6 73 Female
Table 88 . Age at onset of the legally 
1 960.
blind diabetics.
Age (years) All registered Legally blind
Minimum 0 0
Maximum 93 93
1 Mean 64.5 65.5
iMedi an 71.0 71.0
Istandard deviation 22.8 21.9
Table 89. Age at onset parameters of blind persons 
registered during the year 1980.
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aetiological factor of their blindness. The youngest was a 
31 year old male and the oldest a 73 year old female. Sex 
and ages at onset of blindness of these six diabetics are 
shown in Table 88^.
9.3.b, The year 1980
As discussed earlier, 773 people were registered with 
the Society during this year but only 647 forms, 84 per 
cent, were studied in detail because the others were so 
deficient in information.
The 647 comprised 253 males and 394 females; 357, 55 per 
cent, were legally blind and of this number 138 were males 
and 219 females. In either case the male:female ratio was 
1:1,5 which is the same ratio found among people registered 
during the year 1960. Their ages at the onset of blindness
ranged from birth to 93 years with a median age of 71 years. 
The oldest of the registered blind was 98, Table 89.
The age distribution of blindness among the legally 
blind is illustrated in Figure 37 (p. 237 seq). The 
[histograms of age at registration and age at onset are 
imilar but with the data for age at registration shifted 
little to greater age. This is because registration 
sually occurs some time later than the onset of blindness.
,n fact the median time between onset and registration 
[s one year. Some 6 4 per cent of registrations were made 
[ithin two years of onset of blindness but there is a long 
il in the distribution of times and a few registrations 
re actually made more than twenty years after the person 
came blind.
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Xiiv^iue(ice or onset of blindness can be seen in
Figure 37 (p. 2 3 7 seq ) to occur in the 65-74 years age group
with 31 per cent of the legally blind falling within this 
bracket. Because of the delay noted above the peak in age 
at registration occurs later at 75-84 years and accounts for 
32 per cent of the registrations.
When the data for age at onset are split to compare the 
ages of males with those of females, Figure 38, it is found 
that the highest incidence of onset for males is between 65 
and 74 years of age while for females it is in the 7 5-84 
years age group. However when the data are corrected for
age on an actuarial basis using the mid-1980 population esti­
mates for Strathclyde Region (Registrar General, Scotland 
1981) the results show that, as expected, blindness becomes 
increasingly common with advancing age; the incidence rises 
sharply around 60 years of age. Figure 37 shows up 
another interesting point. Among the young, there were no 
registrations of children of up to four years of age, yet 
there were 23 instances of registration of those who had 
suffered the onset of blindness in this age range. Among 
the 23 legally blind children in this age group there were 
119 males and 4 females.
ILINDNESS AMONG DIFFERENT AGE GROUPS
Data on the incidence of various primary blinding causes 
s presented in Figure 39 (p. 237 seq). The results are 
xpressed in terms of the number of eyes blinded by a 
articular cause. A total of 1294 eyes of the registered 
[lind including 714 eyes of the legally blind are considered. 
)me 10 per cent of blind people were found to have differing 
imary cause in their two eyes, but these conditions cover
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the whole spectrum. Thus, the percentage affected by a 
particular cause is sufficiently nearly the same for the
discussion below, whether eyes or people are considered. 
Figure 39 shows thé overall incidence of blinding causes 
both for the registered blind and the legally blind. The 
pattern is the same for-both categories. It is clear that 
senile macular degeneration, by causing legal blindness in 
213 eyes, about 30 per cent, is by far the most comrron 
single cause of blindness in this sample. The other common 
causes in order of frequency, were: Glaucoma 104 eyes, 14.6
per cent; cataract 74 eyes, 10.4 per cent; diabetic reti­
nopathy 61 eyes, 8.5 per cent; myopic degenerations 43 eyes, 
6.0 per cent; and optic nerve atrophy 3 2 eyes, 4.5 per 
cent. Table 90 summarises the leading causes of legal 
blindness for all age groups and individual groups. It can 
be seen that optic nerve atrophy stands as the primary 
blinding cause for both age groups 0-4 and 5-19 years, while 
blindness from diabetic retinopathy and its complications 
[heads the list in the age group 45-64 years, and senile 
iegeneration of the macula constitutes the leading cause of 
lindness in all those above 65 years of age. It can also 
le seen that non-conge ni tal glaucoma makes its first 
ippearance as an important blinding cause in the age group 
0-44 years and reaches its peak at 65-74 years, 20.5 per 
lent.
X variation
Table 91 shows the sex variation of incidence of the
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common causes of blindness. It is noted that senility- 
related causes are more prominent in females than in males 
therefore senile macular degeneration caused around 35 per 
cent out of the legal blindness among females while it 
contributed to 22.5 per cent of blindness in males; and 
cataract furnished 13.2,per cent of cases in females while
it constituted only 5.8 per cent in males; diabetic
retinopathy does not appear at all among the five leading 
causes of legal blindness in males while it ranks third among 
females. There was also a sex variation in the incidence of 
glaucoma which forms about 20 per cent and 11.2 per cent in 
males and females respectively.
Diabetics 1980
Of the 647 individuals studied 59, 9.1 per cent, were 
diabetics; 13 males and 46 females. At the time of 
registration the oldest was an 83 year old female and the 
youngest a 20 year old male who had his onset of blindness
at age 5 caused by optic atrophy. The youngest female to
[be registered was 21, Table 92.
Among the 357 legally blind people 32, 8.9 per cent, 
rere diabetics; 5 males and 27 females, a ratio of 1:5 
hich is comparable to the male:female ratio of the year 
960. Their ages at the onset of blindness ranged from 
1 to 83 with a median of 65 years. In Appendix 9 are 
|isted the ages at registration and at onset, by sex, of the 
|2 legally blind diabetics. Table 93 compared the age at 
îgistration and at onset of blindness in diabetics and 
her blind persons with different primary blinding causes.
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Overall Total
No. of 
Eyes Percent Age Group 45-64
No. of 
Eyes Percent
1. Sen. Mac. Deg. 213 29.8 1. Diab. Ret. 22 18.6
2. Glaucoma 104 14.6 2. Sen. Mac. Deg. 17 14.4
3. Cataract " 74 10.4 3. Glaucoma 15 12.7
4. Diab. Ret. 61 8.5 4. %opic Deg. 10 8.5
5. %opic Deg. 43 6.0 5. Optic AtrcpVy 10 8.5
6. Optic Atrcplry 32 4.5 All Others 44 37.3
7. Corneal Opacity 20 2.8 118 100.0
All Others 167 23.4
714 100.0 Age Group 65-74
lo
2 .
3.
4.
5.
Under 5 years of age
Optic At reply 
Corneal and Other 
Postnatal Infect­
ions
Prenatal Cataract 
Cong, glauccma, 
micrcphthalmos 
Tumour 
All Others
Age Group 5-19
1. Ret. Pigrrentosa
2. Optic Atrcply - 
Cong.
3. P^cpia 
14. Injury
p. Cong. Micrcphthal. 
Toxoplasmos is
Age Group 20-44
Diab. Ret. 
I^opia
Optic At rep by 
Uveitis 
Glaucoma 
All Others
14
12
30.3 
26.1
17.4
1. Sen. Mac. Deg.
2. Glaucoma
3. Cataract
4. Diab. Ret.
5. myopia 
All Others
56
44
24
19
10
61
214
26.2
20.5 
11.2
8.9
4.7
28.5 
100.0
8 17.4 Age Group 75-84
2 4.4
2 4.4 1. Sen. Mac. Deg. 103 47,7
46 100.0 2. Glaucoma 35 16.2
3. Cataract 19 8.8
4. Diab. Ret. 14 6.5
6 42.8 5. Fyopic Deg. 10 4.6
All Others 35 16.2
2 14.3 216 100.0
2 14.3
2 14.3 85 years of age and over
2 14.3 1. Sen. Mac. Deg, 37 48.6
14 100.0 2. Cataract 23 30.3
3. Glauccma 6 7.9
4. Pyopic Deg. 4 5.3
All Others 6 7.9
6 20.0 76 100.0
6 20.0
6 20.0 65 years of age and over
3 10.0
2 6.7 1. Sen. Mac. Deg. 19 6 38.7
7 23.3 2. Glauccma 85 16.8
30 100.0 3. Cataract 63 12.5
4. Diab. Ret. 33 6.5
5. myopia 25 4.9
All Others 104 20.6
506 100.0
Table 90. Cannon causes of legal blindness in the Mbst of Scotiard. 19 80.
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mLES EYES % FEMALES EYES %
1, Senile Macular 
Degeneration
62 22.5 1. Senile Macular
Degeneration
151 34.5
2. Glauconm 55 19.9 2, Cataract 58 13.2
3. Optic Nerve 
At rep by
24 8,7 3. Diabetic
Retincpatby
51 11.6
4. Cataract 16 5.8 4. Glaucoma 49 11.2
5. lyopic
Degeneration
11 4.0 5. Myopic
Degeneration
32 7.3
All other 108 39.1 All other 97 22.2
Total 276 100.0 Total 438 100.0
Table 91. First five comnon causes of legal blindness in male 
and female. 1980.
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Age at registration Age at onset of blindness
Minimum 21 21
Maximum 83 83
Mean 64.9 63.4
Median 67.5 65.0
Standard
deviation 14.2 14.4
Table 92. Age parameters of blind diabetics, 19 80
Blind!ng 
cause
Median age 
at registration
Median age 
at onset
Diabetic retinopathy 65
78Cataract 76
Optic atrophy 44 32
Glaucoma 76 72
All except diabetic 
retinopathy 76 72
Table 93. Median ages at onset and at registration of 
persons blinded by different causes, 1980,
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COUNTRY 1ST CAUSE 2ND CAUSE 3RD CAUSE 4TH CWSE 5TH CAUSE
Scotland Senile Glauccnva Cataract Diabetic
Macular Retincpatliy
Degeneration
%opia
England Senile 
and Wales Macular
Degeneration
Cataract Glauccraa I^opia Diabetic
Retincpatly
U.S.A. Glaucoma Senile
Macular
Degeneration
Cataract Optic Nerve
Atrcpt^
Diabetic
Retincpatty
Canada Senile Diabetic Glaucoma Optic Nerve
Macular Retincpathy Atrcphy
Degeneration
Cataract
(Sweden Tapetoretinal Diabetic Optic Nerve Uveitis 
Degeneration Retincpathy Atrcphy 
of Genetic 
Origin
%opia
India Cataract Glaucoma Staph/loma Optic Nerve Ancphthalnos
At reply
Table 94. Causes of blindness and visual handicap in seme countries.
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□ AT REGISTRATION  
AT O N S ET OF BLINDNESS
0 - 4  5 - 1 9  2 0 - 4 4 4 5 - 6 4  6 5 -74 7 5 - 8 4 8 5 +
AGE GR O UPS
Figure 36. Age at registration and at onset of some
people registered as visually handicapped in the year 1960
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□  By a g e  a t  re g is tra tio n  
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Figure 37. Age distribution,at onset and at registration, 
of legally blind persons registered with the Society of 
the Blind in the year 1980.
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figure 38. Age at onset of blindness in males and females, 
1980 .
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Figure 39. Leading causes of blindness among the legally
blind persons (1980). No one cause of 'all others'
contributes to more than 2,5 per cent of registrations.
It is clear that diabetics tend to be registered with 
the Society and certified as blind much earlier than other 
people blinded by other causes. They also have the onset 
of blindness about 7 years earlier than the rest. These 
differences of age at onset and at registration were found 
to be statistically significant (P< 0.001).
Of the 64 eyes affected by diabetes 61, 95.3 per cent, 
were blinded by retinopathy and its complications, 2 eyes by 
cataract and one eye by glaucoma and in these 3 eyes diabe­
tic retinopathy was a contributory cause.
Among the 59 diabetics^registered with the Society 20, 5 
males and 15 females, were less than 65 years old.
26 individuals, 44 per cent of visually handicapped 
diabetics, which included 6 males and 20 females, were 
registered with the Society after age 64 but they all had 
had the onset of blindness before this age. So about one 
half of the diabetics registered became legally blind while 
still within working age. In the year 1960, 6 out of 11, 
[also about one half, were blinded by diabetic retiopathy.
Comment
The B P 1 registration forms are handled by only a 
ew staff of the Society for the Blind in Glasgow and the 
[est of Scotland thus ensuring precise recording and filing. 
Infortunately an administrative decision was made to destroy 
|ll forms for registration prior to 19 64. Fortunately the 
ïstruction of forms relating to 1960 was incomplete- This 
ide interpretation of the available data
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from the rest of the forms a rather uneasy task; caution is 
necessary in the process of concluding and commenting on the 
findings. However, most of the BPl Forms for the year 19 80 
were available for analysis. The shortage of information 
in some of the BPl's might be due to a possible lack of 
interest, time, or evaluation on the part of the treating 
Ophthalmologist. Completing a BPl Form and certifying a 
person as blind or partially sighted is a responsibility for 
which an Ophthalmologist is usually paid in England but not 
in Scotlandl On the other hand some people might not be 
quite aware of the existance of such institutions as the 
Society for the Blind and would therefore not ask their 
treating Physician to put them on the blind register; this 
might be especially true if they happened to attend an 
Ophthalmologist who was reluctant to certify and label a 
patient as blind for social or other reasons as might happen 
with infants.
However, a few facts could be drawn from the present 
study. The number of people registering with the Society 
every year range between 700 and BOO of whom about 6 0 per 
cent are females. This might generally be due to longer 
longevity of females, a matter which is also indicated by 
Ithe higher rate of age-related blinding causes such as 
[senile macular degeneration and cataract among women. The 
ame predominance of females among the blind has also been 
eported from other countries (Damato 1960; NSPB 1980). 
n the United States for example, after age 65, females 
xceed males at an increasing rate until among those age 85 
Ind over there are 2 blind females for every blind male.
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This predominance of females is noticed whether the whole
group or the legally blind only are studied.
The figure for the frequency of blindness due to senile 
degeneration of the macula in the year 19 60, about 30 per 
cent, is comparable to its incidence in England and Wales
reported by Sorsby (1966), about 27 per cent.
It seems rather bizarre that more than 10 per cent of 
individuals registered with the Society in 1980 were blind 
from cataract since this condition is entirely treatable. 
Possible explanations for this would include long waiting 
operation lists, refusal of surgery, or general health 
being such as to prevent surgery. It is however 
encouraging that the finding shows an improvement since the 
time of Sorsby's survey (1966) when 23 per cent of registra­
tions were due to cataract. Table 94, and from 19 60 in this 
study when slightly less than a quarter of the registrations 
were due to this condition. In England and Wales the 
prevalence of cataract had also declined significantly over 
the last two decades (Sorsby 1972). Still, when the figures 
for cataract and glaucoma, 10.4 and 14.6 per cent, are added 
together it is found that a quarter of the current number of 
[visually handicapped could be reduced since these conditions 
re treatable and preventable respectively.
The incidence of external eye diseases which included 
linding conjunctival, corneal, and other ophthalmic infec- 
ions has dropped sharply since 1960 and this drop, as might 
le expected is due to improvement of hygienic standards and 
[revent ive measures and improved therapy. It is possible 
tat the increasing popularity of corneal grafting had 
>ntributed to this decline.
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In both years studied it was interesting to note that 
retinitis pigmentosa, in spite of the relatively small 
number of cases involved was a major cause of blindness 
among the young and appeared, if at all, only low in the 
ranking for all other age groups. Retinitis pigmentosa is 
also a common cause of visual handicap in other countries 
especially among the young (CNIB 1981; Lindstedt 1969).
See Appendix 11 for an overall comparison of the different 
major blinding causes in the two years 1960 and 1980.
The absence of registration for those in the 0-4 age 
group in both 1960 and 1980 might reflect a reluctance 
by Ophthalmologists to label an infant as blind from a very 
young age, and the rather difficult task of accurately 
assessing the visual acuity in this age category. Gross 
under-reporting of blind infants has also been recognised 
in the United States (NSPB 1980).
The incidence of diabetic retinopathy has not been found 
[to have increased much. In Sorsby’s survey (19 66) diabetic 
etinopathy caused 7.1 per cent of blindness and there has 
leen no clear evidence of any substantial increase in 
lindness from diabetic retinopathy in recent years 
iSorsby 1972). These are somewhat similar figures for 
[he years 1960 and 1980, 6 .8 and 8.5 respectively. Kahn 
id Hiller ( 1974) reported that it was widely believed that 
America blindness from diabetic retinopathy had been 
icreasing in recent years, but they found little evidence 
support this belief. However, diabetic retinopathy 
|s found to be the fourth leading cause of blindness in 
sample studied, the commonest in the 45-64 years age 
)up and the third major cause among females although not 
ng the first five causes among males.
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The calculated prevalence of blindness from all causes 
in the general population is 19 per 100,000 while the 
calculated prevalence of blindness from diabetic retinopathy 
alone is 12 per 100,000 (Caird et al 1969). In the 
present series diabetics constituted about 9 per cent of all 
the legally blind and this is almost 9 times the prevalence 
of diabetes in the Community (Chapter 6) and is another 
confirmation that diabetes is the commonest systemic 
blinding disorder among all age groups especially the 
elderly (McWilliam 1975).
Finally, below is a calculation of the higher risk of 
blindness among diabetics compared to blindness from all 
other causes:
2,418,819 : Population of the West of Scotland - Mid 19 80
(Registrar General 19 81)
357 : Legally blind registered with the Society
during 1980
32 : Legally blind from diabetic retinopathy
1980
325 ; Legally blind from all other causes 1980
325/2418819 = 13.4 persons per 100,000 became legally 
blind every year from all causes
per cent : Prevalence of diabetes in the community
chapter 6
24188 : Number of diabetics in the West of Scotland
Mid 1980
2/24188 = 132 per 100,000 diabetics become legally
blind from retinopathy every year
32/13.4 = 9.8
Diabetics are hence 9.8 times more susceptible to blind- 
iss from diabetic retinopathy than the rest of non-diabetic 
[pulation from all other causes of blindness.
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CHAPTER 10
PHOTOCOAGULATION IN THE TREATMENT 
OF DIABETIC RETINOPATHY
2 4 3
1 0 . 1 .  I NT RODUCTI ON AND HI S T O R Y
Photocoagulation is now the most commonly used procedure 
for the treatment of moderate and advanced forms of diabetic 
retinopathy (Dobree 1974).
With increasing experience the indications, limitations, 
and techniques have become well established and photocoagu- 
lators are now available in most of the well-equipped 
ophthalmic centres. Photocoagulation is more commonly used 
than pituitary ablation which carries serious risks to life 
and is therefore reserved for very few cases of advanced 
"florid" retinopathy especially in the young (Pyke 1976).
It also has wider indications than vitrectomy, a procedure 
which is used only in the treatment of advanced cases of 
proliferative diabetic retinopathy especially those asso­
ciated with un resolving vitreous haemorrhage and fibrosis 
{Machemer 1974).
Ocular photocoagulation was originally employed clini- 
Ically in the spring of 19 49 by Gerd Meye r-Schwi eke rath 
[{L ' Espe ranee and James 19 81) although observations on the 
ffect of light on coloured objects were described by 
fenjamin Franklin in the 18th century and the effect of 
unrays on the retina more precisely noted by Czerny in 1865 
[Raymond 19 77).
The xenon arc photocoagulator was the first instrument 
be used for the treatment of retinal disease and reports 
its histopathological effects and advantages appeared 
Ire than two decades ago (Meye r-Schwicke rath 19 59).
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The laser (Light Amplification by Stimulated Emission of 
Radiation) action was discovered in 1960 (Maiman 1960). A 
laser using a synthetic ruby crystal (chromium in corundum), 
was the first laser to be used for clinical purposes 
(Editorial, British Journal of Ophthalmology 1979), and 
since then many monochromatic systems became available 
(Thyagarajan and Ghatak 19 81).
The argon laser (Zweng, Little, and Peabody 19 71) gained 
more popularity due to its wavelength, 488 and 514.5 nm, 
which allowed direct photocoatulation of blood vessels since 
a large proportion of its energy is absorbed by blood. In 
addition was the relative ease with which it could be applied 
through a slit-lamp delivery system.
Krypton lasers with longer wavelengths (641 nm) became 
available later on. They possess greater penetration 
characteristics and are especially used in patients with 
mild and moderate vitreous haemorrhages (Schulenburg,
Hamilton, and Blach 1979) because of the lack of absorption 
Iby blood thus avoiding the risk of accidental retinal blood 
[vessel closure. This could, at the same time be a disadvantage 
ince 85 per cent of the energy incident on the retinal 
igment epithelium can pass into the choroid and cause unde- 
irable damage.
10.2. BIOPHYSICS
In the xenon photocoagulator a xenon arc bulb is pulsed 
th current to cause a flash of white and infra red light, 
non-arc radiation produces a more wide spread coagulation
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and can be advantageous in seriously affected diabetic 
retinae. It is, however, limited as to the production of 
extremely small spot size, and the beam can be more highly 
absorbed by the ocular media due to the wide spectrum of 
wavelengths that have to pass through the cornea, lens, and 
vitreous.
The ruby laser delivers a 200 p sec pulse of extremely 
intense red radiation which can be useful in performing 
retinal photocoagulation when multiple haemorrhages are pre­
sent in the retina and when considerable retinal oedema is 
present but this instrument became obsolete with the intro­
duction of the argon laser.
In the argon laser photocoagulator a laser tube is 
filled with argon gas at a precise pressure level; when 
current in the form of electrons passes across the tube, 
the argon molecules emit a blue/green light. This is
collected by mirrors at either end of the tube and delivered
to a slit-lamp through a fibre optic cable or an alternative 
[optical system. A narrow laser beam is thus delivered to 
[the eye. This creates a round burn on the retina, generally
eferred to as a burn or spot.
The effect of photocoagulation is produced entirely by 
he conversion of light energy to heat energy in absorbent 
[ubstances (L'Esperance 1965).
The absorption bands of blood lie at approximately 430 
and 500 to 600 mp. Normally, blood pigments absorb 
)proximately 10 per cent of the light incident on the
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human cornea. In the eye, however, the amount of light 
absorbed by any stratum depends markedly upon the spectral 
distribution of the light incident on the cornea. The ther­
mal effects of light absorption by the human eye are deter­
mined primarily by the energy-density gradient within a 
given stratum. The density gradient depends mainly upon 2 
factors, the spectral quality of the light incident upon 
the cornea and the uniformity and density of pigmentation 
within a given layer (Geeraets, Williams, Ghan, and others 
1962). The pigment epithelium or the choroid may absorb or 
scatter separately more energy than do the entire ocular 
media but absorption of energy by the pigment epithelium 
plays the primary if not the entire role in the production 
of mild burns; this is because of the concentration of 
pigment within a very thin layer, approximately 10 u in man. 
For equal energy absorption in pigment epithelium and 
choroid, the influence of pigment epithelium as the source 
of burn would be predominant because of the energy con­
centration within this very thin layer compared with the 
[thicker choroid, approximately 100-200 jj in man. 
absorption of radiant energy in pigment epithelium 
lay, however, be greater than in the choroid or vice versa 
[spending on the individual. Geeraets and co-workers (1962) 
[ound that in White individuals the pigment epithelium 
[ay absorb more energy than the choroid while in darker 
jeople, because the choroid was more densly pigmented than 
L0  pigment epithelium, much more energy was absorbed in 
le choroid. Retinal lesions from patients with blue irises 
re found to require considerably higher dose rates than 
Imparable lesions in individuals with brown
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irises (Tso, Wallow, and Elgin 1977). Geeraets and 
co-workers ( 1962) also found that energy absorption in 
the retinal pigment epithelium is the most important 
factor leading to the development of mild, so called 
"threshold" burns. High light energies can affect other 
structures and may easily rupture a retinal vessel by the 
destructive effect of heat generated in the pigment 
epithelium, by rapid expansion of the blood column or by 
coagulation and necrosis of the vessel wall from a direct, 
focused laser impact (L'Esperance 1965).
There are variations within the same eye as well as from 
eye to eye in both the distribution of granules and the con­
centration of pigment within granules. This variation and 
irregularity of pigment and granule distribution is 
pronounced in the pigment epithelium and in the choroid.
The effect of this variation in both structures becomes 
(more pronounced as the area of irradiation on the fundus 
[is decreased. There is more energy density in a given area 
rom a small laser spot, for example 50 or 100 micron, than 
n a larger spot if the power setting is equal (Constable 
nd Lim 19 81).
l 0 . 3 .  HISTQPATHQLQGY
The effect of photocoagulation on the structure of the 
tina and choroid depends ultimately on the amount of energy 
icident on these structures (Wallow and Davis 19 79) thus the 
.ze of the spot, its duration, and intensity determine the 
Istopathological appearance of the lesion produced.
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Tso, Wallow, and Elgin (1977) correlated 4 grades of 
clinical and pathological lesions 1-2 days after application 
of xenon arc and argon laser spots. In grade 0 no lesion 
was seen on ophthalmoscopy and no change was noted on 
serial sections studied by light microscopy. Eyes with 
grade 1 burns showed a faint grayish-white disc on 
ophthalmoscopy; serial sections showed that the lesions 
were essentially confined to the choriocapillaris and reti­
nal pigment epithelium. Occasional capillaries of the 
choriocapillaris occluded by thrombi and the retinal pigment 
epithelium cells were swollen with irregular displacement of 
melanin granules. In some of the lesions, some nuclei of 
photoreceptor cells were pyknotic but most of the nuclei of 
photoreceptor cells and all the internal layers of the 
retina were spared. Grade 2 lesions consisted of a 
grayish-white ring around a more dense whitish centre. 
Histologically the choriocapillaris was frequently 
occluded with thrombi; the pigment epithelial cells 
showed pyknotic nuclei, granular cytoplasm, and 
[irregular arrangement of the pigment granules, 
lytoplasmic vacuoles in the pigment epithelial cells were 
Iso seen. The photoreceptor outer and inner segments were 
lecrotic, densly stained and shrunken with irregular 
utline. These burns also affected the external limiting 
[embrane and macrophages laden with pigment granules clustered 
[round the damaged photoreceptor cells. Most of the nuclei 
the outer nuclear layers were pyknotic. The blood vessels 
the nerve fibre layer overlying these lesions appeared 
itact. The damage in the retinal pigment epithelium extended 
ond the area of necrosis of the outer nuclear layer.
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Clinically the outer diameter of the grayish-white ring 
corresponded to the damage in the pigment epithelium 
while the diameter of the inner whitish centre corresponded 
to the damage in the outer nuclear layer. On ophthalmoscopy 
grade 3 lesions appeared to have 2 distinct grayish rings 
surrounding a white centre. The two rings corresponded 
to the necrosis of the outer nuclear layer and of the 
pigment epithelium respectively, while the white centre 
represented the damaged inner retinal layers. Light 
microscopy showed damage in the choriocapillaris, retinal 
pigment epithelium, outer nucleaur and inner layers of the 
retina. The choriocapillaris was occluded by thrcwnbi.
The cytoplasm and nuclei of the pigment epithelium and pho­
toreceptor cells were necrotic, homogeneous and poorly 
stained although their outline appeared well preserved.
The outer plexiform layer was vacuolated and the nuclei of 
the inner nuclear layers and of the ganglion cells in the 
nerve fibre layer were shrunken and pyknotic. The pigment 
epithelial cells in the periphery of the lesion were grossly 
[vacuolated with dispersion of the pigment granules. Also 
|in the periphery of the lesion the photoreceptor cells were 
lyknotic and their outline was grossly disrupted (Tso, 
fallow, and Elgin 1977).
At a later stage photocoagulation burns acquire a black 
[igmented centre arranged as a ring or as a solid core and 
le centre of the burn is usually surrounded by a hypo- 
^gmented peripheral zone. This appearance is common to 
th xenon and argon laser burns although, due to the larger
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size of the xenon burn, the area damaged by a single spot is 
wider (Wallow, and Davis 1979). Scar tissue formation in 
the full thickness burn is provided by proliferated retinal 
pigment epithelium and glial cells and numerous pigment- 
laden macrophages are also contained within the scar tissue. 
Wallow and Davis (1979) found that in all lesions, whether 
argon or xenon of long or short duration, B ruch’s membrane 
remained a continuous structure but others (Gass 1972) 
listed rupture of Bruch's membrane as a possible complica­
tion of photocoagulation.
Lesions caused by lasers of different wavelengths show 
the same pattern of retinal damage especially with 
increasing intensity of the applied burn (Wieder, Pome rantze f f, 
and Schneider 19 81). All burns caused by high intensity 
laser application showed damage to the inner as well as 
the receptor cell layers of the retina.
|l0.4. INDICATIONS AND TECHNIQUES
Photocoagulation with either the xenon coagulator or the 
rgon laser is used in the treatment of both proliferative 
iabetic retinopathy and diabetic maculopathy.
The indications and techniques have been more clearly 
[stablished for cases of proliferative diabetic retinopathy 
lan for those with maculopathy.
It has long been recognised that diabetic patients' eyes 
th chorioretinal scars from old uveitis appeared to be 
•otected from developing retinopathy. Random photocoag- 
lation was used in the late 19 50's in an attempt to 
[fluence the prognosis of established diabetic retinopathy 
various types (Meye r-Schwi eke rath 19 57; Wetzig and 
Iton 19 63).
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Initially photocoagulation was directed at the various 
abnormalities present; microaneurysms, new vessels, areas 
of retinitis proliferans etc. Later it became apparent 
that photocoagulation might influence some lesions indirectly 
in particular that disc new vessels might regress following 
extensive photocoagulation applied to the peripheral fundus 
(panretinal coagulation). Indirect photocoagulation is 
thought to reduce the formation of the vasoproli ferat ive factor 
by destroying hypoxic retina (see Chapter 4). Focal 
treatment of leaking capillaries or aneurysms may have a 
place in the management of diabetic maculopathy while in 
proliferative retinopathy focal treatment of new vessels has 
been replaced by indirect panretinal photocoagulation.
Since the introduction of photocoagulation into clinical 
use a large number of studies have been carried out to 
establish the indications, techniques, contra-indications, 
and complications of photocoagulation in the treatment of 
diabetic retinopathy and also to compare the efficacy and 
[complications of the two most widely used photocoagulators 
amely the xenon arc and argon laser (Wetzig and Worlton
963; Irvine and Norton 1971; Gass 1972; Ticho and Patz
973; Kaback and Tanenbaum 1974; Rubenstein and Myska 
i974; Cheng 1975; Little, Zweng, Jack, and Vassiliadis 
[976; Dunnheim and Lullwitz 1977; Francois and Gamble
77; Townsend, Bailey, and Kohner 1979; Blach 1980;
‘ye r-Schwi eke rath and Fried 1981; Plumb, Swan, Chignell,
[d Shilling 1982) .
To establish the usefulness of a given therapeutic 
icedure it is necessary to conduct controlled randomised 
|.'als. In Ophthalmology this means treating one eye and 
iving the other eye, of the same patient, without treatment
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to serve as a control if the two eyes were similar or almost 
similar. Less satisfactorily one may treat one eye of a 
certain patient and compare the outcome of the treatment with 
an untreated eye of another patient provided that similar base 
line criteria in the two patients exist, for example initial 
visual acuity, age, level of control of diabetes etc.
10.4.a. Photocoagulation in proliferative diabetic retinopathy.
Focal photocoagulation 
In the early years of the last decade focal photocoagulation 
of new vessels was the standard procedure. Many authors, 
however, failed to show any significance in visual acuity between 
treated and untreated eyes. In addition there was high risk 
of haemorrhage from treated new blood vessels. This was true 
whether xenon arc or argon laser was used.
Irvine and Norton (1971) followed up for three years 
patients whose disc vessels were directly treated and reported 
cases of identical regression of exudates and new vessels in 
the treated and untreated eyes. After direct xenon 
photocoagulation of proliferating vessels in 42 eyes Wetzig 
[and Worlton ( 1963) found that vessels projecting into the 
itreous continued to be active while flat retinitis proliferans 
:ould be completely obliterated. However, others (Zweng, 
little, and Peabody 19 71; Guinan 19 67) reported more 
favourable results using direct photocoagulation to aneurysms 
id new vessels of the retina. Zetterstrom ( 1980) reported 
73 patients who were treated with the xenon arc photo- 
lagulator and followed up for 9 to 11 years; she noted that 
[vere visual loss occured in 4 and 25 per cent of treated and 
reated eyes respectively; only one patient had severe visual
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loss in the treated group while 18 untreated eyes had 
severe visual loss. Of 15 untreated eyes with background
retinopathy for which focal treatment was given to areas
thought to be potentially subject to neovascularisation 2 
had new vessels 9 to 11 years later; on the other hand of 
15 untreated eyes 11 showed neovascularisation after the 
same period of follow-up (Zetterstrom 1980).
Little, Zweng, Jack, and Vassiliadis (1976) examined 4
techniques using the argon laser in the treatment of disc 
new vessels; (1) focal photocoagulation of new vessels on 
the disc and found that 65 per cent of their patients 
developed a decrease of visual acuity together with ischaemic 
papillitis and optic nerve pallor, (2) photocoagulation of 
the feeder vessel (arteriole) to the neovascular complex.
This method caused deterioration of visual acuity in 46 
per cent of the individuals and was hence abandoned,
(3) feeder frond photocoagulation with panretinal 
photocoagulation; this procedure allowed for maintenance 
of visual acuity in 77 per cent of the treated eyes, and 
finally (4) panretinal photocoagulation alone, w h i c h  gave 
[the best results and was thus recommended as a preliminary 
rocedure in the treatment of advanced ischaemic and moderate 
nd severe proliferative diabetic retinopathy (Little, Zweng, 
ack and Vassiliadis 1976; Dunnheim and Lullwitz 19 77).
Focal photocoagulation may however still be indicated 
lor certain cases of diabetic retinopathy (L'Esperance and 
[ames 1981); (1) as an adjunct to panretinal photocoagulation
ten this technique has failed to obliterate or reduce vitreo- 
tinal neovascularisation, (2) it can be employed in some 
ses of patchy neovascularisation less than 1 disc diameter 
extent on the surface of the retina from which bleeding has
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occured, particularly if the rest of the retinal structure 
appears to be intact. Neovascularisation extending from 
the retina or the optic nerve into the vitreous should be 
treated initially by panretinal photocoagulation and not by 
photocoagulation.
Panretinal photocoagulation 
Multicentre randomised controlled studies on the use of 
xenon arc photocoagulation in the treatment of proliferative 
diabetic retinopathy were carried out in Britain in the 
1970's (Multicentre Controlled Study 1977; Cheng 1979).
The visual acuity was used as a measure of the outcome of 
the trial. In most of the centres which participated in 
the study the policy was to apply scatter photocoagulation 
in addition to focal treatment of areas of new blood vessel 
proliferation. 100 diabetic patients were followed up for 
1 year, 58 for 2 years, and 23 for 3 years. Results of 
the study showed that the mean visual acuity was better in 
treated eyes than in untreated eyes 1, 2, and 3 years after 
Ithe start of the treatment. The visual acuities of both 
[treated and untreated eyes tended to deteriorate, but the 
leterioration was less marked among treated eyes and at 
years the treated eyes had significantly better acuity 
han untreated eyes. There was no difference between 
reated and untreated eyes in those with neovascularisation 
[t the disc, but more untreated developed new vessels at 
le disc later on than did treated eyes. The trial 
.so showed that of the hundred patients followed up for 
year, 18 became blind among whom 13 had had no 
[otocoagulation. Finally the study emphasised the need 
r early diagnosis of serious types of diabetic retinopathy.
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One of the largest studies on proliferative diabetic 
retinopathy so far is that which started in the United 
States in 1971 and in which more than 1700 diabetic patients 
were randomly assigned to either a treatment or to a no 
treatment group; those in the treatment group were again 
assigned to either an argon laser or xenon arc therapy 
(Diabetic Retinopathy Study 1976, 1978). Treated eyes 
received extensive scatter photocoagulation plus focal 
photocoagulation of new vessels. Results of the study 
were in favour of treating cases of early proliferation 
at the disc and elsewhere but failed to show any 
indication for treating severe background retinopathy 
without evidence of proliferation. The cumulative 
incidence rate for a drop in visual acuity to 5/200 in 
two years was 15.9 per cent in untreated eyes but only 
6.4 per cent in treated eyes; in three years the 
rates were 26.4 and 10.5 per cent among the two groups 
respectively. One year after inclusion in the study 
78 per cent of eyes in the treatment group and 50 per 
cent of untreated eyes, initially without new vessels, 
[remained free of neovascularisation. Only 7.5 per cent 
f treated eyes showed evidence of neovascularisation 
fter one year, while 24 per cent of all untreated 
tyes developed new blood vessels one year after they 
rere included in the study. In this study the visual 
esults after argon laser treatment were better than 
|ith xenon coagulation. Xenon burns tend to be larger 
size and full thickness and not confined to the outer 
tinal layers and pigment epithelium as is the case 
th properly applied argon laser burns.
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A recent report of the study (Diabetic Retinopathy 
Study 1979) suggested that four conditions increase the
2-year risk of developing severe visual loss, which was 
defined by the DRS as a visual acuity less than 5/200 at 
2 or more consecutively completed follow up visits 
scheduled at 4-month intervals? these factors are
(1) presence of vitreous or preretinal haemorrhage,
(2) presence of new vessels, (3) location of new 
vessels on or near the optic disc, and (4) severity 
of new vessels» The risk of visual loss grows 
progressively as more risk factors are added.
Like the British study, the need for close supervision 
of patients with advanced changes without vascular 
proliferation was stressed.
In panretinal photocoagulation the number of burns 
which it is recommended should be used varies but a 
minimum of 500 xenon burns or 2,000 argon laser burns 
size 500 u have been suggested (Davies, O'Connell, Murray, 
and Winter 1979). For a successful photocoagulation the 
treatment should be aggressive (Foulds 1978). Davies and 
|co workers ( 1979) also suggested that peripheral application 
f the burns is less likely to cause visual discomfort or 
horoidal oedema with accompanying transient myopia.
In panretinal photocoagulation a topical anaesthetic 
s instilled and a contact lens is inserted. It has been 
[ecommended that retinal ablation procedure is conducted in 
■4 sessions approximately 2-7 days apart (L'Esperance and 
imes 1981), In xenon arc photocoagulation a retrobulbar 
laesthetic is administered. In laser photocoatulation 
lually small coagulations 100-200 u in diameter are 
^aced around the disc; above, below, and nasally, but
2 5 7
avoiding the area temporal to the disc where the papillo­
ma cu la r nerve bundle converges towards the optic nerve. 
Blood vessels are avoided as much as possible. This part 
of the procedure uses the central part of the Goldman
3-mirror contact lens. Peripheral coagulations of larger 
spot size, 500-1000 p, are applied to the whole peripheral 
retina as  far forward as possible using the mirrors of the 
contact lens (Figures 40 and 41).
During the course of this study the author personally 
used argon laser panretinal coagulation in the treatment 
of approximately 250 cases of proliferative diabetic 
retinopathy. A minimum of 2,500 burns of 500 p size and 
of 0.2 sec duration at between 0.2-0.5 Watts were applied 
up to a maximum of 6,000 burns of similar duration and 
intensity. The treatment was given in 3-5 treatment 
sessions usually 1 week apart. In the majority of 
cases 2,500 burns were used and usually resulted in 
satisfactory regression of new blood vessels. Patients 
were seen again 6 weeks after the last treatment session. 
Further laser treatment was given if there was evidence 
of fresh neovascularisation or if there was a failure of 
[the previous new vessels to regress satisfactorily. The 
dditional laser treatment used in these cases was applied 
letween the areas of earlier photocoagulation. In the 
[.nitial therapy a space of approximately 2/3 of a burn size 
fas left between burns.
Only a few cases of maculopathy were treated as another 
rker in the Tennent Institute of Ophthalmology was 
igaged in a study of laser photocoagulation on diabetic 
culopa thy.
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Figure 40. Pattern of panretinal photocoagulation
treatment of proliferative diabetic retinopathy 
(from L'Esperance and James 1981).
Figure 41. Fundus photograph. Pattern of panretinal
photocoagulation treatment of proliferative 
diabetic retinopathy.
1 0 . 4 . b .  P h o t o c o a g u l a t i o n  i n  d i a b e t i c  m a c u l o p a t h y
Visual loss from macular oedema is often less complete 
than from proliferative retinopathy, but nevertheless 
maculopathy is a significant cause of impaired vision in 
diabetics. The maculopathy shows two manifestations, 
oedema and ischaemia from capillary damage and closure.
Maculopathy has been divided into three types (Blach, 
Whitelocke, and Hamilton 1981). In focal maculopathy there 
are focal areas of increased capillary permeability with 
circinate exudates and good capillary perfusion. In the 
cystoid variety increased capillary permeability is more 
widespread and exudates are not a feature. In ischaemic 
maculopathy fluorescein angiography reveals paramacular 
capillary closure.
For focal maculopathy photocoagulation directed at 
areas of capillary leakage has been recommended (Blach 
et al 1981) while a "grid" pattern was used for the 
cystoid and ischaemic types. Focal photocoagulation is 
[sometimes employed to obliterate microaneurysms which are 
eaking serum profusely and to treat other areas of retinal 
'essel leakage within the temporal vascular arcades, 
dfferentiation of new vessels, shunt vessels, and other 
[ascular complexes is necessary here (Henkind 1981).
[acular oedema (Rubenstein and Myska 19 72; Ticho and 
tz 1973) with microcystic changes in the macular region 
n be treated provided that small segments of the macular 
;gion, usually indicated by fluorescein angiography as 
|ot spots" or zones of fluorescein accumulation, are treated 
[ef e rent ial ly with no more than 20 per cent of the macular 
ion treated at any one session.
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Alternative patterns of photocoagulation have been 
recommended for the treatment of diffuse (cystoid) maculopathy. 
A "horse shoe" pattern originally suggested by Rubinstein and 
Myska in 1972 and "illustrated by L'Esperance and James (1981) 
is shown in Figure 42. These latter authors also mention 
the use of a circular distribution of photocoagulation burns 
around the nasal side of the disc and the posterior pole 
outside the vascular arcade. Figure 43.
Focal photocoagulation to obliterate areas of 
capillary leakage in cases of diabetic maculopathy has been 
instituted in a controlled randomised trial in the United 
Kingdom. 76 diabetic patients with maculopathy were seen 
after 1 year, 44 patients were seen after 2 years, and 
25 patients after 3 years. Treated eyes retained 
significantly better visual acuity than non-treated eyes.
In the treated eyes deterioration of visual acuity by 1-2 
lines occurred less often than in the untreated eyes.
Finally it was reported that the prognosis was better in 
those with initial visual acuity of 6/24 or better (Multicentre 
[Controlled Study 1975; Cheng 1975).
Other patterns of photocoagulation such as the "horse 
hoe" pattern have not been tested in any formal manner.
The operation of photocoagulation should be explained 
lo the patient, its disadvantages, and possible complications 
lentionedo It is even possible to show the patient some 
[un du s photographs before the first treatment session 
[amilton 1978; Constable and Lim 1981). Guinan (1978) 
ote "one must not only treat the eye but must give 
ipport and encouragement to a human being who is often 
great need of both".
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Figure 42. Horse-shoe pattern of photocoagulation
treatment of macular oedema(from L'Esperance 
and James 1981) .
nFigure 43. An alternative pattern of photocoagulation
t r e a t m e n t  o f  m acular  oedem a(from  L 'E s p e r a n c e  
and James 1981)  .
CHAPTER 11
COMPLICATIONS OF PHOTOCOAGULATION
1 1 . 1 .  INTRODUCTION
In the present state of knowledge of the pathophy­
siology of diabetes and the absence of an efficient method 
for the prevention*and treatment of the basic changes that 
occur in diabetic retinopathy, photocoagulation is the most 
widely adopted procedure for the local management of the 
serious forms of diabetic retinopathy at the present time.
The favourable functional results obtained from photo­
coagulation have been documented by many authors (Chapter 
10). Most of the publications on photocoagulation have been 
concerned with improvement or stabilisation of visual 
acuity in treated groups of patients (Cheng 1979; Diabetic 
Retinopathy Study 1976, 1978). There is in addition, 
however, a limited number of studies on the disadvantages of 
photocoagulation therapy for retinal disease.
Structural damage to the retina frcm o light of 
varying intensities and from different sources is well 
recognised and many workers have, since the introduction of 
high intensity light sources for ophthalmic examination and 
therapy, reported that human and animal retinae are susceptible 
to structural damage when exposed to light from many sources 
[including clinically used ophthalmic instruments, for example 
|slit lamp microscopes, direct and indirect ophthalmoscopes 
nd different types of photocoagulators.
Retinal damage is dependent on the amount of energy 
bsorbed per unit mass or volume of tissue but when energy 
s absorbed mainly in a specific layer of tissue damage is 
(ore commonly measured as the energy absorbed, or incident,
1er unit surface area. The corneal epithelium for example.
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absorbs most of the ultraviolet radiation up to 29 5 nm and 
visible radiation is absorbed mainly by the photoreceptor 
elements in the rods and cones and by the melanin in the 
pigment epithelium of the retina and in the choroid 
(Geeraetes and Berry 1968). Structural damage to the 
retina depends on the following variables (Lerman 1980).
1. The power density, measured in Watts per square cen­
timetre at the corneal surface or the energy density 
measured in joules per square centimeter entering the eye.
2. The exposure time.
3. The wavelength or the spectral distribution of the
beam at the corneal surface.
4. Transmission through ocular media as a function of the
wave length.
5. Pupillary diameter.
6. The diameter of the retinal image.
7. The absorption or transmission by the retinal pigment
epithelium as a function of wavelength.
8. The absorption or transmission by the choroid as a
function of wavelength.
I In clinical practice lasers emitting between 300 and
tOOO nm are used; these are the wavelengths that can 
fcenetrate the cornea. The cornea absorbs almost all of the 
«Itraviolet radiation shorter than 295 nm. Energy that is 
transmitted by the cornea is absorbed by the lens. Thus all 
■asers that emit anywhere in the UV region are obviously 
fczardous if the cornea or lens is exposed for a sufficient 
ftriod of time and to power densities above threshold levels 
ttellerio 1966). Gerraets and Berry (1968) studied the trans
^Bssion of light in the rabbit, human, and monkey eye and
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demonstrated that well over 50 per cent of the light between 
400 and 800 nm is transmitted through the ocular media and 
that the highest absorption of light at these wavelengths in 
the retinal pigme ht epithelium and choroid occurs in the 450 
to 700 nm spectral region. At these wavelengths retinal 
damage is caused by the-thermal effect of absorbed energy 
while at longer wavelengths a major part of the damage is 
caused by photochemical changes resulting from the absorbed 
energy. An irradiance of 24 Wcm"'^ at a temperature of 
approximately 23*^0 above ambient produced a threshold lesion 
in a rhesus monkey retina in 1000 seconds with the Nd-YAG 
laser (1,064 nm), while the 441.6 nm line f r t h e  HerCd 
laser required only 30 mWcm"^ with negligible temperature 
rise to produce a threshold lesion in a 1000 second exposure. 
The ratio of the two irradiances on the retina is 800 
(Ham, Mueller and Sliney 19 7 6).
Structural damage to the retina has been demonstrated 
in a variety of experiments on animals subjected to varying 
intensities of light for varying periods of time, for 
[example rhesus monkey (Lappin and Coogan 19 70; Tso, Fine 
nd Zimmerman 1972 ; Hochheimer, D'Anna and Calkins 1979; 
Jykes, Robinson, Waxier and Kuwabara 1981), dogs (Buyukmichi 
981), and rabbit (McKechnie and Foulds 1978). A few 
xperiments have also been carried out on human retinae 
[Marshall, Hamilton and Bird 1975; Apple, Whinny, 
ildberg, Polley and Bizzell 1976; Robertson and Erickson 
79; McKechnie and Ghafour 1982).
C l i n i c a l l y  m a n y  c o m p l i c a t i o n s  o f  p h o t o c o a g u l a t i o n  h a v e  
f e n  r e c o g n i s e d .  Some  o f  t h e s e  o c c u r  i n  t h e  i m m e d i a t e
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F i g u r e  4 4 .  A c c i d e n t a l  xenon a r c  burn t o  t h e  f o v e a .  From
C o n s t a b l e  and Lim ( 1 9 8 1 ) .
%F i g u r e  4 5 ,  A c c i d e n t a l  l a s e r  burn v e r y  c l o s e  t o  t h e  f o v e a
From C o n s t a b l e  and Lim ( 1 9 8 1 ) .
postoperative period and may be reversible (Apple et al 
1976) but others may be delayed in onset. Changes can 
affect both the anterior and posterior segments of the eye.
In the anterior segment of the eye the following 
complications have been seen: Corneal oedema due to the
contact lens, the anaesthetic, or possibly the light energy 
itself (Robertson and Erickson 1979), iritis which could 
result from overheating of the aqueous (Okun and Cibis 1966; 
Robertson and Erickson 1979), shallowing of the anterior 
chamber (Kanski 1975; Mensher 1977) with increase of 
intraocular pressure which may last for few hours or up to 
one or two days and might be attributable to congestion and 
hyperaemia in the area, (Diddie and Ernst 1977), swelling of 
ciliary body, or annular choroidal detachment with out­
pouring of fluid from the choroid into the vitreous 
(Blondeau, Pavan and Phelps 1981), temporary myopia associated 
with a forward movement of the iris-lens diaphragm, and 
finally cataract (Kanski 1975; McCanna, Chandra, Stevens, 
Myers, de Venecia and Bresnick 1982 ; Lakhanpal, Schocket, 
Richards and Nirankari 1982),
In the posterior segment macular oedema or an increase 
[of a pre-existing macular oedema is the commonest complica- 
|tion of light exposure (Francois and Cambie 19 76; Okun and 
ibis 1966; Meyers 1980), Other complications include 
ccidental photocoagulation of the fovea with loss of 
lentral acuity (Figs. 44 and 45), vitreous and retinal 
jaemorrhage; contraction of vitreous or preretinal 
îmbrane; subretinal neovascularisation; increase of pre­
dating neovascularisation due to inadequate treatment;
( L b r o u s  t i s s u e  f o r m a t i o n ;  r e t i n a l  d e t a c h m e n t  a n d  o p t i c
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papillitis, a complication which was commonly induced when 
direct photocoagulation of optic nerve vessels was practised 
in the first half of the last decade (Francois, DeLaey, 
Cambie, Hanssens and Victoria Troncoso 1975; Gass 1972; 
Benson, Townsend and Pheasant 1979).
The effect of light, including photocoagulation, on 
the function of the retina has also been studied by many 
authors. Transient myopia due to forward movement of the 
lens - iris diaphragm is sometimes noted and takes only a 
few days to resolve (Kanski 1975). But as would be 
expected the main concern has been the visual acuity and to 
a certain degree the field of vision following photocoagula­
tion treatment.
After photocoagulation with either laser or xenon arc 
deterioration of visual acuity of one or more lines on 
Snellen’s test chart has been reported (Francois and Cambie 
1976; Diabetic Retinopathy Study 1976, 1978) with or with­
out restriction of the field of vision. Xenon arc phocoag- 
ulation therapy is especially prone to cause visual field 
loss although this may not be subjectively noted by the 
patient (Wetzig and Worlton 1963; Okun and Cibis 1966; 
[Multicentre randomised trial 1975; Diabetic Retinopathy 
tudy 1978; Crick, Chignell, and Shilling 19 78; Boldrey, 
little. Flocks and Vassiliadis 1981; Hamilton, Townsend, 
:houry, Gould and Blach 1981). Changes in dark adaptation 
nd electrophysiological behaviour of the retina after pho- 
[ocoagulation have been recorded (Francois, DeRouck, Cambie, 
»d Castanheira 1978; Hamilton et al 1981).
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The effects of light exposure on certain other 
visual functions such as contrast sensitivity or colour 
vision have not been studied thoroughly although some 
contradictory reports have appeared. Birch and Hamilton 
(1981) reported that diabetic patients treated with photo­
coagulation had higher total error scores on the Farnsworth- 
Munsell 100-Hue test 12 months after treatment than before it. 
Whether the deterioration of colour discrimination was due 
to the treatment or to worsening of the retinopathy is not 
clear. In diabetics worsening colour discrimination 
correlates with length of diabetic history (Aspinall 1974) 
and with the severity of diabetic retinopathy (Smith, Ernest 
and Pokorny 1976). On the other hand an improvement of 
colour vision after photocoagulation has been reported by 
other investigators (Crick, Chignell and Shilling 1978) 
and attributed to improvement in the retinopathy.
To assess the short term effects of light exposure 
during laser panretinal photocoagulation on retinal function 
in diabetic patients undergoing treatment for proliferative 
diabetic retinopathy a small study was carried out by the 
lauthor. During laser coagulation the eye being treated is 
[exposed for periods up to 20 minutes to a tungsten illumi- 
lating light projected on the retina through the central 
tort ion of a 3 mirror contact lens in addition to the 
nterraittent focused and scattered laser light introduced 
nto the eye for therapeutic purposes.
If light energy during this type of laser treatment 
[ffects retinal function either source of illumination might 
involved and as both are used together clinically the 
)mbined effect of the tungsten light of the slit-lamp
croscope and of the green-blue light of the argon laser
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photocoagulator was studied. Visual acuity (Snellen's 
chart), contrast sensitivity (Arden grating test), and 
colour vision (Farnsworth-Munsel1 100-Hue test) were measured 
before treatment, '20 minutes after exposure and 24 hours 
later.
11.2. SUBJECTS AND METHODS
The effects of combined tungsten and laser light were 
studied on diabetic patients who were admitted to hospital 
for panretinal photocoagulation for proliferative diabetic 
retinopathy (McKechnie and Ghafour 1982).
A stop was fitted to the rheostatic control of the 
tungsten light on the slit-lamp microscope so that the level 
of illumination was constant for each subject (217 mW/cm^). 
Each session of photocoagulation was made to last 20 minutes 
and during this time an average of 750 (range 500-1000) burns 
size 500 p of 2 msec, duration was given to the retinal 
periphery of one eye.
To assess the effects of light from the slit-lamp 
microscope alone, two other groups of individuals were 
[also examined. The first consisted of nondiabetic 
lormal volunteers who performed the tests before and then 
0 minutes and 24 hours after being subjected to the 
lit-lamp illumination alone. The light was delivered 
^hrough a Goldman 3-mirror contact lens and the pupil was 
ilated in a similar fashion to that used in the clinical 
lituation. The second group consisted of diabetics who 
isponded to written requests to attend for the test and 
iderwent the same procedure. They were all informed 
the nature of the study.
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In all three groups of subjects the pupils were 
dilated prior to the start of the test and a pin-hole was 
used for visual acuity recording before and after exposure 
to the slit-lamp or laser light. For contrast sensitivity 
and colour vision testing a 3-dioptre convex lens was incor­
porated in a trial frame or clipped to the reading glasses 
of individuals who normally used a correction for near 
vision to counteract the effect of cycloplegia.
In the two control groups light from the slit-lamp was 
projected for 20 minutes onto different areas of the fundus 
to mimic clinical examination conditions. In the case of 
diabetics who were receiving laser treatment for their pro­
liferative retinopathy the usual procedure of photocoagula­
tion was followed, the laser beam being directed to the 
peripheral retina avoiding the area between the two temporal 
vascular arcades, blood vessels and the optic nerve 
head. As already noted each laser session lasted 
20-30 minutes during which 500-1000 laser burns were 
applied. Each person, in all categories, was given a 20 
minute rest before a test was repeated. Pupils were again 
dilated 24 hours later and the same test repeated.
One eye from each participant was used for a given 
(test; the number of eyes, thus, represents the number of 
[individuals tested each time. Shown in Table 95 is the 
lumber of eyes used in the various tests.
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11.3. RESULTS
11.3.a. Visual acuity
Visual acuity of 6 normal individuals before, 20 minu­
tes and 24 hours dfter exposure to slit-lamp tungsten light 
are shown in Table 96. All showed some reduction in acuity 
20 minutes after light exposure, one showing a drop in acuity 
from 6/6 to 6/36 20 minutes after light exposure. The mean 
of the differences was - 1.8 Snellen lines. Non parametric 
two tailed paired test showed no significant difference when 
acuities within the group were compared (P = 0.0626). All 
visual acuities had returned to pre-exposure level 24 hours 
later. See Fig. 46.
Visual acuities in the diabetic group of patients who 
were subjected to slit-lamp light showed a significant 
deterioration 20 minutes after light exposure (P = 0.0156).
In 5 of the 8 diabetics in this group the acuity returned to 
the initial level 24 hours later; in 3 there was a one-line 
drop in acuity. This, however, was found to be non­
significant (P = 0.2500). See Fig. 47 and Table 97.
Seven patients received laser treatment and had their 
[visual acuity tested before and after the treatment session.
' h e s e  a r e  s h o w n  i n  T a b l e  9 8 .  A s i g n i f i c a n t  d e t e r i o r a t i o n  w a s  
l O t e d  2 0  m i n u t e s  a f t e r  t r e a t m e n t  ( P  = 0 . 0 3 1 2 ,  n o n  p a r a m e t r i c  
p a i r e d  t e s t )  b u t  f o u r  o u t  o f  s e v e n  h a d  r e t u r n e d  t o  p r e - t r e a t m e n t  
e v e l s  a t  2 4  h o u r s  a n d  t h e r e  w a s  n o  s i g n i f i c a n t  c h a n g e  i n  
I c u i t i e s  (P = 0 . 2 5 0 0 )  a t  t h i s  t i m e  i n t e r v a l ,  F i g .  4 8 .  I t  i s  
| e e n  t h a t  i n  b o t h  d i a b e t i c  c a t e g o r i e s  t h e r e  w a s  a  s i g n i f i c a n t  
o p  i n  v i s u a l  a c u i t y  r e c o r d e d  2 0  m i n u t e s  a f t e r  s l i t - l a m p  
L a m i n a t i o n  o r  l a s e r  t h e r a p y  b u t  t h a t  a l l  h a d  r e t u r n e d  t o  
t h i n  o n e  l i n e  o f  t h e  i n i t i a l  a c u i t y  24  h o u r s  l a t e r .
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Visual
acuity
Contrast 
sens i t ivi ty
Colour 
vi s ion
Normal individuals 
subjected to 
slit-lamp light
6 10 10
Diabetics subjected 
to slit-lamp light 8 14 14
Diabetics subjected 
to laser (and 
slit-lamp)
7 8 8
Table 95. Number 
who pa 
effect
of individuals, normal and diabetic 
rticipated in the study of the 
of light on some visual functions.
Initial 
vi sual
Subject acuity
20 minutes 
after light 24 hours later
1 6/6 6/36 6/6
2 6/6 6/9 6/6
3 6/5 6/9 6/5
1 4 6/6 6/12 6/6
1 5 6/6 6/6 6/6
1 6 6/6 6/9 6/6
Table 96. Initial and subsequent visual acuities 
of normal individuals subjected to 
tungsten slit-lamp light.
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Subject
Initial 
visual 
acu i ty 2 0 minutes 24 hours later
1 6/T2 6/36 6/12
2 6/9 6/12 6/12
3 6/6 6/6 6/6
4 6/9 6/12 6/9
5 6/6 6/12 6/9
6 6/6 6/9 6/6
7 6/18 6/36 6/18
8 6/24 6/60 6/36
Table 97. Effect of slit-lamp light 
of diabetic patients.
on visual acuit}
Patients
Initial
visual
acuity 20 minutes later 24 hours later
1 6/12 6/24 6/12
2 6/6 6/9 6/9
3 6/6 6/6 6/6
4 6/9 6/12 6/9
1 ^ 6/18 6/36 6/24
1 ^ 6/12 6/24 6/12
1 7 6/6 6/9 6/9
Table 98. Effect of laser photocoagulation on 
visual acuity of diabetics with 
proliferative retinopathy.
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Figure 46. Visual acuities of six normal individuals 
subjected to the tungsten light of slit-lamp. Acuities 
are shown before, 20 minutes, and 24 hours after exposure.
6/s
6/9
6/l2
ô/ôO
Patient 2 3 4 5 6 7 8
Figure 47. Visual acuities of 8 diabetic subjects before, 
20 minutes, and 24 hours after exposure to the 
slit-lamp tungsten light.
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|igure 48. Visual acuities of 7 diabetic subjects before,
20 minutes, and 24 hours after a photocoagulation 
session for proliferative diabetic retinopathy.
1 1 . 3 . b .  C o l o u r  v i s i o n  ( F a r n s w o r t h - M u n s e l l  l O Q - H u e  t e s t )
The test was carried out as described in Chapter 5.
Table 99 shows the mean total error score of each 
group of individuâTs who performed the Farnsworth-Munsell 
100-hue test before and after exposure to the two different 
sources of light.
Diabetics had higher mean total error scores than non 
diabetics and those receiving laser therapy had higher scores 
than the group of patients who received only slit-lamp light. 
This was expected since those with proliferative retinopathy 
had a more advanced retinopathy than the other group which 
consisted of diabetics who had no retinopathy or simple forms 
of it and were not specifically chosen on the basis of their 
retinopathy.
Colour discrimination, using the 100-Hue test, was not 
found to change significantly either 20 minutes or 24 hours 
after exposure to tungsten slit-lamp light or laser in any 
of the groups tested. Figs. 49 - 53. Probability figures 
using a non-parametric, two tailed paired test are shown in 
Table 100.
|ll.3.c. Contrast sensitivity (Arden grating test)
Diabetic patients with proliferative retinopathy 
generally have higher contrast thresholds than diabetics 
[/ithout retinopathy or with only simple retinopathy such as 
hose who performed the contrast sensitivity test before and 
fter tungsten light exposure. Diabetics in general have 
jigher thresholds i.e. lower contrast sensitivity than nor- 
1 individuals (Ghafour et al 1982).
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'igure 49. Mean total error scores on the Farnsworth- 
lunsell 100-Hue test of :
fop line : Normal subjects exposed to slit-lamp light. 
|iddle line : Diabetic subjects exposed to slit-lamp light, 
•ttom line : Diabetic subjects exposed to argon laser light
Mean initial 
total score
20 minutes 24 hours 
later later
Normals ; 
slit-lamp (10)
Diabetics ; 
slit-lamp (14)
Diabetics ; 
laser (8)
88.4
160.4
210.7
94.2
159.1
222.0
89.6
156.8
232.0
Table 99. Mean total error scores on the Farnsworth- 
Munsell 100-hue test of different groups 
of subjects exposed to light.
Initial score 
Vs
2 0 minutes
Initial score 
Vs
24 hours
Normals; slit-lamp P = 0.5078 P = 0.7540
Diabetics; slit-lamp P = 0.5810 P = 1.0000
Diabetics; laser P = 0.7266 P = 0.7266
Table 100. Comparison of total error scores on the 
100-hue test of different groups of 
individuals exposed to slit-lamp with 
or without laser after varying periods. 
None of the probabilities is significant
2 7 4
Time of Test 2 3
PLATES
4 5 6 7
Initial 12.75 10.75 12.50 12.75 10.12 9.62
2 0 minutes later 13.12 10.12 12.50 11.50 9.37 10.75
24 hours later 12.50 11.00 12.00 11.62 9.00 10.12
Table 101. Mean contrast thresholds on each plate of 
the Arden grating book of 8 normal 
individuals exposed to slit-lamp light.
PLATES
Time of Test 2 3 4 5 6 7
Initial 12.62 10,50 12.87 13.62 14.37 17 .00
20 minutes later 12.37 11.50 14.75 14.25 15 .00 17 .00
24 hours later 12.12 10.75 12.50 13.12 14.00 16.87
Table 102. Mean contrast threshold on Arden grating 
book of 8 diabetics exposed to the slit- 
lamp light.
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Time of Test 2 3
PLATES
4 5 6 7
Initial 11.66 9.44 13.22 15.88 16.33 17 .55
20 minutes later 12.-3 3 10.88 13.33 15 .77 17 .88 18.11
24 hours later 11.44 10.00 12.44 15.33 16.44 17 .88
Table 103. Mean contrast threshold on Arden grating 
book of 9 diabetics exposed to laser for 
treatment.
Plate
Before Vs 
20 minutes
Before Vs 
24 hours
20 minutes Vs 
24 hours
P = 0.1094 P = 1.0000 P = 0.6876
P = 0.0118 P = 0.2500 P = 0.3750
P = 0.7744 P = 0.2500 P = 0.218
P = 0.3876 P = 1.0000 P = 0.6876
P = 1.0000 P = 1.0000 P = 1.0000
P = 0.7266 P = 1.0000 P = 0.5000
’otal score P = 0.1184 P = 0.5078 P = 0.0704
Table 104. Probability figures of mean contrast 
threshold of diabetics treated with the 
laser. Significant difference is 
marked with
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Figure 50. Farnsworth-Munsell 100-Hue test trace of a 
diabetic patient before exposure to slit-lamp tungsten
light. Total error score 240.
Figure 51. Farnsworth-Munsell 100-Hue test trace of the 
same patient as in Figure 50 after exposure to slit-lamp
light. Total error score 344.
Figure 52. Farnsworth-Munsell 100-Hue test trace of a 
diabetic with proliferative retinopathy before a laser 
treatment session. Total error score 392.
ri
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Figure 53. Farnsworth-Munsell 100-Hue test trace of the 
same patient as in Figure 52 after a laser treatment 
session. Total error score 322.
02
4
6
§ »
10
12
14
16
18
20
PLATE
Figure 54. Mean cotrast threshold on the Arden grating 
|book of normal individuals.
  Before exposure to slit-lamp.
  20 minutes after exposure.
. . .  2 4  h o u r s  l a t e r .
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Figure 55. Mean contrast threshold on the Arden grating 
book of diabetics.
  Before exposure to slit-lamp.
  20 minutes after exposure.
  2 4  h o u r s  l a t e r -
Q
0
1f-
10
k
i
U  12
18
20
PLATE
Figure 56. Mean contrast threshold on the Arden grating
book of diabetics treated with argon laser.
  Before treatment.
  20 minutes after treatment.
. . . .  2 4  h o u r s  l a t e r .
No change of contrast threshold on any plate of the 
Arden grating book was found when the 8 normal individuals 
were re-tested 20 minutes or 24 hours after being exposed to 
the slit-lamp (Table 101). The same finding was obtained 
in the case of diabetics who were exposed to the tungsten 
light of the slit-lamp (Table 102). Diabetics treated with 
the laser showed no difference of contrast sensitivity on 
any plate whether tested 20 minutes or 24 hours after the 
treatment session; the only exception being on plate (3) 20 
minutes after the treatment when a significant mean elevation 
of contrast threshold was noted (P = 0,0118), see Table 104. 
The mean threshold on this plate also had returned to pre­
exposure level 24 hours later (Table 103). Figures 54-56 
display the data of Tables 101-103.
On comparing the patterns of change for the different 
groups of patients it was found that the only statistically 
significant difference was between the normals and the 
lasered diabetics, 20 minutes after exposure and testing 
[with plate 5 (P < 0.0332); all other differences were 
|i ns ign i f icant,
1.4. DISCUSSION
Ophthalmologists all over the world examine, treat, 
nd operate on patients using different sources of illumina- 
ion, yet hardly ever come across a patient who returns to 
(he Ophthalmic Department to report a change in visual per- 
irmance. Many studies however have shown that a 
terioration of visual acuity by one line, in many cases.
2 7 7
takes place after photocoagulation therapy for retinal 
disease, the most commonly treated of which is diabetic 
retinopathy (Francois and Gambie 1976; Diabetic Retinopathy 
Study 1978). Photocoagulation for diabetic retinopathy 
accounts for as much as 63 per cent of all laser treatment 
sessions (Zweng, Little, and Vassiliadis 1977).
In this study normal and diabetic individuals were 
exposed to levels and durations of illumination similar to 
those encountered in everyday practice in ophthalmology.
Patients are very seldom exposed to the illumination 
of a slit-lamp for longer than 20 minutes. Indirect 
Ophthalmoscopy may take 15-2 0 minutes even when drawings 
are being made and a laser session usually lasts a maximum 
of 20-30 minutes. This contrasts with the "experimental" 
conditions under which structural damage to the retina has 
been produced. In these experiments very high energy 
levels have been used and the experimental animals exposed 
for much longer periods than those needed for examination 
of the fundus in humans or for photocoagulation treatment.
In Table 105 some examples of these experiments are shown.
It would not be surprising that such high luminances would 
damage animal and, perhaps, human retinae. Human retinae 
however might be more resistant than animal retinae to 
light damage and rhesus monkey, which is the commonly used 
animal for such experiments, may not be the most suitable 
for the study of such effects (Geeraets and Berry 1968; 
Boldrey et al 1981).
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Boldrey and co workers (1981) reported the visual out­
come in seven workers in laser industry who were acciden­
tally subjected to very high intensities from different 
laser instruments'Vhere the conditions in which the acci­
dents occured were thought to be similar to the conditions 
encountered in the clinical application of laser treatment. 
They found that, in spite of the persistence of minor field 
losses, most of the patients recovered excellent visual 
acuity a few weeks after the accident.
Even in monkeys, the retinal damage which was produced 
after 40 minutes of exposure to the highest possible inten­
sity of light, from an indirect ophthalmoscope, disappeared 
in 4 weeks while exposures of 5, 10, or 20 minutes produced 
no photographically visible change (Hochheimer, D'Anna and 
Calkins 1979).
In the present study the drop of visual acuity 20 
minutes after exposure of normals or diabetic patients to 
slit-lamp or laser light might be thought to be the result 
of incomplete adaptation; this is unlikely. The tests of 
function used here are all cone-mediated and cone adaptation 
is known to be rapid while human rods would require about 
jso minutes to dark adapt after bleaching (Lerman 1980). In 
ixperimental light damage to the retina cones have been 
ihown to be more sensitive to damage than rods (McKechnie 
nd Johnson 1977) but the abnormalities in cone structure are 
japidiy reversible when light damage is moderate; even when 
|he receptor outer segments are generally damaged regeneration 
possible (Tso, Fine and Zimmermann 1972).
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Anima1 
Mode 1
Source 
of light
Conditions of 
the experiment Author
Rhesus Indirect
monkey Ophthalmoscope
Exposure of 1 hour. 
Light "continuously" 
directed on the fovea, 
Transformer set at 
7.5 volts reading.
Tso et al 
1972
Dutch 
rabbi t
Tungsten light Exposure for 1 hour McKechnie 
to white light & Foulds
(67-235 mW/cm2). 1978
Rhesus Slit-lamp and
monkey operating
microscope
Slit-lamp light set 
at maximum voltage, 
5, 10, & 20 minutes 
produced no effect. 
Only 4 0 minutes 
exposure produced 
reversible changes.
Hochheime r 
et al
1979
Rhesus
monkey
Fluorescent
light
Exposure for 12 hours 
repeated for 4 days. 
Intensities as high 
as 24,700 lux were 
u s e d .
Sykes et al 
1981
Dog Indi rect 
Ophthalmoscope
Exposure for 1 hour. 
Eyelid opened by 
speculum. Position 
of light and eye 
maintained constantly. 
Light intensity 
control on Ophthalmos­
cope transformer turned 
up to maximum.
Buyukmi ch i 
1981
Table 105. Experimental conditions in some studies 
which reported retinal damage from light,
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In the present study, although the eye was moved about 
during light exposure and the macular area was not directly 
illuminated scattered light within the eye is likely to have 
affected all areas* of the retina. It is probable that the 
temporary deterioration of visual acuity 20 minutes after 
exposure in all groups of subjects was the result of rever­
sible and temporary damage to cone mediated vision. Tests 
of dark adaptation, electrophysiology and visual fields 
would be necessary to determine whether temporary reversible 
damage to rod mediated vision also occured.
Macular oedema or an increase in pre-existing macular 
oedema was found to follow extensive scatter retinal photo­
coagulation by Gass (19 72) and it would be expected that a 
deterioration of colour vision and other aspects of cone 
mediated vision would result.
It is the policy in some centres to apply a large 
number of burns at the first treatment session. Hamilton 
et al (1981) put more than 500 Xenon burns or 2,000 laser 
burns size 500 p during the first session and an average 711 
xenon or 3459 argon laser burns overall. They reported 
that colour vision (Birch and Hamilton 1981) deteriorated in 
itheir patients together with some loss of visual fields and 
[disturbance of night vision.
Apart from the study reported in this chapter occasional 
latients who appeared to have suffered adverse effects of 
>hotocoagulation have been seen by the author. These 
ncluded a patient of Middle Eastern origin who developed 
temporary choroidal effusion following laser panretinal 
>agulation. In this patient two factors may have 
mtributed to this effect. Firstly, pigmentation in the 
:tinal pigment epithelium was heavier than in the European
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patients usually treated and as a result the photocoagulation 
burns were more intense than usual. Secondly treatment 
sessions were separated by only 24 hours and the choroidal 
effusion developed after the third session. The effusion was 
accompanied by a temporary reduction in acuity from 6/9 
to 6/36. Recovery to pre-treatment level with rapid 
regression of neovascularisation was noted 7 days later.
At the Tennent Institute of Ophthalmology, laser burns 
are usually applied up to an average maximum of 500 - 1000 
at each treatment session. This limitation in the number of 
burns used per treatment session may explain the absence of 
significant short term deterioration in colour vision, visual 
acuity, and contrast sensitivity in the diabetics studied and 
was probably responsible for the low rate of complications 
seen among other patients treated. In another patient 
(McKechnie and Ghafour 1982) a calamitous fall in acuity 
from 6/36 to counting fingers occurred immediately after a 
single treatment session of 700 burns of 500 u size. None 
of the burns were near the macula and the poor acuity was 
associated with severe cystoid macular oedema. A gradual 
recovery of vision to 6/36 occurred over the succeeding 
6 months. No other serious complications of panretinal 
jCoagulation were seen among the 250 patients treated.
In my opinion there is no justification for a treatment 
[regimen which involves a total panretinal ablation in one 
reatment session.
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CHAPTER 12 
FINAL DISCUSSION AND SUGGESTIONS
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Diabetes is the commonest systemic disorder causing 
blindness or visual disability among persons of working age 
(20-64 years). It is responsible for about 10 per cent of 
blind registration' in the West of Scotland (Ghafour, Allan, 
and Foulds 1983 ). Here as in many other developed parts of 
the world diabetes affects about 1 per cent of the popula­
tion. There are in addition likely to be a significant 
number of undiagnosed diabetics. The population in the 
West of Scotland is about 2.5 million (Registrar General, 
Scotland 1981), and consequently there are about 25,000 
diagnosed diabetics in this part of the United Kingdom.
In the studies (Chapter 7 and 8) on diabetic patients 
attending a Hospital diabetic clinic or being cared for in 
General Practice, a prevalence of about 32 per cent of diabetic 
retinopathy was found. One third of patients with diabetic 
retinopathy had a serious sight threatening variety of eye 
disease. Applying these prevalence figures to the West of 
Scotland, 2,750 persons are likely to have serious retino­
pathy necessitating detailed ophthalmological assessment and 
laser or other appropriate treatment.
It has been estimated that at any one time up to one 
third of cases of diabetes are undetected (Amos 1974), As 
60 per cent of diagnosed diabetics were symptom free at the 
t^ ime of diagnosis there is no evidence that those patients 
ith undetected diabetes differ significantly from those 
ith known diabetes. If this were true for the West of 
Scotland then the number of diabetics in this area might 
le as high as 37,500 while some 4,000 patients might have 
lerious retinopathy.
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In relation to the factors of importance in the deve­
lopment of retinopathy several aspects, some well known and 
others new have been identified in the present study.
It is well known that duration of diabetes is one of 
the most important factors in the development of diabetic 
eye disease and this is-confirmed in the present work.
Thus patients with retinopathy had had diabetes for 9 years 
on average while those without retinopathy had been 
recognised as diabetics for only 3 years on average.
There are some significant differences between the 
sexes both in the age of onset of diabetes and of retino­
pathy, Whether this is due to hormonal factors or related 
to other genetically determined parameters is controversial 
(Sabour et al 1962; Siperstein et al 1968). Conceivably
environmental factors might play a role.
In the present study the mean age of diagnosis of 
diabetes in males was 7 years younger than in females (49 
compared with 56 years). As a corollary males with diabe­
tic retinopathy developed diabetes on average some 8 years 
earlier than females with retinopathy (median age at diagno­
sis of diabetes among males with retinopathy was 46 years 
and among females similarly affected 54). Thus males deve- 
|lop both diabetes and its complication, diabetic retinopathy 
t an earlier age than females. The earlier development of 
iabetic retinopathy among males may simply be an expression 
f the duration of the diabetes and its earlier onset among 
[ales but there are suggestions that males may be in addi- 
lion more liable to the development of the complications of 
jiabetes. These findings receive support from a recently 
sported study (Bodansky et al 1982).
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Much interest has been shown over the years in the 
relationship between diabetic control and the development of 
retinopathy. Recently the measurement of glycosylated 
haemoglobin levels" has been hailed as a better method of 
assessing control than the taking of random blood sugar 
levels as it is believed that the level of glycosylated 
haemoglobin is more closely related to the level of control 
over the previous few weeks. It is of interest therefore 
that in this study (Chapter 8) it was found that the 
severity of retinopathy among diabetic patients correlated 
much more with random blood sugar estimations than with levels 
of glycosylated haemoglobin, suggesting that short term 
fluctuations in blood sugar may be more important in the 
development of retinopathy than the average level of control 
as expressed by the measurement of glycosylated haemoglobin 
in the blood. Similar findings have been reported in 
another recent study (Dornan 1982).
It is a well held belief that coincident systemic hyper­
tension in diabetes is a risk factor for the development of 
diabetic retinopathy and its severity. In the present study 
hypertensive diabetics were found not to show a higher prev­
alence of diabetic retinopathy than non hypertensive diabetics. 
[Additionally it was found that in the West of Scotland 
^diabetics are not more susceptible to hypertension than non 
[diabetics (Beevers 1978). On general grounds it is obviously 
if benefit to a hypertensive diabetic patient to have his 
.ypertension treated but the clinical impression that this 
lay prevent the development of diabetic retinopathy or reduce 
ts severity receives no support from the present study.
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Another factor about which there are conflicting opi­
nions is the influence of smoking on the development of 
diabetic retinopathy. Smoking is known to increase whole 
blood viscosity (D'intenfass 1975) and to be associated with 
arterial disease and increased platelet adhesiveness.
Because it has been shown that increasing severity of diabe­
tic retinopathy is associated with increasing whole blood 
viscosity (Lowe et al 1981; Trope et al 1983) there are 
theoretical grounds for recommending that patients at risk 
of developing diabetic retinopathy or indeed those who have 
already developed this complication should not smoke.
In spite of this the present study has failed to find 
any correlation between smoking and diabetic retinopathy. 
Thus the prevalence of retinopathy was similar in smokers 
and non smokers (Chapter 7). Other studies have reported 
similar results. Thus West et al (1980) in a survey of a 
large number of diabetic Pima Indians found no relationship 
between smoking and the prevalence of retinopathy. More 
recently Dornan, Mann and Turner (1982) compared 40 insulin 
dependent diabetics who remained free from diabetic retino­
pathy with 40 similar patients with background retinopathy 
and 47 with proliferative retinopathy. They reported that 
[smoking did not appear to influence the development of 
liabetic retinopathy. The correlation of raised whole 
lood viscosity with severity of diabetic retinopathy and 
■he lack of correlation with smoking which is known to be 
jssociated with raised whole blood viscosity suggests either 
lhat in additon to its effect on blood viscosity smoking may 
lave some other effect on the eye which is protective as
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regards retinopathy or alternatively that the association of 
raised blood viscosity and retinopathy may not be direct and 
that raised blood viscosity may only indicate the presence 
of some other factor which is itself causally related to the 
development of retinopathy.
Diabetics are known to be at risk of vascular complica­
tions in addition to retinopathy and smoking has been iden­
tified as a risk factor in many vascular diseases. It 
would appear reasonable on general grounds although not sup­
ported in relation to retinopathy, that diabetics should be 
strongly advised not to smoke. It is of interest that in 
the present study it was found that general vascular compli­
cations were commoner among diabetics with retinopathy than 
those without, indicating not only that all vascular compli­
cations in diabetes including retinopathy tend to be related 
to the duration of the disease and additionally that the 
state of the retina, while no guide to the severity of the 
diabetes is a good indication of other vascular complica­
tions such as coronary artery disease.
Blindness from any cause has social and econcmic 
aspects apart from the obvious deterioration in the quality 
of life that it may cause. Blindness from diabetes tends 
|to occur at an earlier age than that from other causes (7 
[years earlier on average among blind patients registered 
ith the Society for the Blind in Glasgow and the West of 
Scotland). It is also the commonest form of blindness 
imong those of working age. Prevention of blindness from 
his cause, which has now become a real possibility with the
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advent of laser treatment, would have obvious economic and 
other advantages for the community as well as the affected 
i ndividual.
There is little doubt that to be effective laser 
therapy has to be employed at an early stage in the develop­
ment of serious retinopathy. The detection of serious 
retinopathy at a suitable stage for therapy is therefore the 
most important step in the prevention of blindness from 
diabetes. Many diabetics regularly attend a Hospital 
diabetic clinic and it might seem reasonable that the detec­
tion of serious retinopathy would be part of the assessment 
of the diabetic patient at these units. Not all diabetics 
however, attend hospital clinics regularly. Sixty percent 
of diabetics in one practice studied were looked after 
in general practice.
In this study we have examined the various ways in 
which serious retinopathy might best be detected and it is 
clear {Chapter 5) that Ophthalmoscopy carried out by a 
trained observer is a reliable method.
More sophisticated tests of structure and function such 
as fluorescein angiography, quantitative visual field analy­
sis, measurement of defects of colour vision or of spatial 
frequency contrast sensitivity were found not to be helpful 
n differentiating serious from non serious retinopathy,
|[\any patients with non serious background retinopathy and 
ndeed some diabetic patients without retinopathy showed 
bnormal visual function. The results indicated that 
ignificant changes in retinal function were common among
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patients with diabetes and that these tended to antedate 
the development of visible retinal pathology. Fluorescein 
angiography too detected unsuspected retinopathy in some 20 
per cent of apparently normal diabetic eyes but once again 
this tended to be early background retinopathy of a non 
serious nature not requiring detailed ophthalmological 
investigation or treatment. Neither fluorescein angiography 
norretinal photography were suited to the detection of 
serious retinopathy in screening programmes based in hospital 
or general practice. Fluorescein angiography was however 
of considerable value in assessing the severity of previously 
detected serious retinopathy. Fluorescein angiography 
was particularly useful in demonstrating the extent and 
degree of capillary under perfusion in cases of proliferative 
or ischaemic retinopathy and in detecting areas of 
microvascular abnormality and increased permeability 
in cases of exudative maculopathy.
The problem of screening for diabetic retinopathy is 
greater in general practice than in a hospital-based diabe­
tic clinic. In the latter the screening personnel rapidly 
obtain expertise in the evaluation of retinal signs because 
of the large number of patients available for examination.
In this study it was found (Chapter 5) that trained physi- 
(cians became as accurate in the detection of serious retino- 
jpathy as experienced ophthalmologists although both obser­
vers missed 3-4 per cent of cases of serious retinopathy.
’he physicians involved in the study had spent time in 
he retina clinic of the Tennent Institute of Ophthalmology 
n Glasgow where they were trained in the detection of 
lot only the signs of established serious retinopathy but
2 9 0
a l s o  t h e  w a r n i n g  s i g n s  o f  i m p e n d i n g  s e r i o u s  r e t i n o p a t h y .
It would theoretically be possible for all patients 
attending a diabetic clinic to be screened for serious reti­
nopathy on an annual basis by the physician responsible for 
the care of the patients. It has been calculated that such
a screening programme would necessitate the appointment of 
one additional physician per million population but the 
increased costs would be likely to be offset by financial 
savings to the community of about three t i m e s  the cost 
of the screening programme (Foulds et al 1983). Any 
such screening programme carried out by diabetic 
physicians would only be practical if the physicians 
concerned had been adequately trained in ophthalmoscopy 
and in the assessment of retinal abnormality. Such 
a screening programme would only be of value if backed up by 
an ophthalmology department having facilities for the 
further investigation and treatment of patients believed by 
the physician to have a serious retinopathy.
For patients cared for in general practice the problem 
is greater. Individual general practitioners have relati­
vely few diabetic patients under their care and it would be 
impracticable to expect all such practitioners to develop 
(and maintain skills in the early identification of estab- 
ished or potentially serious retinopathy. The British 
'iabetic Association may undertake the responsibility of 
ncluding a course on the ophthalmoscopic evaluation of 
iabetic eye disease in the training programme for general 
jract itioners and no doubt this would be a useful adjunct 
the detection of diabetic eye disease among patients 
tending either hospital clinics or being cared for
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in general practice (Thorn and Watkins 1982; Thorn and 
Russell 1973; Malins and Stewart 1971).
The role of Ophthalmic Opticians in the detection of 
diabetic eye disedbe is one that requires clarification.
The use of opticians to conduct ophthalmological screening 
of diabetics is a possibility. Such personnel are suitably 
trained in their undergraduate and pre-registration years. 
Calculations show that the use of hospital based opticians 
for the screening of diabetics would show a cost benefit 
ratio of 1:6 (Foulds et al 1983). Recruitment of 
opticians to the hospital service may however prove 
financially unattractive. There seems little doubt that 
ophthalmic opticians outside hospital practice could 
play a role in diabetic screening particularly for those 
patients not attending hospital clinics but the cost benefit 
ratio based on the standard capitation fee paid by the
General Ophthalmic Services would be reduced to at worst
1:1.
Doubtless some diabetic patients are more at risk of 
retinopathy than others. Unfortunately the younger symp- 
tomless patient is most at risk of the severest blinding 
form of the disease. In addition those with late onset 
[diabetes may go many years without trouble but the gradual 
[onset of this form of diabetes and the difficulty of exactly 
afing its onset results in many such patients presenting 
ith established eye disease not long after their diabetes 
as been diagnosed.
F o r  a l l  t h o s e  r e a s o n s  a  y e a r l y  s c r e e n i n g  o f  d i a b e t i c s
l o r  e y e  d i s e a s e  h a s  m u c h  t o  c o m m e n d  i t .
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Screening programmes need to be simple to be effective 
and as a matter of pragmatism a general ocular screening of 
all diabetics has much to commend it. On grounds of cost 
effectiveness alort'e it can be easily defended.
In this discussion the beneficial aspects of laser 
treatment in relation to the prevention of blindness have 
been stressed. Laser therapy is however a destructive form 
of treatment and will undoubtedly be replaced by more phy­
siological forms of therapy in due course.
No one at present doubts the efficiency of laser 
therapy in preventing a significant (at least 60 percent) 
amount of blindness among diabetics (Diabetic Retinopathy 
Study 1976; Cheng 1979; Lawson et al 1983). Recently 
however the possible deleterious effects of light on retinal 
function and structure have raised doubts about the safety 
of laser therapy. Contrary to this the work reported in 
this thesis (Chapter 11) on the short term effects of laser 
or of slit lamp illumination on various aspects of visual 
function have been reassuring.
In clinical practice occasional instances of untoward 
reaction to laser photocoagulation are seen. These include 
[temporary choroidal or retinal detachment, macular oedema, 
lacular pucker, temporary myopia, shallowing of the anterior 
:hamber, elevation of intraocular pressure and uveitis. In 
leneral these effects are short lived but permanent macular 
:hanges from oedema or pucker do occasionally occur. It is 
lossible that suitable fractionation of the laser dose may 
leduce the incidence of these complications.
2 9 3
The inadvertent photocoagulation of the macular retina 
is an occasional accident and its occurance stresses the 
need for all ophthalmologists using the laser not only to be 
adequately trained" in the use of this potentially dangerous 
instrument but to be conscious continually of fundal land­
marks and to be ever watchful and attentive during its use.
We look forward to the day when more efficient and 
natural treatment of diabetes will obviate the development 
of retinopathy and render laser and similar treatments obso­
lete, Until that day, it behoves us to do all we can to 
detect retinopathy in its early treatable stage and to apply 
the treatment we have available in the most efficacious and 
efficient way that we can.
2 9 4
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Error scores 
No Back Exud-
Normal retino- ground ative
subjects pathy retinopathy retinopathy
Proli fer- 
at ive 
retinopathy
96 96 106 334 58
104 84 142 28 8 68
80 152 136 440 336
98 128 244
76 66 78 5 28 28 4
80 74 388 252
84 84 66 192 136
64 222 112
76 104 58 164 502
108 482
152 88 228 128 118
108 212 322
102 68 104 144 228
104 94 88 192
72 88 98 344 78
66 102 102 29 8 56
68 164 17 8 402 60
78 132 200 384
82 58 88 112
90 72 134
22 222 28 6 76
34 18 6 84
114 74 304 140
96 90 356 104
56 102 102 28 6
140 262
134 100 68 248
152 94 270
198 78 19 8
162
112 114 184
106 212
3 0 6
N u m b e r  o f  e y e s
2 4  27
Number of subjects 
14 16
27
16
15 29
16
Appendix 2. Individual total error scores of diabetic and
non-diabetic subjects tested for colour vision.
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i c i Ni NDi Nl  I N S T I T U T E  O F  O P H T H A L M O L O G Y  
U N I V E R S I T Y  O F  G L A S G O W
>epartnt€nt
so R  W. S. F o u l d s
We s t e r n  I n f i r m a r y  
G l a s g o w  G i i  6NT.
TEL: 041-339 8822.
EXT. 640.
Date as post marked
Dear Sirs ,
I am currently preparing a Ph.D. Thesis on some aspects of 
diabetes-induced blindness and diabetic retinopathy in the 
west of Scotland under Professor W.S.Foulds' supervision .
To this end I wonder if you would be kind enough to send me 
any information relating to the common causes of blindness 
and the prevalence of diabetes and diabetic retinopathy in 
your Country/Province/Area or any other information that you 
night think helpful in relation to my work .
C should be very grateful for your cooperation in this matter
Yours faithfully
Issara M.Ghafour
Appendix 3. The letter which was sent to different 
Societies and Authorities involved in 
the epidemiology of diabetes and blind­
ness in some countries .
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WOODSIDE HEALTH CENTRE
I.M.Ghafour
Name
Age
Sex
Duration of diabetes 
Treatment 
Family history 
Smoking 
Treating body 
Blood pressure( Sitting ) 
V.A.R ~ Distant 
Reading 
iV.A.L - Distant 
Reading 
Eye condition 
Right 
Left 
unduscopy
Right 
Left
andom blood sugar
bAlc
Referral
omment
Appendix 4 . Form used for collection of data 
at Woodside Health Centre .
309
0-4 5-15 1 6-44 45-64 65 + Total
1 19 365 1975 ■ 838 549 3890
.9) (47.4) (50,4) (55.4) (47.4) (35.2) (49.0)
132 359 1590 930 1010 4047
1) (52.6) (49.6) (44.6) (52.6) (64.8) (51.0)
70 251 724 3565 1768 1559 7937
.9) (3.2) (9.1) (45.0) (22.2) (19.6)
|R 65 YEAR OLDS AT WOODSIDE HEALTH CENTRE ARE : 5366 OUT OF 
{ 14.1 per cent ).
Appendix 5, Age and sex distribution of patients 
on Woodside Health Centre practice 
list.
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GLASGOW ROYAL INFIRMARY I.M.Ghafour
Name
Diabetic clinic number
Age
Sex
Duration of diabetes 
Treatment 
Smoking habit 
Blood pressure 
Visual acuity
Right 
Left 
Eye abnormality 
Right 
Left
Funduscopy (Describe) 
Right 
Left
Referral
Comment
Appendix 6. Form used for collection of data 
at Glasgow Royal Infirmary .
31 1
Duration (years) ,, Male Female All
0-1 43 46 89
l'*'-2 18 ' 25 43
2^-5 43 50 93
5^-10 41 47 88
10^-15 23 19 42
15^-20 5 8 13
20^ " 17 15 32
Total 190 210 400
Appendix 7. Known duration of diabe
and numbers of patients among 400 
diabetic patients studied at Glasgow 
Royal Infirmary .
3 1 2
Duration(years) Diet O.H.A. Insulin
0-1 43 39 7
1^-2 1 8 20 5
2^-5 24 52 17
5^-10 9 44 35
10^-15 3 12 27
15^-20 1 2 10
20*^ 3 4 25
Total 101 173 126
Appendix 8. Numbers of patients on different 
types of treatment . The total 
number is 400 patients studied at 
Glasgow Royal Infirmary .
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Patient No. Sex Age at registration Age at onset
1 M 68 65
2 " M 72 71
3 M 58 58
4 M 82 82
5 M 29 29
6 F 67 63
7 F 79 79
8 F 78 78
9 F 50 48
10 F 69 69
11 F 78 77
12 F 70 65
13 F 21 21
14 F 39 39
15 F 66 65
16 F 57 57
17 F 75 75
18 F 64 64
19 F 73 73
20 F 64 64
21 F 61 60
22 F 67 62
23 F 59 47
24 F 75 73
25 F 66 66
26 F 57 53
27 F 59 59
28 F 78 78
3 1 4
29 F 68 68
30 F 83 83
31 " F 70 69
32 F 75 74
Appendix g ^ Sex, age at onset, and age at registration of 
32 legally blind diabetics ( 1980).
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..........................................................................  B.P.1
CERTIFICATION OF PERSONS W H O  ARE EITHER ( I )  SO BLIND AS TO BE 
UNABLE TO PERFORM ANY WORK FOR WHICH EYESIGHT IS ESSENTIAL,* OR        ' I ............................
( 2 )  SUBSTANTIALLY A N D  PERMANENTLY HANDICAPPED BY DEFECTIVE VISION 
PARTICULARS OF PERSON, A N D  FORM OF MEDICAL CERTIFICATE
i t h o r i t y ...................     D a te  of  a pp l i c a t i o n .
le.....         ;.....................
r e s s  ............................. ...................................................... ....................................................................
ige  o f  a d d r e s s .
p a r t  I — p a r t i c u l a r s  OF PERSON 
© a t e  g f  B irth . , . ,   .......   S e x .
[arried (ji) Single (hi) W idowed -
gatpgpry applicable) '
jipn in h o u s e h o ld = ^ ( i )  H e a d  (Ü) M e m b e r  o f  fa m ily  (iii) L o d g e r  
efliegory applicable)
»er o f dependants and their relationship 
ip§Fson;=^
adults  ... .....................................
}) ehiWren under 16, .............. ....................................................................
leeupatipn befere vision began to fa i l  ..... .............................. .........................
of any o ther occupation before vision
in to  fail,!!!»t.tt>ttirftftt,ttrttnftrittrrfrr,tf   ...... .
N ature ef any w ork undertaken since 
t o n  failed;  ............   ê........................................................
w hether w ork  l§ still being carried on.
[r willing to  u n d e r g o  a c o u r s e  o f  
lical tra in in g  :
|o ,.w hether application already m ade to. 
local authority; 
education authority; "pr
departm ent o f  E m p lo y m e n t
receiving injury ,or d isa b le m e n t  
u n d e r  N a t io n a l  'Insurance (Indus- 
U uries)  A c t ,  1946
kr relevant inform ation
3 1 6
;.V.qn. UlWiici* çonlAlned 1% Wï4(vft U  llic N.UlenjI A iiM ancc Acl, IV-IO.
a c u ity —
u n aid ed  ...................................
with correcting g lasses ...
both eyes —  best direct 
vision after correction ....
RIGHT EYE LEIT EYE
(also ring appropriate category—(1) less than 3/GO; (2) less than 0/60; 
(3) less than G/3G; (4) loss than 0/18;
(5) 6/18 or more.)
f vision ..................
1, Nil 4. Central scotoma 
g category applicable) 2. Less than 10® 5. Hemianopia
3, Contracted 6. Good
orbit, m u s c le s ,  tension
g m u s ,  etc. .... ...........................................................................
1. Nil 4. Central scotoma
2. Less than 10* S. Hemianopia
3. Contracted 6. Good
1
ciliary body .... ...........................................................................
f
I'Ve ..................................................'................ ....................................
DIAGNOSIS
far disease producing  
«S /  substantial and
icnt defect o f  vision (1 )  ............................................................... (D...
ion s  a n d  s e q u e la e (2 )  ........................... ............................... ( 2 U
fa r  d i s e a s e s (3) ................................... :......... (3)...
la in  ocular disease (4) .......................... .................... (4)...
^ e  t r o u b le  .................... A g e ............................................................... A g e
&) b l i n d n e s s * .................... A g e ............................................................... A g e
S u b s t a n t i a l  an d  p e r m a -
# c t  o f  v i s i o n * .................... A g e ............................................................... A g e
remediable
P RO GNOSIS (R in g  c a te g o r y  a p p licab le )
2. Likely to deteriorate 3. Stationary 4. Likely fo impfdvd
HISTORY (R in g  c a teg o ry  a p p licab le )
I1Ç TREATMENT—
»ne
amenable to treatment i
^atmcnt refused (including refusal to 
complete full course of treatment) 
lEFECT IN PARENTS OR RELATIVES 
known 2. No
IINITY OF PARENTS
2. No
4. Treatment accepted and still being giVert
5, Treatment completed—successful 
G. Treatment completed—failed
7. Not known
3, Yes
known 
ILITIC TREATMENT 
known
3. Yes (state relationship).
2. No 3. Yes
R E C O M M E N D A T I O N S  ( R i n g  c a t e g o r y  a p p l i c a b l e )
■NT OR CONTINUATION OF TREATM ENT RECOMMENDED?
2. Medical 4. Optical
3. Surgical ' 5. Inadvisable on medical g rounds
tATMENT PROBADLY CURE OR PREVENT *BLINDNESS/DEFECT OF VISION?
2. Yes 3. Doubtful
[NATION NECESSARY, AND AFTER W H A T  INTERVAL?
2. Yes In te rva l ..........................................................
)f the  applicant being employable, can  you indicate—
|liv iiy  considered unsuitable  (e.g., s tooping, the lifting of heavy  weights) .................
rivity th a t  is part icu larly  su itable  (e.g., a si tt ing  job, possibly handling
[natcrial,  for a g laucoma patient with small fields and good centra l vision) .................
uigc of pre.sent occupation is d e s i r a b l e ...........................................
pigc of form.
( Rliig ta'uooi^r
lUCHtLVt
illIdUirdct
twalfd lent
raymut
■lyupli
itltaltnoi
)li(lt,tlnioi
ulhalmot
It
nlwn
nds of the eyeball
uiicUva; Inflantiiuilory d lieatet 
Dttcllvj: EiiL'iitI.il itirlnkayc, etc, 
and lia r  lue: )iillaiiiin<itury d lieaiet 
luruly^li
a: liillammatory ditcates 
ca; Utccijitve keratitis 
:a: in lm tl i la l  keratitis 
:a: Other diseases 
:al Dystrophies 
i-a; Keratoconus 
cyclitit
ihthalm llis, panophthatmltli 
itheilc ophlliatmia 
iental fibroplasia
ipalhy, exudative; Neoro-retlnopathy
patliy, cintrai exudative (disciform)
rative rctinapaih/: Retinitis pigmentosa, k it,
macular degeneration
icolar haemorrhage
on retinal artery
on retinal vein
Culltls retinae; Eales' disease 
ascular diseases of the retina
130
110111
112 
j;.(i 
ICO 
100 
loo
}%
210
221
220
230210
ibt)
200
290
310
n s
320
0
1
2
3
Ê
Detachment of retina
Churoldai atrophy— not myopic
Clyi a le  alruphy: Cliutolduraeniia
Central tmacular ) atiuphy
Optic nerve .iiiupliy anil neuritis
Iteliobullrar neuriiis and toxic arhblydplh
Tiiniutrrt ocular aJiicxa
Tiiniour; Intro ocuhir Indeiermlnalt
Clioiuld.il tumour, primary
Cli.iiuidal tumour, sicoiidarÿ
(teiliMl luiiifiiir
Caiaraci— not congenital
Aphakia (surgical)
Otslocated lens 
Other lens anumallct 
Myopia
Normal eye and refractive error», not myopik
èlaticoma, primary 
Nystagmus
Cortical and trac t lesion's 
Amblyopia ex anopsia (Amblyojilà frôA 
functional disiiirhaiices 
Indeterminate conditions 
Others
. . „  , CO M PÙ tA trÔ lft
No complications
Corneal opacity or slaphylofhà
Occiuslo, Secluslo
Secondary cataract
Detachment of the retlftâ
Choroidal-retinal diseasè
Optic nerve atrophy
Enucleated eye: PliUilsIs BttIM
Secondary glaucoma .
Others, Including conjunct (vit and bfephàHm
CAUSES OP IVÊ DEPICTS
NOTES.— (a )  Ring category teaiégorleil applltàble. Indicating htâlôh caust by (1 ) and other cause. If any, by ( è K  
■ (b ) Where cause It not ipecllied In appropriate catcgéry Insert particulars In blank bracket provldefk
Ü
àlO  traum a, category not ascertained 
350 Sympathetic ophthalmia 
360 Chemico-loxic 
400 Scheduled Industrial d isé istt
Bi s y s t e m ic  d is e a s e s
50d Anaemia and blood diseases
501 Haemoirhage
502 Pernicious anaemli
503 Leukaemia 
Polycythaemia
AND UNDETERMINED 
al anomalies 
files, etc.
If globe and orbit
prs of refraction 
primary 
I primary
ed maternal Infection 
I Rubella 
iToxoplasmosts 
îthers. ( ........ ..........
i m
[AND TOXIC 
N eonatorum  
Sonococcal 
Inclusion body 
V h e rs  ( .......
Ither virus Infections ( .  
I f  outer coats of eye 
Specify. ................ .
,y 111
Igenltal 
acquired 
lins 
laslcs 
lallpox 
|u s  Meningitis 
encephalitis 
Ipes ophthalmicus 
|pes febritis
III
IN
.)■ IQ?
vttlons 
Uheria 
kict fever
|lngococcal meningitis 
nteningltls
meioroal infections not specified.. 
Itrumous, etc. 
lemla, etc.
CHEMICAL
raiima
Ihold accidents 
pr sport
: or transportation
lal, surgical or radtatlonal procedures. 
Iiflicted
u
la ?
-201 
I 202 
• 203 
204
Itural
(...
le  service: d irect 
Inal
.....
I
317
321
322
325
326 
) 327
333 
331 
. )  335
108
110
120
m
150
IE
iC S
ËS
270
200
30(5
310
32(5
330
504
505 Others (.
$18 blabetes
511 Hyperthyroidism
512 Lipoidosis
513 Other endroclne and metabolic diséâsts
• . (   .............
520
530
540
550
S60
570
6Ç0
49:
620
630
610
650
Nephritis
Disease of pregnancy and chlldblftf) 
Vascular diseases ' '
511 Essential hyperterisloA
542 Arteriosclerosis
543 Cerebral arterio-iclerôtis
544 Others ( ............................
Intracranial neoplasm
Disease of central nervous systeiri 
' 561 Disseminated sclerosis
562 Tabes
563 Other syphilis
564 Hydrocephalus
565 Friedreich's ataxia
566 Brain abcess
567 Others ( ............................
Functional Diseases
571 Hysteria
572 Malingering 
573 . Others ( , ;
A rthritic atfectlons 
'6 0 1  ' Rlieurnatold
6Ô2' Sponrfylltls ' 
603 Others
Disease of Bony System
611 Oxycephaly
612 LConiiosIs ossea
613 Others
Nutritional deficiency 
Diseases ol skin 
‘631 Acme rosacea 
Pemphigus 
Sclcrodenna 
ktilhyosts
Epidermolysis bullosa. 
Others ( ........ ............
632
636
Phakomatoscs 
Mesodermal syndromes 
651 ArachnorJactyly
602 fhislosls dyslrophlca
653 Laurence Moon-Deldl
654 Others ( ..................
£ 700 NOT CLASSIFIED OWING TO LACK OF DATA
F ,800 NO DEFECT (Normal eye)
G 900 (If category If not sufficiently specific, s tate
,
1 603.
.)• 612
I
635 
. )  ' 636
til
cause
any other 
 )
m .
619
62Ô
630
658
700
000
318
1. iNone
2. McuuU defect
3. Deafness
See NOTE a t (oot of first page of form.
4. ueai-miitism
5. D efects of hands and  arm s 
G. D efects of low er lim bs
7. F its
8. General disease (specify further if possible)
9. O ther
CERTIFICATE
IF AN ADULT, IS THE PERSON SO BLIND AS TO BE UNABLE TO PERl-’ORM 
ANY WOlUC FOR WHICH EYESIGHT IS ESSENTIAL? (Write "Yes" or "No")
IF UNDER 16 YEARS, IS THE PERSON SO BLIND AS ONLY TO BE CAPABLE 
OF EDUCATION BY METHODS SUITABLE FOR CHH.DREN WHO HAVE 
INSUFFICIENT VISION TO BENEFIT FROM EDUCATION AS PARTIALLY 
SIGHTED? (Write "Yes" or "No") ........................................................................
NOT SO BLIND AS TO BE UNABLE TO PERFORM ANY WORK FOR WHICH 
ESIGHT IS ESSENTIAL,
is the person substantially and permanently handicapped by defective vision? 
(Write "Yes" or “No”) ............................................................................................. .
if so, Is the handicap due to—
1. Congenital defect? 2. Disease or injury? (Ring category applicable) ....
is the person, if under 16 years of age,
1. Likely to become, before reaching that age, so blind as to be unable to 
perform any work for which eyesight is essential? (Write "Yes" or "No”) ....
2. Likely to benefit by class for visually handicapped? (Write "Yes” or "No") ....
|or is the person, if 16 years of age or over, likely to become so blind as to be un- 
lable to perform any work for which eyesight is essential (Write "Yes” or “No")
|f in the affirmative, is blindness likely to occur so soon, or is the nature of the 
fisual defects such, that the person would benefit from training for employment 
)r other services appropriate to blind people? (Write "Yes" or "No") ...............
(1) Signature
(2) Signature
Ophthalmic Surgeon
Ophthalmic Surgeon
PART -FURTHER NOTES
PES OF EYE INJURY
defect is due to industrial or non-industrial trauma;—
I Precise occupation at time of onset .... ......................... ..
[Description of accident, including nature of object striking eye or
*##« •••• •••• ##,#
‘RMAN TEST
)ate specimen ta k e n ........................................................................
tcsult ("Positive" or "Negative") .......................................
LCtion taken in positive cases ..................................................
No. of Specimen
lENT
ACTION TAKEN O N  RECOMMENDATIONS.AND REGISTRATION FORM 
(If no action necessary, write “Nil” across item)
EDUCATIONAL TREATMENT
when reported to education authority ............................■ ...............
fR EDUCATION, TECHNICAL OR PROFESSIONAL 
/hen reported to (a) local authority ..................................................
(b) education authority ......................................
(c) Department of Employment and National Service 
riNATION
il 1^ u 1 n tc 1^ .... .... .If. .... .... .... .... .... ....
X 10.
ANY OTHER RELEVANT INFORMATION 
T h e  F o r m  B P l .
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C a u s e T h e  y e a r  1 9 6 0 T h e  y e a r  1 9 8 0
Cataract 22.2 10.4%
Myopia 14.2 6.0%
Senile macular 
degeneration
External eye 
disease
9.8
7.4%
29.8%
2.8
Glaucoma 9.2% 14.6%
Diabetic retinopathy 6.8% . 5%
Optic nerve 
atrophy
4.9' 4.5%
Appendix A comparison of the leading
causes of legal blindness in 
the years 1960 and 1980(West 
of Scotland) .
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Contrast sensitivity in diabetic subjects with and 
without retinopathy
I. M . G H A F O U R ,'  W . S. F O U L D S ,' D . A L L A N ,*  a n d  E . M cC L U R E '
From  the ^Tennent Institute o f  Ophthalm ology, University o f  Glasgow, and the
^West o f  Scotland Health Boards, Departm ent o f  Clinical Physics and Bio-Engineering, Glasgow
S U M M A R Y  T h e  c lin ic a l u s e fu ln e s s  o f  th e  A r d e n  g ra tin g  te s t  in  a s se s s in g  e a r ly  a b n o r m a lit ie s  in 
r e t in a l  fu n c t io n  o f  d ia b e t ic s  h a s  b e e n  e x p lo r e d . A lth o u g h  th e  te s t  r e v e a le d  s ig n ifica n t d if f e r e n c e s  in 
c o n s t r a s t  s e n s i t iv i t ie s  b e t w e e n  d ia b e t ic s  an d  n o r m a l p e r s o n s , th e  la r g e  v a r ia n c es  in th e  te s t  s c o r e s  o f  
d ia b e t ic s  lim it  it s  u s e  a s  a c l in ic a l t o o l  fo r  th e  s c r e e n in g  o f  d ia b e t ic  p a tie n ts .
D iabetes is said to be associated with detectable 
alterations in colour perception before the 
developm ent of ophthalmoscopically detectable 
retinopathy.' The Arden grating test* is claimed to 
d etect disturbances o f retinal integrative function 
even  when acuity is normal. The test was used to 
assess whether it was o f clinical value in detecting 
early abnormality in retinal function in diabetic 
subjects without retinopathy or in those with 
established retinopathy and whether it was useful in 
differentiating serious from not serious retinopathy.
M aterials and methods
T he test was carried out as described by Arden and 
Jacobson* except that standard artificial daylight was 
used (Verivide Cabinet, Leslie Hubble Ltd). Plates 
w ere presented at a standard distance o f 57 cm and 
each eye was tested separately. The test was used in 
80 normal subjects (age range 24 to 68, mean age 46, 
m edian age 45 years) and in 99 diabetic subjects (age 
range 27 to 70, mean age 47, median age 49 years). 
T he ages o f the 2 groups o f subjects were comparable 
(p>0*5, M ann-W hilney nonparametric test). Forty- 
two o f  the diabetics had no detectable retinopathy on 
ophthalm oscopy. Twenty-two had background 
retinopathy, that is, scattered haemorrhages, micro­
aneurysm s, and a small number o f hard exudates with 
retention o f  normal visual acuity. Twenty-nine 
patients had proliferative retinopathy as evidenced by 
disc or other new vessels. The visual acuities among
Correspondence to Professor W. S. Foulds. Tennenl Institute of 
Ophthalmology. Western Infirmary. Glasgow G 11 6NT.
patients with proliferative retinopathy ranged from 
6/5 to 6/36 with a mean level o f 6/9 and a median of 
6/9. For analysis only one eye (the right) was used 
from each patient tested.
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Fig. I Mean contrast thresholds on Arden grating test for
normal persons. (_____ ) Our controls. {_______ ) Arden
and Jacobson normal persons.
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■ Table 1 A comparison o f  mean contrast thresholds for Arden and Jacobson’s normals, our controls, all diabetics, and 
different groups o f diabetic patients. Standard deviations are shown in brackets
Plate 2 3 4 .9 6 7
A rden’s figures (SD =2) 11-50 10-00 11-50 11-50 10-00 9-00
M ean readings o f our normal subjects 11-96 10-26 11-33 10-90 9-08 9-19
(2-27) (1-89) (2-08) (1-98) (2-25) (2-56)
M ean reading of normal subjects n-% 10-26 11-33 10-90 9-08 9-19
(227) (1-89) (2-08) (1-98) (2-25) (2-56)
M ean reading of 99 diabetics 13-42 11-17 13-37 13-73 13-91 15-80
(3 72) (3-39) (3-54) (399) (6-39) (7-31)
Normal 11-96 10-26 11-33 10-90 9-08 9-19
(2-27) (1:89) (24X8) (1-98) (2-25) (2-56)
‘No retinopathy ' diabetic group 12-86 9-53 11-73 11-60 12-40 13-26
(4 03) (2-99) (3-32) (3-50) (7-28) (8-07)
Norm al controls 11-96 10-26 11-33 10-90 9-08 9-19
(2-27) (1-89) (2-08) (198) (2-25) (2-56)
‘Background* retinopathy group 13-60 12-00 13-33 13-13 12-66 14-86
(2-87) (2-23) (3-06) (2-64) (4-33) (5-20)
‘Proliferative’ retinopathy group 13-80 12-00 15-06 16-46 16-66 19-26
(4-31) (4-22) (3-65) (4 18) (6-65) (7-43)
L 5
P la te  num ber
Fig. 2 Mean contrast thresholds for: (- J Our
normals. ( ) Arden and Jacobson’s normals.
(............ ) A ll diabetics. The vertical bars mark ±2 SD limits
fo r our normals.
R e su lts
T he mean contrast thresholds for normal and diabetic 
subjects for each o f  the 6 plates o f differing spatial 
frequency used are shown in Table 1 together with the 
relevant standard deviations, as also are the mean 
normal values quoted by Arden and Jacobson.*
In general, for normal subjects our results for each 
plate were in agreement with those o f  Arden and 
Jacobson (Fig. 1) except for plates 5 and 6, where a 
significantly lower threshold was found for our normal 
subjects (p<0*001, each plate).
W hen the results for the 99 diabetic patients were 
com pared with our normal results (or with those pub­
lished by Arden and Jacobson), a significantly higher 
mean threshold was found for each plate (Fig. 2). 
W hen the results for our normal controls (Fig. 3) 
were compared with those from diabetic subjects 
without retinopathy, a significant increase in the 
threshold was found for the higher frequency plates 6 
and 7 (whereas with Arden’s control values a 
significant difference was also found with the low 
frequency plate number 2).
A s would be expected, the results from our normal 
controls differed significantly from those obtained  
from patients with either background retinopathy or 
proliferative retinopathy (Fig. 4), as did the same 
results when Arden’s control data were used.
W hen the various grades o f retinopathy within the 
diabetic group were compared, the results were less 
clear-cut, though significant differences were found.
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Fig. 3 Mean contrast thresholds for: (_____ ) Our
normals. (----------- ) 'No retinopathy’ group. ± 2 SD limits
fo r  the normals are shown.
P la te  n um b er
Fig. 4 Mean contrast thresholds for: (_____ ) Our
normals. (----------- ) ‘Background’ retinopathy group.
(.......... ) ' Proliferative’ retinopathy group. ± 2 3 0  limits for
normals are shown.
T hus the results for patients with diabetes but without 
retinopathy were significantly different in plates 3, 4, 
and 5 from those with background retinopathy and in 
all plates except plate 2 when compared with results 
from patients with proliferative retinopathy. Even 
when background retinopathy was compared with 
proliferative retinopathy, this latter group showed 
significantly increased thresholds for plates 5, 6, and 7 
as com pared with the former group. The results of the 
above comparisons are summarised in Fig. 5. The 
com parisons were made by a modified t test, 
applicable to cases with unequal variances.
It is worth noting that unlike the control group, in 
which the variance for each plate was similar (S D =  
1*89 to 2 56), in all the diabetic groups the variances 
tended to be greater than in the controls, and 
particularly when higher frequency plates were used. 
A n F test was used to asses§ whether the increased 
variance was significant, and significant values are 
m arked with an asterisk in Fig. 6.
Discussion
Our results with the Arden grating test in normal
subjects show a lower threshold for plates 5 and 6(1*6  
cycles/degree and 3*2 cycles/degree respectively) 
than those previously published by Arden and 
Jacobson^ but are in agreement with figures recently  
published by Singh et al.^ The results o f the Arden  
grating test are to som e degree age-related,"* and the 
difference may reflect a different age com position in 
Arden and Jacobson’s material and our own.
It is of interest that diabetic patients without 
retinopathy show increased thresholds at the higher 
spatial frequencies tested, which suggests that the 
functional deficit for these frequencies may precede 
ophthalmoscopically visible retinopathy.
Even within the group o f diabetic patients 
increasing severity o f retinopathy (background versus 
proliferative) was, as might be expected, associated  
with a decreased contrast sensitivity to grating 
patterns and an increasing variability in results, 
especially for plates o f high frequency content.
Unfortunately the relatively large standard devia­
tions in the groups affected by retinopathy resulted in 
considerable overlap between groups, so that the-test 
was not found to be clinically useful in separating 
individual diabetic patients into serious or not serious
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Fig. 5 Summary o f  the comparison o f  mean contrast 
thresholds. Differences significant at the level o f  at least 
p=0'05 are indicated by*.
categories o f  retinopathy. The test is, however, easily 
carried out and in conjunction with other findings 
may be useful in the assessment of the functional 
status o f  the eye in diabetic patients.
W e  thank Miss F. Maitland for secretarial assistance and Mr F. 
Addison for the preparation of the illustrations.
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Common causes of blindness and visual handicap in the 
west of Scotland
IS S A M  M . G H A F O U R ,' D O N A L D  A L L A N ,=* a n d  W A L L A C E  S. F O U L D S '
From the ^Tennent Institute o f  Ophthalmology, Glasgow, and the ^West o f  Scotland Health Boards,
Departm ent o f  Clinical Physics and Bio-Engineering, Glasgow
S U M M A R Y  A n  a n a ly s is  o f  b lin d  reg istra tio n  fo rm s w a s m a d e  to  d e ter m in e  th e  c o m m o n e st  c a u se s  o f  
b lin d n e s s  in  th e  w e s t  o f  S c o tla n d . It w a s fo u n d  that th e  lead in g  ca u ses  o f  b lin d n ess  in  o r d e r  o f  
fr e q u e n c y  o f  in c id e n c e  w e r e  s e n ile  m a cu la r  d e g e n e r a tio n , g la u co m a , ca taract, d ia b e tic  r e t in o p a th y ,  
a n d  m y o p ic  d e g e n e r a t io n . D ia b e t ic  r e tin o p a th y  w a s th e  lea d in g  ca u se  o f  b lin d n ess  a m o n g  p e r so n s  
o f  w o r k in g  a g e .
In the UK all persons with legal blindness— that is, 
those whose vision is too poor to allow work for which 
eyesight is necessary (in general a corrected visual 
acuity o f less than 3/60 in the better eye or a visual 
field o f less than 10°)— may be placed on the blind 
register by having a certificate of blind registration 
com pleted by an ophthalmologist (Form B Pl in 
Scotland and Form BD8 in England). Persons who 
have a permanent and significant visual handicap as 
the result o f a congenital defect, an injury, or disease 
(in general a vision of 3/60-6/60) may be similarly 
registered as partially sighted.
Analyses o f the predominant causes of blindness 
have been performed for a number of countries, 
including England and Wales,' Sweden,^ and the 
United States o f America.^ In this paper a comparison 
is made between the causes of blindness in the west of 
Scotland and those reported from other parts of the 
world.
Materials and methods
Forms B P l for the year ended 31 December 1980 and 
returned to the Society for the Blind in Glasgow and 
the W est o f Scotland were studied. These forms relate 
to people resident in Strathclyde Region. This is the 
area covered by the area health boards of Greater 
Glasgow, Argyll and Clyde, Ayrshire and Arran, and 
Lanarkshire.
Seven hundred and seventy two visually handicap­
ped people were registered with the society during the 
year 1980. O f this number 125 forms, 16% of the
Correspondence to Professor W, S. Foulds, Tennent Institute of 
Ophthalmology, Glasgow G 11 6NT.
total, had to be excluded from further analysis 
because of lack o f essential information. These 
rejected forms contained nothing other than the name 
o f the ophthalmologist and person being registered. 
W e believe that the exclusions do not invalidate our 
findings; all the rejected forms came from one oph­
thalmologist in an area with no apparent abnormal 
incidence of causes of blindness, as assessed from a 
study of forms returned by other ophthalmologists 
working in the same area.
Patients with visual loss from cerebrovascular 
accident where visual loss was a homonymous field 
defect were classed as partially sighted for the purpose 
o f the study. In some instances ophthalmologists 
registered such patients as legally blind and in others 
as partially sighted. Because these patients in general 
retained a useful field o f vision, it was thought that the 
partially sighted category was the more appropriate.
Computer input was prepared from the remaining 
647 fully completed forms, summarising the most 
important data on the Forms B P l. The facts con­
sidered were the age and sex of the person, the visual 
acuity and the visual field for each eye, and the 
primary cause o f blindness for each eye. Both the age 
of the person at the time of examination for registra­
tion and that at which the visual handicap developed  
were noted. The data were analysed on the Edinburgh 
Regional Computer Centre ICL 2980 by means of 
som e o f the standard data handling facilities of the 
M INITAB program package.
For the purpose of analysis patients were divided 
into the following age groups 0 -4 , 5 -19 , 20-44, 
4 5 -6 4 , 6 5 -7 4 ,7 5 -8 4 , and 85+ . This age grouping has 
been used in a previous study.^
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Fig. 1 Numbers o f eyes registered blind classified by age: 
1 I by age o f registration: V ///A  by age at onset o f  
blindness.
Fig. 2 Numbers o f eyes registered blind per 100000 
population: ■ ■  for males; I J for females.
Results
The 647 completed Forms B P l were in respect o f 253 
males and 394 females. O f these, 138 males and 219 
fem ales were legally blind (total 357 or 55% ), The 
m ale-to-female ratio was 2:3 both for the total regis? 
tration and for the legally blind. The male-to-female 
ratio in the population as a whole is 1 :11  in the west 
o f Scotland.'*
Fig. 1 depicts the age distribution of the legally 
blind. Because registration usually takes place some 
time after the onset of blindness, the distribution for 
‘age at registration’ tended to be shifted to an older 
age than that for ‘age at onset.’ In fact the median 
tim e between the onset o f the visual defect and 
registration was one year. Some 64% of registrations 
were made within 2 years of the onset of blindness, 
but owing to the long tail o f the distribution times a
few registrations were made more than 20 years after 
the person became blind.
The peak incidence of onset of blindness occurred 
in the 75r-84 year age group, but there were almost as 
many whose onset of visual loss was between 65 and 
74 years o f agei. 30%, o f  all registrations fell within 
. qach o f  thes&2 age ^dups.- The incidence of registra­
tion reached a peak in the 75-84  year group with 33% 
o f  all legally blind registrations.
The data have been corrected for age on an 
actuarial basis by using the mid-1980 population 
estimates for Strathclyde Region.** The results are 
shown in Fig. 2, and it was found that, as expected, 
blindness became increasingly common with 
advancing age, and the incidence rose sharply around 
60 years of age. The corrected incidences are 
comparable for males and females, given the limits on 
interpretation set by the small numbers o f registra­
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Table 1 Leadingcausesof legal blindness for all ages and individual age groups, west of Scotland, 1980
No. of 
eyes %
No. of 
eyes %
Overall total Age group 45-64
t. Sen. mac. deg 213 29 8 1. Diab. ret. 22 18-6
2. Glaucoma 104 14 6 2. Sen. mac. deg. 17 14-4
3. Cataract 74 10 4 3. Glaucoma 15 12-7
4. Diab. ret. 61 8-5 4. Myopic deg. 10 8-5
5. Myopic deg. 43 6 0 5. Optic atrophy 10 8-5
6. Optic atrophy 32 4-5 a Ii others 44 37-3
7. Comeal opacity 20 2-8 Total 118 100-0
Alt others 167 23-4 Age group 65-74
Total 714 1000 I. Sen. mac. deg. 56 26-2
Under 5 years of age 2. Glaucoma 44 20-5
1. Optic atrophy 14 30-3 3. Cataract 24 11-2
2. Corneal and other postnatal infections 12 26-1 4. Diab. ret. 19 8-9
3. Prenatal cataract 8 17-4 5. Myopia 10 4-7
4. Cong, glaucoma, microphthalmos 8 17-4 All others 61 28-5
5. Tumour 2 4-4 Total 214 1000
All others 2 4-4 Age grottp 75-84
Total 46 1000 1. Sen. mac. deg. 103 47-7
Age group 5-19 2. Glaucoma 35 16-2
1. Ret. pigmentosa 6 42 8 3. Cataract 19 8-8
2. Optic atrophy— cong. 2 14-3 4. Diab. ret. 14 6-5
3. Myopia 2 14-3 5. Myopic deg. 10 4 6
4. Injury 2 14-3 All others 35 16-2
5. Cong, microphthal. toxoplasmosis 2 14-3 Total 216 100-0
Total 14 100-0 85 years of age and over
Age group 20-44 1. Sen. mac. deg. 37 48-6
1. Diab. ret. 6 20-0 2. Cataract 23 30-3
2. Myopia 6 20-0 3. Glaucoma 6 7-9
3. Optic atrophy 6 20-0 4. Myopic deg. 4 5-3
4. Uveitis 3 10-0 All others 6 7-9
5. Glaucoma 2 6-7 Total 76 100-0
All others 7 23-3 65 years of age and over
Total 30 100-0 1. Sen. mac. deg. 1% 38-7
2. Glaucoma 85 16-8
3. Cataract 63 12-5
4. Diab. ret. 33 6-5
5. Myopia 25 4-9
All others 104 20-6
Total 506 100-0
tions in some of the age groups. When the raw data 
for age at onset of visual defect for males is compared 
with that for females, it is seen that the recorded age 
of onset for females was about one decade later than 
for males.
Although no children in the age group 0 -4  were 
registered, subsequent registration revealed that in 23 
instances (19 males and 4 females) the onset of 
blindness was prior to age 5.
Data on the incidence of various primary blinding 
causes are presented in Fig. 3. The results are 
expressed in terms o f the number of eyes blinded by a 
particular cause. A  total o f 1240 eyes were considered 
of which 714 eyes were legally blind. Fig. 3 shows the 
overall ineidence of causes of blindess both for total 
registrations and the legally blind. The pattern is the 
same for both categories. It is clear that senile 
macular degeneration, accounting for about 30% of
the registrations, was by far the commonest single 
cause of blindness in our sample.
In Table 1 the incidence of various causes of 
blindness among the legally blind is broken down by 
age of the person at onset of blindness. It is seen that 
retinitis pigmentosa was the main cause o f blindness 
among the 5-19  year olds, but it appeared, if at all, 
only low in the ranking for all other age groups.
Diabetic retinopathy was one of the 3 first equal 
causes in the 20-44 year olds, the principal cause for 
the 45-64 years age group, the fourth most frequent 
cause for 65-74 and 75-84 year olds, but it did not 
occur at all as the blinding cause for any of the 78 eyes 
of the legally blind in the age group 85 years and over.
Senile macular degeneration first appeared among 
the 45-64 year olds and was the leading blinding 
cause in later years. It is interesting that of the 17 eyes 
blinded by senile degeneration of the macula in the
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SMD=senile macular degeneration.
45-64 year olds 12 eyes were in men and 5 in women.
Several differences in the pattern of blindness in 
the 2 sexes have already been mentioned, but others 
show up in the data. Table 2 shows the incidence of  
the different leading causes of blindness in males and 
females.
Discussion
The homogeneity of the population of the west of  
Scotland is greater than in some countries, and both 
environment and level o f health care are uniform over 
this region. The moderate number o f registration 
forms is handled by only a few staff o f the Society for
Table 2 Common causes o f blindness in males and females, west o f Scotland, 1980
the Blind in Glasgow and the West of Scotland, which 
helps to ensure precise recording and filing of the 
Forms B P l, and information can be extracted easily 
by one person, which again assists uniform 
interpretation.
Although guidelines are provided to aid the the 
ophthalmologist in deciding whether a patient should 
be registered ‘blind’ or ‘partially sighted,’ some 
subjectivity evidently enters into the decision. To 
minimise this problem the registered blind who 
satisfied the United Kingdom criteria for legal 
blindness were considered here. In some previous 
; analyses* no distinction was drawn between age at 
registration and age at onset of visual defect. In the 
present study the age of onset was considered the 
more useful of these 2 alternatives.
There are problems in comparing surveys of the 
blind. Even when objective criteria for blindness are 
used, comparison with other studies is difficult, 
because many different definitions of blindness are in 
use throughout the world; the World Health Organ­
isation accepts some 65 definitions of blindness.® To 
give one example of the differences, the legally blind 
in the USA are those whose corrected visual acuity 
for distance is 20/200 (6/60) or poorer in the better eye 
or with a field of vision not greater than 20® at its 
maximum. Such differences may differentially exclude 
or include particular conditions, and so comparison 
must again be made cautiously.
However, the data from the present study shows 
som e points which are worthy of comment. The male- 
to-fernale ratio o f 2:3 among all those registered and 
among the legally blind is to be expected because of 
the longer average life span of women and the 
demonstrated relationship between aging and 
incidence o f blindness. The absence of registration 
for those in the 0 -4  age group reflects not only a 
reluctance o f ophthalmologists to register as blind a 
young infant whose visual function may be difficult to 
assess, but also a more recently introduced policy of 
delaying registration in infancy.
Som e 10% of blind people were found to have 
differing primary causes o f blindness in their 2 eyes, 
but these conditions cover the whole range. Thus the 
percentage affected by a particular cause is about the 
same whether eyes or people are considered.
Males Eyes % Females Eyes %
1. Senile macular degeneration 62 22 5 I. Senile macular degeneration 151 34-5
2. Glaucoma 55 199 2. Cataract , 58 13-2
3. Optic nerve atrophy 24 87 3. Diabetic retinopathy 51 11-6
4. Cataract 16 5 8 4. Glaucoma 49 11 2
5. Myopic degeneration 11 40 5. Myopic degeneration 32 7-3
All other 108 39 1 All other 97 22-2
Total 276 100-0 Total 438 100-0
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Table 3 Comparison o f the important causes o f blindness in some countries
Country 1st cause 2nd cause 3rd cause 4th cause 5th cause
Scotland Senile macular 
degeneration
Glaucoma Cataract Diabetic
retinopathy
Myopia
England and Senile macular Cataract Glaucoma Myopia Diabetic retinopathy
Wales degeneration
U S A Glaucoma Senile macular 
degeneration
Cataract Optic nerve atrophy Diabetic retinopathy
Canada Senile macular Diabetic Glaucoma Optic nerve atrophy Cataract
degeneration retinopathy
Sweden Tapetoretinal 
degeneration of 
genetic origin
Diabetic
retinopathy
Optic nerve atrophy Uveitis Myopia
India Cataract Glaucoma Staphyloma Optic nerve atrophy Anophthalmos
If the figures for cataract and glaucoma are 
com bined, one finds that about a quarter of all legal 
blindness or severe visual handicap results from these 
2 conditions, the effects o f which are largely treatable 
or preventable respectively. It is encouraging to note 
that the figure of 10% of the registrations attributable 
to  senile cataract signifies an improvement since the 
time o f Sorsby’s survey,' when 23% of registrations 
were for this reason. The percentage for glaucoma 
has shown little change (14-6% for our data and 13% 
in Sorsby’s results).
It has been suggested that a tight control o f the 
diabetic state together with early treatment of pro­
liferative retinopathy with laser or xenon arc photo­
coagulation might prevent 60% of blindness from 
diabetes.® If this was achieved, some 8% of the blind 
registrations in the west of Scotland would be 
eliminated.
Thus about 30% of current registrations might be 
prevented by rigorous application of current treat­
ment techniques for cataract, glaucoma, and diabetic 
retinopathy. But a proportion of those whose sight 
was saved would subsequently lose vision from an as 
yet untreatable cause of blindness such as senile 
macular degeneration.
It has already been noted that diabetes is the 
com m onest systemic disorder causing blindness, yet it 
does not figure as a major cause of blindness among 
the 85 year olds. This evidently reflects the shorter life 
expectancy o f diabetics, and in addition many are 
blinded while still relatively young and so do not 
contribute to registrations in the older age groups.
Cataract is a more important cause of blindness for 
women than for men, again reflecting the longer life 
span for females. Diabetic retinopathy ranks as the 
third cause of blindness for females, yet it does not 
show among the first 5 conditions for men. This again 
might be a phenomenon related to life expectancy 
(Table 2).
C O M P A R I S O N  W I T H  O T H E R  C O U N T R I E S
As remarked earlier, there are many obstacles to
comparing the results of surveys such as this. With 
these reservations in mind, the pattern o f incidence of 
common causes of blindness is shown for several 
countries in Table 3. It is apparent that at least for 
developed countries'”®’ the same causes tend to 
appear among the leading 5, although the order 
changes.
A s an example of the problems of detailed 
comparison, one might speculate that the interchange 
o f  the order o f glaucoma and senile macular 
degeneration for the USA in comparison with the UK  
might be due to the different visual field criteria for 
blindness used in each. There is not sufficient 
information about visual fields on the Form BPl to 
analyse blind population data for the west of Scotland 
by the USA criteria.
The contrast between India (Venkataswamy 1981, 
personal communication) and the other nations is 
marked, but it is much what the differing social and 
medical care conditions would lead one to expect.
W e  wish to thank Mr D. Anderson and Mr S. J. Magill of the Society 
for the Blind in Glasgow and the West of Scotland and their staff for 
their help and co-operation during the conduct of this study. Our 
thanks are due also to Miss O. M. Rankin and Mrs J. Murray for 
secretarial services.
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Potential retinal light damage from the use of therapeutic 
instruments
N, M. McKECHNIE and I. M. GHAFOUR
From the Tennent Institute o f  Ophthalmology, University o f  Glasgow
Summary
The question of light damage to the retina occurring as a direct consequence of the use of therapeutic or diagnostic 
procedures is posed. It would appear from theoretical and experimental considerations that, in some instances, light 
damage may occur. This possibility is discussed with reference to the available literature and experimental work 
undertaken by the authors.
There exists in the literature a vast amount of evidence 
attesting to the damaging effects of light on the retina 
(Table I). The aim of this paper is to relate some of this 
experimental work to the clinical situation. Are, for 
instance, slit-lamp biomicroscopy of the retina or 
indirect ophthalmoscopy liable to produce retinal 
damage?
( I )  Possible causes o f  light damage
Light can produce an effect on the retina in three ways:
(i) Mechanically,
(i7) Thermally,
(Hi) Photochemically.
These types of damage are not mutually exclusive and 
areas of overlap exist between them. However, both 
mechanical damage and thermal damage are produced 
by irradiance levels and short exposure times which are 
beyond the scope of this paper. The type of damage 
which may result from the use of diagnostic instru­
ments clinically is photochemical and perhaps also 
thermally enhanced photochemical damage. The 
probable sites of photochemical damage are shown in 
Fig. 1.
The most obvious group of photosensitive molecules 
are the visual pigments. Experimental work on rhesus 
monkeys by Harwerth and Sperling (1971) has shown 
that particular classes of cone cells can be damaged by 
light of the appropriate wavelength, appropriate in this 
context being wavelengths which are close to the peak 
absorbance of the visual pigment of the damaged 
receptor cell type. Noell (1980) has postulated that light 
damage produced in rats exposed to low levels of 
fluorescent illumination is also mediated by a visual pig­
ment, in this case rhodopsin. The mechanisms postu-
Address for reprints: N. M. McKechnie, Tennent Institute of 
Ophthalmology, Glasgow.
lated include structural instability of the outer segment 
due to loss of rhodopsin (Noell, Walker, Kang, and 
Berman, 1966), or to a retinotoxic membranolytic 
action of free retinol (Noell and Albrecht, 1971). This 
type of damage would be mostly restricted to the outer 
segment. A third suggestion (Noell, 1980) is that light 
could initiate destructive oxidizing reactions in the 
retina. Photoreceptor discs are mostly composed of 
unsaturated fatty acids. Noell suggests that the action of 
light on the photopigments begins a series of reactions 
which result in the production of free radicals. These 
free radicals could initiate a chain reaction, which is un­
checked by the presence of antioxidants such as vitamin 
E and could proceed to the oxidization of the lipid mem­
branes (Feeney and Berman, 1976). Hayes (1974) has 
shown that cone outer segment damage occurs in 
vitamin E deficient monkeys. -
In addition to the photopigments, there are various 
other molecules which are photolabile and capable of 
producing free radicals. These include nucleic acids, 
specifically those containing adenine and guanine, some 
amino-acids, namely histadine, tryptophan, and tyrosine 
(Fowlks, 1959; Gallo and Santa Maria, 1972). It is also 
thought that melanin is capable of free radical produc­
tion and electron transfer to other molecules (Mason, 
Ingram, and Allan, 1960; Proctor, McGinnes, and 
Corry, 1974). Some photosensitizing drugs (pheno- 
thiazines, psoralens, and tetracyclines) can bind to uveal 
melanin (Potts, 1964a, b). This may enhance the 
damage produced by photochemical mechanisms.
(2) Appearance o f  light damage
The appearance of light-damaged retinal tissue varies 
with species and exposure regime. However, when 
relating experimental work to the clinical situation, it is 
exposure times, in the range of seconds to hours and 
retinal irradiances from milliwatts to hundreds of milli­
watts per square centimetre, which are of consequence.
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Table I Summary o f some o f the mq/or damage studies, 1966 to 1981
Authors Species Source
Estimated 
retinal 
irradiance 
(xlO-^ Wcm-^) Duration Maximum damage
Noell and 
others (1966)
Rat Fluorescent 3.3* 1 hr-2 days Receptor cells and retinal pigment 
epithelium gone
Friedman and 
Kuwabara (1968)
Rhesus
monkey
Indirect
ophthalmoscope
270* 5-60 min Degeneration of outer segment and 
retinal pigment epithelium
Grignolo and 
others (1969)
Rat Fluorescent 0.2-3.0* 8-100 hrs Receptor cells and retinal pigment 
epithelium gone
Rad not and 
others (1969)
Human Incandescent 7,5* 43 min Outer segment disintegration 
Miiller and horizontal cell damage
Marshall and 
others (1972)
Pigeon Fluorescent 0.09* 6—24 hrs Cone outer segment damage
Tso and 
others (1972)
Rhesus
monkey
Indirect 50-1 (X) 
ophthalmoscope approx.
1 hr Outer segment loss 
Retinal pigment epithelium 
depigmentation
Tso (1973) Rhesus
monkey
Indirect 50-100 
ophthalmoscope approx.
1 hr Outer segment loss 
Retinal pigment epithelium 
depigmentation
Lawwill
(1973)
Rabbit Argon laser 17-47* 4 hrs Receptor cells and retinal pigment 
epithelium gone
Xenon arc 150-1600* 4 hrs Patchy severe outer retina damage
Sperling and 
others (1980)
Rhesus
monkey
436 nm 0.1 80 min/day 
for 7-21 days
Cone cell death 
Loss of blue sensitivity
520 nm 0.1 80 min/day 
for 7-21 days
Loss of green sensitivity 
18 days
Sykes and 
others (1981)
Rhesus
monkey
Pigtail
macaque
Fluorescent 0.36-0.61 12 hrs Rod outer segment damage
* Estimates of retinal irradiance from Lanum (1978)
The average retinal irradiance produced by such pro­
cedures as indirect ophthalmoscopy and slit-lamp bio­
microscopy has been estimated (Hochheimer, D’Anna, 
and Calkins, 1979; Calkins and Hochheimer, 1980) 
(Fig. 2). In general, light damage produced by retinal 
irradiances in the range of 10"® to 10“' mW cm"’, with 
exposure durations of seconds to hours, usually results 
in damage to the outer retina. With higher irradiances 
other retinal layers may be involved (McKechnie and 
Foulds, 1981) (Fig. 3).
If damage is restricted to the photoreceptor outer
segment it seems likely that the outer segment will 
regenerate (Wyse, 1980), presumably as a result of the 
outer segment renewal process (Young, 1978).
If the damage to the outer retina is severe, for 
example with destruction of both the receptor cell outer 
segments and the RPE, there is usually a macrophagic 
response within 24 to 48 hours. These ceils rapidly 
remove any remaining cellular debris. Recovery of 
severely damaged retina is only partial, gliosis of the 
outer retina being a common result (Fig. 4) (McKechnie 
and Foulds, 1980).
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FIG. 1 Some possible sites of light 
damage
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FIG. 2 A N S I (1976) guideline fo r  
safe use o f  lasers compared to 
selected light damage studies. 
Estimates o f  retinal irradiance 
(Calkins and Hochheimer. 1980) fo r  
slit-lamp biomicroscopy and indirect 
ophthalmoscopy also shown.
Exposure time (s)
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FIG. 3 Low-power electron 
micrographs showing appearance o f 
rabbit retina. Estim ât^ retinal 
irradiances: (a) 39mW cm~ ;^ (b)
84m W cm"'. In both the outer retina 
has sitffered considerable damage. 
PE: pigment epithelium; OS: outer 
segments: IS: inner segments; RCN: 
receptor cell nuclei, x 700
FIG. 4 (a) Electron micrograph
showing appearance o f rabbit retina 
4 days after a 1 -hour exposure to 
light with an estimated retinal 
irradiance o f84m W cm"'. Numerous 
macrophages present within retinal 
tissue.
(b) Similar to (a), but after 2 weeks' 
recovery. Little remains o f outer 
retina, both the receptor cells and the 
retinal pigment epithelium having 
been destroyed. BM: Bruch's 
membrane; M: macrophage; INL: 
inner nuclear layer. x560.
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(3) Effect o f pre-existing pathology 
Some authors have questioned the effect of light 
exposure when coupled with a pre-existing pathology 
(Pomerantzoff, Govignon, and Schepens,, 1969). To 
investigate this problem we have conducted a series of 
experiments in which rabbit eyes were exposed to a 
combined insult of pressure-induced ischaemia and light 
exposure. The rabbit eyes were exposed to a retinal 
irradiance of approximately 20 mW cm"' for 1 hour, 
which produced only minor disturbances of outer 
segments of the receptor cells. The 1 hour’s light 
exposures were coupled with various periods of 
ischaemia (15, 30, 45, or 60 min). The morphology of 
light-exposed ischaemic eyes was compared to. that of 
eyes which had been subjected to acute ischaemia in 
total darkness (Johnson and Foulds, 1978). It was found 
that the light-exposed ischaemic eyes suffered consider­
ably more damage, a unique feature of the combined 
insult being focal detachments of the RPE (Fig. 5) 
(McKechnie, Johnson, and Foulds, 1982). From these 
results it would seem that a pre-existing pathology may 
increase the susceptibility of the retina to light damage.
(4) Possible light damage in humans 
Given that both indirect ophthalmoscopy and slit-lamp 
biomicroscopy can produce retinal irradiances suffi­
cient to cause retinal damage in rhesus monkeys (Fig. 
2), why is light damage not observed in human subjects? 
TTiere are probably two parts to the answer:
(a) The exposure times may not be sufficiently long. 
Examination of different regions of the fundus and eye 
movements during examination will tend to diminish the 
total exposure of any one area.
% j*
FIG. 5 Light macrograph showing 
effect on retinal structure o f 
combining light exposure and 
ischaemia. Eyes were exposed to light 
for I hour (estimated retinal 
irradiance 23 m IV cm~ )^ and made 
ischaemic for periods o f IS, 30, 45, 
or 60 min. In all instances the 
resulting retinal damage was more 
severe than that produced by 
ischaemia or light separately.
(a) Light plus IS min ischaemia.
(b) Light plus 30 min ischaemia.
(c) Light plus 4S min ischaemia.
(d) Light plus 60 min ischaemia.
A unique feature o f the insult is the 
production o f a proteinaceous 
detachment (PD) o f the retinal 
pigment epithelium. x280
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(6) Any harmful effect of the exposure may be 
ascribed to the further development of a pre-existing 
pathology.
A loss of blue sensitivity after argon laser and xenon 
arc panretinal ablation has been described by Birch and 
Hamilton (1981). They suggest that the loss of blue 
sensitivity may be related to the suggestion that rods 
share a neural pathway with blue-sensitive cones 
(Trezona, 1970). Birch and Hamilton (1981) also 
suggest that the loss in hue sensitivity may result from 
light scatter occurring during photocoagulation. The 
experimental work of Harwerth and Sperling (1971) and 
Sperling, Johnson, and Harwerth (1980) suggests that 
particular classes of cones can be selectively damaged 
by light of the appropriate wavelength. In this respect 
blue cones appear to be the most sensitive, showing little 
or no recovery (Sperling and others, 1980).
As part of a larger study assessing visual function in 
diabetics before and after panretinal coagulation, 
normal subjects were exposed to the viewing light of a 
Carl Zeiss 95021 slit-lamp. The subjects were asked to 
move their eyes during the exposure and not to fix the 
light. On subsequent testing of visual acuity (Table II) 
and contrast sensitivity, there was no significant finding. 
Assuming the retinal irradiance of the slit-lamp to be 
217 mW cm"^  (Calkins and Hochheimer, 1980), an 
exposure of 15 min results in a total energy input of 
195.3 J cm“^ . This represents an exposure 67 times
greater than the maximum permissible exposure of 
2.92 J cm"^  recommended by the American National 
Standards Institute (ANSI Z-136. 1-1976). However, 
the effect of eye movements during the exposure period 
is unknown, but movement must reduce the time during 
which any one area of retina is exposed.
Table II Visual acuity o f six normal subjects 15 min and 
24 hrs after exposure to slit-lamp biomicroscopy for 15 min
Subject
no.
Visual
acuity
before
exposure
Assessment qfter 
biomicroscopy
15 min 24 hrs
1 6/6 6/36 6/6
2 6/6 6/9 6/6
3 6/5 6/9 6/5
4 6/6 6/12 6/6
5 6/6 6/6 6/6
6 6/6 6/9 6/6
Conclusion
Although light damage would appear to be an unlikely 
consequence of therapeutic or diagnostic procedures, 
the effects of pre-existing pathology, extended viewing 
times, and photosensitizing agents should be borne in 
mind.
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I N T R O D U C T I O N
Diabetes is one of the four commonest causes of blindness in 
the United Kingdom and the commonest cause of blindness in the 
working population (1). A recent investigation of blind 
registration statistics in the West of Scotland (2) established 
that diabetes was responsible for 10% of the 1000 persons 
registered as blind or partially sighted during the year ended 
December 1980, and was the commonest cause of blindness in the 
age groups 45-54 and 55-64.
The main blinding complication of diabetes is diabetic reti­
nopathy. It is known that, diabetic retinopathy is a complica­
tion of long-standing diabetes (3) but estimates of its preva­
lence among the diabetic population are inexact.
Diabetic retinopathy is thought to evolve through the 
following stages:
NO RETINOPATHY 
BACKGROUND OR "SIMPLE” RETINOPATHY 
EXUDATIVE MACULOP/^HY  -------- ^  PROLIFERATIVE RETINOPATHY
Many patients with diabetes will develop retinopathy within 
5 years of onset of the disease (4). Initially this is of the 
background or simple variety characterised by retinal haemorrha­
ges, microaneurysms and hard exudates with the retention of good 
vision. A proportion of patients will develop more serious 
sight-threatening retinopathy of either an exudative or proli­
ferative variety. Exudative macuiopathy secondary to increased 
capillary permeability is characteristic of late onset diabetes. 
The resulting visual loss affects central vision only and is
incomplete. P r o I i 1 e r a t i e retinopathy in which new iO rme d
2 .
blood vessels develop in the fundus of the eye is characteristic 
of early onset insulin dependent diabetes. This form of retino­
pathy may lead to recurrent vitreous haemorrhage, intraocular 
fibrosis, retinal detachment and complete blindness. Mixed 
forms occur and occasionally patients with exudative macuiopathy 
subsequently develop proliferative retinopathy.
Until recently no useful therapy for diabetic retinopathy was 
available. With the advent of xenon arc and laser photocoagula­
tion, it has been established beyond doubt that suitable treat­
ment may halt or reverse the development of diabetic retinopathy 
(5, 6).
During the years 1979 to 1982 (inclusive) a study of the preva­
lence of diabetic retinopathy and the cost-effectiveness of its 
detection and treatment was given financial support by the SHHD 
(Grant K/MRS/C186).
This study was conducted jointly by members of the staff of 
the Tennent Institute of Ophthalmology at the Western Infirmary, 
Glasgow and the staff of the Diabetic Clinic at the Glasgow Royal 
Infirmary. A pilot study of patients attending one general prac­
tice at Woodside Health Centre was also undertaken.
The aims of the study were to assess the prevalence of diabe­
tic retinopathy as diagnosed by ophthalmoscopy, to assess the inci­
dence of fresh retinopathy arising annually, to compare the 
effectiveness of ophthalmoscopic screening by Diabetic Physicians 
with that conducted by Ophthalmologists, to categorise ttie 
relative prevalences of the different stages and types of retino­
pathy found and to assess the financial and staffing implications
3 .
of mounting a screening programme for diabetic retinopathy in the 
West of Scotland.
MATERIAL AND METHODS
Arrangements were made for all patients attending the diabetic 
out-patient clinic of the Glasgow Royal Infirmary to have an 
annual ocular examination. This examination was carried out in a 
darkened room with the patients pupils dilated. Patients were 
seen either by a Physician who had received training in the classi­
fication of diabetic eye disease in the Retina Clinics of the 
Tennent Institute of Ophthalmology, or by an experienced 
Ophthalmologist. On the basis of this examination, the patient 
was classified as either having no retinopathy, background retino­
pathy or serious retinopathy.
Serious retinopathy was sub-divided into three categories.
1. Exudative macuiopathy: Exudates or oedema affecting the
macular retina and usually accompanied by symptoms of visual 
impairment.
2. Proliferative retinopathy: The presence of new formed blood 
vessels on the optic disc or elsewhere in the fundus.
3. Ischaemic retinopathy: A pre-proliferative stage of which 
the ophthalmoscopic signs are of background retinopathy with 
additional soft exudates in the absence of overt hypertension.
The total number of ophthalmoscopic examinations by 
either an Ophthalmologist or a Physician was 2 115. This total 
included a preliminary examination of 1212 patients and 903 re­
examinations. 132 patients were seen yearly on 3 occasions, 421
4 .
patients were seen on two occasions in successive years and 38 
patients were examined in year 1 and year 3 of the study.
All patients categorised as having some form of serious reti­
nopathy were referred for full ophthalmological investigation in 
the Tennent Institute of Ophthalmology. This further investiga­
tion included a battery of tests of visual function [quantitative 
visual field analysis, quantitative and qualitative assessment of 
colour vision (a sensitive test of visual function), determination 
of spatial contrast sensitivity (a measure of retinal integrative 
function) and fluorescein angiography].
Detailed results of this part of the study have been or are 
being published elsewhere (7).
On the basis of this further investigation a final categorisa­
tion of stage or type of retinopathy was made and the accuracy of 
the original classification determined. A decision was also made 
as to whether treatment was indicated. If laser therapy were 
considered appropriate this was carried out.
In addition to patients undergoing regular yearly 
ophthalmoscopic examination, a group of 93 patients chosen at ran­
dom underwent full ophthalmological investigation even if on 
ophthalmoscopy there was no evidence of retinopathy.
In a parallel pilot study, 76 patients witli diabetes were 
identified from perusal of all 7189 case records of one general 
practice at Woodside Health Centre. These patients were called 
for ophthalmoscopic examination and categorised according to the 
state of the fundi. Those with ophthalmoscopically diagnosed
5.
serious retinopathy were referred for full ophthalmological 
investigation to the Tennent Institute of Ophthalmology.
RESULTS
1. IDENTIFICATION OF DIABETIC RETINOPATHY
Prevalence of diabetic retinopathy.
From the first 1000 patients serially examined by either a 
Physician or an Ophthalmologist (8) the prevalence of retinopathy 
was found to be 26.7%, and of serious retinopathy 9.5%. This 
group of patients was representative of diabetics in general in 
terms of age, insulin requirements, blood pressure etc.
From the 93 patients selected at random, 181 eyes were 
available for study, and from examination of these eyes the pre­
valence of retinopathy was found to be 28% and of serious retino­
pathy 11%.
Of the 76 patients identified as having diabetes from among 
7139 patients making up one general practice (1.06% of the total 
practice population) 54 responded to a request for ophthalmosco­
pic examination. Of these 35% had retinopathy and 11% serious 
retinopathy. Some bias may have been introduced in this group 
of patients as those presenting for ocular examination might have 
been expected to be those with some ocular complaint.
Nevertheless the prevalence figures for patients attending 
Woodside Health Centre are comparable with those for patients 
attending the Diabetic Clinic of the Glasgow Royal Infirmary, and 
the prevalence of retinopathy in the diabetic population appears 
to lie between 26 and 35%, and of serious retinopathy between 9.5 
and 11%.
6 .
I n c i d e n c e  o f  d i a b e t i c  r e t i n o p a t h y .
Figures for the yearly incidence of fresh retinopathy were 
obtained from patients examined on 2 or 3 occasions. It was found 
that the annual overall incidence of fresh retinopathy was 5% per 
annum and of serious retinopathy 1.2% per annum.
Accuracy of diagnosis by Physician or Ophthalmologist.
182 patients were examined by both a Physician and an 
Ophthalmologist separately without the diagnosis made by one being 
available to the other. A further 349 patients were seen only by 
a Physician and 635 only by an Ophthalmologist. The prevalences 
of retinopathy diagnosed by the Physicians in these two categories 
were 22% and 26% respectively. Similarly the prevalences of reti­
nopathy diagnosed by Ophthalmologists were 25% and 20%. The pre­
valences of serious retinopathy diagnosed by Physicians in the two 
categories were 4% and 10% respectively and Ophthalmologists 10% 
and 6%. Overall Physicians and Ophthalmologists detected similar 
numbers of patients with serious retinopathy (see Table 1) 
although some variation in individual assessments was apparent.
In general there was more variance in the diagnosis of serious 
retinopathy by Physicians as compared with Ophthalmologists but 
the differences are unlikely to be significant.
On the basis of further ophthalmalogical investigation the 
number of patients thought initially to have serious retinopathy 
and who subsequently proved to have non serious retinopathy was 
determined and from this the accuracy of the initial ophthalmosco­
pic diagnosis was compared between Physician and Ophthalmologist. 
24% of referred cases fell into this false positive category in 
both the Ophthalmologists and Physicians referral figures. The
7 .
T a b l e  1 .  R e l a t i v e  p r e v a l e n c e s  o f  D i a b e t i c  R e t i n o p a t h y
Ophthalmoscopic Assessment
No Background Serious
Retinopathy Retinopathy Retinopath
Prevalence of Diabetic
retinopathy in random 72% 17% 11%
sample
Prevalence diagnosed
by Physicians 75% 17% 8%
Prevalence diagnosed
by Ophthalmologists 79% 14% 7%
Both the Physicians and Ophthalmologists may have under­
diagnosed serious retinopathy.
Tests of Visual Function
It is not thought appropriate that a detailed presentation of 
the result of the various tests of visual function should be pre­
sented here. In general many of the tests of function showed evi­
dence of abnormality before ophthalrnoscopical ly visible changes 
were evident. While interesting in relation to the development 
of diabetic retinopathy the tests were found not to be useful in 
separating patients requiring laser treatment from those not 
requiring treatment.
Fluorescein Angiography
In the case of fluorescein angiography some 20% of eyes which 
appeared normal on ophthalmoscopy revealed evidence of early 
retinopathy on fluorescein angiography. Unsuspected serious 
retinopathy was rarely encountered. The main value of 
fluorescein angiography was in relation to which form of iaser 
therapy (if any) was appropriate for an already identified case 
of serious retinopathy.
C o n c l u s i o n
Annual ophthalmoscopy carried out either by a suitably 
trained Physician or an Ophthalmologist in a darkened room with 
the patients pupils dilated is a highly effective way of 
detecting retinopathy and in particular in detecting sight 
threatening retinopathy among diabetic patients. Referral of all 
patients with ophthalmoscopically classified serious retinopathy 
for further ophthalmological investigation including fluorescein 
angiography will identify virtually all of those at risk of 
blindness from diabetic retinopathy, and allow treatment with 
photocoagulation to be undertaken at an appropriate stage in the 
evolution of the disease. About a quarter of those so referred 
will have retinopathy which is not sight-threatening.
Such a screening programme could certainly be justified 
purely on the basis of the reduction in blindness which would 
result from earlier identification and treatment of those with 
sight-threatening retinopathy. The question of whether such an 
exercise would be cost-effective is however important.
2. CQ5T-EFFECTIVENESS OF SCREENING FOR DIABETIC RETINOPATHY.
The results presented in this section are based on a pro­
jected annual ophthalmoscopic examination of all diabetic patients 
in the West of Scotland. It may be argued that some patients are 
more at risk than others and that a less frequent examination of 
low risk patients might be appropriate. Unfortunately, many 
patients with serious retinopatliy are symptom-free and not infi'e- 
quently serious retinopathy is found at or shortly after the
glasc
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diagnosis of diabetes has been made. From the figures of annual 
incidence derived from the present study, an annual examination of 
all diabetic patients would appear to be justified.
Cost analysis of proposed screening programme.
In order to cost the identification and treatment of 
patients with sight-threatening retinopathy each stage in the 
process was timed and the staff requirements identified.
The time required for consultation including full 
ophthalmoscopic examination of both eyes of each patient was 
found to be 8 minutes approximately. The staff involved was a 
Diabetic Physician or Ophthalmologist aided by a nurse.
The time required for ophthalmological examination including 
fluorescein angiography was approximately 30 minutes. The staff 
involved was an Ophthalmologist and Technician.
The time required for laser therapy was on average 40 minu­
tes per eye treated (20 minutes for exudative macuiopathy, 60
minutes for proliferative retinopathy). The staff involved was
an Ophthalmologist.
Projected Workload
The population of the West of Scotland is approximately 2.5 
million (10). The prevalence of diagnosed diabetes is 1% so that 
in the West of Scotland there should be 25,000 diagnosed diabetics. 
As 25 patients can reasonably be examined ophthalmoscopically in 
one clinic session, provided patient preparation, including dilata­
tion of the pupils is carried out by a nurse, examination of 25,000
patients would require 1,000 working sessions annually. On the
assumption that 10 sessions per week are available, and that 45
1 0 .
working weeks are available in the calendar year, this workload 
would occupy the equivalent of 2.2 fulltime Physicians' or 
Ophthalmologists' sessions plus an additional 2.2 fulltime nurses' 
and in total would cost £51,800 per annum.
The incidence of fresh serious retinopathy is 1.2% per 
annum and 300 patients per annum would be expected to come into 
this category in the West of Scotland and require full ophthalmo- 
logical investigation. This workload would require 0.1 of an 
Ophthalmologists' time per annum and 0.1 of a Technicians' time.
The annual cost of this ophthalmological investigation including 
photographic film etc., at £1 per patient would be £3,500.
The total annual cost to identify patients with serious reti­
nopathy would therefore be £55,300 or £183 per patient with serious 
retinopathy identified. To these costs must be added the costs of 
treatment of 150 patients per annum * which on the same basis of 
calculation as before would amount to £2,730 per annum or £18 per 
patient treated. The total cost per annum of identifying and 
treating patients at risk of blindness is therefore £387 per 
patient treated.
In the first year because of the backlog of some 2,500 
patients with serious retinopathy of whom 1,250 might need laser 
therapy, the cost of identification and treatment would be 
increased by the time required for full investigation and treatment 
of those Identified as having serious retinopathy, while the ini­
tial screening costs would remain unaltered. The total cost in the 
first year to identify and investigate the backlog of 2,500 
patients with serious retinopathy in the West of Scotland and to
1 1 .
treat approximately 1,250 of these by laser would amount to 
£108,000 or £86 per patient treated.
* It has been our experience that 50% of patients referred with 
suspected serious retinopathy require laser treatment. As 
already noted 25% of referred cases prove not to have sight- 
threatening retinopathy, but 75% of the remainder require laser 
treatment.
Economic benefit of screening for diabetic retinopathy.
The staffing costs of the Blind Welfare Service in the 
Strathclyde Region for 1981-82 are estimated at £420,794. There 
are 5,048 registered blind, and most of the cost of the service is
related to these persons. A smaller proportion of the costs
relates to 1,707 patients registered as partially sighted. The 
staffing costs are therefore approximately £75 per blind patient.
The average patient going blind from diabetic retinopathy is
in the forties and likely to have a family commitment. Most
will be unable to continue in employment and require support from 
the state. The average cost per patient is difficult to deter­
mine, but from discussions with the Blind Welfare Services and 
the Department of Employment, a reasonable estimate would be 
£3,500 per patient per annum.
The average savings per person prevented from going blind 
would therefore be -
1. Proportion of costs of Blind Welfare Services £ 75
2. State benefits £3,5 00
TOTAL £3,57 5
It has been estimated that appropriate laser therapy will 
prevent 60% of blindness from diabetic retinopathy (9). In rela-
1 2 .
tion to the estimated 150 patients per annum requiring laser 
therapy (after the backlog has been dealt with), adequate laser 
treatment should prevent 90 of these 150 patients from going 
blind with an annual saving per patient treated of £2,145. The 
annual saving per patient identified as having serious retino­
pathy would be £1,073, and per patient screened would be £12.87p. 
The total savings to the State per annum in treating and pre­
venting 60% of patients threatened with blindness from going
blind would be £193,050. In the case of the backlog of 2,500
patients with serious retinopathy of whom 1,250 will require 
treatment and of whom 750 may be prevented from going blind, the 
total once only saving would be £1,612,500.
Thus the annual cost per annum for screening and treating 
diabetic patients in the West of Scotland would be £58,030, and 
the total annual, saving in preventing 90 patients from going 
blind from diabetic retinopathy would be £193,050 with a net 
saving of £135,025 per annum. (In addition there would be a 
net once only saving of £1,504,500 in identifying and treating 
the backlog of patients at present requiring laser therapy).
The cost benefit ratio of using Consultant Physicians or 
Consultant Ophthalmologists to conduct the initial screening 
would be 1 : 3.3.
In addition to direct savings identified above, additional 
account should be taken of the likely earnings of such patients. 
The average income in the United Kingdom is at present £6,292 per 
annum. The 90 patients prevented from going blind in the West of
Scotland per year by adequate identification and laser treatment 
would be expected to earn per annum a total sum of £5,666,280.
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From further enquiries it appears that a small proportion 
of blind patients are not in receipt of state benefit. The 
savings from prevention of blindness from diabetes could there­
fore be reduced proportionately but would still be significant.
Apart entirely from economic considerations there are obvious 
social and physcological losses in blindness which cannot be assess 
in economic terms.
There are implications in terms of staffing and facilities 
of any projected screening programme for diabetic retinopathy.
In order to institute an annual screening programme such as 
outlined above would require in the first year and subsequent 
years the appointment of an additional 2.2 whole time equivalent 
Consultant Physicians or Ophthalmologists in the West of 
Scotland. In addition the temporary appointment in the first 
year of the équivalant of one full time Ophthalmologist and one 
full time Technician for the ophthalmological investigation and 
treatment of the backlog of diabetic patients with serious reti­
nopathy identified by the initial screening would be required.
In subsequent years it is believed that the annual incidence of 
fresh retinopathy is such that the numbers requiring ophthalmolo- 
gical investigation and laser therapy could be accommodated 
within existing staffing levels, although return visits of 
patients with serious retinopathy identified and treated would 
add to the return out-patient load and might as a result justify 
additional ophthalmic staffing. As far as equipment is con­
cerned, in the West of Scotland at present there are at least six 
lasers suitable for the treatment of diabetic patients. The 
treatment of the backlog of patients with serious diabetic
14 .
retinopathy identified in the proposed screening programme would 
fully utilise the equivalent of one laser for a year.
Subsequently the relatively small number of patients requiring 
treatment annually could easily be accommodated without any 
increase in facilities. Laser installations are of course used 
in the treatment of a wide variety of ophthalmic conditions and 
geographic considerations have to be taken into account in their 
provision.
It would thus appear both on grounds of cost-effectiveness 
and on social need, a screening programme for the early detection 
of serious diabetic retinopathy is desirable.
For patients attending a hospital diabetic clinic this 
screening could reasonably carried out by the Physician who has 
overall responsibility for the patients health providing he were 
suitably trained in the recognition of sight-threatening retino­
pathy. For patients being cared for in general practice, the 
problem is more difficult, and for these patients the Optician or 
Ophthalmic Medical Practitioner working in the General Ophthalmic 
Services may well have a role. If patients were being seen by 
an Optician or Ophthalmic Medical Practitioner purely for ophth- 
moscopic screening rather than for full refraction and ocular 
assesssment, it may be that a reduced fee for this service would 
be appropriate.
There is no doubt that many patients with diabetic eye 
disease are referred tragically too late for laser treatment to 
be effective in the prevention of blindness, and some mechanism 
for the earlier detection of such patients is undoubtedly 
required.
15 .
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1.
SUMMARY:
42 p a t i e n t s  w i t h  l o n g s t a n d i n g  r e t i n a l  v e i n  t h r o m b o s i s  and 
36  p a t i e n t s  w i t h  d i a b e t e s  had t h e i r  b l o o d  v i s c o s i t y  l e v e l s  
m e a s u r e d .  In b o t h  c o n d i t i o n s  b l o o d  v i s c o s i t y ,  p lasma v i s c o s i t y ,  
and serum f i b r i n o g e n  l e v e l s  were  s i g n i f i c a n t l y  h i g h e r  i n  t h o s e  
p a t i e n t s  w i t h  c a p i l l a r y  n o n - p e r f u s i o n  a n d / o r  new v e s s e l s  on 
F l u o r e s c e i n  A n g i o g r a p h y ,  compared t o  t h o s e  p a t i e n t s  w i t h o u t  t h e s e  
c o m p l i c a t i o n s .  The p o s s i b l e  r o l e  o f  abnormal  b l o o d  v i s c o s i t y  i n  
p r o d u c i n g  c a p i l l a r y  n o n - p e r f u s i o n  and i t s  s e q u e l a e  i n  b o t h  c o n ­
d i t i o n s  i s  d i s c u s s e d .
2.
INTRODUCTION:
B l o o d  v i s c o s i t y  i s  a major  d e t e r m i n a n t  o f  b l o o d  f l o w  ( 1 ) .  
R a i s e d  b l o o d  v i s c o s i t y  i s  known t o  d e c r e a s e  r e t i n a l  b l o o d  f l o w  ( 2 ) ,  
R a i s e d  b l o o d  v i s c o s i t y  h as  b een  shown t o  e x i s t  i n  p a t i e n t s  w i t h  
r e t i n a l  v e i n  t h r o m b o s i s  ( ^ ) and d i a b e t i c  r e t i n o p a t h y  ( 4 ) .
C a p i l l a r y  n o n - p e r f u s i o n  on f l u o r e s c e i n  a n g i o g r a p h y  i s  
b e l i e v e d  t o  h e r a l d  t h e  o n s e t  o f  new v e s s e l s  i n  b o t h  c o n d i t i o n s  
( 5 ,  6)^ The a e t i o l o g y  o f  c a p i l l a r y  n o n - p e r f u s i o n  r e m ai n s  u n c e r ­
t a i n ,  but  i t  i s  p r e s e n t l y  b e l i e v e d  t h a t  p o or  r e t i n a l  c i r c u l a t i o n  
i s  r e s p o n s i b l e  f o r  t h i s  a n g i o g r a p h i c  f e a t u r e  and f o r  i t s  
s e q u e l a e ,  n e o v a s c u l a r i s a t i o n  ( ^ ^ ) .
The p u r p o s e  o f  t h i s  s t u d y  was t o  m easu re  b l o o d  v i s c o s i t y  
and i t s  d e t e r m i n a n t s  i n  p a t i e n t s  w i t h  r e t i n a l  v e i n  t h r o m b o s i s  and 
d i a b e t i c  r e t i n o p a t h y .  We wish?Jto d e t e r m i n e  w h e t h e r  p a t i e n t s  
w i t h  c a p i l l a r y  n o n - p e r f u s i o n  o r  new v e s s e l s  from t h e s e  d i s e a s e s  
have  h i g h e r  b l o o d  v i s c o s i t y  l e v e l s  t han  t h o s e  p a t i e n t s  w i t h o u t  
t h e s e  c o m p l i c a t i o n s .  In v i ew of  t h e  r e l a t i o n s h i p  b e t w e e n  b l o o d  
v i s c o s i t y  and r e t i n a l  b l o o d  f l o w ,  i t  was f e l t  t h a t  such a s t u d y  
would  p r o v i d e  i n s i g h t  i n t o  t h e  mechanism of  p r o d u c t i o n  of  
c a p i l l a r y  n o n - p e r f u s i o n  and i t s  c o m p l i c a t i o n s  -  i r i s  and 
p o s t e r i o r  s e g m e n t  new v e s s e l s .
3.
METHODS AND MATERIAL:
2 g r o u p s  o f  p a t i e n t s  were  s t u d i e d .  Group I had 
l o n g s t a n d i n g  r e t i n a l  v e i n  t h r o m b o s i s  w h i l e  Group 2 had D i a b e t e s .  
B ot h  g r o u p s  c o n t a i n e d  p a t i e n t s  w i t h  c a p i l l a r y  n o n - p e r f u s i o n  and 
o r  new v e s s e l s  on f l u o r e s c e i n  a n g i o g r a p h y .
Group 1 : 42 p a t i e n t s  w i t h  l o n g s t a n d i n g  r e t i n a l  v e i n  t h r o m b o s i s
we re  s t u d i e d  ( 9 ) .  Th es e  p a t i e n t s  were  examined  from t h r e e  months  
t o  t h r e e  y e a r s  s i n c e  t h e i r  o n s e t  o f  symptoms t o  r u l e  o u t  an a c u t e  
-  p h a s e  i n c r e a s e  o f  t h e i r  b l o o d  v i s c o s i t y .  A l l  u nd e rw en t  f u l l  
o p h t h a l m o l o g i c a l  and m e d i c a l  a s s e s s m e n t  i n c l u d i n g  f l u o r e s c e i n  
a n g i o g r a p h y .  A l l  p a t i e n t s  were  a mb u l a n t ,  and none  had any a c u t e  
i l l n e s s e s .  The mean age  was 67 y e a r s .  20 o f  t h e  p a t i e n t s  had 
c a p i l l a r y  n o n - p e r f u s i o n  or  new v e s s e l s .  24 p a t i e n t s  had c e n t r a l  
r e t i n a l  v e i n  o c c l u s i o n ,  16 had branch v e i n  o c c l u s i o n ,  and two had 
b o t h .
Group 2 : 36 p a t i e n t s  w i t h  d i a b e t e s  were  s t u d i e d .  18 p a t i e n t s
had p r o l i f e r a t i v e  r e t i n o p a t h y  c o n f i r m e d  on f l u o r e r s c e i n  
a n g i o g r a p h y  and t h e  o t h e r  18 had background o r  n i l  r e t i n o p a t h y .  
Both t h e  p r o l i f e r a t i v e  and n o n - p r o l i f e r a t i v e  g r o u p s  were  matched  
f o r  a g e ,  s e x ,  s mo k i ng ,  d u r a t i o n ,  and t y p e  o f  d i a b e t i c  t r e a t m e n t .  
The mean age was 5 3 . 3  y e a r s  and mean d u r a t i o n  of  d i a b e t e s  17 
y e a r s .
Both g r o u p s  had v i s c o s i t y  measured i n  t h e  same manner.
A m i d - m o r n i n g ,  n o n - f a s t i n g  forearm v e n o u s  sampl e  was t a k e n .
B l o o d  was a n t i c o a g u l a t e d  w i t h  e d e t i c  a c i d  (EDTA, 1 . 5  mg/ml )  f o r  
b l o o d  v i s c o s i t y  s t u d i e s  a t  low ( 0 . 9 4 s “ l )  and h igh  ( 9 4 s " ^ )  s h e a r
r a t e s  u s i n g  a CONTRAVES LS30 r o t a t i o n a l  v i s c o m e t e r  a t  37oC.
4.
H a e m a t o c r i t  was measured u s i n g  a Hawksley mi croh aemat û c r i t ,  
c e n t r i f u g e a i s , OOOg x 5 m in s . )  Plasma v i s c o s i t y  was measured  
u s i n g  a C o u l t e r - H a r k n e s s  c a p i l l a r y  v i s c o m e t e r ,  f 25^C ) , Plasma  
f i b r i n o g e n  was measured u s i n g  a Dode f i b r o m e t e r  and s t a n d a r d s .
B l o o d  v i s c o s i t y  i s  p r e s e n t e d  a s  measured a t  n a t i v e  h a e m a t o c r i t ,
and a l s o  a f t e r  c o r r e c t i o n  t o  a s t a n d a r d  h a e m a t o c r i t  o f  0 . 4 5  u s i n g  
r e g r e s s i o n  e q u a t i o n s .  C o r r e c t e d  v i s c o s i t y  a l l o w s  s t u d i e s  o f  
f a c t o r s  o t h e r  t h an  h a e m a t o c r i t  which a f f e c t  b l o o d  v i s c o s i t y .
S t a t i s t i c a l  a n a l y s e s  o f  t h e  r e t i n a l  v e i n  t h r o m b o s i s  group  
was perf ormed u s i n g  t h e  2 T a i l e d  S t u d e n t s  t - t e s t ,  and 
Mann-Whitney U t e s t  as  a p p r o p r i a t e .  S t a t i s t i c a l  a n a l y s i s  on t h e  
d i a b e t i c  group i n c l u d e d  t h e  u s e  o f  t h e  2 T a i l e d  S t u d e n t s  t - t e s t
and W i l c o x o n ' s  rank sum t e s t .
5.
RESULTS:
T a bl e  I shows t h e  r e s u l t s  of  b l o o d  v i s c o s i t y  m e a s ur em e nt s  
( b o t h  u n c o r r e c t e d  and c o r r e c t e d )  i n  p a t i e n t s  w i t h  r e t i n a l  v e i n  
t h r o m b o s i s .  The grou p of  p a t i e n t s  w i t h  c a p i l l a r y  n o n - p e r f u s i o n  
or  new v e s s e l  f o r m a t i o n  have s t a t i s t i c a l l y  s i g n i f i c a n t  i n c r e a s e s  
i n  mean v a l u e s  of  t h e i r  b l o o d  v i s c o s i t y ,  plasma v i s c o s i t y ,  and 
pl asma f i b r i n o g e n .  H a e m a t o c r i t  was a l s o  h i g h e r  but  t h e  d i f ­
f e r e n c e  b e t w e e n  t h e  2 g r o u p s  was not  s t a t i s t i c a l l y  s i g n i f i c a n t .
T a b l e  I I  co mpa res  b l o o d  v i s c o s i t y  and i t s  d e t e r m i n a n t s  i n  
t h e  two t y p e s  of  d i a b e t i c  p a t i e n t s .  B l oo d v i s c o s i t y  a t  b o t h  
u n c o r r e c t e d  and c o r r e c t e d  l e v e l s  a r e  not ed  t o  be h i g h e r  i n  t h e  
p r o l i f e r a t i v e  group of  p a t i e n t s .  T h i s  r a i s e d  b l o o d  v i s c o s i t y  i s  
a s s o c i a t e d  w i t h  an i n c r e a s e  in  plasma v i s c o s i t y  and plasma  
f i b r i n o g e n  l e v e l s .
RESULTS:
TABLE I
Capi l l a r y  
n o n - p e r f  u s i o n /  
new v e s s e l s
U n c o m p l i c a t e d  
r e t i n a l  v e i n  
t h r o m b o s i s
P v a l u e
B l o o d  V i s c o s i t y  (m P a . s )
0 . 9 4 s - l
9 4 s - l
2 3 . 2  ( 1 . 6 )  
6 . 5 4  ( 0 . 3 0 )
1 7 . 2  ( . 6 )  
5 . 3 7  ( 0 . 1 7 )
P 4 0 . 0 1  
P^ 0 . 0 1
C o r r e c t e d  B lo o d  V i s c o s i t y  
(m P a . s )
0 . 9 4 S - 1
9 4 s " l
2 2 . 8  ( 0 . 8 )  
6 . 4 8  ( 0 . 1 7 )
1 9 . 3  ( 0 . 4 )  
6 . 0 5  ( 0 . 1 2 )
P < 0 . 0 1  
P < 0 . 0 1
Plasma V i s c o s i t y  (m P a . s ) 1 . 8 8  ( 0 . 0 3 ) 1 . 7 9  ( 0 . 0 3 ) P< 0 . 0 5
F i b r i n o g e n  ( g / L )
1
3 . 6 7  ( 0 . 2 0 )  1 2 . 7 9  ( 0 . 1 5 )  
1
PC 0 . 0 1
H a e m a t o c r i t
1
0 . 4 5 0 ( 0 . 0 1 0 )  1 0 . 4 2 5 ( 0 . 0 0 8 )  
1
N. S.
RETINAL VEIN THROMBOSIS GROUP.
Blood viscosity and its determinants In patients with capillary 
non-perfusion/new vessels, and in patients without these 
complications. Levels expressed as mean values ( S E M  ' in brackets) 
m Pa.s = Millipascal seconds 
N.S. = Not significant
TABLE II
7.
P r o l l f e r a t i v e  
R e t i n o p a t h y
U n c o m p l i c a t e d
d i a b e t e s
P v a l u e
B l o o d  V i s c o s i t y  (m P a . s )
0 . 9 4 s - l  
9 4 s - l
2 0 . 8  ( 1 . 2 )  
6 . 1 2  ( 0 . 1 8 )
1 7 . 8  ( 0 . 9 )  
5 . 3 5  ( 0 . 2 1 )
P< 0 . 0 5  
P<r 0 . 0 1
C o r r e c t e d  B loo d V i s c o s i t y  
(m P a . s )
0 . 9 4 S - 1
9 4 s ~ l
2 1 . 7  ( 0 . 8 )  
6 . 2 5  ( 0 . 1 5 )
1 9 . 3  ( 0 . 6 )  
5 . 5 7  ( 0 . 1 5 )
P < 0.021  
P < 0.001
Plasma V i s c o s i t y  (m P a . s ) 1 . 8 9  ( 0 . 0 3 ) 1 . 7 1  ( 0 . 0 2 ) P < 0 . 0 0
F i b r i n o g e n  ( g / L ) 3 . 6 9  ( 0 . 2 5 ) 3 . 1 9  ( 0 . 1 6 ) P< 0 . 0 5
Haema t o c r i t 0 . 4 3 7  ( 0 . 0 0 9 ) 0 . 4 3 3  ( 0 . 0 0 5 ) N.S.
V i s c o s i t y  measurements  in p r o l i f e r a t i v e  and n o n - p r o l i f e r a t i v e  d i a b e  
g r o u p s .
m Pa.s = Millipascal seconds. N.S. = not significant.
8 .
DISCUSSION:
T h i s  s t u d y  c l e a r l y  shows t h a t  p a t i e n t s  w i t h  c a p i l l a r y  n on -  
p e r f u s i o n  o r  new v e s s e l  f o r m a t i o n  from d i a b e t e s  o r  r e t i n a l  v e i n  
t h r o m b o s i s  have s i g n i f i c a n t l y  h i g h e r  b l o o d  v i s c o s i t y  l e v e l s  than  
p a t i e n t s  w i t h o u t  t h e s e  c o m p l i c a t i o n s .  I t  i s  i n t e r e s t i n g  t o  n o t e  
t h a t  t h e  c o m p l i c a t e d  r e t i n a l  v e i n  t h r o m b o s i s  group have h i g h e r  
v i s c o s i t y  l e v e l s  t han  t h e  u n c o m p l i c a t e d  d i a b e t i c  group.  The low 
s h e a r  r a t e  l e v e l s  i n  t h e  r e t i n a l  v e i n  t h r o m b o s i s  group were  
i n c r e a s e d  by 35%, w h i l e  h i g h  s h e a r  r a t e  l e v e l s  were  i n c r e a s e d  by 
22% compared t o  t h e  u n c o m p l i c a t e d  group.  The p r o l i f e r a t i v e  
d i a b e t i c s  had a 17% i n c r e a s e  i n  t h e i r  h i gh  s h e a r  r a t e  v i s c o s i t y  
l e v e l s  and a 14% i n c r e a s e  i n  t h e i r  low s h e a r  r a t e  l e v e l s  compared  
t o  d i a b e t i c s  w i t h o u t  t h e s e  c o m p l i c a t i o n s .  The b l o o d  v i s c o s i t y  
d i f f e r e n c e  c o u l d  i n  p a r t  be due to  t h e  o l d e r  age of  t h e  r e t i n a l  
v e i n  t h r o m b o s i s  p a t i e n t s ,  and i n  p a r t  to  t h e i r  h i g h e r  h a e m a t o c r i t .
Both the complicated retinal vein thrombosis group and pro­
liferative diabetic group had increases in their plasma viscosity 
levels. These were due to increased fibrinogen levels.
Capillary circulation is thought to depend at least in part on 
plasma viscosity (10). It is therefore possible that capillary 
non-perfusion as detected on fluorescein angiography may be due 
to increases in plasma viscosity secondary to hyper- 
fibrinogenaemia. Red cell deformabillty also Influences 
capillary circulation (10). A study of red cell deformabillty 
is indicated in patients with capillary non-perfusion or new 
vessel formation from retinal vein thrombosis or diabetic 
retinopathy.
9.
As i n d i c a t e d  a b o v e ,  b l o o d  v i s c o s i t y  i s  i n c r e a s e d  i n  
p a t i e n t s  w i t h  p r o l i f e r a t i v e  d i a b e t i c  r e t i n o p a t h y  and c o m p l i c a t e d  
r e t i n a l  v e i n  t h r o m b o s i s .  T h i s  s u g g e s t s  t h a t  abnormal  b l o o d  
v i s c o s i t y  may p l a y  an e t i o l o g i c a l  r o l e  i n  t h e  f o r m a t i o n  of  
c a p i l l a r y  n o n - p e r f u s i o n  a n d / o r  new v e s s e l  f o r m a t i o n .  I f  t h e s e  
r h e o l o g i c a l  f a c t o r s  do p r e d i s p o s e  to  c a p i l l a r y  n o n - p e r f u s i o n  and 
new v e s s e l  f o r m a t i o n ,  r e d u c t i o n  o f b l o o d  v i s c o s i t y  c o u l d  have a 
p l a c e  i n  p r e v e n t i n g  t h e  i s c h a e m i c  c o m p l i c a t i o n s  o f  b o t h  c o n ­
d i t i o n s .
1 0 .
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